3762926;Adrenergic Fibers/analysis;Adrenergic Fibers/ultrastructure*;Aging/physiology;Animals;Cerebellar Cortex/cytology*;Cerebellar Cortex/physiopathology;Cerebellar Cortex/ultrastructure;Mice;Mice, Inbred C57BL;Mice, Neurologic Mutants/anatomy & histology*;Microscopy, Electron;Nerve Degeneration;Purkinje Cells/cytology*
3781940;Bacteriuria/microbiology;Drug Contamination;Equipment Contamination;Humans;Pseudomonas/classification;Pseudomonas/isolation & purification*;Pseudomonas/metabolism;Pseudomonas Infections/microbiology;Sepsis/microbiology
3844516;Emergencies*;Extremities/injuries;Extremities/surgery*;Humans
3848047;Ear, Inner/physiology;Ear, Middle/physiology;Hearing/physiology*;Humans;Sound
3890593;Adult;Alcoholism/blood*;Cholesterol/blood;Erythrocyte Membrane/analysis*;Fatty Acids/blood*;Female;Humans;Linoleic Acids/blood;Male;Middle Aged;Oleic Acids/blood;Phosphatidylcholines/blood;Phospholipids/blood*
3894012;Amino Acid Sequence;Amnion/cytology;Animals;Antibodies;Base Sequence;Cell Transformation, Neoplastic;Enzyme-Linked Immunosorbent Assay;Female;Fluorescent Antibody Technique;Humans;Mice;Molecular Weight;Oncogenes*;Osteosarcoma/genetics*;Placenta/cytology;Pregnancy;Protein Biosynthesis;Tissue Distribution;Transcription, Genetic;Viral Proteins/analysis;Viral Proteins/genetics*
3949055;Complement Pathway, Classical;Female;Humans;Middle Aged;Pleural Effusion/etiology*;Recurrence;Vasculitis, Leukocytoclastic, Cutaneous/complications*;Vasculitis, Leukocytoclastic, Cutaneous/immunology
3992331;Anti-Bacterial Agents/pharmacology*;Bacteria/drug effects;Bacteria/isolation & purification;Bacterial Infections/microbiology*;Humans;In Vitro Techniques;Microbial Sensitivity Tests;Tetrazolium Salts;Wound Infection/microbiology*
4031571;Body Weight;Computers*;Female;Fetus/anatomy & histology;Gestational Age;Humans;Microcomputers*;Pregnancy;Prenatal Care*;Regression Analysis
4070970;Catheterization/adverse effects;Catheterization/instrumentation;Collagen;Connective Tissue/ultrastructure*;Equipment Failure;Humans;Microscopy, Electron, Scanning;Peritoneal Dialysis, Continuous Ambulatory/adverse effects*;Peritoneal Dialysis, Continuous Ambulatory/instrumentation;Polytetrafluoroethylene
4104156;Canada;Geriatric Nursing;Occupational Health Services;Outpatient Clinics, Hospital;Patient Care Team;Perioperative Nursing;Personal Health Services;Public Health Nursing;Rehabilitation Centers;Student Health Services
4123437;Aged;Animals;Femoral Neoplasms/drug therapy*;Femoral Neoplasms/etiology;Femoral Neoplasms/radiotherapy;Humans;Male;Neoplasm Metastasis;Osteitis Deformans/complications*;Osteitis Deformans/drug therapy;Osteosarcoma/drug therapy*;Osteosarcoma/etiology;Osteosarcoma/radiotherapy;Salmonidae
4125512;Animals;Antibody Formation;Antigens;Antigens, Viral;Autoantibodies;Autoimmune Diseases/genetics*;Chickens;Epitopes;Gene Frequency;Genes;Heterozygote;Histocompatibility Antigens;Hypothyroidism/immunology;Isoantigens;Mice;Peptides;Thyroglobulin;Thyroiditis/genetics*
4150455;Animals;Cell Division/drug effects;Clone Cells/drug effects;Hematopoietic Stem Cell Transplantation;Hematopoietic Stem Cells/drug effects*;Hematopoietic Stem Cells/metabolism;Imidazoles/pharmacology;Male;Mice;Mice, Inbred BALB C;Mice, Inbred DBA;Prostaglandins/pharmacology*;Radiation Chimera;Stimulation, Chemical;Thymidine/metabolism;Transplantation, Homologous;Tritium
4219538;Acridines;Chemical Phenomena;Chemistry;Coloring Agents*/chemical synthesis;Coloring Agents*/classification;Fluorometry;Phenazines;Spectrophotometry;Xanthenes
4331713;Adrenocorticotropic Hormone/therapeutic use*;Adult;Aged;Delayed-Action Preparations/therapeutic use*;Female;Gout/drug therapy*;Humans;Male;Middle Aged
4383348;Animals;Atropine/pharmacology;Barbiturates/pharmacology;Chlordiazepoxide/pharmacology;Chlorpromazine/pharmacology;Cold Temperature*;Electroshock*;Escape Reaction;Humans;Psychophysiologic Disorders;Quaternary Ammonium Compounds/pharmacology;Rats;Stomach Ulcer*;Stress, Physiological*
4398297;Animals;Graft vs Host Reaction*;Isoenzymes;L-Lactate Dehydrogenase/analysis*;Methods;Mice;Rats
4434575;Carbamates/chemical synthesis;Chemical Phenomena;Chemistry;Cyanogen Bromide*;Cyclic N-Oxides*;Ethanol;Quinolines*
4437645;Administration, Oral;Amprolium/therapeutic use;Animals;Antiprotozoal Agents/administration & dosage;Antiprotozoal Agents/therapeutic use*;Benzamides/therapeutic use;Brain/parasitology;Carboxylic Acids/therapeutic use;Chlorobenzenes/therapeutic use;Ethers/therapeutic use;Feces/parasitology;Guanidines/administration & dosage;Guanidines/therapeutic use*;Injections, Intraperitoneal;Mice;Nitrobenzenes/therapeutic use;Pyridines/therapeutic use;Pyrimidines/therapeutic use;Quinolines/therapeutic use;Sulfadimethoxine/therapeutic use;Sulfanilamides/analogs & derivatives;Sulfanilamides/therapeutic use;Toxoplasmosis, Animal/drug therapy*;Toxoplasmosis, Animal/etiology;Toxoplasmosis, Animal/parasitology
4450658;Arterial Occlusive Diseases/diagnosis;Coronary Disease/diagnosis*;Heart Function Tests*/methods*;Humans;Intermittent Claudication*;Male;Middle Aged;Physical Exertion*;Posture
4524346;Carotenoids/analysis;Chlorophyll/analysis;Chloroplasts/analysis;Chloroplasts/cytology;Chloroplasts/enzymology;Chloroplasts/metabolism*;Cytochromes/analysis;Electrophoresis, Polyacrylamide Gel;Freeze Etching;Glycerides/analysis;Manganese/analysis;Membranes/analysis;Microscopy, Electron;Organoids/analysis;Organoids/enzymology;Organoids/metabolism;Oxidation-Reduction;Phospholipids/analysis;Photochemistry;Plants;Xanthines/analysis
4579382;France;History, 20th Century;Pathology/history;Senegal
4620443;Acute Disease;Adjuvants, Immunologic;Adult;Animals;Antineoplastic Agents/therapeutic use*;BCG Vaccine/therapeutic use;Cytarabine/therapeutic use;Humans;Immunosuppressive Agents/therapeutic use*;Immunotherapy;Leukemia L1210/drug therapy;Leukemia L1210/immunology;Leukemia L1210/therapy;Lymphoma/drug therapy;Lymphoma/immunology;Lymphoma/therapy;Melanoma/drug therapy;Melanoma/immunology;Melanoma/therapy;Mice;Neoplasms/drug therapy;Neoplasms/immunology;Neoplasms/therapy*;Neoplasms, Experimental;Prednisone/therapeutic use;Vincristine/therapeutic use
4746183;Germany, West;Hospitals*;Income Tax*;Training Support*
4763803;Administration, Oral;Adolescent;Adult;Aged;Arrhythmias, Cardiac/drug therapy;Evaluation Studies as Topic;Female;Humans;Injections, Intravenous;Male;Middle Aged;Practolol/administration & dosage;Practolol/therapeutic use*;Tachycardia, Paroxysmal/drug therapy*
4850712;Adenosine Triphosphate/analysis*;Autoanalysis/instrumentation;Firefly Luciferin;Luciferases;Microchemistry/instrumentation;Pressure;Syringes*
4886205;Dentistry;Denture Retention;Denture, Partial;Denture, Partial, Removable
4910003;Cannabis*/analysis;Cannabis*/chemical synthesis;Cannabis*/isolation & purification;Cannabis*/metabolism;Cannabis*/pharmacology;Chemical Phenomena;Chemistry*;Research;Terminology as Topic
4933823;Bibliography as Topic;Ecology;Nursing
5066566;Animals;Electrophoresis, Disc;Erythropoietin/blood*;Iodine Isotopes;Molecular Weight;Sheep;Sodium Dodecyl Sulfate;Ultracentrifugation
5103405;Animals;Anura/growth & development*;Brain/cytology;Brain Chemistry*;Catecholamines/analysis*;Diencephalon/analysis;Fluorescence;Histocytochemistry;Medulla Oblongata/analysis;Mesencephalon/analysis;Metamorphosis, Biological;Microscopy, Fluorescence;Nerve Fibers, Myelinated/analysis;Neurons/analysis;Neurons/growth & development*;Pituitary Gland/analysis;Telencephalon/analysis;Thalamus/analysis
5119722;France;Humans;Pacemaker, Artificial*;Statistics as Topic;Switzerland
5130642;Action Potentials;Electrophysiology/instrumentation*;Photography
5134716;Australia;Referral and Consultation*;State Medicine*
5198651;Education, Nursing, Baccalaureate;Education, Nursing, Diploma Programs;Hospitals;United States
5217858;Dentist-Patient Relations;Dentistry
5227836;Dentistry;Tooth/transplantation;Tooth Replantation
5240193;Dental Implantation;Dentistry
5253608;Medicine*;Politics*;Public Opinion*
5256545;Cephalometry*;Humans;Orthodontics, Corrective*
5295048;Animals;Chemical Phenomena;Chemistry;Enzymes*;Esterases*;In Vitro Techniques;Metals/pharmacology*;Snakes;Venoms*
5328017;Antidepressive Agents/therapeutic use*;Clinical Trials as Topic;Depression/drug therapy*;Female;Humans;Imipramine/therapeutic use;Male;Phenelzine/therapeutic use;Statistics as Topic
5355553;17-Ketosteroids/urine;Adult;Age Factors;Drug Synergism;Dysmenorrhea/drug therapy;Ethinyl Estradiol/therapeutic use;Female;Follow-Up Studies;Humans;Infertility, Female/drug therapy*;Megestrol/therapeutic use;Menorrhagia/drug therapy;Menstruation Disturbances/drug therapy*;Metrorrhagia/drug therapy;Pregnanes/administration & dosage;Pregnanes/therapeutic use*;Progestins/administration & dosage;Progestins/therapeutic use*;Time Factors
5378771;Abdomen*;Adult;Female;Humans;Labor, Obstetric*;Pregnancy;Pressure
5398412;Adult;Cervical Vertebrae;Electromyography*;Humans;Middle Aged;Radiculopathy/etiology;Spinal Cord Diseases/diagnosis*;Spinal Diseases/complications;Spinal Osteophytosis/diagnosis*;Spondylitis/etiology
5410079;Aged;Ampicillin/therapeutic use;Bronchiectasis/complications;Diabetes Complications;Erythromycin/therapeutic use;Humans;Lung/diagnostic imaging;Male;Oxacillin/therapeutic use;Pneumonia, Staphylococcal*/drug therapy;Radiography;Sputum/microbiology;Staphylococcus/pathogenicity;Tetracycline/therapeutic use;Virulence
5426562;Acclimatization;Animals;Body Temperature Regulation*;Chiroptera*;Temperature;Tropical Climate
5431763;Humans;Shock/drug therapy*;Shock/physiopathology;Vasoconstrictor Agents/therapeutic use;Vasodilator Agents/therapeutic use
5454170;Anesthesia;Animals;Apnea/therapy;Bronchial Spasm/therapy;Dogs;Electric Stimulation*;Electrodes;Humans;Hyperventilation/therapy;Methods;Phrenic Nerve*;Postoperative Complications/therapy;Respiration*
5473001;Blood Vessels/injuries*;Extremities/blood supply*;Humans;Methods;Vascular Surgical Procedures*
5496290;Animals;Blood Pressure;Brain Stem/physiology*;Cardiovascular System/innervation*;Cerebellum/physiology*;Dogs;Heart Rate;Pulse;Reaction Time;Vasomotor System/physiology*
5569408;Adult;Aged;Blood Flow Velocity;Cerebrovascular Circulation*;Cerebrovascular Disorders/physiopathology*;Female;Humans;Iodine Radioisotopes;Male;Middle Aged
5615129;Acenocoumarol/administration & dosage;Anticoagulants/administration & dosage*;Heparin/administration & dosage;Humans;Postoperative Care;Preoperative Care;Thrombelastography;Thrombosis/prevention & control*;Vascular Diseases/surgery*
5645744;Carbon Dioxide/metabolism;Carbon Isotopes;Cell Wall/metabolism;Glucose/metabolism;Neurospora/growth & development;Neurospora/metabolism*;Oxidative Phosphorylation/drug effects;Oxygen Consumption;Sorbitol/metabolism;Sorbose/pharmacology*
5680854;Adenoma/diagnostic imaging*;Bronchial Neoplasms/diagnostic imaging*;Humans;Radiography
5775266;Glycosides/analysis*;Plants/analysis*;Terpenes/analysis
5783651;Adult;Autoimmune Diseases/complications*;Autoimmune Diseases/pathology;Hepatomegaly;Hodgkin Disease/complications*;Humans;Lupus Erythematosus, Discoid/complications*;Male;Splenomegaly
5797265;Hospitalization*;Hospitals, Psychiatric*;Humans;Mediterranean Islands
5802311;Humans;Pulmonary Embolism/prevention & control*;Vena Cava, Inferior/surgery*
5885201;Acrylates;Blood Protein Electrophoresis*;Blood Sedimentation;Centrifugation*;Glucose;In Vitro Techniques
5887718;Adolescent;Adult;Antitubercular Agents/therapeutic use*;Child;Drug Resistance, Microbial*;Humans;Tuberculosis, Pulmonary/drug therapy*
5894643;Animals;In Vitro Techniques;Iron/metabolism*;Iron Isotopes;Liver/metabolism*;Rats
5971550;Chromatography, Paper*;Chromatography, Thin Layer*;Dioxins;Kerosene;Porphyrins/analysis*
5999658;Homeostasis*;Humans
6012681;Humans;Laryngectomy*;Male;Motion Pictures;Speech*;Sperm Capacitation;Voice Training
6041377;Adolescent;Adult;Female;Humans;Male;Pennsylvania;Smoking*;Students*;Universities*
6045149;Animals;Insecta/metabolism*;Intestinal Absorption*;Water*
6054087;Humans;Romania;Tuberculosis/prevention & control*
6076006;Animals;Cholesterol/blood*;Female;Liver/drug effects*;Mestranol/pharmacology*;Norethynodrel/pharmacology*;Rats;Thyroid Gland/drug effects*
6081010;Carcinogens*;Humans;Lung Neoplasms/etiology*;Plants, Toxic*;Smoking*;Tobacco*
6207761;Adult;Alcohol Drinking*;Alcoholism/blood*;Alkaline Phosphatase/blood;Amylases/blood;Aspartate Aminotransferases/blood;Bilirubin/blood;Blood Proteins/metabolism;Humans;Liver Function Tests*;Male;Middle Aged;Reference Values;Time Factors;gamma-Glutamyltransferase/blood
6288696;Base Sequence;Cloning, Molecular*;DNA Restriction Enzymes;DNA-Directed RNA Polymerases/metabolism;Escherichia coli/genetics*;Genes*;Genes, Bacterial*;Lac Operon*;Nucleic Acid Conformation;Plasmids;Templates, Genetic;Transcription, Genetic*
6361610;Animals;Disease Models, Animal*;Dogs/surgery*;Graft Survival;Liver/blood supply;Liver Circulation;Liver Transplantation*;Swine/surgery*
6447297;5,6-Dihydroxytryptamine/pharmacology;5-Hydroxytryptophan/pharmacology*;Animals;Behavior, Animal/drug effects*;Brain Chemistry/drug effects;Conditioning, Operant/drug effects;Defecation/drug effects*;Feeding Behavior/drug effects;Fenclonine/pharmacology;Male;Rats;Serotonin/pharmacology*
6529387;Body Weight;Breast Feeding;Female;Gestational Age;Humans;Infant Food;Infant, Newborn;Jaundice, Neonatal/epidemiology*;Jaundice, Neonatal/etiology;Male;Meconium;New Zealand;Nurseries, Hospital
6560839;Adult;Colitis/diagnosis*;Colonic Diseases/diagnosis*;Colonic Diseases, Functional/diagnosis;Humans;Tropical Medicine
6567582;Data Collection/methods*;Education, Nursing*;Postal Service;Research Design/standards*;Surveys and Questionnaires*;United States
6605304;Blood Platelets/metabolism*;Carbohydrates/blood;Electrophoresis, Polyacrylamide Gel;Erythrocyte Aggregation/blood*;Granulocytes/metabolism*;Humans;Lectins;Molecular Weight;Sialoglycoproteins/blood*;T-Lymphocytes/metabolism*;Wheat Germ Agglutinins
6653008;Adult;Antimony;Female;Humans;Intestines/diagnostic imaging*;Lymphangiectasis, Intestinal/diagnostic imaging*;Lymphoscintigraphy*;Protein-Losing Enteropathies/diagnostic imaging*;Technetium;Technetium Compounds*
6665777;Adult;Aged;Carcinogens, Environmental/adverse effects*;Female;Humans;Life Style;Male;Middle Aged;Neoplasms/epidemiology;Neoplasms/etiology*;Occupational Diseases/etiology*
6697550;Animals;Arginine Vasopressin/pharmacology*;Blood Pressure/drug effects*;Dose-Response Relationship, Drug;Electric Stimulation;Heart Rate/drug effects;Male;Mesencephalon/physiology*;Oxytocin/pharmacology*;Rats;Rats, Inbred Strains
6722693;Aged/psychology*;Canada;Financing, Personal*;Humans;Legal Guardians;Male;Neurocognitive Disorders/complications;Personality Disorders/etiology
6774533;Adolescent;Adult;Cerebral Decortication;Corpus Striatum*;Electroencephalography;Epilepsies, Partial/complications;Epilepsies, Partial/diagnosis*;Epilepsies, Partial/surgery;Eye Movements;Female;Follow-Up Studies;Frontal Lobe/surgery;Globus Pallidus;Head;Humans;Male;Middle Aged;Movement;Reflex, Abnormal/complications;Temporal Lobe/surgery
6809136;Health Planning/organization & administration*;Physician's Role*;Primary Health Care;Role*;United Kingdom
6853892;Communication*;Communication Barriers*;Connecticut;Female;Humans;Physician-Patient Relations;Psychotherapy*;Student Health Services*
6868455;Biliary Tract Diseases/rehabilitation*;Child;Humans;Physical Fitness;Physical Therapy Modalities*;Respiratory Tract Diseases/rehabilitation*
6868727;Animals;Brain Stem/blood supply;Constriction, Pathologic;Dominance, Cerebral/physiology;Electroencephalography;Rabbits;Rheology;Ultrasonography;Vertebrobasilar Insufficiency/diagnosis;Vertebrobasilar Insufficiency/surgery*
6933167;Adolescent;Decalcification, Pathologic;Dental Enamel Solubility/drug effects*;Female;Fluorides, Topical/therapeutic use*;Humans;Male;Orthodontics, Corrective/adverse effects*;Self Administration
6944928;Adolescent;Child;Female;Humans;Male;Prognathism/physiopathology*;Respiration*;Spirometry
6989764;Animals;Antibodies, Neoplasm/biosynthesis*;Brain/immunology;Brain Neoplasms/immunology*;Cell Line;Cytotoxicity Tests, Immunologic;Fluorescent Antibody Technique;Humans;Immunoglobulin G/analysis;Immunoglobulin M/analysis;Lymphoma/immunology*;Mice;Mice, Nude;Neoplasm Transplantation;Neoplasms, Experimental/immunology;Transplantation, Heterologous
7009541;Bacterial Proteins/genetics*;DNA Repair;DNA, Bacterial/genetics;DNA, Single-Stranded/physiology;Enzyme Induction/radiation effects;Escherichia coli/genetics*;Escherichia coli/radiation effects;Mutation;Rec A Recombinases;Recombination, Genetic;Time Factors;Ultraviolet Rays*
7078687;Hospitals, Psychiatric;Humans;Mental Disorders/psychology;Mental Disorders/therapy*;Person-Centered Therapy/methods;Physician-Patient Relations;Psychiatric Department, Hospital;Psychotherapy/methods;Psychotic Disorders/therapy;Schizophrenia/therapy
7107522;Acylation;Alkylation;Anti-Bacterial Agents/pharmacology*;Bacteria/drug effects;Biotransformation;Drug Resistance, Microbial;Microbial Sensitivity Tests;Poly U/metabolism;Structure-Activity Relationship;Tobramycin/analogs & derivatives;Tobramycin/pharmacology*
7121695;Adolescent;Adult;Heroin Dependence/blood*;Heroin Dependence/psychology;Humans;Luteinizing Hormone/blood*;Male;Psychosexual Development*;Puberty/drug effects;Sex Characteristics;Sexual Behavior/drug effects;Testosterone/blood*
7165864;Animals;Binding, Competitive;Guinea Pigs;Ileum/drug effects;Ileum/metabolism;In Vitro Techniques;Kinetics;Male;Parasympathomimetics/metabolism*;Parasympathomimetics/pharmacology;Quinuclidinyl Benzilate/metabolism;Radioligand Assay;Receptors, Cholinergic/metabolism*;Receptors, Muscarinic/metabolism*;Structure-Activity Relationship;Tritium
7208325;Bronchial Diseases/etiology;Esophageal Diseases/complications*;Female;Humans;Hydrogen-Ion Concentration;Middle Aged;Pneumonia, Aspiration/etiology*
7216978;Adult;Amyloidosis/etiology*;Dysgammaglobulinemia/complications;Dysgammaglobulinemia/etiology*;Humans;IgA Deficiency*;Immunoglobulin M/deficiency*;Leprosy/complications*;Male
7239558;Animals;Astacoidea/immunology;Cell Adhesion;Dose-Response Relationship, Immunologic;Erythrocytes/immunology*;Hemagglutination;Hemagglutinins/immunology*;Hemolymph/immunology*;Lectins/immunology;Macrophages/immunology*;Mice;Sheep/immunology;Urochordata/immunology*
7249551;Animals;Aorta/metabolism*;Blood Pressure/drug effects;Desoxycorticosterone*/pharmacology;Hypertension/chemically induced*;Hypertension/metabolism;Male;Muscles/metabolism;Potassium/metabolism;Rats;Sodium/metabolism;Sodium Chloride*/pharmacology
7321098;Adenoviridae/genetics;Adenoviridae/growth & development;Adenoviridae/metabolism*;Animals;Cell Line;Cricetinae;DNA, Viral/biosynthesis;Genes, Viral;HeLa Cells;Humans;Nucleic Acid Hybridization;Polyribosomes/analysis;RNA, Messenger/biosynthesis*;RNA, Viral/biosynthesis*
7341384;Humans;Viruses/isolation & purification*;Water Microbiology*
7372709;Cholesterol/analysis;Cholesterol/pharmacology;Cholesterol/physiology*;Erythrocyte Membrane/analysis;Erythrocyte Membrane/ultrastructure*;Erythrocytes/ultrastructure*;Humans;Liposomes;Membrane Lipids/analysis;Membrane Lipids/physiology*;Surface Properties;Temperature
7378668;Abdomen;Athletic Injuries/diagnosis*;Athletic Injuries/therapy;Bursitis/diagnosis;Diagnosis, Differential;Hernia/diagnosis;Hip Joint;Humans;Inflammation/diagnosis;Joint Diseases/diagnosis;Male;Muscles/injuries*;Nerve Compression Syndromes/diagnosis;Periostitis/diagnosis;Sprains and Strains/diagnosis;Tendinopathy/diagnosis;Thigh*
7407389;Animals;Aryl Hydrocarbon Hydroxylases/biosynthesis*;Benzopyrene Hydroxylase/biosynthesis*;Drug Synergism;Enzyme Induction/drug effects;Liver/drug effects*;Liver/enzymology;Male;Methylcholanthrene/pharmacology*;Mice;Mice, Inbred C57BL/metabolism*;Mice, Inbred DBA/metabolism*;Phenobarbital/pharmacology*
7444898;Adult;Hand/innervation;Humans;Male;Neuritis/complications;Neuritis/etiology;Neuritis/therapy*;Ulnar Nerve/injuries*;Wrist/innervation
7457099;Adult;Age Factors;Aged;Female;Humans;Middle Aged;Muscle Contraction;Parity;Pressure;Radiography;Urinary Bladder Diseases/diagnostic imaging*;Urinary Bladder Diseases/physiopathology;Urodynamics
7489582;Animals;Doxorubicin*;Female;Nephrotic Syndrome/chemically induced;Nephrotic Syndrome/drug therapy*;Nephrotic Syndrome/urine;Pefloxacin/therapeutic use*;Proteinuria;Rats;Rats, Wistar
7544591;Algorithms;Base Sequence;Biological Evolution*;Biotechnology/methods;Models, Genetic*;Models, Structural;Molecular Sequence Data;Nucleic Acid Conformation*;Point Mutation;RNA/chemistry*;RNA/genetics*
7570508;Biopsy, Needle;Breast/pathology;Breast Neoplasms/chemistry;Breast Neoplasms/metabolism*;Breast Neoplasms/pathology;Estrogens/analysis*;Female;Histological Techniques;Humans;Neoplasm Proteins/analysis*;Proteins*;Receptors, Estrogen/metabolism*;Trefoil Factor-1;Tumor Suppressor Proteins
7604117;Adult;Breast Diseases/etiology*;Breast Implants/adverse effects*;Female;Hematoma/etiology*;Humans;Mammaplasty/adverse effects*;Mastectomy/rehabilitation;Silicones
7667987;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;Heart Failure/complications;Heart Failure/drug therapy*;Humans;Hypertension/complications;Hypertension/drug therapy*;Hypotension/chemically induced
7794975;Activities of Daily Living;Adult;Aged;Arthritis, Rheumatoid/physiopathology*;Evaluation Studies as Topic;Female;Hand/physiopathology*;Hand Strength;Humans;Male;Middle Aged;Predictive Value of Tests
7807811;Counseling*;Humans;Telephone*
7877090;Animals;Disease Models, Animal*;Dogs;Macaca;Periodontal Attachment Loss/physiopathology;Periodontal Attachment Loss/therapy;Periodontal Diseases/physiopathology;Periodontal Diseases/surgery;Periodontal Diseases/therapy*;Periodontium/physiology;Regeneration*;Research Design
7999374;Contract Services/economics;Economic Competition/trends*;Family Practice/economics;Group Purchasing*;Health Expenditures;Purchasing, Hospital;State Medicine/economics*;United Kingdom
8067367;Epidemiology/history;History, 20th Century;National Institute for Occupational Safety and Health (U.S.)/history;Occupational Medicine/history;United States
8120247;Age Factors;Ear Canal/physiology*;Ear, External/physiology;Female;Hearing/physiology*;Humans;Infant*;Longitudinal Studies;Male;Orientation/physiology;Pitch Perception/physiology;Reference Values;Sound Localization/physiology;Sound Spectrography;Transducers, Pressure
8128093;Adult;Aged;Aged, 80 and over;Female;Forecasting;Home Care Services*;Humans;Hypercapnia/physiopathology;Hypoxia/physiopathology;Life Style;Long-Term Care*;Lung Diseases, Obstructive/physiopathology;Lung Diseases, Obstructive/therapy;Male;Middle Aged;Oxygen Inhalation Therapy*/instrumentation;Oxygen Inhalation Therapy*/methods;Patient Compliance*;Prescriptions;Prospective Studies;Respiratory Insufficiency/physiopathology;Respiratory Insufficiency/therapy;Smoking/physiopathology;Time Factors
8129901;Animals;Apoptosis;Cell Differentiation;Cell Division;Cell Nucleus;Cell Size;Cellular Senescence;Cytoplasm;DNA/analysis;Fibroblasts/chemistry;Fibroblasts/ultrastructure*;Lipids/analysis;Proteins/analysis;Rats;Sarcoma, Experimental/pathology;Selection, Genetic;Tumor Cells, Cultured
8205550;Animals;Cell Division/physiology;Cerebellar Neoplasms/chemistry;Cerebellar Neoplasms/genetics;Cerebellar Neoplasms/pathology*;Genotype;Humans;Immunohistochemistry;Karyotyping;Medulloblastoma/chemistry;Medulloblastoma/genetics;Medulloblastoma/pathology*;Mice;Mice, Nude;Neoplasm Transplantation;Neuroectodermal Tumors, Primitive/chemistry;Neuroectodermal Tumors, Primitive/genetics;Neuroectodermal Tumors, Primitive/pathology*;Phenotype;Rats;Spinal Cord Neoplasms/chemistry;Spinal Cord Neoplasms/genetics;Spinal Cord Neoplasms/pathology*;Tumor Cells, Cultured*
8234615;Adolescent;Adult;Boredom*;Depression/psychology*;Female;Humans;Male;Personality Inventory;Suicide/psychology*
8235899;Gasoline/history;Gasoline/toxicity;History, 20th Century;Humans;Tetraethyl Lead/history*;Tetraethyl Lead/toxicity
8309860;Adult;Embolism/diagnosis;Embolism/etiology;Embolism/therapy;Female;Hemorrhage/diagnosis;Hemorrhage/etiology;Hemorrhage/therapy;Humans;Hypertension/diagnosis;Hypertension/etiology;Hypertension/therapy;Obstetric Labor Complications*;Pregnancy;Pregnancy Complications*;Pregnancy Complications, Cardiovascular/diagnosis;Pregnancy Complications, Cardiovascular/etiology;Pregnancy Complications, Cardiovascular/therapy;Pregnancy Complications, Hematologic/diagnosis;Pregnancy Complications, Hematologic/etiology;Pregnancy Complications, Hematologic/therapy;Pregnancy Complications, Infectious/diagnosis;Pregnancy Complications, Infectious/etiology;Pregnancy Complications, Infectious/therapy;Risk Factors
8341726;Blood Coagulation/drug effects;Blood Coagulation/physiology*;Blood Platelets/drug effects*;Blood Platelets/physiology;Humans;Hypercholesterolemia/metabolism;Hyperlipidemias/metabolism;In Vitro Techniques;Lipoproteins/pharmacology*;Lipoproteins/physiology;Thromboxane A2/biosynthesis*;Thromboxane B2/metabolism
8343442;Cataract Extraction*/adverse effects;Humans;Incidence;Myopia/surgery*;Retinal Detachment/etiology
8413637;Biotechnology/legislation & jurisprudence*;Europe;United Kingdom
8440340;Animals;Chromosome Deletion*;Chromosomes/radiation effects*;Dose-Response Relationship, Radiation;Gamma Rays;Leukemia, Myeloid/genetics*;Leukemia, Myeloid/pathology*;Male;Mice;Mice, Inbred CBA;Neutrons;Phenotype;Ploidies;X-Rays
8476887;Adult;Alprostadil/therapeutic use*;Blood Pressure/drug effects;Cardiac Catheterization;Cardiac Output/drug effects;Female;Heart Transplantation*;Humans;Male;Middle Aged;Preoperative Care;Pulmonary Artery/drug effects;Pulmonary Artery/physiopathology*;Survival Rate;Vascular Resistance/drug effects*;Waiting Lists*
8514424;Autoantibodies/immunology*;Follicle Stimulating Hormone/antagonists & inhibitors*;Follicle Stimulating Hormone/blood;Humans;Immunoglobulin G/immunology;Infertility, Male/blood;Infertility, Male/immunology*;Luteinizing Hormone/blood;Male;Receptors, FSH/immunology*;Retrospective Studies
8517281;AIDS Serodiagnosis;Adolescent;Adult;Aged;Belgium;Blood Donors;Blood Transfusion;Confidentiality;Ethics, Medical*;Female;HIV Infections/prevention & control*;HIV Infections/transmission;Health Personnel;Humans;Jurisprudence;Male;Middle Aged;Patient Advocacy;Sexually Transmitted Diseases/prevention & control*
8563379;Attitude to Computers;Computer Systems;Consumer Behavior;Cost-Benefit Analysis;Hospital Information Systems/economics;Hospital Information Systems/utilization*;Hospitals, University;Humans;Iowa;Medical Staff, Hospital;Nursing Staff, Hospital
8649499;Biotechnology/economics*;Public Policy;United Kingdom
8651371;Adolescent;Adult;Female;Humans;Iodine/deficiency;Middle Aged;Pregnancy/physiology*;Thyroid Gland/physiology*;Thyroid Hormones/blood
8749196;Alkaloids/pharmacology*;Animals;Capsaicin/pharmacology*;Cochlea/blood supply*;Cochlea/drug effects*;Cochlea/physiopathology;Endolymphatic Hydrops/physiopathology*;Female;Guinea Pigs;Laser-Doppler Flowmetry;Male
8750352;Cell Division;Humans;Image Processing, Computer-Assisted/methods*;Ki-67 Antigen/analysis*;Lymphoma, Non-Hodgkin/pathology*;Microtomy;Nucleolus Organizer Region/pathology*;S Phase;Silver Staining/methods
8768633;Adult;Anticholesteremic Agents/administration & dosage*;Anticholesteremic Agents/adverse effects;Combined Modality Therapy;Fatty Acids, Monounsaturated/administration & dosage*;Fatty Acids, Monounsaturated/adverse effects;Female;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors*;Hyperlipoproteinemia Type II/blood;Hyperlipoproteinemia Type II/diet therapy;Hyperlipoproteinemia Type II/drug therapy*;Indoles/administration & dosage*;Indoles/adverse effects;Lipids/blood;Male;Middle Aged;Prospective Studies;Sex Characteristics;Time Factors
8823491;Animals;Antibiotics, Antineoplastic/administration & dosage*;Antibiotics, Antineoplastic/pharmacokinetics;Aorta/drug effects;Aorta/pathology;Carcinoma, Squamous Cell/drug therapy*;Carcinoma, Squamous Cell/pathology;Delayed-Action Preparations;Drug Carriers;Fibrin Tissue Adhesive/administration & dosage*;Fibrin Tissue Adhesive/adverse effects;Fibrin Tissue Adhesive/pharmacokinetics;Intestinal Diseases/chemically induced;Male;Mice;Mice, Inbred BALB C;Mitomycin/administration & dosage*;Mitomycin/pharmacokinetics;Neoplasm Transplantation;Rats;Rats, Inbred F344;Sarcoma, Experimental/drug therapy*;Sarcoma, Experimental/pathology;Tissue Adhesions/chemically induced;Tumor Cells, Cultured;Venae Cavae/drug effects;Venae Cavae/pathology
8858620;Animals;Blotting, Western;Cell Differentiation/physiology;Dystrophin/analogs & derivatives*;Dystrophin/genetics;Gene Expression/drug effects;Gene Expression/physiology;Microtubule-Associated Proteins/analysis;Nerve Growth Factors/pharmacology;PC12 Cells/cytology*;PC12 Cells/drug effects;PC12 Cells/physiology*;Polymerase Chain Reaction;RNA, Messenger/analysis;Rats;Time Factors
8891650;Acetylcholinesterase/analysis*;Analysis of Variance;Animals;Cell Count;Denervation;Exploratory Behavior/physiology*;Female;Glial Fibrillary Acidic Protein/analysis;Hippocampus*;Immunohistochemistry;Maze Learning/physiology*;Microinjections;Neurons/transplantation*;Rats;Septum Pellucidum/cytology;Septum Pellucidum/transplantation*
8977969;Histiocytosis/classification;Histiocytosis/physiopathology*;Histiocytosis, Langerhans-Cell/physiopathology;Humans
9016275;Adolescent;Adult;Behavior, Addictive/diagnosis;Behavior, Addictive/epidemiology;Comorbidity;Compulsive Behavior/diagnosis*;Compulsive Behavior/epidemiology;Female;Homosexuality/psychology;Homosexuality/statistics & numerical data;Humans;Male;Masturbation;Mental Disorders/epidemiology;Middle Aged;Paraphilic Disorders/diagnosis;Paraphilic Disorders/epidemiology;Personality Disorders/diagnosis;Personality Disorders/epidemiology;Prevalence;Psychiatric Status Rating Scales;Sex Factors;Sexual Behavior/psychology*;Sexual Partners/psychology;Substance-Related Disorders/diagnosis;Substance-Related Disorders/epidemiology
9074710;Blotting, Western;Collagenases/analysis;Collagenases/metabolism*;Coronary Artery Bypass*;Enzyme Activation;Gelatinases/analysis;Gelatinases/metabolism*;Humans;Immunohistochemistry;In Situ Hybridization;Matrix Metalloproteinase 2;Matrix Metalloproteinase 9;Metalloendopeptidases/analysis;Metalloendopeptidases/metabolism*;Muscle, Smooth, Vascular/enzymology;Muscle, Smooth, Vascular/injuries*;Organ Culture Techniques;Saphenous Vein/enzymology;Saphenous Vein/injuries*
9222811;Animals;Body Temperature Regulation;Calorimetry;Computer Simulation*;Ferric Compounds;Humans;Hyperthermia, Induced/methods*;Models, Biological;Neoplasms/physiopathology;Neoplasms/therapy;Nickel*;Palladium*;Temperature
9231295;Clinical Competence;Community Health Nursing;Critical Care;Decision Making;Humans;Intuition*;Nursing Process;Nursing Research*
9322049;Computational Biology*;Computer Communication Networks;Databases, Factual*;Genome*;Molecular Biology*;Semantics*
9352343;Aged;Antipsychotic Agents/therapeutic use*;Benzodiazepines;Clinical Trials as Topic;Clozapine/therapeutic use;Dementia/psychology;Dementia/therapy*;Humans;Pirenzepine/analogs & derivatives;Pirenzepine/therapeutic use;Risperidone/therapeutic use
9430422;Animals;Electric Stimulation;Guinea Pigs;In Vitro Techniques;Male;Muscle Contraction/drug effects;Muscle Contraction/physiology;Muscle Relaxation/drug effects;Muscle Relaxation/physiology;Muscle, Smooth/drug effects;Muscle, Smooth/enzymology;Muscle, Smooth/innervation;Muscle, Smooth/physiology;Nitric Oxide/pharmacology;Nitric Oxide/physiology*;Nitric Oxide Synthase/metabolism;Nitroprusside/pharmacology;Prostate/drug effects;Prostate/enzymology;Prostate/innervation;Prostate/physiology*;Rabbits;Rats;Rats, Sprague-Dawley;Species Specificity;Swine;Synaptic Transmission/physiology*
9523470;Adenosine Deaminase/metabolism*;Cells, Cultured;Humans;Isoenzymes/metabolism*
9543650;Aspirin/therapeutic use;Brain/blood supply;Brain/diagnostic imaging;Brain/drug effects;Brain Ischemia/chemically induced;Brain Ischemia/drug therapy*;Brain Ischemia/physiopathology;Cerebrovascular Circulation/drug effects;Cocaine/adverse effects*;Cocaine-Related Disorders/complications*;Cocaine-Related Disorders/physiopathology;Cognition Disorders/etiology*;Excitatory Amino Acid Antagonists/therapeutic use;Female;Glutamic Acid/adverse effects;Humans;Intracranial Embolism and Thrombosis/chemically induced;Intracranial Embolism and Thrombosis/drug therapy;Male;Nerve Degeneration/chemically induced;Nerve Degeneration/physiopathology;Neuropsychological Tests;Platelet Aggregation Inhibitors/therapeutic use;Radionuclide Imaging;Substance Withdrawal Syndrome/physiopathology
9552122;Amphibians/metabolism*;Animals;Chromatography, High Pressure Liquid;Female;Immunohistochemistry;Male;Oxytocin/analogs & derivatives*;Oxytocin/analysis;Pituitary Gland, Posterior/chemistry*;Radioimmunoassay;Staining and Labeling;Vasotocin/analysis*
9554613;Humans;Lung Diseases/epidemiology*;Postoperative Complications/epidemiology*;Risk Factors;Smoking/adverse effects*;Smoking Cessation;Surgical Procedures, Operative
9622195;Action Potentials/physiology*;Collagen/physiology;Extracellular Matrix Proteins/physiology*;Humans;Hybrid Cells;Laminin/physiology;Neurons/physiology*;Peptide Fragments/physiology;Tumor Cells, Cultured
9623072;Adult;Brain Neoplasms/secondary*;Brain Neoplasms/surgery*;Female;Humans;Lung Neoplasms/pathology*;Male;Middle Aged;Postoperative Complications;Retrospective Studies
9631364;Fluorine Radioisotopes;Fluorodeoxyglucose F18*;Humans;Lung Neoplasms/diagnostic imaging*;Lung Neoplasms/radiotherapy*;Radiotherapy Planning, Computer-Assisted*;Retrospective Studies;Tomography, Emission-Computed
9666672;Health Maintenance Organizations*;Humans;Missouri;Public Opinion*;United States
9696847;Animals;Antibodies, Viral/immunology;Cell Line;Disease Progression;Female;Gene Deletion;Gene Products, env/immunology;Gene Products, gag/immunology;Genes, nef;Macaca mulatta;Neutralization Tests;RNA, Viral/blood;Simian Acquired Immunodeficiency Syndrome/immunology;Simian Acquired Immunodeficiency Syndrome/prevention & control*;Simian Acquired Immunodeficiency Syndrome/virology;Simian Immunodeficiency Virus/genetics;Simian Immunodeficiency Virus/immunology*;Simian Immunodeficiency Virus/physiology;Vaccination;Vaccines, Attenuated/immunology;Viral Load;Viral Vaccines/immunology*;Virus Replication*
9704306;Adolescent;Comorbidity;Enchondromatosis/epidemiology*;Enchondromatosis/pathology;Enchondromatosis/surgery;Female;Granulosa Cell Tumor/epidemiology*;Granulosa Cell Tumor/pathology;Humans;Ovarian Neoplasms/epidemiology*;Ovarian Neoplasms/pathology;Ovary/pathology
9711756;Adolescent;Adult;Cerebral Cortex/physiopathology;Cerebral Cortex/surgery*;Child;Child, Preschool;Electroencephalography;Epilepsia Partialis Continua/physiopathology;Epilepsia Partialis Continua/surgery;Epilepsy/surgery*;Epilepsy, Complex Partial/physiopathology;Epilepsy, Complex Partial/surgery;Female;Frontal Lobe/physiopathology;Frontal Lobe/surgery;Functional Laterality/physiology;Humans;Infant;Male;Monitoring, Intraoperative;Neural Pathways/physiopathology;Neural Pathways/surgery
9757568;Amino Acids/analysis;Carbohydrates/analysis;Chromatography, Gel;Chromatography, High Pressure Liquid;Culture Media;Electrophoresis, Polyacrylamide Gel;Hexosamines/analysis;Lentinula/chemistry;Lentinula/enzymology*;Molecular Sequence Data;Molecular Weight;RNA, Fungal/analysis;RNA, Fungal/chemistry;Ribonucleases/chemistry*;Ribonucleases/isolation & purification;Sequence Analysis;Sequence Homology, Amino Acid;Substrate Specificity;Yeasts/genetics
9806745;Acetylcholine/pharmacology;Animals;Cattle;Cells, Cultured;Cholinergic Agonists/pharmacology;Electrophysiology;Endothelin-1/pharmacology*;Histamine/pharmacology*;Ion Channels/drug effects*;Membrane Potentials/drug effects*;Methacholine Chloride/pharmacology;Muscle, Smooth, Vascular/drug effects*;Patch-Clamp Techniques;Quaternary Ammonium Compounds/pharmacology;Trachea/drug effects*
10126289;Continuity of Patient Care/organization & administration;Economic Competition;Health Policy;Managed Care Programs/trends*;Michigan;Multi-Institutional Systems/organization & administration*;Physicians;United States
10152446;Biomedical Engineering/education*;Biomedical Engineering/standards*;Developing Countries*;Diffusion of Innovation;Health Services Needs and Demand;International Educational Exchange;Private Sector;Technology Transfer;United States;Voluntary Health Agencies/organization & administration*
10173227;Adult;Anti-Bacterial Agents/pharmacology*;Cross Infection/prevention & control;Drug Resistance, Microbial*;Drug Therapy, Combination/therapeutic use;Hospitals;Humans;Male;Michigan;Staphylococcal Infections/prevention & control*;Staphylococcus/drug effects*;Vancomycin/pharmacology*
10183451;Adult;Humans;Male;Nevada;Right to Die/legislation & jurisprudence*
10287496;Consumer Behavior*;Hospitals, Osteopathic/organization & administration*;Hospitals, Special/organization & administration*;Quality of Health Care/standards*;United States
10314891;Audiovisual Aids;Health Education/methods*;Hospital Shared Services*;Inservice Training/methods*;New Jersey;Personnel, Hospital/education*
10324722;Job Satisfaction*;Methods;Operating Room Nursing/organization & administration*;Personnel Management*;Personnel Staffing and Scheduling*;United States
10366527;Amino Acid Sequence;Bacterial Proteins/genetics;Conjugation, Genetic;DNA, Bacterial/genetics;Escherichia coli/genetics;F Factor/genetics*;Genes, Bacterial;Molecular Sequence Data;Open Reading Frames;Sequence Homology, Amino Acid
10418594;Adult;Colorado;Female;Humans;Incidence;Male;Retrospective Studies;Surgical Procedures, Operative/adverse effects*;Time Factors;Utah
10444780;Diagnostic Tests, Routine;Germany;Humans;Melanoma/diagnostic imaging*;Melanoma/pathology;Neoplasm Staging;Nevus, Pigmented/diagnostic imaging*;Nevus, Pigmented/pathology;Observer Variation;Palpation;Prospective Studies;Regression Analysis;Skin Neoplasms/diagnostic imaging*;Skin Neoplasms/pathology;Ultrasonography/methods*
10469803;Child;Clinical Trials as Topic;Drug Labeling;Drug Therapy*;Ethics, Medical;Humans;Infant;Patient Selection;Pediatrics*;Professional Staff Committees;Research Design;United States;United States Food and Drug Administration
10498035;Adult;Antisocial Personality Disorder/epidemiology;Antisocial Personality Disorder/etiology*;Child;Child Abuse/psychology;Child Rearing/psychology*;Criminal Psychology*;Factor Analysis, Statistical;Family Health*;Humans;Male;Middle Aged;Parent-Child Relations;Personality Development;Prisoners/psychology;Prisoners/statistics & numerical data;Regression Analysis;Retrospective Studies;Risk Factors;Social Environment*
10535961;Adaptor Proteins, Signal Transducing*;Adrenergic beta-1 Receptor Agonists;Animals;Carrier Proteins/metabolism*;Cattle;Cell Line;GTP-Binding Protein alpha Subunits, Gs/metabolism;Humans;Proline/metabolism;Protein Binding;Receptors, Adrenergic, beta-1/chemistry;Receptors, Adrenergic, beta-1/metabolism*;src Homology Domains
10555285;3' Untranslated Regions;5' Untranslated Regions;Animals;Base Sequence;COS Cells;Cattle;DNA, Complementary;Exons*;Fucosyltransferases/genetics*;Humans;Introns*;Molecular Sequence Data;Multigene Family;Promoter Regions, Genetic;RNA, Messenger/genetics;Sequence Homology, Nucleic Acid
10609855;Down Syndrome/diagnosis*;Female;Health Policy;Humans;Pregnancy;Prenatal Diagnosis/methods*;United Kingdom
10618970;Ambulatory Surgical Procedures*;Analgesics/administration & dosage*;Child;Drug Administration Schedule;Humans;Pain, Postoperative/prevention & control*;Parents;Patient Satisfaction*;Prospective Studies
10651798;Animals;Base Sequence;Brain/metabolism*;Carrier Proteins/chemistry;Carrier Proteins/genetics*;Carrier Proteins/metabolism*;DNA Primers/genetics;Diaphragm/metabolism;Gene Expression;Homer Scaffolding Proteins;Humans;Mice;Muscle, Skeletal/metabolism;Muscles/metabolism*;Myocardium/metabolism;Neuropeptides/chemistry;Neuropeptides/genetics*;Neuropeptides/metabolism*;Protein Isoforms/chemistry;Protein Isoforms/genetics;Protein Isoforms/metabolism;RNA, Messenger/genetics;RNA, Messenger/metabolism;Reverse Transcriptase Polymerase Chain Reaction;Tissue Distribution
10721428;Animals;Chromosome Mapping*;DNA/genetics;DNA Primers;Genome*;Microsatellite Repeats/genetics*;Nucleic Acid Hybridization;Quality Control;Turkeys/genetics*
10909147;Arteriosclerosis/microbiology*;Arteriosclerosis/physiopathology;Chlamydia Infections/complications;Chlamydophila pneumoniae/pathogenicity;Humans;Inflammation
10911731;Chlorophyll/chemistry*;Chlorophyll/radiation effects;Cold Temperature;Fabaceae/chemistry;Fabaceae/radiation effects;Light-Harvesting Protein Complexes;Peas/chemistry;Peas/radiation effects;Photochemistry;Photosynthetic Reaction Center Complex Proteins/chemistry;Photosynthetic Reaction Center Complex Proteins/radiation effects;Photosystem I Protein Complex;Photosystem II Protein Complex;Plants, Medicinal;Spectrometry, Fluorescence
10974038;Animals;Cytokines/biosynthesis*;DNA-Binding Proteins/physiology;Enzyme Precursors/physiology;Interleukin-2/genetics;Intracellular Signaling Peptides and Proteins;Mast Cells/metabolism*;Mice;Mice, Inbred C57BL;NFATC Transcription Factors;Nuclear Proteins*;Phosphorylation;Promoter Regions, Genetic;Protein-Serine-Threonine Kinases*;Protein-Tyrosine Kinases/physiology;Proto-Oncogene Proteins/physiology*;Proto-Oncogene Proteins c-akt;Receptors, IgE/physiology;Syk Kinase;Transcription Factor AP-1/physiology;Transcription Factors/physiology;Tumor Necrosis Factor-alpha/genetics;src-Family Kinases/physiology
10987031;Cysts/surgery*;Humans;Laparoscopy*/methods;Liver Diseases/surgery*;Liver Neoplasms/surgery*
11000348;Animals;Apatites/analysis;Bone Density/drug effects*;Bone Density/physiology;Calcification, Physiologic/drug effects*;Calcium/analysis;Diphosphonates/administration & dosage;Diphosphonates/therapeutic use*;Disease Models, Animal;Dose-Response Relationship, Drug;Electron Probe Microanalysis;Female;Lumbar Vertebrae/chemistry;Lumbar Vertebrae/drug effects;Lumbar Vertebrae/ultrastructure*;Magnesium/analysis;Microscopy, Electron, Scanning;Osteoporosis/drug therapy*;Osteoporosis/pathology;Ovariectomy;Phosphorus/analysis;Rats;Rats, Sprague-Dawley
11012702;Adolescent;Adult;Antifibrinolytic Agents/standards;Antifibrinolytic Agents/therapeutic use*;Child;Drug Evaluation;Hemarthrosis/drug therapy*;Hemarthrosis/etiology;Hemophilia A/complications*;Hemophilia A/therapy;Humans;Injections, Intra-Articular/methods;Injections, Intra-Articular/standards;Male;Outcome Assessment (Health Care);Patient Satisfaction;Rifampin/standards;Rifampin/therapeutic use*;Synovectomy;Synovial Membrane/radiation effects*
11207579;Bacterial Proteins/genetics;Bacterial Proteins/metabolism*;Blotting, Western;Cyclic AMP Response Element-Binding Protein/genetics;Cyclic AMP Response Element-Binding Protein/metabolism*;HeLa Cells;Humans;Mitogen-Activated Protein Kinases/genetics;Mitogen-Activated Protein Kinases/metabolism;Phosphorylation;Reverse Transcriptase Polymerase Chain Reaction;Signal Transduction*;Spleen/cytology;Transcription Factor AP-1/metabolism;Tumor Cells, Cultured;Yersinia pseudotuberculosis/genetics;Yersinia pseudotuberculosis/metabolism*;Yersinia pseudotuberculosis/pathogenicity*;Yersinia pseudotuberculosis Infections/microbiology;p38 Mitogen-Activated Protein Kinases
11241398;Acetylcholine/pharmacology;Anguilla/physiology*;Animals;Aorta/drug effects*;Atrial Natriuretic Factor/pharmacology;Biological Evolution;Endothelin-1/pharmacology;Fishes/physiology*;Hagfishes/physiology;Lampreys/physiology;Muscle, Smooth, Vascular/drug effects*;Natriuretic Peptide, C-Type/pharmacology;Nitric Oxide/pharmacology;Nitroprusside/pharmacology;Prostaglandins/pharmacology;Receptors, Cell Surface/metabolism;Signal Transduction;Species Specificity;Vasoconstriction;Vasoconstrictor Agents/pharmacology*;Vasodilation;Viper Venoms
11247260;Adult;Diagnostic Errors/legislation & jurisprudence*;Expert Testimony/legislation & jurisprudence;Humans;Lymphoma, Follicular/diagnostic imaging*;Male;Malpractice/legislation & jurisprudence*;Ontario;Radiography;Referral and Consultation/legislation & jurisprudence;Stomach Neoplasms/diagnostic imaging*
11247992;Acoustic Stimulation;Action Potentials/physiology;Animals;Arousal/physiology;Auditory Cortex/cytology;Auditory Cortex/physiology*;Biological Clocks/physiology*;Electric Stimulation;Electrodes, Implanted;Electroencephalography;Evoked Potentials, Auditory;Intralaminar Thalamic Nuclei/physiology;Male;Nerve Net/physiology;Neurons/physiology;Pyramidal Cells/physiology;Rats;Rats, Sprague-Dawley;Signal Processing, Computer-Assisted;Thalamus/physiology*
11270103;Adolescent;Adult;Aged;Aged, 80 and over;Analysis of Variance;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Child;Female;Follow-Up Studies;Humans;Male;Middle Aged;Nasopharyngeal Neoplasms/drug therapy;Nasopharyngeal Neoplasms/pathology;Nasopharyngeal Neoplasms/radiotherapy;Nasopharyngeal Neoplasms/therapy*;Neoplasm Staging;Prognosis;Radiotherapy Dosage;Retrospective Studies;Survival Analysis
11277445;Adolescent;Adult;Attention*;Cognition*;Cues;Humans;Intelligence*;Male;Memory*;Reaction Time;Regression Analysis
11322006;Adolescent;Adult;Female;Humans;Scleroderma, Localized/complications*;Scleroderma, Localized/immunology;Thrombocytopenia/etiology*;Thrombocytopenia/immunology
11334853;Amides/pharmacology;Animals;Anticoagulants/pharmacology;Aspirin/pharmacology;Biphenyl Compounds/pharmacology;Bleeding Time;Blood Platelets/drug effects;Drug Synergism;Fibrinolytic Agents/agonists;Fibrinolytic Agents/pharmacology*;Guinea Pigs;Hemorrhage/blood*;Heparin/pharmacology;Heptanoic Acids/pharmacology;Hindlimb/drug effects;Male;Methacrylates/pharmacology;Middle Cerebral Artery/drug effects;Partial Thromboplastin Time;Platelet Aggregation/drug effects;Platelet Aggregation Inhibitors/pharmacology;Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors*;Platelet Glycoprotein GPIIb-IIIa Complex/metabolism;Thromboxane-A Synthase/antagonists & inhibitors*;Thromboxane-A Synthase/metabolism
11346911;Aged;Cardiovascular Diseases/etiology;Cardiovascular Diseases/prevention & control*;Cholesterol/blood*;Cholesterol, HDL/blood;Cholesterol, LDL/blood;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/complications*;Diagnosis, Differential;Female;Humans;Hyperlipidemias/blood;Hyperlipidemias/complications*;Hyperlipidemias/diagnosis*;Hyperlipidemias/drug therapy;Hypolipidemic Agents/pharmacology;Hypolipidemic Agents/therapeutic use*;Male;Middle Aged;Randomized Controlled Trials as Topic;Treatment Outcome;Triglycerides/blood
11370144;Anatomy/education*;Education, Medical, Undergraduate*;Humans;Problem-Based Learning*;South Africa;Students, Medical/psychology
11388538;Anesthetics, Inhalation/pharmacology*;Animals;Calcium/metabolism*;Ferrets;Isoflurane/pharmacology*;Male;Myocardial Contraction/drug effects*;Papillary Muscles/drug effects*;Papillary Muscles/physiology
11394890;B-Lymphocytes/drug effects;B-Lymphocytes/metabolism;Carcinoma, Squamous Cell/metabolism;Cell Division/drug effects;Cell Line;Culture Media, Conditioned/pharmacology;Enzyme-Linked Immunosorbent Assay;Epithelial Cells/drug effects;Epithelial Cells/metabolism;Fibroblast Growth Factor 2/metabolism*;Fibroblasts/drug effects;Fibroblasts/metabolism;Heparan Sulfate Proteoglycans/genetics;Heparan Sulfate Proteoglycans/metabolism;Heparan Sulfate Proteoglycans/pharmacology*;Humans;Hyaluronan Receptors/genetics;Hyaluronan Receptors/metabolism;Kidney/drug effects;Kidney/metabolism;Ligands;Monocytes/drug effects;Monocytes/metabolism;Protein Binding/drug effects;Protein Isoforms/genetics;Protein Isoforms/metabolism;Recombinant Proteins/genetics;Recombinant Proteins/metabolism
11610248;Greek World;History of Medicine;Skin Diseases/history*;Urology/history*
11648541;Arkansas;Blood Transfusion*;Christianity*;Diagnosis;Disclosure;General Surgery;Humans;Jehovah's Witnesses*;Jurisprudence;Liability, Legal*;Malpractice;Physicians*;Referral and Consultation*;Religion;Treatment Refusal*;Wounds and Injuries
11653790;Acquired Immunodeficiency Syndrome*;Blood Donors;Criminal Law*;HIV Seropositivity*;Humans;Jurisprudence*;Law Enforcement;Legislation as Topic;Liability, Legal*;Military Personnel;Patients*;Sex Offenses;Sex Work;Social Control, Formal;State Government;United States
11719439;Adult;Aged;Aged, 80 and over;Amino Acid Sequence;DNA, Complementary/genetics;DNA, Neoplasm/genetics;Enzyme Activation;Female;Gastrointestinal Neoplasms/enzymology*;Gastrointestinal Neoplasms/genetics*;Gastrointestinal Neoplasms/pathology;Humans;Immunohistochemistry;Male;Middle Aged;Molecular Sequence Data;Mutation;Phosphorylation;Proto-Oncogene Proteins c-kit/biosynthesis;Proto-Oncogene Proteins c-kit/genetics*;Proto-Oncogene Proteins c-kit/metabolism;Sequence Homology, Amino Acid;Stromal Cells/enzymology;Stromal Cells/pathology
11756489;Amino Acid Transport System A/antagonists & inhibitors;Amino Acid Transport System A/genetics;Amino Acid Transport System A/metabolism*;Amino Acid Transport Systems, Neutral*;Animals;Binding, Competitive/physiology;Biological Transport/physiology;Carrier Proteins/metabolism;Cells, Cultured;Glutamine/metabolism*;Glutamine/pharmacokinetics;Glutamine/pharmacology;Hippocampus;Humans;Hydrogen-Ion Concentration;Kinetics;Membrane Potentials/drug effects;Membrane Transport Proteins*;Molecular Sequence Data;Neural Inhibition/physiology;Neurons/cytology;Neurons/drug effects;Neurons/metabolism*;Organ Specificity;Protein Binding/physiology;Protons*;Rats;Sodium/metabolism;Transfection;beta-Alanine/analogs & derivatives*;beta-Alanine/pharmacology
11773351;Acute Disease;Bronchodilator Agents/therapeutic use*;Combined Modality Therapy;Epoprostenol/therapeutic use*;Fatal Outcome;Humans;Lung/diagnostic imaging;Lung Diseases, Interstitial/diagnostic imaging;Lung Diseases, Interstitial/drug therapy*;Lung Diseases, Interstitial/therapy;Male;Middle Aged;Nitric Oxide/therapeutic use*;Oxygen Inhalation Therapy;Tomography, X-Ray Computed
11774289;Acetaldehyde/analysis;Acetaldehyde/chemistry*;Acetaldehyde/metabolism;Adult;Area Under Curve;Carcinogens/chemistry;Cysteine/analysis;Cysteine/chemistry*;Cysteine/metabolism;Gastrointestinal Neoplasms/diagnosis;Gastrointestinal Neoplasms/prevention & control;Humans;Male;Protein Binding;Saliva/chemistry*;Saliva/metabolism*;Time Factors
11794315;Ophthalmology*
11828809;Acute Disease;Humans;Mental Disorders/diagnosis;Mental Disorders/etiology;Mental Disorders/therapy;Prognosis;Psychotherapy/methods;Randomized Controlled Trials as Topic;Stress Disorders, Post-Traumatic/diagnosis;Stress Disorders, Post-Traumatic/therapy;Wounds and Injuries/psychology*
11837023;Acquired Immunodeficiency Syndrome*;Euthanasia/legislation & jurisprudence*;Humans;Ontario;Suicide, Assisted/legislation & jurisprudence*
11959160;Adult;Auditory Perception/physiology;Brain Stem/physiopathology;Cochlear Diseases/diagnosis;Cochlear Diseases/etiology*;Cochlear Diseases/physiopathology*;Deafness/diagnosis;Deafness/etiology;Deafness/physiopathology;Dizziness/diagnosis;Dizziness/etiology;Dizziness/physiopathology;Evoked Potentials, Auditory, Brain Stem/physiology;Female;Fibromyalgia/complications*;Fibromyalgia/physiopathology*;Humans;Middle Aged;Reaction Time;Tinnitus/diagnosis;Tinnitus/etiology;Tinnitus/physiopathology;Vertigo/diagnosis;Vertigo/etiology;Vertigo/physiopathology;Vestibular Diseases/diagnosis;Vestibular Diseases/etiology*;Vestibular Diseases/physiopathology*
11963304;Adult;Angiography;Arteriovenous Fistula/diagnostic imaging*;Arteriovenous Fistula/etiology;Catheterization, Central Venous/adverse effects;Humans;Iatrogenic Disease*;Male;Ultrasonography, Doppler, Duplex;Vertebral Artery/diagnostic imaging*
12010543;Acids/metabolism;Adsorption;Antifungal Agents/pharmacology*;Antioxidants/pharmacology;Cell Membrane/drug effects*;Culture Media/metabolism;Cycloheximide/pharmacology;Esters/pharmacology;Gallic Acid/analogs & derivatives*;Gallic Acid/pharmacology*;Glucose/pharmacology;Potassium/metabolism;Reactive Oxygen Species/metabolism;Saccharomyces cerevisiae/drug effects*;Saccharomyces cerevisiae/metabolism
12012844;Humans;New Zealand;Nursing Services/manpower*;Personnel Loyalty;Personnel Management/methods*;Personnel Turnover;Salaries and Fringe Benefits
12117968;Amino Acid Sequence;Antibodies/metabolism;Bacterial Adhesion;Bacterial Outer Membrane Proteins/metabolism*;Brain/blood supply*;Capillaries/metabolism;Cells, Cultured;Chromatography, Affinity/methods;Endothelium, Vascular/cytology;Endothelium, Vascular/metabolism*;Escherichia coli/metabolism*;Escherichia coli/physiology;Humans;Membrane Glycoproteins/isolation & purification;Membrane Glycoproteins/metabolism*;Molecular Sequence Data;Nerve Tissue Proteins/isolation & purification;Nerve Tissue Proteins/metabolism*;Phytohemagglutinins/metabolism;Receptors, Cell Surface/isolation & purification;Receptors, Cell Surface/metabolism*
12140121;Adult;Cognition Disorders/diagnosis;Cognition Disorders/etiology*;Cognition Disorders/physiopathology;Corpus Striatum/physiopathology;Female;Frontal Lobe/physiopathology;Humans;Male;Methamphetamine*;Neuropsychological Tests;Paranoid Disorders/etiology;Paranoid Disorders/physiopathology;Reaction Time;Severity of Illness Index;Substance-Related Disorders/complications*;Surveys and Questionnaires
12140155;Adenocarcinoma, Mucinous/diagnosis*;Animals;Bites and Stings*;Breast/injuries*;Breast Neoplasms/diagnosis*;Diagnosis, Differential;Female;Horses*;Humans;Magnetic Resonance Imaging/methods*;Middle Aged
12181871;Dental Implantation, Endosseous/instrumentation;Dental Implantation, Endosseous/methods;Dental Implants*;Dental Prosthesis Design*;Dental Prosthesis, Implant-Supported;Denture Retention*;Humans;Miniaturization;Minimally Invasive Surgical Procedures;Treatment Outcome
12205198;Action Potentials/physiology;Animals;Electrophysiology;Male;Neurons/physiology;Preoptic Area/cytology;Preoptic Area/physiology*;Rats;Rats, Sprague-Dawley;Sleep, REM/physiology*;Theta Rhythm;Wakefulness/physiology*
12219465;Defecation;Diet;Evidence-Based Medicine;Fecal Incontinence/etiology*;Fecal Incontinence/nursing*;Humans;Hygiene;Nurse's Role*;Nursing Assessment;Nursing Care;Quality of Life;Spinal Cord Injuries/complications*
12226525;Acyltransferases/genetics*;Acyltransferases/isolation & purification;Acyltransferases/metabolism;Amino Acid Sequence;Arabidopsis/genetics;Benzoates/metabolism*;DNA, Complementary/chemistry;DNA, Complementary/genetics;Escherichia coli/genetics;Esters;Gene Expression Regulation, Enzymologic;Gene Expression Regulation, Plant;Immunoblotting;Kinetics;Molecular Sequence Data;Onagraceae/enzymology*;Onagraceae/genetics;Onagraceae/metabolism;Phylogeny;Plant Leaves/metabolism;Plant Stems/metabolism;Sequence Analysis, DNA;Sequence Homology, Amino Acid;Stress, Mechanical;Substrate Specificity;Tobacco/genetics;Volatilization
12238999;Aged;Arthroplasty/methods;Arthroplasty/standards;Cartilage, Articular/surgery*;Catheter Ablation/adverse effects*;Cell Death*;Chondrocytes/physiology*;Female;Hot Temperature/adverse effects;Humans;Knee Joint/surgery;Male;Therapeutic Irrigation*
12424072;Antineoplastic Combined Chemotherapy Protocols/therapeutic use*;Carcinoma/drug therapy*;Carcinoma/radiotherapy*;Clinical Trials as Topic;Combined Modality Therapy;Dose Fractionation;Head and Neck Neoplasms/drug therapy*;Head and Neck Neoplasms/radiotherapy*;Humans;Survival Analysis
12436366;Aged;Amnesia/blood;Amnesia/chemically induced*;Amnesia/diagnosis;Amnesia/psychology;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/adverse effects*;Antipsychotic Agents/pharmacokinetics;Benzodiazepines;Chronic Disease;Dose-Response Relationship, Drug;Drug Overdose/blood;Drug Overdose/diagnosis*;Drug Overdose/psychology;Electroencephalography/drug effects;Humans;Male;Mental Recall/drug effects*;Neuropsychological Tests;Pirenzepine/administration & dosage;Pirenzepine/adverse effects*;Pirenzepine/analogs & derivatives*;Pirenzepine/pharmacokinetics;Risk Factors;Schizophrenia, Paranoid/diagnosis;Schizophrenia, Paranoid/drug therapy*;Schizophrenia, Paranoid/psychology
12443793;Adenine/analogs & derivatives*;Adenine/chemistry*;Base Pairing;Base Sequence;DNA Damage;Hydrolysis;Oligonucleotides/chemistry*;Oxidation-Reduction
12472133;Acute Disease;Analgesia;Chronic Disease;Humans;Pain, Postoperative/etiology*;Pain, Postoperative/physiopathology;Pain, Postoperative/therapy;Syndrome;Thoracic Surgery, Video-Assisted/adverse effects;Thoracic Surgical Procedures/adverse effects*;Thoracotomy/adverse effects
12500410;Antineoplastic Agents/therapeutic use;Child;Clinical Pharmacy Information Systems;Drug Utilization Review;Hospitals, Pediatric/standards;Hospitals, Teaching/standards;Humans;Massachusetts;Medical Oncology;Medication Errors/prevention & control;Medication Systems, Hospital/organization & administration*;Pediatrics/standards;Pharmacies/utilization;Process Assessment (Health Care)/organization & administration*
12531870;Animals;Glucose/metabolism*;Hormones, Ectopic/pharmacology*;Hormones, Ectopic/physiology;Insulin Resistance*;Liver/metabolism*;Nerve Growth Factor;Obesity/etiology;Proteins*;Rats;Resistin
12617579;Animals;Chromatography, Liquid/methods*;Erythromycin/analysis*;Food Analysis/methods*;Salmon*;Sensitivity and Specificity;Solvents;Spectrometry, Mass, Electrospray Ionization*;Tissue Extracts/chemistry
12712672;Borderline Personality Disorder/diagnosis;Borderline Personality Disorder/nursing*;Borderline Personality Disorder/therapy;Humans;Psychiatric Nursing*
12719166;Adult;Arthralgia/etiology;Fatal Outcome;Female;Humans;Lightning Injuries/pathology*;Male;Middle Aged;Skin/injuries*;Skin/pathology
12764790;Cell Culture Techniques/methods*;Cell Differentiation;Cells, Cultured;Collagen;Culture Media;Gels;Humans;Nasal Mucosa/cytology*;Nasal Mucosa/ultrastructure
12785171;Antigens, Bacterial/analysis*;Enzyme-Linked Immunosorbent Assay/methods;Humans;Predictive Value of Tests;Reagent Kits, Diagnostic*;Sensitivity and Specificity;Serologic Tests;Sputum/microbiology;Tuberculosis, Pulmonary/diagnosis*;Tuberculosis, Pulmonary/immunology
12856155;Adult;Carcinoma/blood;Carcinoma/drug therapy;Carcinoma/metabolism*;Carcinoma/radiotherapy;Dose-Response Relationship, Drug;Female;Humans;Iodine Radioisotopes/blood*;Iodine Radioisotopes/pharmacokinetics*;Iodine Radioisotopes/therapeutic use;Kinetics;Male;Metabolic Clearance Rate/drug effects;Middle Aged;Neoplasm Recurrence, Local/blood;Neoplasm Recurrence, Local/drug therapy;Neoplasm Recurrence, Local/metabolism*;Neoplasm Recurrence, Local/radiotherapy;Radiopharmaceuticals/pharmacokinetics;Radiopharmaceuticals/therapeutic use;Recombination, Genetic;Thyroid Gland/drug effects;Thyroid Gland/metabolism*;Thyroid Gland/radiation effects;Thyroid Neoplasms/blood;Thyroid Neoplasms/drug therapy;Thyroid Neoplasms/metabolism*;Thyroid Neoplasms/radiotherapy;Thyrotropin/administration & dosage*
12889060;Animals;Cell Movement*;Chick Embryo;Extracellular Matrix*;Fluorescent Antibody Technique;Heparin Lyase;Microscopy, Electron;Myocardium/cytology*;Pericardium/embryology*;Staining and Labeling
12909423;Accidents, Occupational/statistics & numerical data*;Adult;Attitude of Health Personnel*;Blood*;Cross-Sectional Studies;Female;Humans;Male;Medical Staff, Hospital/psychology*;Middle Aged;Nigeria/epidemiology;Nursing Staff, Hospital/psychology*;Surveys and Questionnaires
12928857;Activities of Daily Living/psychology;Adolescent;Automobiles/statistics & numerical data;Bicycling/physiology;Cross-Sectional Studies;Exercise/physiology*;Female;Humans;Low Back Pain/epidemiology;Low Back Pain/etiology*;Low Back Pain/physiopathology;Male;Norway;Physical Fitness/physiology*;Quality of Life/psychology;Risk Factors;Sports/physiology;Surveys and Questionnaires;Vibration/adverse effects;Walking/physiology
13016804;Animals;Dogs;Humans;Urinary Tract Physiological Phenomena*;Urine*
13039423;Clubfoot/therapy*;Heel*;Humans;Orthopedic Equipment*;Orthopedic Procedures*;Orthopedics/instrumentation*;Periostitis*;Rheumatic Diseases*;Splints*;Tenotomy*
13063210;Abortion, Induced*;Abortion, Spontaneous*;Female;Humans;Microscopy*;Pregnancy
13064207;Animals;Antiviral Agents*;Fungi*;Mice;Penicillium*;Poliomyelitis*;Poliovirus*
13074933;Colitis*;Colitis, Ulcerative*
13159609;Angiography*;Diagnosis, Differential*;Echinococcosis*;Humans;Lung*;Lung Neoplasms*;Neoplasms*
13190922;Humans;Neoplasms*;Penicillins/therapeutic use*;Psychotherapy, Multiple*;Sarcoma*;Sarcoma, Kaposi/therapy*
13212529;Anti-Bacterial Agents/therapeutic use*;Antibiotics, Antitubercular*;Bone Transplantation*;Humans;Jaw/surgery*;Orthognathic Surgery*
13283766;Animals;Heavy Metal Poisoning;Intestines/metabolism*;Metals, Heavy*;Mice;Nucleic Acids/metabolism*;Organometallic Compounds;Poisoning*;Research*;Thallium/poisoning*
13401778;Analgesics/therapeutic use*;Phenylbutazone/therapeutic use*;Rheumatic Fever/therapy*
13433022;Health Services Needs and Demand*;Occupational Health*
13451633;Carbohydrate Metabolism*;Carbohydrates*;Castor Bean*;Fats/metabolism*;Humans;Lipid Metabolism*;Seeds*
13493087;Cauda Equina*;Ependymoma*;Follow-Up Studies;Humans;Neoplasms*
13545781;Dihydrostreptomycin Sulfate/adverse effects*;Humans;Streptomycin/adverse effects*
13635283;Disease Management*;Face/surgery*;Humans;Maxilla/injuries*;Maxillofacial Injuries*
13636692;Blood Group Antigens*;Conservation of Natural Resources*;Erythrocytes*;Humans;Isoantibodies*;Oxygen/blood*;Rho(D) Immune Globulin*
13656303;Heart*;Heart Diseases*;Humans;Necrosis*
13695610;Communicable Diseases*;Nucleic Acids/chemistry*;Plants*;Tobacco Mosaic Virus*;Viruses*
13711127;Histological Techniques*;Humans;Liver/anatomy & histology*
13724091;Angina Pectoris/therapy*;Iproniazid/therapy*
13756245;Asia;Haptoglobins*;Mucoproteins/blood*;Transferrin*
13763525;Humans;Male;Radiation Injuries*
13797555;Dreams*;Humans;Schizophrenia/psychology*;Schizophrenic Psychology*
14078196;Animals;Humans;Lice Infestations*;Pediculus*;Phthiraptera*;Research*;Rickettsia*;Rickettsia Infections*;Ticks*
14244773;Air Pollution*;Air Pollution, Radioactive*;Gases*;Humans;Radiation Protection*;Radioactivity*;Radioisotopes*;Radiometry*
14249040;Cell Respiration*;Copper*;Copper Sulfate*;Culture Media*;Fermentation*;Metabolism*;Pharmacology*;Research*;Respiration*;Saccharomyces*;Saccharomyces cerevisiae*;Sulfates*
14314825;Aphasia*;Audiometry*;Child;Deafness*;Humans
14350060;Child;Eye*;Humans;Parents*;Refraction, Ocular*
14359665;Heart Failure/therapy*;Humans
14378263;Humans;Neurotic Disorders*;Periodicity*
14419960;Female;Humans;Pregnancy;Pregnancy Complications*;Stroke*;Uterine Hemorrhage*
14475784;Catheterization/complications*;Humans;Paraplegia/complications*;Urinary Tract Infections/etiology*
14567759;Administration, Oral;Analysis of Variance;Animals;Aphrodisiacs/pharmacology*;Aphrodisiacs/toxicity;Female;Male;Mice;Myristica fragrans*;Plant Extracts/pharmacology*;Plant Extracts/toxicity;Seeds;Sex Factors;Sexual Behavior, Animal/drug effects*;Syzygium*;Toxicity Tests, Acute
14618480;Adult;Aged;Analysis of Variance;Body Mass Index*;Cross-Sectional Studies;Electric Impedance*;Female;Humans;Male;Middle Aged;Predictive Value of Tests;Sex Characteristics
14666511;Animals;Cell Differentiation/physiology*;Cells, Cultured;Electroporation*;Embryo, Mammalian/cytology*;Gene Transfer Techniques;Genes, Reporter;Macaca fascicularis;Promoter Regions, Genetic/genetics*;Stem Cells/cytology*
14668618;Humans;Patient Selection;Positive-Pressure Respiration/methods*;Prone Position*;Pulmonary Gas Exchange;Research Design/standards;Respiratory Distress Syndrome, Adult/etiology;Respiratory Distress Syndrome, Adult/therapy*;Tidal Volume;Treatment Outcome
14686797;Adjuvants, Immunologic/pharmacology;Animals;Antibody-Producing Cells/drug effects;Antibody-Producing Cells/immunology;Echinacea*;Erythrocytes/immunology;Female;Humans;Immunization;Immunoglobulin M/biosynthesis*;Mice;Plant Extracts/pharmacology;Sheep
14703015;Adrenalectomy;Animals;Cell Membrane/metabolism;Cells, Cultured;Cytosol/metabolism;Immunoblotting;Pituitary Gland, Anterior/metabolism;Pituitary Gland, Anterior/physiology*;RNA, Messenger/biosynthesis;Radioimmunoassay;Rats;Receptors, Corticotropin-Releasing Hormone/biosynthesis;Receptors, Corticotropin-Releasing Hormone/physiology*
14782841;Blood Proteins*;Humans;Neoplasms*;Plasmacytoma*;Purpura*;Purpura, Hyperglobulinemic*
14841026;Fingersucking*;Humans
14880376;Behavior*;Humans;Psychological Tests*
14883722;Bronchoscopy*;Humans;Lung*;Tuberculosis*;Tuberculosis, Pulmonary*
14926657;Animals;Embryo, Mammalian/metabolism*;Embryo, Nonmammalian*;Histocytochemistry*;Neoplasms/metabolism*;Oxidoreductases*
14958521;Anti-Bacterial Agents*;Antibiotics, Antitubercular*;Dermatologic Agents*;Humans
14984921;Angioplasty, Balloon, Coronary/methods*;Cohort Studies;Coronary Angiography;Female;Hospital Mortality*/trends;Humans;Male;Middle Aged;Multivariate Analysis;Myocardial Infarction/complications;Myocardial Infarction/mortality;Myocardial Infarction/therapy*;Prospective Studies;Shock, Cardiogenic/complications*;Shock, Cardiogenic/mortality;Stents;Treatment Outcome
15023404;Epitopes, T-Lymphocyte/genetics;Epitopes, T-Lymphocyte/immunology;Humans;Immunotherapy/methods;Major Histocompatibility Complex;RNA, Messenger/metabolism*;T-Lymphocytes, Cytotoxic/physiology*
15173602;Adult;Canada/epidemiology;Female;Financing, Organized/economics;Health Care Costs;Health Expenditures;Health Resources/economics*;Health Status;Humans;Lupus Erythematosus, Systemic/economics*;Lupus Erythematosus, Systemic/epidemiology;Lupus Erythematosus, Systemic/mortality;Male;Outcome Assessment (Health Care)/economics*;Surveys and Questionnaires;United Kingdom/epidemiology;United States/epidemiology
15252840;Adenocarcinoma/genetics*;Adenocarcinoma/physiopathology*;Cadherins/biosynthesis*;Cadherins/genetics;Cadherins/pharmacology;Cell Transformation, Neoplastic;Colonic Neoplasms/genetics*;Colonic Neoplasms/physiopathology*;Cytoplasm;Disease Progression;Gene Expression Profiling*;Humans;Neoplasm Invasiveness/physiopathology*;Nuclear Proteins/pharmacology;RNA/analysis;Reverse Transcriptase Polymerase Chain Reaction;Transcription Factors/pharmacology;Twist-Related Protein 1
15296668;Health Services Research/methods*;Qualitative Research*;Research Design*
15313049;Adrenal Hyperplasia, Congenital/therapy*;Animals;Cystoscopy;Fetal Diseases/etiology;Fetal Diseases/surgery;Fetal Diseases/therapy*;Humans;Hydronephrosis/diagnosis;Hydronephrosis/etiology;Hydronephrosis/therapy*;Infant, Newborn;Meningomyelocele/surgery*;Prenatal Care;Ultrasonography, Prenatal;Urogenital Abnormalities/diagnostic imaging;Urogenital Abnormalities/therapy*
15320576;Aged;Chylothorax/drug therapy*;Coronary Artery Bypass*;Female;Humans;Internal Mammary-Coronary Artery Anastomosis*;Octreotide/therapeutic use*;Postoperative Complications/drug therapy*
15326503;Aged;Collateral Circulation*;Coronary Angiography;Coronary Circulation;Coronary Vessels/diagnostic imaging*;Diastole;Echocardiography, Doppler;Echocardiography, Transesophageal;Female;Humans
15413597;Feces*;Humans;Steatorrhea*
15419678;Breast Feeding*;Female;Humans;Lactation*
15424989;Denmark;Humans;Radiotherapy*
15493699;Algorithms*;Burns/classification;Burns/pathology*;Burns/physiopathology;Cicatrix/classification;Cicatrix/pathology*;Cicatrix/physiopathology;Cluster Analysis;Computer Simulation;Elasticity;Humans;Image Enhancement/methods;Image Interpretation, Computer-Assisted/methods*;Information Storage and Retrieval/methods;Models, Biological*;Pattern Recognition, Automated/methods;Reproducibility of Results;Sensitivity and Specificity;Severity of Illness Index;Skin/pathology*;Skin/physiopathology*
15501920;Bacterial Proteins/metabolism;Binding Sites;DNA/chemistry;DNA/metabolism*;DNA-Binding Proteins/metabolism;Deoxyribonucleases, Type III Site-Specific/metabolism*;Lac Repressors;Models, Biological;Protein Transport;Repressor Proteins/metabolism;Substrate Specificity
15627710;Arabidopsis/genetics;Arabidopsis/physiology*;Arabidopsis Proteins/genetics*;Arabidopsis Proteins/physiology;Cation Transport Proteins/genetics*;Cation Transport Proteins/physiology;Cell Membrane Permeability;Osmotic Pressure;Polyethylene Glycols/pharmacology;Signal Transduction/physiology*;Symporters/genetics*;Symporters/physiology
15689460;Aging;Disabled Persons/rehabilitation*;Humans;Research
15737624;Adaptation, Physiological/physiology;Animals;Aorta/cytology;Aorta/physiology;Blood Vessels/growth & development*;Cattle;Cell Culture Techniques/methods*;Cell Differentiation/physiology;Cell Movement/physiology*;Cells, Cultured;Elasticity;Endothelial Cells/physiology*;Integrins/metabolism;Matrix Metalloproteinases/metabolism;Mechanotransduction, Cellular/physiology*;Neovascularization, Physiologic/physiology*;Periodicity;Physical Stimulation/methods;Stress, Mechanical;Tissue Engineering/methods
15739599;Aged;Aged, 80 and over;Cholesterol, HDL/blood*;Frail Elderly/statistics & numerical data*;Homes for the Aged*;Humans;Logistic Models;Longitudinal Studies;Mortality*;Nursing Homes*;Risk Factors;Serum Albumin/analysis*
15746694;Abnormalities, Drug-Induced/etiology*;Abortion, Spontaneous/chemically induced;Antidepressive Agents, Second-Generation/adverse effects*;Birth Weight/drug effects;Bupropion/adverse effects*;Female;Fetal Death/chemically induced;Humans;Pregnancy;Pregnancy Outcome*;Prospective Studies;Smoking Cessation/methods
15778852;Animal Feed;Animals;Diet*;Duodenum/ultrastructure;Enterocytes/ultrastructure;Ileum/ultrastructure;Intestinal Mucosa/ultrastructure*;Intestine, Small/ultrastructure*;Jejunum/ultrastructure;Lichens;Male;Reindeer/physiology*;Seasons*
15791520;Adolescent;Area Under Curve;CD4 Lymphocyte Count;Child;Child, Preschool;Drug Therapy, Combination;Female;HIV Infections/drug therapy*;Humans;Indinavir/administration & dosage*;Indinavir/adverse effects;Indinavir/pharmacokinetics;Indinavir/therapeutic use*;Infant;Male;Ritonavir/administration & dosage*;Ritonavir/adverse effects;Ritonavir/therapeutic use*;Viral Load
15815113;Adolescent;Adult;Complementary Therapies/utilization*;Female;Humans;Italy;Male;Middle Aged;Socioeconomic Factors
15912522;Adipocytes/cytology;Adipocytes/metabolism;Animals;Cell Adhesion Molecules, Neuronal/metabolism*;Endothelium, Vascular/cytology;Endothelium, Vascular/embryology;Endothelium, Vascular/metabolism;Extracellular Matrix Proteins/metabolism*;Female;Fetal Development/physiology*;Fetus/embryology;Fetus/metabolism*;Fluorescent Antibody Technique, Indirect;Gestational Age;Humans;Immunoenzyme Techniques;Liver/cytology;Liver/embryology;Liver/metabolism*;Lymphatic Vessels/cytology;Lymphatic Vessels/embryology;Lymphatic Vessels/metabolism*;Nerve Tissue Proteins/metabolism*;Rats;Rats, Wistar;Serine Endopeptidases/metabolism*
15943164;1,4-alpha-Glucan Branching Enzyme/metabolism;Adult;Aged;Amylopectin/metabolism;Biopsy;Cardiomyopathies/etiology;Cardiomyopathies/metabolism;Cardiomyopathies/physiopathology;Child, Preschool;Disease Progression;Enzymes/metabolism;Female;Humans;Inclusion Bodies/metabolism;Inclusion Bodies/pathology;Inclusion Bodies/ultrastructure;Male;Microscopy, Electron, Transmission;Middle Aged;Muscle Fibers, Skeletal/metabolism;Muscle Fibers, Skeletal/pathology*;Muscle Fibers, Skeletal/ultrastructure;Muscle Weakness/etiology;Muscle Weakness/pathology;Muscle Weakness/physiopathology;Muscle, Skeletal/metabolism;Muscle, Skeletal/pathology*;Muscle, Skeletal/ultrastructure;Muscular Diseases/metabolism*;Muscular Diseases/pathology*;Muscular Diseases/physiopathology;Polysaccharides/metabolism*
15945236;Adrenergic beta-Antagonists/therapeutic use;Angiotensin II/antagonists & inhibitors;Angiotensin-Converting Enzyme Inhibitors/therapeutic use;Chronic Disease;Defibrillators, Implantable;Digitalis Glycosides/therapeutic use;Diuretics/therapeutic use;Endothelin Receptor Antagonists;Erythropoietin/therapeutic use;Heart Failure*/diagnosis;Heart Failure*/drug therapy;Heart Failure*/epidemiology;Heart Failure*/physiopathology;Heart Failure*/prevention & control;Heart Failure*/therapy;Heart-Assist Devices;Humans;Hungary/epidemiology;Immunologic Factors/therapeutic use;Mineralocorticoid Receptor Antagonists/therapeutic use;Pacemaker, Artificial;Peptide Hydrolases/drug effects;Primary Prevention/methods;Risk Factors;Severity of Illness Index;Vasopressins/antagonists & inhibitors
15946570;Aged;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;CA-125 Antigen/blood;Cisplatin/therapeutic use;Combined Modality Therapy;Cyclophosphamide/therapeutic use;Cystadenocarcinoma, Papillary*/blood;Cystadenocarcinoma, Papillary*/drug therapy;Cystadenocarcinoma, Papillary*/pathology;Cystadenocarcinoma, Papillary*/surgery;Disease-Free Survival;Doxorubicin/analogs & derivatives;Doxorubicin/therapeutic use;Female;Follow-Up Studies;Humans;Middle Aged;Neoplasm Staging;Ovarian Neoplasms*/blood;Ovarian Neoplasms*/drug therapy;Ovarian Neoplasms*/pathology;Ovarian Neoplasms*/surgery;Paclitaxel;Peritoneal Neoplasms*/blood;Peritoneal Neoplasms*/drug therapy;Peritoneal Neoplasms*/pathology;Peritoneal Neoplasms*/surgery;Retrospective Studies;Taxoids/therapeutic use
16033137;Adult;Diagnosis, Differential;Granuloma, Plasma Cell/diagnosis*;Granuloma, Plasma Cell/pathology;Granuloma, Plasma Cell/surgery;Histiocytosis, Sinus/diagnosis*;Histiocytosis, Sinus/pathology;Histiocytosis, Sinus/surgery;Humans;Magnetic Resonance Imaging;Male;Paranasal Sinuses/pathology*;Paranasal Sinuses/surgery;Skull Base/pathology*;Skull Base/surgery;Spinal Cord/pathology*;Spinal Cord/surgery;Treatment Outcome
16199599;Donor Selection/ethics*;Family;Female;HLA Antigens/immunology*;Hematopoietic Stem Cell Transplantation/ethics*;Histocompatibility Testing/ethics*;Histocompatibility Testing/methods;Humans;Intention;Pregnancy;Preimplantation Diagnosis/ethics;Risk Factors;Tissue Banks/ethics;Tissue and Organ Harvesting/ethics;Tissue and Organ Harvesting/methods
16216426;Animals;Central Nervous System Depressants/antagonists & inhibitors;Central Nervous System Depressants/pharmacology*;Depression, Chemical;Ethanol/antagonists & inhibitors;Ethanol/pharmacology*;GABA Antagonists/pharmacology;Hippocampus/drug effects*;In Vitro Techniques;Long-Term Potentiation/drug effects*;Male;Neuronal Plasticity/drug effects*;Picrotoxin/pharmacology;Rats;Rats, Sprague-Dawley;Receptors, N-Methyl-D-Aspartate/drug effects
16230478;Animals;Dendritic Cells/cytology;Dendritic Cells/metabolism;Humans;Interferon-alpha/blood*;Leukocytes, Mononuclear/metabolism;Lupus Erythematosus, Systemic/blood;Lupus Erythematosus, Systemic/etiology*;Lupus Erythematosus, Systemic/metabolism;Mice;Mice, Inbred BALB C;Oligonucleotides/metabolism*;Reverse Transcriptase Polymerase Chain Reaction;Signal Transduction*;Toll-Like Receptor 7/metabolism*;Toll-Like Receptor 9/metabolism*;Viruses/immunology
16320667;Adult;Ear Neoplasms/complications;Ear Neoplasms/diagnosis*;Ear Neoplasms/pathology;Female;Headache/etiology;Hearing Loss/etiology;Humans;Magnetic Resonance Imaging;Meningeal Neoplasms/complications;Meningeal Neoplasms/diagnosis*;Meningeal Neoplasms/pathology;Meningioma/complications;Meningioma/diagnosis*;Meningioma/pathology;Neurilemmoma/complications;Neurilemmoma/diagnosis*;Neurilemmoma/pathology;Neurofibromatosis 2/complications;Neurofibromatosis 2/diagnosis*;Neurofibromatosis 2/pathology;Tinnitus/etiology;Vestibule, Labyrinth*
16327872;Antipsychotic Agents/adverse effects;Antipsychotic Agents/therapeutic use;Death, Sudden, Cardiac/epidemiology;Electrocardiography/drug effects;Heart Diseases/chemically induced;Heart Diseases/complications*;Heart Diseases/epidemiology*;Humans;Schizophrenia/complications*;Schizophrenia/drug therapy;Schizophrenia/epidemiology*
16388076;Humans;Life Change Events*;Stress Disorders, Post-Traumatic*/diagnosis;Terminology as Topic*
16392873;Animals;Calcitonin Gene-Related Peptide/antagonists & inhibitors*;Calcitonin Gene-Related Peptide/metabolism*;Cerebrovascular Circulation/drug effects;Headache Disorders, Primary/drug therapy*;Headache Disorders, Primary/physiopathology;Humans;Migraine Disorders/drug therapy;Migraine Disorders/physiopathology;Receptors, Calcitonin Gene-Related Peptide/antagonists & inhibitors;Receptors, Calcitonin Gene-Related Peptide/metabolism;Trigeminal Nerve/drug effects;Trigeminal Nerve/physiopathology
16394907;Adolescent;Adult;Child;Child, Preschool;Humans;Incidence;Infant;Injury Severity Score;Retrospective Studies;Risk Assessment;Survival Rate;Thromboembolism/epidemiology*;Thromboembolism/etiology;Thromboembolism/prevention & control*;Treatment Outcome;Venous Thrombosis/epidemiology*;Venous Thrombosis/etiology;Venous Thrombosis/prevention & control*;Wounds and Injuries/complications*;Wounds and Injuries/therapy
16427609;Animals;Chromosome Aberrations;Codon, Initiator;Cystatins/genetics*;DNA, Complementary/metabolism;Down-Regulation;Exons;Female;Gene Expression Regulation, Developmental*;Genotype;Immunohistochemistry;Male;Mice;Mice, Knockout;Mice, Transgenic;Models, Genetic;Open Reading Frames;Ovary/metabolism;Promoter Regions, Genetic;RNA, Messenger/metabolism;Reverse Transcriptase Polymerase Chain Reaction;Sex Differentiation*;Spermatogenesis;Spermatozoa/metabolism;Testis/metabolism;Time Factors;Up-Regulation
16740148;Alleles;Amino Acid Substitution;Ascomycota/physiology*;Cloning, Molecular;Crops, Agricultural/genetics*;Evolution, Molecular*;Gene Pool;Genes, Plant;Genetic Variation;Immunity, Innate;Polyploidy;Triticum/genetics*;Triticum/physiology
16792647;Adult;Alopecia/epidemiology;Alopecia/surgery*;Equipment Design;Follow-Up Studies;Graft Survival*;Hair Follicle/transplantation*;Humans;Incidence;Korea/epidemiology;Male;Middle Aged;Retrospective Studies;Transplantation, Autologous/instrumentation;Treatment Outcome
16799899;Disease Progression;Esophagitis/etiology;Esophagitis/physiopathology*;Follow-Up Studies;Gastroesophageal Reflux/physiopathology*;Humans
16810882;Bilirubin*;Blood*;Blood Proteins*;Humans
16828035;Humans;Legionellosis/diagnosis*;Legionellosis/epidemiology;Legionellosis/prevention & control;Legionellosis/transmission;Sanitation/standards
16884100;Adult;Aged;Female;Follow-Up Studies;Humans;Kidney Neoplasms/surgery*;Laparoscopy/methods*;Male;Middle Aged;Nephrectomy/methods*;Peritoneum
16905421;Antineoplastic Agents/administration & dosage;Catheter Ablation;Colorectal Neoplasms/pathology*;Contraindications;Hepatectomy;Humans;Laparoscopy;Liver Neoplasms/secondary*;Liver Neoplasms/therapy*;Liver Transplantation;Microwaves/therapeutic use
16949480;Atherosclerosis/physiopathology*;Atherosclerosis/prevention & control;Cardiovascular Diseases/physiopathology*;Cardiovascular Diseases/prevention & control;Case-Control Studies;Cross-Sectional Studies;Folic Acid/therapeutic use;Homocysteine/blood;Homocysteine/metabolism*;Humans;Prospective Studies;Risk Factors;Thrombosis/physiopathology*;Thrombosis/prevention & control;Treatment Outcome
16952067;Animals;Biomarkers*;DNA/genetics;DNA/physiology*;DNA Methylation;DNA, Mitochondrial/physiology;Genome, Human*;Humans;Multiple Sclerosis/diagnosis;Multiple Sclerosis/therapy;Neoplasms/diagnosis;Neoplasms/therapy;Oncogenes/genetics;Proteins/genetics;Proteins/physiology*;Proteomics/trends*
16996997;Angiotensin-Converting Enzyme Inhibitors/adverse effects*;Aprotinin/adverse effects*;Cardiac Surgical Procedures/adverse effects*;Cardiovascular Agents/adverse effects*;Drug Synergism;Hemostatics/adverse effects*;Humans;Renal Insufficiency/chemically induced;Renal Insufficiency/etiology*
17004601;Adult;Aged;Aged, 80 and over;Female;Follow-Up Studies;Hip Prosthesis*;Humans;Male;Middle Aged;Prosthesis Design;Time Factors;Titanium*;Treatment Outcome
17018304;Adult;Aged;Aged, 80 and over;Female;Humans;Male;Middle Aged;Neoplasm Staging/methods;Radiographic Image Enhancement*;Rectal Neoplasms/diagnostic imaging*;Rectal Neoplasms/pathology;Sensitivity and Specificity;Statistics, Nonparametric;Tomography, X-Ray Computed/methods*
17112846;ATP-Binding Cassette, Sub-Family B, Member 1/genetics*;Body Weight;China;Dose-Response Relationship, Drug;Genotype;Immunosuppressive Agents/blood;Immunosuppressive Agents/pharmacokinetics;Immunosuppressive Agents/therapeutic use;Kidney Transplantation/immunology;Kidney Transplantation/physiology*;Polymorphism, Single Nucleotide*;Retrospective Studies;Tacrolimus/blood;Tacrolimus/pharmacokinetics*;Tacrolimus/therapeutic use
17130349;Adult;Aorta/anatomy & histology;Coronary Vessel Anomalies/diagnosis*;Coronary Vessel Anomalies/pathology;Coronary Vessels/anatomy & histology;Fatal Outcome;Humans;Male;Pulmonary Artery/anatomy & histology
17136212;Education, Pharmacy/trends*;Faculty*;Humans;Patient Selection;Schools, Pharmacy*;Students, Pharmacy
17229231;Aged;Blood Pressure;Cardiac Output;Cardiovascular Physiological Phenomena*;Coronary Artery Bypass*;Female;Humans;Lung/physiology*;Male;Middle Aged;Sternum/surgery*;Ventricular Function, Left
17265404;Clostridium difficile*;Cross Infection;Diarrhea/microbiology;Diarrhea/prevention & control*;Disinfectants*;Enterocolitis, Pseudomembranous/prevention & control;Humans;Intensive Care Units;Sodium Hypochlorite/pharmacology*
17301464;Algorithms*;Body Burden;Computer Simulation;Models, Biological*;Photons/therapeutic use*;Radiometry/methods*;Radiotherapy Dosage;Radiotherapy Planning, Computer-Assisted/methods*;Radiotherapy, High-Energy/methods*;Relative Biological Effectiveness
17365248;Aged;Alzheimer Disease/epidemiology;Alzheimer Disease/psychology;Artifacts;Cognition/physiology;Cohort Studies;Dementia/epidemiology*;Dementia/psychology;Dementia, Vascular/epidemiology;Dementia, Vascular/psychology;Education*;Female;Follow-Up Studies;Humans;Intelligence/physiology;Longitudinal Studies;Male;Mental Processes/physiology;Neuropsychological Tests;Research Design;Risk Factors;Sex Factors;Socioeconomic Factors;Survivors
17449211;Aged;Aged, 80 and over;Amino Acid Sequence;Anti-Bacterial Agents/pharmacology;Base Sequence;Cluster Analysis;Community-Acquired Infections/microbiology*;Cross Infection/microbiology*;DNA Fingerprinting;DNA, Bacterial/genetics;Escherichia coli/enzymology*;Escherichia coli/isolation & purification;Escherichia coli Infections/microbiology*;Female;Humans;Klebsiella Infections/microbiology*;Klebsiella pneumoniae/enzymology*;Klebsiella pneumoniae/isolation & purification;Male;Microbial Sensitivity Tests;Middle Aged;Molecular Epidemiology;Molecular Sequence Data;Sequence Analysis, DNA;Thailand;beta-Lactamases/analysis;beta-Lactamases/genetics*
17475379;Anti-Obesity Agents/adverse effects*;Anti-Obesity Agents/history;Anti-Obesity Agents/pharmacology;Anti-Obesity Agents/therapeutic use;Dinitrophenols/adverse effects*;Dinitrophenols/history;Dinitrophenols/pharmacology;Dinitrophenols/therapeutic use;Health Knowledge, Attitudes, Practice;History, 20th Century;Humans;Legislation, Drug/history*;Obesity/drug therapy*;Physicians;Quackery/history;United States;United States Food and Drug Administration/history;United States Food and Drug Administration/legislation & jurisprudence
17494399;Animals;Animals, Domestic/physiology;Animals, Wild/physiology;Conservation of Natural Resources*;Feeding Behavior;Models, Statistical;Plant Development*;Rain;South Africa
17616331;Adult;Anti-HIV Agents/therapeutic use;Antiviral Agents/therapeutic use*;Causality;Comorbidity;Depression/epidemiology*;Drug Therapy, Combination;Fatigue/epidemiology*;Female;France/epidemiology;HIV Infections/drug therapy*;HIV Infections/epidemiology*;Hepatitis C/drug therapy*;Hepatitis C/epidemiology*;Humans;Male;Middle Aged;Prevalence;Risk Assessment/methods*;Risk Factors;Self-Examination;Surveys and Questionnaires
17624549;Castor Oil/chemistry*;Chromatography, Gel;Electrophoresis, Polyacrylamide Gel;Kinetics;Phosphorylation;Protein-Serine-Threonine Kinases/chemistry;Protein-Serine-Threonine Kinases/isolation & purification*;Seeds/enzymology*
17671223;Animals;Biomarkers, Tumor/genetics;Biomarkers, Tumor/metabolism;Blotting, Northern;Blotting, Western;Carcinoma, Squamous Cell/metabolism*;Carcinoma, Squamous Cell/prevention & control;Carcinoma, Squamous Cell/secondary;Cell Division/physiology;Female;Head and Neck Neoplasms/metabolism;Head and Neck Neoplasms/pathology;Head and Neck Neoplasms/prevention & control*;Humans;Lung Neoplasms/metabolism;Lung Neoplasms/prevention & control*;Lung Neoplasms/secondary;Mice;Mice, Nude;Molecular Sequence Data;Neovascularization, Pathologic/prevention & control;Oligonucleotide Array Sequence Analysis;Oligopeptides/therapeutic use*;RNA, Messenger/genetics;RNA, Messenger/metabolism;Receptors, CXCR4/antagonists & inhibitors;Receptors, CXCR4/genetics;Receptors, CXCR4/metabolism*;Reverse Transcriptase Polymerase Chain Reaction;Transduction, Genetic
17680843;Adult;Blood Glucose/metabolism;Body Mass Index;Case-Control Studies;Fatty Liver/blood*;Fatty Liver/pathology;Fatty Liver/virology*;Female;Glucose Tolerance Test;Hepatitis C, Chronic/blood*;Hepatitis C, Chronic/complications*;Hepatitis C, Chronic/pathology;Humans;Insulin/blood*;Insulin Resistance/physiology*;Male;Middle Aged;Risk Factors
17710418;Birth Weight;Child;Child, Preschool;Cognition/physiology*;Developmental Disabilities/epidemiology*;Diseases in Twins/epidemiology*;Female;Humans;Infant, Newborn;Infant, Premature, Diseases/epidemiology*;Male;Neuropsychological Tests;Pregnancy;Premature Birth;Twins/physiology*
17846111;Aged;Causality;Comorbidity;Diffusion Magnetic Resonance Imaging;Female;Humans;Intracranial Embolism/diagnostic imaging;Intracranial Embolism/drug therapy;Intracranial Embolism/epidemiology;Ischemic Attack, Transient/diagnosis;Ischemic Attack, Transient/epidemiology;Male;Middle Cerebral Artery/diagnostic imaging;Multivariate Analysis;Prospective Studies;Risk Factors;Secondary Prevention;Stroke/diagnosis*;Stroke/epidemiology;Time Factors;Ultrasonography, Doppler, Transcranial
17874277;Basic Helix-Loop-Helix Transcription Factors/blood;Blotting, Western;Carcinoid Tumor/physiopathology*;Cell Cycle/drug effects*;Cell Proliferation/drug effects*;Chromogranin A/blood;Cyclin D1/analysis;Humans;Hydroxamic Acids/pharmacology*;Receptor, Notch1/drug effects;Tumor Cells, Cultured
17894662;Hot Temperature/therapeutic use*;Humans;Infection Control;Oxygen/therapeutic use*;Perfusion*;United Kingdom;Wound Healing/physiology*
17926425;Air Pollutants/chemistry;Air Pollutants/isolation & purification*;Air Pollutants/metabolism;Air Pollution/prevention & control;Biodegradation, Environmental;Biofilms*;Bioreactors/microbiology*;Filtration/instrumentation;Pseudomonas putida/metabolism;Pseudomonas putida/physiology*;Toluene/chemistry;Toluene/isolation & purification*;Toluene/metabolism;Volatilization
18123257;Appendix*;Cecal Diseases*;Disease*;Intestinal Diseases*
18237138;Animals;Biomedical Engineering*;Biotechnology*;Humans
18279346;Bacteria/classification;Bacteria/genetics;Bacteria/growth & development*;Biomass;DNA Fingerprinting;DNA, Bacterial/genetics;DNA, Bacterial/isolation & purification;Electrophoresis, Polyacrylamide Gel;Metals, Heavy/metabolism*;Microbial Viability/drug effects*;Nitrosomonadaceae/genetics;Nucleic Acid Denaturation;Phylogeny;Plant Roots/microbiology*;Populus/metabolism*;Populus/microbiology;Pseudomonas fluorescens/genetics;RNA, Ribosomal, 16S/genetics;Sequence Analysis, DNA;Sequence Homology;Soil Microbiology*;Soil Pollutants/metabolism*
18300559;Case Management;Family*;Humans;Indiana;Multi-Institutional Systems/standards*;Organizational Case Studies;Patient Participation*;Safety Management/organization & administration*
18374027;Drainage/methods*;Endoscopy/methods*;Feasibility Studies;Humans;Pancreatic Ducts/diagnostic imaging;Pancreatic Ducts/pathology;Pancreatic Ducts/surgery*;Pancreatic Fistula/diagnosis;Pancreatic Fistula/etiology;Pancreatic Fistula/surgery*;Pancreatic Pseudocyst/diagnosis;Pancreatic Pseudocyst/etiology;Pancreatic Pseudocyst/surgery*;Pancreatitis, Acute Necrotizing/complications*;Tomography, X-Ray Computed;Treatment Outcome
18378566;Adolescent;Adult;Aged;Anemia, Aplastic/surgery*;Antineoplastic Combined Chemotherapy Protocols/therapeutic use;Blast Crisis/surgery;Decision Making;Female;Graft vs Host Disease/drug therapy;Graft vs Host Disease/surgery*;Health Care Surveys;Health Services Accessibility;Healthcare Disparities;Hematopoietic Stem Cell Transplantation*/standards;Hematopoietic Stem Cell Transplantation*/statistics & numerical data;Humans;Immunosuppressive Agents/therapeutic use;Internet;Leukemia/drug therapy;Leukemia/surgery*;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/surgery*;Leukemia, Myeloid, Acute/surgery;Lymphoma, Non-Hodgkin/surgery*;Male;Middle Aged;Patient Selection*;Practice Guidelines as Topic;Practice Patterns, Physicians'*/standards;Practice Patterns, Physicians'*/statistics & numerical data;Precursor Cell Lymphoblastic Leukemia-Lymphoma/surgery;Quality of Health Care;Residence Characteristics;Surveys and Questionnaires;Transplantation Conditioning;Transplantation, Homologous
18428080;Adult;Diagnosis, Differential;Female;Humans;Panic Disorder/chemically induced*;Panic Disorder/therapy*;Patient Education as Topic;Psychoses, Substance-Induced/etiology*;Psychoses, Substance-Induced/therapy*;Relaxation;Sodium Lactate*/adverse effects
18573633;Bacteria, Aerobic/metabolism*;Bioreactors/microbiology*;Forecasting;Industrial Waste/prevention & control*;Sewage/microbiology*;Water Pollution/prevention & control*;Water Purification/methods*
18590769;Actins/metabolism;Animals;Bluetongue/virology*;Bluetongue virus/genetics;Bluetongue virus/physiology*;Cattle;Cattle Diseases/virology*;RNA, Viral/analysis;RNA, Viral/genetics*;Reverse Transcriptase Polymerase Chain Reaction/methods*;Sheep
18663580;Brain/drug effects;Brain/embryology;Child;Child Nutrition Disorders/epidemiology;Child Nutrition Disorders/metabolism;Child Nutrition Disorders/prevention & control*;Developing Countries;Female;Fetal Development/drug effects;Humans;Hypothyroidism/epidemiology;Hypothyroidism/metabolism;Hypothyroidism/prevention & control*;India/epidemiology;Iodine/deficiency*;Iodine/pharmacology;Maternal Nutritional Physiological Phenomena;Pregnancy;Psychometrics;Sodium Chloride, Dietary/pharmacology;Thyroid Hormones/metabolism;Thyroid Hormones/pharmacology
18675801;Animals;Cell Division/genetics;Cells, Cultured;Chromosome Mapping;Chromosomes/genetics*;DNA Replication/genetics*;Embryo, Mammalian/cytology;Embryo, Mammalian/metabolism*;Embryonic Development/genetics*;Epigenesis, Genetic/genetics;Female;Fertilization/genetics;Genomic Imprinting/genetics*;Genomic Instability/genetics;In Situ Hybridization, Fluorescence;Male;Mice;Mice, Inbred C57BL;Morula/cytology;Morula/metabolism;RNA, Untranslated/genetics;Time Factors;Transcriptional Activation/genetics;Zygote/cytology;Zygote/metabolism
18859141;Aqueous Humor*;Humans;Leprosy*
18920363;Immunity*
18976433;European Continental Ancestry Group/genetics*;Gene Frequency;Genetic Predisposition to Disease*;HLA-DR Antigens/genetics*;HLA-DRB1 Chains;Humans;Keloid/ethnology;Keloid/genetics*;Keloid/immunology;Phenotype
19057792;Base Sequence;DNA/chemistry*;Kinetics;Nucleic Acid Hybridization*;Surface Plasmon Resonance
19195524;Body Mass Index;Coronary Artery Disease/etiology*;Death, Sudden, Cardiac/etiology*;Echocardiography;Humans;Hypertrophy, Left Ventricular/complications*;Hypertrophy, Left Ventricular/diagnosis*;Obesity/complications*;Risk Factors
19205006;Analysis of Variance;Biometry/methods*;Clinical Trials as Topic/statistics & numerical data*;Computer Simulation/statistics & numerical data;Dose-Response Relationship, Drug*;Humans;Models, Statistical
19248229;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Biopharmaceutics/classification*;Cell Line;Cell Membrane Permeability*;Humans;Hydrogen-Ion Concentration;Pharmaceutical Preparations/metabolism*;Time Factors
19276920;Adult;External Fixators;Fracture Fixation/instrumentation*;Fractures, Bone/rehabilitation;Fractures, Bone/surgery*;Fractures, Comminuted/rehabilitation;Fractures, Comminuted/surgery;Hand Strength;Humans;Male;Metacarpal Bones/injuries*;Range of Motion, Articular;Thumb/injuries*;Young Adult
19282141;Acute Disease;Adult;Arousal*;Diagnostic and Statistical Manual of Mental Disorders;Escape Reaction*;Factor Analysis, Statistical;Female;Humans;Male;Mood Disorders/diagnosis;Mood Disorders/psychology*;Severity of Illness Index;Stress Disorders, Post-Traumatic/diagnosis;Stress Disorders, Post-Traumatic/psychology*
19285442;Adolescent;Anthropometry;Bone Density;Child;Cholesterol/metabolism;Chylomicrons/metabolism*;Cohort Studies;Diarrhea/etiology;Diarrhea/metabolism;Eye Diseases/etiology;Eye Diseases/metabolism;Fatty Acids/metabolism;Female;Humans;Intestinal Absorption/genetics;Male;Monomeric GTP-Binding Proteins/genetics*;Mutation;Nervous System Diseases/etiology;Nervous System Diseases/metabolism;Steatorrhea/genetics;Steatorrhea/metabolism*;Vitamin E/metabolism
19351464;Accidents, Traffic*;Adolescent;Adult;Aged;Aged, 80 and over;Aorta, Thoracic;Aortic Rupture/etiology;Aortic Rupture/surgery;Biomarkers/blood;Creatine Kinase, MB Form/blood*;Electrocardiography;Female;Fracture Fixation, Internal/methods;Fractures, Bone/complications*;Fractures, Bone/diagnosis;Fractures, Bone/enzymology*;Fractures, Bone/surgery;Heart Injuries/diagnosis;Heart Injuries/enzymology*;Heart Injuries/etiology*;Heart Injuries/surgery;Humans;Injury Severity Score;Male;Middle Aged;Pericardial Effusion/etiology;Retrospective Studies;Sternum/injuries*;Treatment Outcome
19400006;Cataract*;Cataract Extraction*;Humans;Internet*;Lens Implantation, Intraocular*;Ophthalmology*;Patient Education as Topic/methods*;Patient Satisfaction;United States
19404332;Adaptor Proteins, Signal Transducing/physiology;Animals;Endopeptidases/physiology;Genes, Viral/physiology;Host-Pathogen Interactions/physiology*;Humans;Models, Biological;Ubiquitin/physiology*;Ubiquitin-Protein Ligases/physiology;Viral Proteins/physiology
19428897;Animals;Aotidae/immunology*;Disease Models, Animal;Immunogenetic Phenomena/genetics;Immunogenetic Phenomena/immunology*;Malaria Vaccines/genetics;Malaria Vaccines/immunology*;Malaria Vaccines/metabolism;Plasmodium vivax/genetics*;Plasmodium vivax/immunology*;Plasmodium vivax/metabolism;Protozoan Proteins/genetics*;Protozoan Proteins/immunology*;Protozoan Proteins/isolation & purification;Protozoan Proteins/metabolism
19429506;Animals;Antigens, Helminth*/therapeutic use;Antigens, Surface/drug effects;Databases, Nucleic Acid;Drug Delivery Systems/methods*;Genes, Helminth;Humans;Life Cycle Stages/immunology;Proteomics/methods*;Schistosoma/genetics*;Schistosoma/immunology*;Schistosoma/metabolism;Schistosomiasis/prevention & control;Vaccines/immunology*;Vaccines/therapeutic use
19549177;Adolescent;Breast;Child;Cicatrix/pathology;Cicatrix/radiotherapy*;Female;Follow-Up Studies;Humans;Low-Level Light Therapy/methods*;Patient Satisfaction;Skin/pathology*;Skin/radiation effects;Thigh
19580367;Aerosols;Airway Obstruction/etiology*;Communicable Diseases/transmission;Exhalation;Humans;Models, Biological*;Respiration*;Respiratory Mechanics
19635079;Autistic Disorder/psychology*;Child;Electromyography;Emotions/physiology*;Facial Expression*;Humans;Male
19660598;Aged;Angioplasty, Balloon, Coronary*;Cohort Studies;Echocardiography, Doppler, Color;Female;Humans;Male;Middle Aged;Myocardial Infarction/diagnostic imaging;Myocardial Infarction/physiopathology*;Myocardial Infarction/therapy*;Risk Factors;Stress, Mechanical;Stroke Volume/physiology;Time Factors;Troponin T/blood*;Ventricular Function, Left/physiology*
19680898;Benzhydryl Compounds;Chromatography, Liquid/methods;Dietary Fats/analysis*;Estrogens, Non-Steroidal/analysis*;Fluorometry/methods;Food Analysis/methods*;Food Contamination/analysis;Food Preservation*;Phenols/analysis*;Risk Factors;Spain
19735583;Algorithms;Alphaproteobacteria/genetics;Alphaproteobacteria/metabolism;Animals;Gene Expression Regulation;Genome;Humans;RNA, Untranslated/genetics*;RNA, Untranslated/metabolism;Sequence Analysis, RNA/methods;Sequence Homology, Nucleic Acid
19744567;Aged;Anisotropy;Brain/anatomy & histology*;Corpus Callosum/anatomy & histology;Diffusion Tensor Imaging/methods*;Female;Humans;Image Processing, Computer-Assisted;Longitudinal Studies;Male;Middle Aged;Neural Pathways/anatomy & histology;Observer Variation;Organ Size;Pyramidal Tracts/anatomy & histology;Reproducibility of Results;Time Factors
19769869;Humans;Ocular Hypertension/pathology*;Ocular Hypertension/physiopathology*;Prospective Studies;Retina/pathology;Visual Field Tests*/methods
19797924;Absorptiometry, Photon*;Adult;Antirheumatic Agents/therapeutic use;Bone Density;Bone Diseases, Metabolic/complications*;Female;Femur;Follow-Up Studies;Humans;Male;Middle Aged;Ossification, Heterotopic/complications*;Osteoporosis/complications;Severity of Illness Index;Spine;Spondylitis, Ankylosing/complications*;Spondylitis, Ankylosing/drug therapy
19837921;Adult;Amenorrhea/blood*;Amenorrhea/psychology*;Anorexia Nervosa/blood*;Anorexia Nervosa/psychology*;Anxiety/blood*;Anxiety/psychology*;Body Weight/physiology;Bone Density/physiology;Bone Diseases/blood*;Data Interpretation, Statistical;Depressive Disorder/blood*;Depressive Disorder/psychology*;Female;Humans;Hydrocortisone/blood*;Hypothalamic Diseases/blood*;Hypothalamic Diseases/psychology*;Psychiatric Status Rating Scales;Young Adult
20069676;Atrioventricular Block/diagnostic imaging*;Atrioventricular Block/embryology;Atrioventricular Block/physiopathology;Echocardiography, Doppler/methods*;Echocardiography, Doppler/standards;Female;Heart Rate, Fetal/physiology*;Humans;Pregnancy;Prospective Studies;ROC Curve;Reference Values;Ultrasonography, Prenatal
20070878;Adolescent;Analysis of Variance;Chi-Square Distribution;Child;Conduct Disorder/classification;Conduct Disorder/complications;Conduct Disorder/psychology*;Cross-Sectional Studies;Executive Function*;Female;Humans;Male;Memory;Memory Disorders/complications;Memory Disorders/psychology*;Neuropsychological Tests;Psychiatric Status Rating Scales;Severity of Illness Index
20075327;Age Factors;Analysis of Variance;Career Mobility*;Centers for Disease Control and Prevention (U.S.)/organization & administration*;Decision Making, Organizational;Educational Status;Employment/organization & administration;Fellowships and Scholarships;Female;Gender Identity*;Humans;Logistic Models;Male;Personnel Staffing and Scheduling/organization & administration;Policy Making;Prejudice;Public Health Administration/education;Public Health Administration/trends*;Salaries and Fringe Benefits/statistics & numerical data*;Sex Factors;Time Factors;United States;Women, Working/education;Women, Working/psychology;Women, Working/statistics & numerical data*
20171018;Aged;Aging/metabolism*;Cohort Studies;Female;Humans;Hydrocortisone/analysis;Hydrocortisone/secretion*;Male;Middle Aged;Pituitary-Adrenal System/chemistry;Pituitary-Adrenal System/physiology*;Saliva/chemistry;Sex Factors;Sleep/physiology;Smoking;Wakefulness/physiology;Walking/physiology
20220228;Anti-Bacterial Agents/isolation & purification;Bioreactors*;Chromatography, Liquid/methods;Endocrine Disruptors/chemistry;Endocrine Disruptors/isolation & purification*;Endocrine System/drug effects*;Humans;Mass Spectrometry/methods;Membranes, Artificial;Pharmaceutical Preparations/analysis;Sewage/chemistry;Trimethoprim/isolation & purification;Waste Disposal, Fluid/methods;Water Pollutants, Chemical/isolation & purification*;Water Purification/methods*
20240000;Appetite*;Diet/psychology*;Feeding Behavior*;Food Preferences*;Humans;Learning*
20288062;Humans;Nephritis/therapy*
20448521;Adult;Aged;Cognition Disorders/diagnosis;Cognition Disorders/etiology*;Depression/therapy*;Diagnostic and Statistical Manual of Mental Disorders;Electroconvulsive Therapy/adverse effects*;Female;Humans;Male;Memory Disorders/diagnosis;Memory Disorders/etiology*;Mental Status Schedule;Middle Aged;Neuropsychological Tests;Outcome Assessment (Health Care);Regression Analysis;Retrospective Studies;Severity of Illness Index
20464587;Age Factors;Aged;Aged, 80 and over;Biofeedback, Psychology;Chronic Disease/therapy;Diagnosis, Differential;Female;Headache Disorders, Primary/diagnosis*;Headache Disorders, Primary/physiopathology;Headache Disorders, Primary/therapy;Humans;Male;Relaxation Therapy;Risk Factors;Sex Factors
20465223;Cerebral Ventricles*;Cerebrospinal Fluid/chemistry*;Dextrans/chemistry;Humans;Microdialysis/methods*;Perfusion;Polymers/chemistry;Proteins/analysis*;Proteins/isolation & purification;Surface Properties
20537372;Aged;Aged, 80 and over;Analysis of Variance;Asymptomatic Diseases;Brain Ischemia/blood;Brain Ischemia/complications;Brain Ischemia/drug therapy*;Chi-Square Distribution;Female;Fibrinolytic Agents/adverse effects*;Germany;Humans;Intracranial Hemorrhages/blood;Intracranial Hemorrhages/chemically induced;Intracranial Hemorrhages/diagnosis*;Magnetic Resonance Imaging;Male;Middle Aged;Odds Ratio;Predictive Value of Tests;Prothrombin Time*;Recombinant Proteins/adverse effects;Risk Assessment;Risk Factors;Stroke/blood;Stroke/drug therapy*;Stroke/etiology;Thrombolytic Therapy/adverse effects*;Tissue Plasminogen Activator/adverse effects*;Treatment Outcome
20596752;Antibiotics, Antineoplastic/pharmacology;Blotting, Western;Brain Neoplasms/enzymology;Brain Neoplasms/genetics*;Brain Neoplasms/pathology;Cell Proliferation/drug effects;DNA Methylation*;DNA, Neoplasm;Doxorubicin/pharmacology;Drug Resistance, Neoplasm/genetics;Epigenesis, Genetic;GTP-Binding Proteins/genetics*;Gene Expression Regulation, Neoplastic*;Glioma/enzymology;Glioma/genetics*;Glioma/pathology;Humans;Mutagenesis, Site-Directed;Mutation/genetics;Polymerase Chain Reaction;Promoter Regions, Genetic/genetics*;Transglutaminases/genetics*;Tumor Cells, Cultured
20649048;Brain/physiology*;Communication Aids for Disabled;Electroencephalography/instrumentation*;Humans;Man-Machine Systems*;Signal Processing, Computer-Assisted;User-Computer Interface*
20696650;Brain Neoplasms/epidemiology;Brain Neoplasms/etiology*;Child;Electromagnetic Fields/adverse effects*;Global Health;Humans;Incidence;Neoplasms, Radiation-Induced/epidemiology*;Risk Factors
20817956;4-Aminopyridine/pharmacology;Action Potentials/drug effects*;Animals;Calcium Channel Blockers/pharmacology;Dogs;Electrophysiological Phenomena;Female;Guinea Pigs;Heart/drug effects*;Heart/physiology*;Humans;In Vitro Techniques;Male;Models, Cardiovascular;Nifedipine/pharmacology;Potassium Channel Blockers/pharmacology;Rabbits;Rats;Rats, Wistar;Species Specificity;Tetraethylammonium/pharmacology
20837566;Genetic Predisposition to Disease;Humans;Mental Disorders/genetics*;Mental Disorders/metabolism;Mental Disorders/psychology;Personality;Phenotype;Polymorphism, Genetic*;Risk Assessment;Risk Factors;Serotonin Plasma Membrane Transport Proteins/genetics*;Serotonin Plasma Membrane Transport Proteins/metabolism;Suicidal Ideation*;Temperament
20869589;Actomyosin/metabolism;Animals;Cell Cycle/physiology;Cell Differentiation/physiology*;Cell Nucleus/physiology*;Cell Nucleus/ultrastructure;Cell Polarity/physiology;Centrosome/physiology;Centrosome/ultrastructure;Cerebral Ventricles/cytology;Humans;Microtubules/metabolism;Neurons/physiology;Neurons/ultrastructure*;Stem Cells/physiology*;Stem Cells/ultrastructure
20930020;Adult;Down Syndrome/diagnosis*;Emotions;Female;Health Personnel;Humans;Midwifery;Parent-Child Relations*;Parents/psychology*;Pregnancy;Prenatal Diagnosis*;Professional-Patient Relations*
20942807;Biodegradation, Environmental;Chloroflexi/classification;Chloroflexi/genetics;Chloroflexi/metabolism*;DNA, Bacterial/genetics;Geologic Sediments/chemistry;Geologic Sediments/microbiology;Halogenation*;Hexachlorobenzene/metabolism*;RNA, Ribosomal, 16S/genetics;Rivers/chemistry;Rivers/microbiology*;Sequence Analysis, DNA;Spain;Vinyl Chloride/metabolism*
20960175;Adult;Asian Continental Ancestry Group/genetics*;Blood Glucose/metabolism*;China;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/genetics*;Female;Glucose/administration & dosage;Humans;Interleukin-18/genetics*;Male;Middle Aged;Polymorphism, Single Nucleotide*;Promoter Regions, Genetic
20964732;Adult;Apoptosis/physiology;Autophagy/physiology;Cell Cycle/physiology*;Cell Death/physiology*;Disease*;Homeostasis/physiology;Humans
20965338;Animals;Cattle;Corpus Luteum/physiology;Cryopreservation/veterinary;Culture Media*/pharmacology;Embryo Culture Techniques/veterinary*;Embryo Transfer/methods;Embryo Transfer/veterinary*;Embryonic Development/drug effects;Female;Fertilization in Vitro/veterinary*;Insemination, Artificial/veterinary;Lactation*;Pregnancy;Time Factors
20988200;Copper*;Humans
21004271;Fatigue/therapy*;Humans;Sports*;Thiopental*
21142530;Budgets/legislation & jurisprudence;Health Care Reform/legislation & jurisprudence*;Patient Protection and Affordable Care Act/legislation & jurisprudence*;Politics*;Taxes/legislation & jurisprudence;United States
21181066;Calcium/blood*;Female;Humans;Hydrogen-Ion Concentration;Hypocalcemia/blood*;Hypocalcemia/etiology;Magnesium/blood*;Male;Middle Aged;Phosphorus/blood*;Postoperative Period;Preoperative Care;Prospective Studies;Thyroidectomy/adverse effects*
21203976;Alternative Splicing;Amino Acid Sequence;Animals;Base Sequence;CARD Signaling Adaptor Proteins/genetics;CARD Signaling Adaptor Proteins/metabolism*;Cell Line;Dendritic Cells/drug effects;Dendritic Cells/immunology;Dendritic Cells/metabolism*;Humans;In Vitro Techniques;Lipopolysaccharides/pharmacology;Lymphocyte Activation;Mice;Mice, Inbred C57BL;Mitochondria/metabolism;Molecular Sequence Data;Nitric Oxide/biosynthesis*;Nitric Oxide Synthase Type II/metabolism;Nuclear Proteins/genetics;Nuclear Proteins/metabolism*;Protein Isoforms/genetics;Protein Isoforms/metabolism;RNA, Messenger/genetics;RNA, Messenger/metabolism;T-Lymphocytes/immunology;T-Lymphocytes/metabolism;Trans-Activators/genetics;Trans-Activators/metabolism*;Up-Regulation/drug effects
21261252;Chemical Phenomena/drug effects;Gliadin/chemistry*;Hydrogen-Ion Concentration;Sodium Chloride/pharmacology;Solubility;Surface Tension;Triticum/chemistry*
21276679;Aged;Aortic Aneurysm, Abdominal/diagnostic imaging;Aortic Aneurysm, Abdominal/mortality;Aortic Aneurysm, Abdominal/surgery*;Aortic Rupture/etiology;Aortography/methods;Blood Vessel Prosthesis*;Blood Vessel Prosthesis Implantation/adverse effects;Blood Vessel Prosthesis Implantation/instrumentation*;Blood Vessel Prosthesis Implantation/mortality;Chi-Square Distribution;Chicago;Endoleak/etiology;Endovascular Procedures/adverse effects;Endovascular Procedures/instrumentation*;Endovascular Procedures/mortality;Female;Humans;Kaplan-Meier Estimate;Logistic Models;Male;Pennsylvania;Permeability;Prosthesis Design;Retrospective Studies;Risk Assessment;Risk Factors;Stents*;Time Factors;Tomography, X-Ray Computed;Treatment Outcome;Ultrasonography, Doppler, Duplex
21368199;Africa;Agriculture*/statistics & numerical data;Climate Change*;Greenhouse Effect;Humans;Models, Statistical
21412823;Administration, Intravesical;Analysis of Variance;Angiogenesis Inducing Agents/administration & dosage*;Animals;Collagen/metabolism;Cystitis/genetics;Cystitis/metabolism;Cystitis/pathology;Cystitis/physiopathology;Cystitis/therapy*;Endothelial Cells/metabolism;Endothelial Cells/transplantation*;Female;Fibrosis;Gene Expression Regulation;Neovascularization, Physiologic/drug effects*;Neovascularization, Physiologic/genetics;Platelet Endothelial Cell Adhesion Molecule-1/genetics;Radiation Injuries, Experimental/genetics;Radiation Injuries, Experimental/metabolism;Radiation Injuries, Experimental/pathology;Radiation Injuries, Experimental/physiopathology;Radiation Injuries, Experimental/therapy*;Rats;Rats, Inbred Lew;Reverse Transcriptase Polymerase Chain Reaction;Time Factors;Urinary Bladder/blood supply*;Urinary Bladder/metabolism;Urinary Bladder/pathology;Vascular Endothelial Growth Factor A/administration & dosage*;Vascular Endothelial Growth Factor A/genetics;Vascular Endothelial Growth Factor A/metabolism;Vascular Endothelial Growth Factor Receptor-2/genetics;von Willebrand Factor/metabolism
21429592;Female;Humans;Male;Paranoid Disorders/diagnosis*;Paranoid Disorders/psychology*;Personal Satisfaction;Predictive Value of Tests;Psychiatric Status Rating Scales;Regression Analysis;Self Concept*;Surveys and Questionnaires
21603899;Adult;Aged;Colitis, Ulcerative/diagnosis;Colitis, Ulcerative/diagnostic imaging*;Colitis, Ulcerative/pathology;Colonoscopy;Female;Humans;Intestine, Large/diagnostic imaging;Intestine, Large/pathology;Male;Middle Aged;Multidetector Computed Tomography*;Young Adult
21623635;Hydrogen/chemistry;Ligands;Linear Models;Models, Molecular*;Proteins/chemistry;Sulfur/chemistry
21720614;Climate Change*;New York;Rivers*/chemistry;Seasons;Temperature
21722003;Adult;Exercise/psychology*;Female;Goals;Health Promotion;Humans;Male;Middle Aged;Young Adult
21732500;Adult;Anorexia Nervosa/psychology;Anorexia Nervosa/therapy*;Caregivers/psychology*;Education;Family/psychology*;Family Therapy/methods*;Female;Humans;Inpatients/psychology*;London;Male;Middle Aged;Treatment Outcome
21822589;Aging/immunology;Animals;Bacterial Infections/complications*;Bacterial Infections/immunology;Brain/growth & development*;Brain/immunology*;Cognition Disorders/immunology;Humans;Inflammation/immunology*;Neuroglia/immunology*;Neuroimmunomodulation/physiology*
21840842;Animals;Classification/methods*;Genes, Insect/genetics;Genetic Heterogeneity;Lepidoptera/classification*;Lepidoptera/genetics*;Nucleotides/genetics;Phylogeny*;Statistics as Topic
21864682;Animals;Aristolochic Acids/administration & dosage;Aristolochic Acids/adverse effects*;Aristolochic Acids/pharmacology;Biomarkers/analysis;Blood Urea Nitrogen;Cadherins/metabolism;Collagen Type I/genetics;Collagen Type I/metabolism*;Connective Tissue Growth Factor/genetics;Connective Tissue Growth Factor/metabolism;Disease Models, Animal;Disease Progression;Epithelial Cells/drug effects;Epithelial Cells/metabolism*;Epithelial Cells/pathology;Female;Fibrosis/etiology;Fibrosis/metabolism;Fibrosis/pathology*;Kidney/pathology*;Kidney Tubules/cytology;Laser Capture Microdissection;Male;Mice;Mice, Inbred C57BL;Mice, Transgenic;Promoter Regions, Genetic;Transcriptional Activation;Transgenes
21917642;Calcium/analysis;Calcium/metabolism*;Calcium Sulfate/administration & dosage;Calcium Sulfate/adverse effects;Calcium Sulfate/analysis;Calcium Sulfate/pharmacology;Chemical Phenomena;Crops, Agricultural/chemistry*;Crops, Agricultural/drug effects;Crops, Agricultural/growth & development*;Crops, Agricultural/ultrastructure;Dose-Response Relationship, Drug;Fertilizers/adverse effects;Fertilizers/analysis;Fertilizers/economics;Food, Preserved/analysis*;Fruiting Bodies, Fungal/chemistry;Fruiting Bodies, Fungal/drug effects;Fruiting Bodies, Fungal/growth & development;Fruiting Bodies, Fungal/ultrastructure;Hot Temperature;Hydroponics/methods;Hyphae/chemistry;Hyphae/drug effects;Hyphae/growth & development;Hyphae/ultrastructure;Microscopy, Electron, Scanning;Mycology/methods*;Pleurotus/chemistry*;Pleurotus/drug effects;Pleurotus/growth & development*;Pleurotus/ultrastructure;Quality Control;Silicates/administration & dosage;Silicates/adverse effects;Silicates/chemistry;Silicates/pharmacology;Silicon/analysis;Silicon/metabolism*;Thailand;Time Factors;Water/analysis
22028053;Animals;Colony Count, Microbial;Escherichia coli/radiation effects*;Food Microbiology*;Food Preservation/methods;Fungi/radiation effects;High-Energy Shock Waves*;Hot Temperature;Humans;Milk/microbiology;Milk/radiation effects*;Odorants/analysis*;Staphylococcus/radiation effects*;Ultraviolet Rays*;Volatile Organic Compounds/analysis;Yeasts/radiation effects
22086098;Female;Fractures, Compression/radiotherapy*;Fractures, Compression/surgery*;Humans;Male;Radiotherapy, Computer-Assisted/methods*;Spinal Fractures/radiotherapy*;Spinal Fractures/surgery*;Vertebroplasty/methods*
22157574;Adrenal Cortex Hormones/therapeutic use;Anti-Inflammatory Agents/therapeutic use;Austria;Chronic Disease;Eye Diseases/diagnosis*;Eye Diseases/drug therapy*;Germany;Graft vs Host Disease/complications*;Graft vs Host Disease/diagnosis;Graft vs Host Disease/drug therapy;Hematopoietic Stem Cell Transplantation/adverse effects;Humans;Immunosuppressive Agents/therapeutic use;Quality of Life;Switzerland
22207689;Cysteine/chemistry;Cysteine/genetics;Disulfides/chemistry;Disulfides/metabolism;Endoplasmic Reticulum/genetics*;Endoplasmic Reticulum/metabolism;HEK293 Cells;Humans;Models, Biological;Mutation*;Plasmids;Protein Conformation;Protein Folding;Protein Multimerization/genetics;Protein Subunits/chemistry;Protein Subunits/genetics;Serine/chemistry;Serine/genetics;Transfection;Tyrosine/chemistry;Tyrosine/genetics;Weibel-Palade Bodies/chemistry;Weibel-Palade Bodies/genetics*;Weibel-Palade Bodies/pathology;von Willebrand Diseases/genetics;von Willebrand Diseases/metabolism;von Willebrand Diseases/pathology;von Willebrand Factor/chemistry;von Willebrand Factor/genetics*
22261766;Aged;Aged, 80 and over;Carcinoma, Hepatocellular/diagnosis*;Carcinoma, Hepatocellular/diagnostic imaging;Carcinoma, Hepatocellular/pathology;Contrast Media;Disease Progression;Female;Humans;Image Interpretation, Computer-Assisted;Liver Cirrhosis/diagnosis;Liver Cirrhosis/diagnostic imaging;Liver Cirrhosis/pathology;Liver Neoplasms/diagnosis*;Liver Neoplasms/diagnostic imaging;Liver Neoplasms/pathology;Magnetic Resonance Imaging/methods*;Male;Middle Aged;Retrospective Studies;Statistics, Nonparametric;Time Factors;Tomography, X-Ray Computed/methods*
22303811;Drinking Water/analysis*;Fluorides/analysis*;Fluorides/isolation & purification;Fluorides/toxicity;Humans;India;Water Pollutants, Chemical/analysis*;Water Pollutants, Chemical/isolation & purification;Water Pollutants, Chemical/toxicity;Water Purification/instrumentation;Water Purification/methods*
22349495;Adult;Animals;Bone and Bones/chemistry*;Burial*;Carbon Isotopes/analysis;Diet*;Fishes/metabolism;Fossils;Humans;Isotopes/analysis;Male;Nitrogen Isotopes/analysis;Radiometric Dating;Romania
22370644;Antigens, CD/genetics;Antigens, CD/metabolism;Cadherins/genetics;Cadherins/metabolism;Carcinoma/genetics;Carcinoma/metabolism;Carcinoma/pathology;Cell Growth Processes/physiology;Cell Line, Tumor;Cell Movement/genetics;Down-Regulation;Gastric Mucosa/metabolism;Gastric Mucosa/pathology;Humans;Matrix Metalloproteinase 2/genetics;Matrix Metalloproteinase 2/metabolism;Matrix Metalloproteinase 9/genetics;Matrix Metalloproteinase 9/metabolism;MicroRNAs/genetics*;MicroRNAs/metabolism;Neoplasm Invasiveness;Neoplasm Metastasis;Stomach Neoplasms/genetics*;Stomach Neoplasms/metabolism;Stomach Neoplasms/pathology*
22391664;Cost Control/legislation & jurisprudence;Female;Home Care Services/economics;Home Care Services/legislation & jurisprudence*;Humans;Male;Medicare/economics*;Medicare/legislation & jurisprudence;Needs Assessment;Policy Making;Reimbursement Mechanisms/economics*;Reimbursement Mechanisms/legislation & jurisprudence;United States
22396027;Kinetics;Mass Spectrometry/methods*;Peptide Mapping/methods*;Peptides/chemistry*
22480960;Adolescent;Child;Child, Preschool;Documentation/statistics & numerical data*;Esophagogastric Junction/diagnostic imaging*;Female;Humans;Infant;Infant, Newborn;Intubation, Gastrointestinal/instrumentation*;Intubation, Gastrointestinal/statistics & numerical data*;Male;Practice Patterns, Physicians'/statistics & numerical data*;Prosthesis Fitting/methods;Prosthesis Fitting/statistics & numerical data*;Radiography, Interventional/statistics & numerical data*;Reproducibility of Results;Sensitivity and Specificity;United States/epidemiology
22490545;Aged;Area Under Curve;Breast Neoplasms/diagnostic imaging*;Breast Neoplasms/pathology;Case-Control Studies;Female;Humans;Logistic Models;Mammography/methods*;Middle Aged;Odds Ratio;Risk Factors
22509416;Alleles;Animals;DNA, Protozoan/genetics;Haplotypes;Humans;Longitudinal Studies;Malaria, Vivax/epidemiology;Malaria, Vivax/parasitology*;Malaria, Vivax/transmission*;Microsatellite Repeats*;Molecular Epidemiology;Plasmodium vivax/classification*;Plasmodium vivax/genetics*;Plasmodium vivax/isolation & purification;Polymorphism, Genetic*;Recombination, Genetic;Republic of Korea/epidemiology
22526147;Adenocarcinoma/complications;Adenocarcinoma/rehabilitation*;Adult;Aged;C-Reactive Protein;Dyspnea/etiology;Dyspnea/rehabilitation;Exercise Test;Exercise Therapy/methods*;Exercise Tolerance*;Fatigue/etiology;Fatigue/rehabilitation;Female;Humans;Insulin Resistance;Lung Neoplasms/complications;Lung Neoplasms/rehabilitation*;Male;Middle Aged;Muscle Strength;Oxygen Consumption*;Physical Endurance;Prognosis;Quadriceps Muscle;Quality of Life;Surveys and Questionnaires;Treatment Outcome
22537962;Animals;Asthma/drug therapy;Asthma/immunology*;Female;Interleukin-4/blood*;Interleukin-8/blood*;Lipopolysaccharides/pharmacology*;Mice;Mice, Inbred BALB C;Vascular Endothelial Growth Factor A/analysis*;Vascular Endothelial Growth Factor A/physiology
22556095;Amebiasis/mortality*;Female;Humans;Male
22608191;Adolescent;Adult;Aged;Antitubercular Agents/therapeutic use*;Cohort Studies;Emigrants and Immigrants;Female;Humans;Incidence;Logistic Models;Male;Medication Adherence/statistics & numerical data*;Middle Aged;Public Health Surveillance;Retrospective Studies;Risk Factors;Spain/epidemiology;Tuberculosis/drug therapy*;Tuberculosis/epidemiology;Young Adult
22752523;Algorithms;Animals;Arteries/pathology*;Computer Simulation;Contrast Media/pharmacology*;Image Processing, Computer-Assisted/methods;Magnetic Resonance Imaging/methods*;Models, Statistical;Phantoms, Imaging;Rabbits;Time Factors;Ultrasonography/methods*
22817799;Adenocarcinoma/pathology;Adenocarcinoma/surgery*;Adenoma/pathology;Adenoma/surgery*;Adult;Aged;Aged, 80 and over;Female;Follow-Up Studies;Humans;Intestinal Mucosa/pathology;Intestinal Mucosa/surgery*;Male;Middle Aged;Operative Time;Postoperative Complications;Proctoscopy/instrumentation;Proctoscopy/methods*;Rectal Neoplasms/pathology;Rectal Neoplasms/surgery*;Treatment Outcome
22863264;Asian Continental Ancestry Group;Cyclooxygenase 2/genetics*;Disease Progression;Female;Genetic Predisposition to Disease;Hepatitis C, Chronic/complications;Hepatitis C, Chronic/genetics*;Hepatitis C, Chronic/pathology*;Humans;Inflammation/genetics;Inflammation/pathology;Interleukins/genetics;Lipase/genetics;Liver Cirrhosis/genetics*;Liver Cirrhosis/pathology*;Male;Membrane Proteins/genetics;Middle Aged;Polymorphism, Genetic*;Promoter Regions, Genetic*
22875926;Analysis of Variance;Animals;Choice Behavior/physiology*;Excitatory Amino Acid Agonists/toxicity;Food Deprivation;Hippocampus/injuries;Hippocampus/physiology*;Inhibition (Psychology)*;Male;Motor Activity/drug effects;Motor Activity/physiology;N-Methylaspartate/toxicity;Neural Pathways/physiology*;Prefrontal Cortex/injuries;Prefrontal Cortex/physiology*;Psychomotor Performance/physiology;Rats;Rats, Long-Evans;Reaction Time/physiology;Time Factors
22879033;Humans;Hypoxia/drug therapy*;Neoplasms/blood supply*;Neoplasms/metabolism*;Neoplasms/therapy;Oxygen/analysis*;Precision Medicine*
22900038;ARNTL Transcription Factors/genetics*;ARNTL Transcription Factors/metabolism;Animals;CLOCK Proteins/genetics*;CLOCK Proteins/metabolism;Cytoplasmic Granules/metabolism*;Cytoplasmic Granules/ultrastructure;Germ Cells/metabolism*;Male;Mice;Mice, Knockout;Protein Binding;Protein Transport;RNA Processing, Post-Transcriptional*;Spermatids/metabolism;Spermatogenesis/genetics
22957803;Analgesics/chemical synthesis*;Analgesics/chemistry;Analgesics/pharmacology;Animals;Body Temperature/drug effects;CHO Cells;Capsaicin/pharmacology;Cricetinae;Cricetulus;Dopamine/analogs & derivatives;Dopamine/pharmacology;Hot Temperature;Humans;Hydrogen-Ion Concentration;Hydrophobic and Hydrophilic Interactions;Male;Mice;Mice, Inbred C57BL;Mice, Knockout;Molecular Docking Simulation;Neuralgia/drug therapy;Pyridines/chemical synthesis*;Pyridines/chemistry;Pyridines/pharmacology;Rats;Rats, Sprague-Dawley;Stereoisomerism;Structure-Activity Relationship;Sulfonamides/chemical synthesis*;Sulfonamides/chemistry;Sulfonamides/pharmacology;TRPV Cation Channels/antagonists & inhibitors*;TRPV Cation Channels/genetics
22962439;Angiogenesis Inhibitors/pharmacokinetics;Angiogenesis Inhibitors/therapeutic use*;Animals;Antibodies, Monoclonal/pharmacokinetics*;Antibodies, Monoclonal/therapeutic use*;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use*;Biomarkers/blood;Glycosylphosphatidylinositols/blood;Humans;Macaca fascicularis;Neoplasm Staging;Neoplasms/drug therapy*;Neoplasms/pathology*;Neuropilin-1/blood;Signal Transduction/drug effects
23139410;Amino Acid Motifs/genetics;Aptamers, Nucleotide/chemistry*;Aptamers, Nucleotide/metabolism*;Crystallography, X-Ray;DNA Primers/genetics;Hydrophobic and Hydrophilic Interactions*;Models, Molecular*;Molecular Sequence Data;Molecular Structure;Phosphorylation;Protein Binding;Proto-Oncogene Proteins c-sis/chemistry;Proto-Oncogene Proteins c-sis/metabolism*;SELEX Aptamer Technique/methods*;Sequence Analysis, DNA;Transition Temperature
23347532;Child;Earthquakes*;Family;Health Education;Humans;Japan;Mental Health Services/organization & administration*;Suicide/prevention & control
23399383;Environmental Monitoring;Geologic Sediments/chemistry*;Groundwater/chemistry*;Models, Theoretical;Particle Size;Time Factors;Uranium/chemistry*;Water Pollutants, Radioactive/chemistry*
23414112;Adolescent;Adult;Analysis of Variance;Biomarkers/blood;Blood Loss, Surgical;Blood Pressure;Body Temperature Regulation;Equipment Design;Female;Germany;Humans;Length of Stay;Male;Maxilla/surgery*;Maxillary Osteotomy/adverse effects;Maxillary Osteotomy/instrumentation*;Maxillary Sinus/surgery;Middle Aged;Pain, Postoperative/etiology;Palatal Expansion Technique/adverse effects;Palatal Expansion Technique/instrumentation*;Patient Satisfaction;Piezosurgery/adverse effects;Piezosurgery/instrumentation*;Prospective Studies;Surgical Instruments*;Time Factors;Treatment Outcome;Young Adult
23478303;Aged;Alzheimer Disease/diagnosis*;Alzheimer Disease/physiopathology*;Brain/physiopathology*;Brain Mapping;Cognitive Dysfunction/diagnosis;Cognitive Dysfunction/physiopathology;Delta Rhythm/physiology*;Diagnosis, Differential;Disease Progression;Female;Humans;Magnetoencephalography*;Male;Reference Values;Synaptic Transmission/physiology
23560618;Adolescent;Adult;Amine Oxidase (Copper-Containing);Asthma, Exercise-Induced/diagnosis*;Asthma, Exercise-Induced/metabolism;Athletes*;Breath Tests/methods*;Bronchial Hyperreactivity/diagnosis;Bronchial Hyperreactivity/metabolism;Bronchoconstrictor Agents;Female;Humans;Male;Methacholine Chloride;Nitric Oxide/metabolism*;Predictive Value of Tests;ROC Curve;Respiratory Function Tests/methods*;Respiratory Function Tests/standards*;Young Adult
23580002;Humans;Magnetic Resonance Imaging;Musculoskeletal System/diagnostic imaging;Osteoarthritis/diagnostic imaging;Rheumatic Diseases/diagnostic imaging*;Sjogren's Syndrome/diagnostic imaging;Spondylarthropathies/diagnostic imaging;Synovitis/diagnostic imaging;Tendinopathy/diagnostic imaging;Ultrasonography;Vasculitis/diagnostic imaging
23599523;Acute Pain/drug therapy*;Acute Pain/epidemiology*;Emergency Medical Services/methods*;Female;Humans;Male;Wounds and Injuries/therapy*
23680157;Adult;Anti-Inflammatory Agents/chemistry;Anti-Inflammatory Agents/pharmacology*;Antioxidants/chemistry;Antioxidants/pharmacology*;Butea/chemistry*;Cells, Cultured;Chalcones/chemistry;Chalcones/pharmacology;Cytokines/metabolism;Dermatitis/drug therapy*;Dermatitis/metabolism;Dinoprostone/metabolism;Epidermis/drug effects;Epidermis/metabolism;Female;Flavonoids/chemistry;Flavonoids/pharmacology;Flowers/chemistry*;Humans;Inflammation/drug therapy;Inflammation/metabolism;Keratinocytes/drug effects;Keratinocytes/metabolism;Matrix Metalloproteinases/metabolism*;Plant Extracts/chemistry;Plant Extracts/pharmacology*;Skin/drug effects;Skin/metabolism
23702482;Animals;Cell Line;Chloroquine/pharmacology*;Enzyme Activation/drug effects;Glucose/pharmacokinetics*;Glycogen Synthase/metabolism*;Male;Muscle Fibers, Skeletal/drug effects;Muscle Fibers, Skeletal/metabolism*;Proto-Oncogene Proteins c-akt/metabolism*;Rats;Rats, Wistar
23711310;Aged;Atrial Fibrillation/surgery*;Catheter Ablation*;Dexmedetomidine/administration & dosage*;Female;Humans;Hypnotics and Sedatives/administration & dosage*;Male;Middle Aged;Retrospective Studies
23764227;Adult;Advisory Committees;Aged;Clinical Competence*/standards;Female;Guideline Adherence;Humans;Knowledge*;Male;Middle Aged;Practice Guidelines as Topic*;Pregnancy;Pregnancy Trimester, Second*;Professional Practice/standards;Surveys and Questionnaires;Ultrasonography, Prenatal/methods;Ultrasonography, Prenatal/standards*
23966200;Computer Communication Networks/instrumentation*;Computer Simulation;Computer-Aided Design*;Equipment Design;Equipment Failure Analysis;Information Storage and Retrieval/methods*;Models, Theoretical;Signal Processing, Computer-Assisted/instrumentation*;Transducers*
23975755;Child;Child Health Services/organization & administration*;Cost-Benefit Analysis;Female;Health Care Surveys;Health Resources/organization & administration*;Humans;Immunization Programs/economics*;Immunization Programs/utilization;Linear Models;Male;Mass Vaccination/methods;Mass Vaccination/organization & administration*;Measles Vaccine/administration & dosage;Measles Vaccine/economics;Poliovirus Vaccines/administration & dosage;Poliovirus Vaccines/economics;Primary Health Care/organization & administration;Regression Analysis;South Africa;Vitamin A/administration & dosage;Vitamin A/economics;Vitamin A Deficiency/economics;Vitamin A Deficiency/prevention & control;Vitamins/administration & dosage;Vitamins/economics
24005617;Diabetes Mellitus, Type 2/physiopathology;Diabetes Mellitus, Type 2/therapy*;Diet;Exercise;Glucose/metabolism;Humans;Hypoglycemic Agents/therapeutic use;Kidney/metabolism
24048604;Data Collection/methods*;Humans;Personnel Staffing and Scheduling/standards*;Pharmacists/standards;Pharmacy Residencies/methods*;Pharmacy Residencies/standards*;Societies, Pharmaceutical/standards*;United States;Workload/standards*
24062321;Adult;Blood Glucose/analysis;Body Size;Fasting/blood;Female;Glucose/metabolism*;Glucose Clamp Technique;Glucose Intolerance/blood;Glucose Intolerance/physiopathology*;Glucose Tolerance Test*;Humans;Insulin/blood;Insulin Resistance/physiology;Insulin-Secreting Cells/physiology;Intestinal Absorption*;Male;Middle Aged;Prediabetic State/physiopathology*;Sex Factors
24069673;Age Factors;Hepatitis C/diagnosis*;Hepatitis C/drug therapy;Humans;Mass Screening;Practice Guidelines as Topic;Risk Factors;Serologic Tests;United States
24115117;Caliciviridae Infections/epidemiology*;Caliciviridae Infections/virology*;Child, Preschool;Female;Gastroenteritis/epidemiology*;Gastroenteritis/virology*;Genetic Variation*;Genotype;Humans;Infant;Male;Molecular Sequence Data;Norovirus/classification*;Norovirus/genetics;Norovirus/isolation & purification;Phylogeny;Polymerase Chain Reaction;Prevalence;Sapovirus/classification*;Sapovirus/genetics;Sapovirus/isolation & purification;Sequence Analysis, DNA;Thailand/epidemiology
24215357;Animals;Cell Proliferation/drug effects;Cell Proliferation/physiology;Drug Delivery Systems/methods*;Drugs, Chinese Herbal/administration & dosage*;Female;Flavanones/administration & dosage*;Glycyrrhetinic Acid/administration & dosage*;Hep G2 Cells;Hepatocytes/drug effects*;Hepatocytes/physiology;Humans;Liposomes;Male;Mice;Mice, Inbred ICR;Treatment Outcome;Xenograft Model Antitumor Assays/methods
24277383;Adult;Australia;Female;General Practice/methods*;Humans;Logistic Models;Middle Aged;Neoplasms/pathology;Neoplasms/therapy*;Palliative Care*;Practice Patterns, Physicians'*;Referral and Consultation*;Surveys and Questionnaires
24313544;Amines/chemistry*;Animals;Antioxidants/chemistry*;Cattle;Cooking*;Grape Seed Extract/chemistry*;Heterocyclic Compounds/chemistry*;Hot Temperature;Liposomes/chemistry;Meat/analysis*
24334889;Biofouling*;Chlorides;Copper;Ferric Compounds;Membranes, Artificial*;Ultrafiltration
24442162;Animals;Antibodies, Monoclonal/pharmacokinetics*;Biomarkers/metabolism;Contrast Media/pharmacokinetics;E-Selectin/metabolism*;Microbubbles;Molecular Imaging/methods*;Myocardial Reperfusion Injury/diagnostic imaging*;Myocardial Reperfusion Injury/metabolism*;P-Selectin/metabolism*;Rats;Reproducibility of Results;Sensitivity and Specificity;Statistics as Topic;Ultrasonography/methods
24542946;Anti-Bacterial Agents*;Drug Resistance, Microbial*;Microbial Sensitivity Tests*;Micrococcus*;Prevalence;Staphylococcus*;Staphylococcus aureus*
24552827;Adolescent;Adult;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/immunology;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*;Antibodies/blood;Antibodies, Monoclonal/adverse effects;Antibodies, Monoclonal/immunology;Antibodies, Monoclonal/therapeutic use*;Child;Child, Preschool;Colitis, Ulcerative/drug therapy*;Crohn Disease/drug therapy*;Drug Therapy, Combination;Female;Follow-Up Studies;Humans;Immunosuppressive Agents/therapeutic use;Infliximab;Maintenance Chemotherapy;Male;Methotrexate/therapeutic use;Remission Induction;Retrospective Studies;Tertiary Care Centers;Time Factors;Treatment Failure;Young Adult
24595848;Alanine Transaminase/blood;Animals;Aspartate Aminotransferases/blood;Blood Urea Nitrogen;Cerebrovascular Circulation/drug effects;Creatinine/metabolism;Fluorescein/chemistry;Ganglionic Stimulants/toxicity;Inflammation;L-Lactate Dehydrogenase/metabolism;Liver/enzymology;Macrophages/metabolism;Male;Mice;Microcirculation/drug effects;Necrosis;Nicotine/toxicity*;Oxidative Stress;Smoking/adverse effects;Superoxide Dismutase/metabolism;Thromboembolism/chemically induced*;Thrombosis/chemically induced;gamma-Glutamyltransferase/blood
24750390;Adult;Alleles;Anticoagulants/pharmacology*;Cytochrome P-450 CYP2C9/genetics;Cytochrome P-450 Enzyme System/genetics;European Continental Ancestry Group/genetics*;Female;Gene Frequency;Genetics, Population;Genotype;Humans;Male;Pharmacogenetics*;Polymorphism, Single Nucleotide*;Slovakia;Vitamin K Epoxide Reductases/genetics;Warfarin/pharmacology*
24931680;Carbonated Beverages*;Congresses as Topic/economics*;Food Industry*;Health Promotion/economics*;Humans;Motor Activity*
25015036;Adolescent;Adult;Aged;Aged, 80 and over;Antigens, CD/metabolism*;Biomarkers/metabolism;Biopsy;Cadherins/metabolism*;Child;Child, Preschool;Endoglin;Female;Humans;Immunohistochemistry/methods;Male;Middle Aged;Mouth Neoplasms/metabolism;Mouth Neoplasms/pathology*;Oral Submucous Fibrosis/metabolism;Oral Submucous Fibrosis/pathology*;Receptors, Cell Surface/metabolism*;Vascular Endothelial Growth Factor A/metabolism*;Young Adult
25079814;Animals;Aquatic Organisms/parasitology;Australia;Body Size;Dracunculoidea/anatomy & histology;Dracunculoidea/classification*;Dracunculoidea/physiology;Dracunculoidea/ultrastructure*;Female;Fishes/parasitology*;Gonads/parasitology*;Male;Species Specificity
25172190;Acute Disease;Adult;Diagnosis, Computer-Assisted/methods*;Electrocardiography/methods*;Female;Humans;Male;Myocarditis/complications*;Myocarditis/diagnosis*;Reproducibility of Results;Sensitivity and Specificity;Ventricular Dysfunction, Left/diagnosis*;Ventricular Dysfunction, Left/etiology*
25176576;Antibodies, Monoclonal, Humanized/therapeutic use*;Antineoplastic Agents/therapeutic use*;Carcinoma, Squamous Cell/drug therapy;Carcinoma, Squamous Cell/radiotherapy;Carcinoma, Squamous Cell/therapy*;Cetuximab;Combined Modality Therapy;Head and Neck Neoplasms/drug therapy;Head and Neck Neoplasms/radiotherapy;Head and Neck Neoplasms/therapy*;Humans;Organoplatinum Compounds/therapeutic use*
25233500;Case-Control Studies;Child;Female;Heart Defects, Congenital/blood;Heart Defects, Congenital/complications;Heart Defects, Congenital/physiopathology*;Humans;Hypertension, Pulmonary/blood;Hypertension, Pulmonary/complications;Hypertension, Pulmonary/physiopathology*;Male;Matrix Metalloproteinases/blood*;Tissue Inhibitor of Metalloproteinases/blood*;Ultrasonography;Ventricular Dysfunction, Left/diagnostic imaging;Ventricular Dysfunction, Left/physiopathology;Ventricular Dysfunction, Right/diagnostic imaging;Ventricular Dysfunction, Right/physiopathology
25249052;Biodegradation, Environmental/drug effects;Biofouling/prevention & control*;Environmental Pollutants/isolation & purification;Environmental Pollutants/metabolism*;Hydrocarbons/isolation & purification;Hydrocarbons/metabolism*;Nitrates/pharmacology;Petroleum/metabolism*;Proteobacteria/genetics;Proteobacteria/metabolism*;Vitamins/pharmacology
25287252;Alveolar Process/pathology*;Alveolar Ridge Augmentation/methods*;Atrophy;Dental Implants*;Humans;Maxilla;Maxillary Sinus/surgery*;Sinus Floor Augmentation
25325951;Aminoacridines/chemistry;Animals;Buffers;Chemistry, Pharmaceutical;Chondroitin Sulfates/blood;Chondroitin Sulfates/urine;Chromatography, High Pressure Liquid;Disaccharides/analysis;Disaccharides/blood*;Disaccharides/urine*;Electrophoresis/methods*;Electrophoresis, Polyacrylamide Gel;Fluorescent Dyes/chemistry*;Glycosaminoglycans/analysis;Glycosaminoglycans/blood*;Glycosaminoglycans/isolation & purification;Glycosaminoglycans/urine*;Heparin/isolation & purification;Heparitin Sulfate/isolation & purification;Humans;Hyaluronic Acid/analysis;Lens Capsule, Crystalline/metabolism;Mice;Pharmaceutical Preparations/chemistry*;Rats
25338685;Awards and Prizes*;History, 20th Century;History, 21st Century;Humans;Ophthalmology/history*;Poland;Retinal Diseases/history*;United States
25356626;Alleles;Animals;Colorectal Neoplasms/metabolism;Colorectal Neoplasms/pathology*;Female;HCT116 Cells;Humans;Matrix Metalloproteinase 9/genetics;Matrix Metalloproteinase 9/metabolism;Mice;Mice, Inbred BALB C;Mice, Nude;Neoplasm Metastasis/prevention & control;Phosphatidylinositol 3-Kinase/antagonists & inhibitors;Phosphatidylinositol 3-Kinase/genetics*;Phosphatidylinositol 3-Kinase/metabolism;Tissue Inhibitor of Metalloproteinase-1/genetics;Tissue Inhibitor of Metalloproteinase-1/metabolism;Vitamin A/pharmacology*;Xenograft Model Antitumor Assays
25401193;Anti-HIV Agents/therapeutic use;HIV Infections/drug therapy*;History, 20th Century;History, 21st Century;Humans;Tanzania;Uganda
25423485;Animals;Autistic Disorder/genetics*;Cerebellum/metabolism*;Cerebellum/pathology;Chromatin/metabolism;DNA Damage*;DNA Methylation;Disease Models, Animal;Female;Humans;Male;Mice;Oligonucleotide Array Sequence Analysis;Oxidation-Reduction;Postmortem Changes
25478916;Cardiovascular Diseases/complications*;Cardiovascular Diseases/physiopathology*;Cognition*;Dementia/etiology*;Dementia/physiopathology*;Humans;Models, Cardiovascular*;Time Factors
25542181;Amino Acid Motifs;Amino Acid Sequence;Animals;Calcium/metabolism;Calcium/pharmacology*;Calmodulin/metabolism;Cell Line;Cell Size/drug effects;Dipeptides/pharmacology;Ether-A-Go-Go Potassium Channels/chemistry;Ether-A-Go-Go Potassium Channels/metabolism*;Humans;Intracellular Space/metabolism*;Ion Channel Gating/drug effects;Male;Models, Biological;Molecular Sequence Data;Mutant Proteins/chemistry;Mutant Proteins/metabolism;Mutation/genetics;Proteolysis/drug effects*;Rats, Sprague-Dawley
25545991;Conservation of Natural Resources*;Environmental Policy/legislation & jurisprudence*;Policy Making*;Politics*
25560064;Arsenicals/chemistry*;Cysteine/chemistry*;History, 20th Century;Recombinant Fusion Proteins/chemistry*;Staining and Labeling/history
25581781;Adult;Aged;Aged, 80 and over;Biopsy, Fine-Needle*;Biopsy, Large-Core Needle*;Female;Humans;Male;Middle Aged;Prospective Studies;Salivary Glands/pathology*;Sensitivity and Specificity;Young Adult
25611266;Animals;Cell Count;Endometrium/cytology;Endometrium/metabolism;Enzyme-Linked Immunosorbent Assay;Epithelium/metabolism;Female;Immunohistochemistry;Immunosuppression*;Interleukins/genetics;Interleukins/metabolism*;Male;Mice;Minor Histocompatibility Antigens;Pregnancy;Protein Subunits/genetics;Protein Subunits/metabolism;RNA, Messenger/genetics;RNA, Messenger/metabolism;Real-Time Polymerase Chain Reaction;Receptors, Cytokine/genetics;Receptors, Cytokine/metabolism;Reference Standards;Uterus/metabolism*
25687939;Aged;Aged, 80 and over;Cerebrovascular Disorders/diagnosis;Cerebrovascular Disorders/physiopathology*;Cerebrovascular Disorders/rehabilitation*;Female;Hand/physiopathology*;Humans;Male;Middle Aged;Predictive Value of Tests;Psychomotor Performance;ROC Curve;Recovery of Function/physiology*;Regression Analysis;Treatment Outcome*;Upper Extremity/physiopathology*
25692771;Aminoglycosides/pharmacology;Aminoglycosides/therapeutic use*;Amoxicillin/pharmacology;Amoxicillin/therapeutic use;Animals;Female;Gentamicins/pharmacology;Gentamicins/therapeutic use;Methicillin-Resistant Staphylococcus aureus/drug effects*;Methicillin-Resistant Staphylococcus aureus/pathogenicity;Mice;Microbial Sensitivity Tests;Penicillins/pharmacology;Penicillins/therapeutic use;Peptides/pharmacology*;Peptides/therapeutic use*;Staphylococcal Infections/drug therapy*;Staphylococcus aureus/drug effects*;Staphylococcus aureus/pathogenicity;beta-Lactams/pharmacology*;beta-Lactams/therapeutic use*
25725934;Adult;Alcoholism/epidemiology;Alcoholism/psychology;Alcoholism/therapy;Comorbidity;Diagnostic and Statistical Manual of Mental Disorders;Female;Humans;Male;Mental Disorders/epidemiology;Mental Disorders/psychology;Patient Acceptance of Health Care/statistics & numerical data*;Predictive Value of Tests;Probability;Socioeconomic Factors;Substance-Related Disorders/epidemiology;Substance-Related Disorders/psychology;Substance-Related Disorders/therapy*;United States/epidemiology
25919405;Adult;Blood Glucose/analysis;Diabetes Mellitus, Type 1/blood*;Epinephrine/blood;Exercise/physiology*;Female;Growth Hormone/blood;Humans;Hyperglycemia/blood*;Insulin/blood;Interleukin-6/blood;Male;Norepinephrine/blood;Resistance Training*
26092160;Genetic Variation*;Mycobacterium avium subsp. paratuberculosis/genetics;Mycobacterium avium subsp. paratuberculosis/growth & development;Mycobacterium avium subsp. paratuberculosis/pathogenicity;Mycobacterium avium subsp. paratuberculosis/physiology*;Paratuberculosis/epidemiology;Paratuberculosis/microbiology*;Virulence
26095088;Adult;Brain/physiology*;Brain Mapping;Comprehension/physiology;Female;Humans;Magnetic Resonance Imaging;Male;Multilingualism*;Multivariate Analysis;Nerve Net/physiology;Reading*;Young Adult
26179128;Alginates/chemistry;Biological Oxygen Demand Analysis/instrumentation*;Biosensing Techniques/instrumentation*;Boron/chemistry*;Diamond/chemistry*;Electrodes;Glucuronic Acid/chemistry;Gold/chemistry*;Hexuronic Acids/chemistry;Oxygen/analysis;Oxygen/chemistry;Rhodotorula/chemistry*
26259864;Adolescent;Adult;Aged;Aged, 80 and over;Brain Neoplasms/diagnostic imaging*;Brain Neoplasms/pathology;Brain Neoplasms/secondary;Child;Diagnosis, Differential;Female;Fluorodeoxyglucose F18*;Glioma/diagnostic imaging*;Glioma/pathology;Humans;Male;Middle Aged;Positron-Emission Tomography/methods;Radiopharmaceuticals;Tomography, X-Ray Computed;Young Adult
26291910;Anti-Bacterial Agents/analysis*;Anti-Bacterial Agents/chemistry;Boron/chemistry;Diamond/chemistry;Electrochemical Techniques/instrumentation;Electrochemical Techniques/methods*;Hydrogen Peroxide/chemistry*;Hydroxyl Radical/chemistry;Iron/chemistry*;Kinetics;Levofloxacin/analysis*;Levofloxacin/chemistry;Models, Theoretical;Oxidation-Reduction;Sulfides/chemistry*;Water Pollutants, Chemical/analysis*;Water Pollutants, Chemical/chemistry;Water Purification/instrumentation;Water Purification/methods*
26293551;Attitude of Health Personnel*;Continuity of Patient Care;Cross Infection;Health Services Accessibility;Hospitalization/statistics & numerical data*;Humans;Patient Safety;Patient Satisfaction;Pediatrics*;Surveys and Questionnaires;United States
26348568;Adult;Aged;Brain Edema/diagnosis*;Brain Edema/physiopathology*;Female;Glioma/diagnosis;Glioma/physiopathology;Humans;Magnetic Resonance Imaging;Male;Meningeal Neoplasms/diagnosis;Meningeal Neoplasms/physiopathology;Meningioma/diagnosis;Meningioma/physiopathology;Middle Aged;Multivariate Analysis;Natriuretic Peptide, Brain/blood*;Peptide Fragments/blood*;Prospective Studies;Reference Values;Statistics as Topic;Supratentorial Neoplasms/diagnosis*;Supratentorial Neoplasms/physiopathology*;Supratentorial Neoplasms/secondary
26371235;Amino Acid Oxidoreductases/genetics;Amino Acid Oxidoreductases/metabolism;Amino Acid Sequence;Arabidopsis/genetics;Arabidopsis/metabolism*;Arabidopsis Proteins/genetics;Arabidopsis Proteins/metabolism*;Chloroplast Proteins/genetics;Chloroplast Proteins/metabolism;Chloroplasts/metabolism;Metalloendopeptidases/genetics;Metalloendopeptidases/metabolism;Models, Biological;Molecular Sequence Data;Plant Proteins/genetics;Plant Proteins/metabolism;Protein Processing, Post-Translational*;Protein Stability;Proteome*;Ribulose-Bisphosphate Carboxylase/genetics;Ribulose-Bisphosphate Carboxylase/metabolism
26416884;Ethical Theory*;Humans;Personal Autonomy;Personhood*
26540186;Breast Neoplasms/drug therapy;Breast Neoplasms/genetics*;Camptothecin/pharmacology*;Cell Survival/drug effects;Cell Survival/genetics;DNA Topoisomerases, Type I/genetics*;Down-Regulation/drug effects;Down-Regulation/genetics*;Drug Resistance, Neoplasm/drug effects;Drug Resistance, Neoplasm/genetics*;Etoposide/pharmacology;HT29 Cells;Humans;MCF-7 Cells;Nitric Oxide/metabolism*;Topoisomerase I Inhibitors/pharmacology;Tumor Cells, Cultured;Up-Regulation/drug effects;Up-Regulation/genetics
26582321;1-Methyl-4-phenylpyridinium/pharmacokinetics;Cations/pharmacokinetics;Cell Line;Dopamine/metabolism*;Dopamine Plasma Membrane Transport Proteins/antagonists & inhibitors;Dopamine Plasma Membrane Transport Proteins/metabolism;Enzyme Inhibitors/pharmacology;Flavonoids/pharmacology*;Humans;Neurons/drug effects*;Neurons/metabolism;Neurotransmitter Agents/pharmacology*;Piperazines/pharmacology;Signal Transduction/drug effects
26643768;Female;Homosexuality, Female/psychology*;Humans;Middle Aged;Personal Satisfaction*;Psychometrics;Reproducibility of Results;Self Concept;Surveys and Questionnaires/standards*;Translating;Young Adult
26693202;Adult;Biomarkers, Tumor/genetics*;Colorectal Neoplasms/genetics*;Colorectal Neoplasms/metabolism;Colorectal Neoplasms/pathology;CpG Islands;DNA Methylation*;Female;Gene Silencing*;Humans;Male;MicroRNAs/genetics*;Middle Aged
26742522;Alzheimer Disease/drug therapy;Alzheimer Disease/genetics;Alzheimer Disease/metabolism*;Amyloid beta-Peptides/genetics;Amyloid beta-Peptides/metabolism*;Amyloid beta-Protein Precursor/genetics;Animals;Clozapine/pharmacology;Clozapine/therapeutic use*;Male;Memory Disorders/drug therapy;Memory Disorders/genetics;Memory Disorders/metabolism*;Mice;Mice, Inbred C57BL;Mice, Transgenic;Peptide Fragments/genetics;Peptide Fragments/metabolism*;Presenilin-1/genetics
26774948;Flavoring Agents/analysis*;Humans;Taste Perception;Tobacco Industry/methods*;Tobacco Products/analysis*;United States
26778096;Child, Preschool;Humans;Male;Melioidosis/complications;Melioidosis/diagnosis*;Muscle Hypotonia/microbiology*;Paralysis/microbiology*
26791226;Adolescent;Adult;Attention/physiology*;Brain/physiology*;Brain Mapping/methods;Conflict (Psychology)*;Female;Humans;Magnetic Resonance Imaging/methods*;Male;Photic Stimulation/methods;Psychomotor Performance/physiology*;Reaction Time/physiology*;Young Adult
26847934;Adult;Aged;Aged, 80 and over;Female;Humans;Male;Middle Aged;Postoperative Care;Pressure Ulcer/pathology;Pressure Ulcer/surgery*;Retrospective Studies;Surgical Flaps;Young Adult
26924808;Analgesics, Opioid/pharmacology*;Animals;Conditioning, Operant/drug effects*;Extinction, Psychological/drug effects*;Locomotion/drug effects;Male;Morphine/pharmacology*;Peptide Fragments/pharmacology;Peptides/pharmacology*;Rats;Rats, Sprague-Dawley;Receptors, AMPA/chemistry*;Receptors, AMPA/metabolism;Reinforcement (Psychology);Time Factors;tat Gene Products, Human Immunodeficiency Virus/pharmacology
26988439;Basic Helix-Loop-Helix Leucine Zipper Transcription Factors;Coronary Artery Disease/drug therapy;Coronary Artery Disease/etiology;Coronary Artery Disease/metabolism;Coronary Artery Disease/prevention & control;Gene Expression Regulation;Genome-Wide Association Study;Humans;Hydrolysis;Lipid Metabolism/drug effects*;Lipogenesis;Lipoproteins/blood;Lipoproteins/metabolism;Liver/metabolism;Molecular Targeted Therapy;Risk Factors;Signal Transduction;Toll-Like Receptors/metabolism;Triglycerides/blood;Triglycerides/metabolism*
27006063;Blood Pressure*;Heart Failure/mortality*;Humans;Prognosis;Retrospective Studies;Risk Factors;Ventricular Dysfunction, Left
27011197;Air Pollutants/toxicity*;Air Pollution/analysis*;Cardiovascular Diseases/chemically induced;Cardiovascular Diseases/mortality*;Cities;Cross-Over Studies;Environmental Exposure*;Humans;Models, Theoretical;Particle Size;Particulate Matter/toxicity*;Respiration Disorders/chemically induced;Respiration Disorders/mortality*;Taiwan
27042849;Adolescent;Adult;Child;Female;Hematopoietic Stem Cell Transplantation/methods*;Hematopoietic Stem Cell Transplantation/mortality;Humans;Leukemia, Myeloid, Acute/mortality;Leukemia, Myeloid, Acute/therapy*;MDS1 and EVI1 Complex Locus Protein/analysis*;Male;Middle Aged;Myeloablative Agonists/therapeutic use;Prognosis;Recurrence;Remission Induction/methods;Retrospective Studies;Survival Analysis;Transplantation Conditioning/methods;Transplantation, Homologous;Young Adult
27043577;Bacteria/classification;Bacteria/isolation & purification*;Biosensing Techniques/methods*;Fungi/classification;Fungi/isolation & purification;Gases/chemistry;Gases/isolation & purification*;Porphyrins/chemistry;Quartz Crystal Microbalance Techniques/methods;Volatile Organic Compounds/chemistry;Volatile Organic Compounds/isolation & purification*
27057247;Health Communication*;Humans;Physician-Patient Relations;Physicians;Quality of Health Care*
27072433;4-Aminobenzoic Acid/administration & dosage;4-Aminobenzoic Acid/chemistry;4-Aminobenzoic Acid/pharmacokinetics*;Administration, Oral;Animals;Area Under Curve;Biological Availability;Drug Delivery Systems*;Glycerides/chemistry;Male;Rats;Rats, Wistar;Skin
27108119;Aged;Bone Density*;Cohort Studies;Densitometry;Female;Humans;Male;Manitoba;Middle Aged;Osteoporotic Fractures/diagnosis*;Registries;Risk Assessment*;Risk Factors
27175491;Bacteremia/microbiology*;Drug Resistance, Multiple, Bacterial/genetics;Escherichia coli/drug effects*;Escherichia coli/genetics;Escherichia coli/isolation & purification;Escherichia coli Infections/microbiology*;Humans;Klebsiella/drug effects*;Klebsiella/genetics;Klebsiella/isolation & purification;Klebsiella Infections/microbiology*;Polymerase Chain Reaction;Polymorphism, Restriction Fragment Length;Quinolones/pharmacology*;R Factors;Sequence Alignment;beta-Lactamases/biosynthesis
27265306;Adolescent;Adult;Aged;Aged, 80 and over;Cameroon;Cross-Sectional Studies;Diet*;Female;Food Supply*;Forests*;Humans;Middle Aged;Rural Population*;Young Adult
27458727;Aeromonas veronii/physiology;Animals;Antibiosis/physiology;Gastrointestinal Microbiome/physiology*;Gastrointestinal Motility/physiology*;Gastrointestinal Tract/microbiology*;Larva/genetics;Larva/microbiology;Larva/physiology;Microbiota/physiology*;Microscopy, Fluorescence;Mutation;Population Dynamics;Species Specificity;Vibrio cholerae/physiology;Zebrafish
27474768;Adipocytes/transplantation*;Adipose Tissue/transplantation;Cell Survival;Graft Survival;Humans;Obesity*;Stem Cells;Tissue and Organ Harvesting
27496395;Adult;Early Detection of Cancer*;Female;Health Communication/methods*;Humans;Male;Mass Screening*;Missouri;Neoplasms/diagnosis;Neoplasms/prevention & control;Poverty;Preventive Health Services/methods*;Referral and Consultation;Risk Assessment/methods;Smoking Cessation;Stress, Psychological;Telephone;Vulnerable Populations/ethnology;Vulnerable Populations/psychology
27533779;3' Untranslated Regions;Aged;Apoptosis;Apoptosis Regulatory Proteins/genetics*;Apoptosis Regulatory Proteins/metabolism;Cell Line, Tumor;Cell Movement;Cell Proliferation;Female;Gene Expression Profiling;Gene Expression Regulation, Neoplastic;Humans;MAP Kinase Signaling System;Male;Melanoma/genetics;Melanoma/metabolism;Melanoma/pathology*;Membrane Proteins/genetics*;Membrane Proteins/metabolism;MicroRNAs/genetics*;Middle Aged;NF-kappa B/genetics;NF-kappa B/metabolism;PTEN Phosphohydrolase/genetics*;PTEN Phosphohydrolase/metabolism;Phosphoproteins/genetics*;Phosphoproteins/metabolism;RNA-Binding Proteins/genetics*;RNA-Binding Proteins/metabolism;Skin Neoplasms/genetics;Skin Neoplasms/metabolism;Skin Neoplasms/pathology*
27579919;Bdellovibrio bacteriovorus/metabolism*;Cell Line;Escherichia coli/metabolism*;Escherichia coli Infections/metabolism*;Humans;Inflammation/metabolism;Inflammation/microbiology
27719639;Animals;Antineoplastic Agents/pharmacology*;Epigenesis, Genetic/drug effects*;Epigenesis, Genetic/genetics;Female;Hedgehog Proteins/antagonists & inhibitors*;Hedgehog Proteins/genetics;Hedgehog Proteins/metabolism;Humans;Mutation;Ovarian Neoplasms/drug therapy*;Ovarian Neoplasms/genetics;Ovarian Neoplasms/metabolism;Signal Transduction/drug effects*;Signal Transduction/genetics
27846974;Darier Disease*;Diagnosis, Differential;Humans;Kidney*
27849160;Demography;Florida;Genetic Variation*;Geography;High-Throughput Nucleotide Sequencing;Likelihood Functions;Louisiana;Mississippi;Polymorphism, Genetic;Sequence Analysis, DNA;Taxodium/genetics*;Taxodium/physiology;Texas;Trees
27894763;Adolescent;Anti-Bacterial Agents/pharmacology;Child;Child, Preschool;Drug Resistance, Multiple, Bacterial*;Gram-Negative Bacteria/drug effects;Gram-Negative Bacteria/isolation & purification;Gram-Negative Bacterial Infections/diagnosis;Gram-Negative Bacterial Infections/etiology;Gram-Negative Bacterial Infections/microbiology*;Gram-Negative Bacterial Infections/urine;Humans;Infant;Infant, Newborn;Recurrence;Retrospective Studies;Risk Assessment;Risk Factors;Urinary Tract Infections/diagnosis;Urinary Tract Infections/etiology;Urinary Tract Infections/microbiology*;Urinary Tract Infections/urine;Urogenital Abnormalities/complications*;beta-Lactam Resistance*;beta-Lactams/pharmacology
27914074;Bacterial Proteins/chemistry*;Bacterial Proteins/genetics;Bacterial Proteins/isolation & purification;Bacterial Proteins/metabolism*;Cloning, Molecular;Gene Expression;Helicobacter Infections/microbiology;Helicobacter pylori/genetics;Helicobacter pylori/metabolism*;Humans;Plasmids/genetics;Protein Stability;Proteolysis;Recombinant Fusion Proteins/chemistry;Recombinant Fusion Proteins/genetics;Recombinant Fusion Proteins/isolation & purification;Recombinant Fusion Proteins/metabolism;Spectrometry, Fluorescence;Structure-Activity Relationship
28116023;Educational Measurement/standards*;Emergency Medicine/education*;Humans;Internship and Residency/economics*;Internship and Residency/standards*;Physician Executives;Surveys and Questionnaires;United States
28178320;Animals;Arctic Regions;Biodiversity;Biomass;Ecosystem*;Environment*;Salinity;Temperature;Zooplankton*
28236866;Equipment Design;Humans;International Agencies;Laryngoscopes/standards*;Laryngoscopy/instrumentation*;Laryngoscopy/methods;Light*;Operating Rooms;Smartphone*
28290231;Adolescent;Adult;Aged;Aged, 80 and over;Benign Paroxysmal Positional Vertigo/diagnosis;Benign Paroxysmal Positional Vertigo/physiopathology;Caloric Tests;Electronystagmography*;Female;Humans;Male;Middle Aged;Physical Examination*;Prospective Studies;Surveys and Questionnaires;Vertigo/diagnosis*;Vertigo/physiopathology;Vestibular Diseases/diagnosis;Vestibular Diseases/physiopathology;Vestibular Function Tests;Young Adult
28389048;Amino Acid Sequence;Animals;Animals, Newborn;Cloning, Molecular;Gene Expression Regulation, Developmental/physiology*;Hypothalamo-Hypophyseal System/metabolism*;Male;Neuropeptides/genetics;Neuropeptides/metabolism*;Phylogeny;RNA, Messenger/genetics;RNA, Messenger/metabolism;RNA-Directed DNA Polymerase;Real-Time Polymerase Chain Reaction;Receptors, Neurotransmitter/genetics;Receptors, Neurotransmitter/metabolism*;Swine;Testis/metabolism*
28393012;Accelerometry;Brain/diagnostic imaging*;Brain Concussion/diagnostic imaging*;Brain Concussion/etiology*;Brain Mapping*;Cerebrovascular Circulation/physiology;Football/injuries*;Humans;Image Processing, Computer-Assisted;Male;Nerve Fibers/pathology;Neural Pathways/diagnostic imaging;Neuroimaging*;Seasons;Universities;Young Adult
28394346;Acetylation;Adaptor Proteins, Signal Transducing/genetics;Adaptor Proteins, Signal Transducing/metabolism;Carrier Proteins/metabolism*;Cell Line, Tumor;Cyclin-Dependent Kinase 2/genetics;Cyclin-Dependent Kinase 2/metabolism;DNA Mutational Analysis;DNA-Binding Proteins/metabolism*;Humans;Mast Cells/metabolism;Melanoma/genetics;Melanoma/metabolism*;Membrane Proteins/genetics;Membrane Proteins/metabolism;Microphthalmia-Associated Transcription Factor/genetics;Microphthalmia-Associated Transcription Factor/metabolism*;Nerve Tissue Proteins/genetics;Nerve Tissue Proteins/metabolism*;Phosphorylation;Protein Binding;Protein Processing, Post-Translational*;Signal Transduction;Skin Neoplasms/genetics;Skin Neoplasms/metabolism*;Transcriptional Activation*
28401353;Abortion, Spontaneous*;Adolescent;Child;Child, Preschool;Female;Humans;Infant;Infant, Newborn;Leukemia, Myeloid, Acute/etiology*;Male;Precursor Cell Lymphoblastic Leukemia-Lymphoma/etiology*;Pregnancy;Risk Factors;Stillbirth*
28438541;Antineoplastic Agents/pharmacology*;Cell Line, Tumor;Cell Proliferation/drug effects;Colonic Neoplasms/pathology*;Diarylheptanoids/chemistry;Diarylheptanoids/pharmacology*;Humans;Superoxide Dismutase/metabolism
28463447;Adolescent;Adolescent Behavior;Age Factors;Bullying/statistics & numerical data*;Child;Crime Victims/statistics & numerical data*;Female;Humans;Male;Prevalence;Schools/statistics & numerical data*;Sex Factors;Spain/epidemiology;Violence/statistics & numerical data
28482117;Genes, Homeobox;Genome-Wide Association Study;Genotype;Hordeum/cytology;Hordeum/genetics*;Hordeum/growth & development;Mutation;Phenotype;Phylogeny;Plant Leaves/cytology;Plant Leaves/genetics;Plant Leaves/growth & development;Plant Proteins/genetics;Plant Proteins/metabolism;Transcription Factors/genetics;Transcription Factors/metabolism*;Transcriptome*
28687683;Administration, Intravenous;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/therapeutic use;Australia/epidemiology;Catheter-Related Infections/complications;Catheter-Related Infections/drug therapy;Catheter-Related Infections/microbiology*;Catheterization, Central Venous/adverse effects*;Catheterization, Central Venous/economics;Catheterization, Central Venous/instrumentation;Central Venous Catheters/adverse effects*;Central Venous Catheters/economics;Central Venous Catheters/microbiology;Child, Preschool;Cost of Illness;Equipment Failure/economics;Female;Gastroschisis/diagnosis;Gastroschisis/surgery*;Humans;Infant;Klebsiella pneumoniae/isolation & purification;Parenteral Nutrition/instrumentation*;Parenteral Nutrition/methods;Short Bowel Syndrome/complications*;Treatment Outcome
28700188;Biomedical Technology*;Humanism*;Humans
28826714;Cadaver;Cerebral Revascularization/methods*;Feasibility Studies;Humans;Maxillary Artery/anatomy & histology*;Maxillary Artery/surgery*;Neurosurgical Procedures/methods*;Temporal Arteries/anatomy & histology*;Temporal Arteries/surgery*
28834109;Humans;Particle Accelerators*;Phantoms, Imaging;Radiotherapy Planning, Computer-Assisted;Radiotherapy, Intensity-Modulated/instrumentation*;Radiotherapy, Intensity-Modulated/methods;Respiration*
28919037;Bacillus subtilis/drug effects;Bacterial Proteins/genetics;Bacterial Proteins/metabolism;Cell Membrane/metabolism*;Extracellular Vesicles/metabolism*;Gene Deletion;Multigene Family/genetics;Mutation;Polyketides/metabolism*;Polyketides/pharmacology;Streptomyces/cytology*;Streptomyces/genetics;Streptomyces/metabolism*
10851844;Adverse Drug Reaction Reporting Systems;Drug Interactions*;Drug Therapy, Combination;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions;Humans
10883418;Biological Availability;Contraceptives, Oral, Synthetic/adverse effects;Contraceptives, Oral, Synthetic/pharmacokinetics;Cross-Over Studies;Dietary Fats/metabolism*;Estradiol/adverse effects;Estradiol/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Middle Aged;Norgestrel/adverse effects;Norgestrel/analogs & derivatives*;Norgestrel/pharmacokinetics*;Postmenopause/metabolism*;Women's Health
10890261;Administration, Oral;Aged;Beverages*;Chromatography, High Pressure Liquid;Citrus*/adverse effects;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/blood;Depression/blood;Depression/drug therapy*;Female;Food-Drug Interactions*;Humans;In Vitro Techniques;Male;Microsomes/drug effects;Microsomes/metabolism;Middle Aged;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/blood;Prospective Studies;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/pharmacokinetics*;Sertraline/administration & dosage;Sertraline/analogs & derivatives;Sertraline/antagonists & inhibitors;Sertraline/metabolism;Sertraline/pharmacokinetics*;Treatment Outcome
10994537;Acute Disease;Adult;Anticoagulants/adverse effects*;Drug Interactions;Drug and Narcotic Control;Female;Food-Drug Interactions;Garlic/adverse effects*;Ginkgo biloba/adverse effects*;Hematoma, Subdural/chemically induced;Humans;Medical History Taking;Nursing Assessment;Phytotherapy*;Plants, Medicinal*;Warfarin/adverse effects*
10994829;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;Beverages/adverse effects*;Beverages/analysis;Biological Availability;Calcium Channel Blockers/metabolism;Citrus/adverse effects*;Citrus/chemistry;Cyclosporine/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/drug effects;Dose-Response Relationship, Drug;Food-Drug Interactions/physiology*;Histamine H1 Antagonists/metabolism;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Immunosuppressive Agents/metabolism;Intestinal Mucosa/drug effects;Intestinal Mucosa/enzymology;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/drug effects;Psychotropic Drugs/metabolism;Tacrolimus/metabolism;Terfenadine/metabolism
11069440;Administration, Oral;Adult;Amlodipine/adverse effects;Amlodipine/pharmacokinetics*;Amlodipine/pharmacology*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Antihypertensive Agents/pharmacology;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology*;Citrus*;Cross-Over Studies;Food-Drug Interactions*;Humans;Injections, Intravenous;Male;Middle Aged;Placebos;Pulse;Stereoisomerism
11078178;Age Factors;Angiotensin-Converting Enzyme Inhibitors/pharmacology;Blood Pressure/drug effects*;Blood Pressure/physiology*;Calcium Channel Blockers/pharmacology;Double-Blind Method;Enalapril/pharmacology*;Female;Food-Drug Interactions/physiology;Humans;Hypertension/physiopathology*;Isradipine/pharmacology*;Male;Middle Aged;Patient Compliance;Sex Factors;Sodium Chloride, Dietary/administration & dosage*;Sodium Chloride, Dietary/adverse effects*;Time Factors
11141164;Beverages/adverse effects*;Citrus*;Food-Drug Interactions*;Humans;Torsades de Pointes/chemically induced*
7722194;Administration, Oral;Alcoholic Beverages/adverse effects;Allium;Anticoagulants/administration & dosage;Anticoagulants/pharmacology*;Beverages;Caffeine/pharmacology;Coumarins/administration & dosage;Coumarins/pharmacology;Dietary Fats/pharmacology;Food-Drug Interactions*;Humans;Peptide Hydrolases/administration & dosage;Peptide Hydrolases/pharmacology;Silicones/administration & dosage;Silicones/pharmacology;Vitamin K/administration & dosage;Vitamin K/pharmacology;Vitamins/administration & dosage;Vitamins/pharmacology
11210398;Administration, Oral;Adult;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting/metabolism*;Food-Drug Interactions*;Humans;Intestinal Absorption;Male;Middle Aged;Tacrolimus/adverse effects;Tacrolimus/pharmacokinetics*
11216183;Anti-Ulcer Agents/adverse effects*;Anti-Ulcer Agents/pharmacokinetics;Arrhythmias, Cardiac/chemically induced*;Aryl Hydrocarbon Hydroxylases*;Beverages;Cisapride/adverse effects*;Cisapride/pharmacokinetics;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Oxidoreductases, N-Demethylating/drug effects;Oxidoreductases, N-Demethylating/metabolism
11332259;Adult;Antihypertensive Agents/adverse effects*;Diagnostic Errors*;Female;Food-Drug Interactions*;Glycyrrhiza/adverse effects*;Humans;Hydrochlorothiazide/adverse effects;Hypertension/chemically induced*;Hypertension/diagnosis;Hypertension/drug therapy;Hypokalemia/etiology;Medical History Taking;Muscle Cramp;Netherlands;Plants, Medicinal*;Tea/adverse effects*
11334062;Cyclosporine/adverse effects*;Food-Drug Interactions*;Humans;Immunosuppressive Agents/adverse effects*;Intestinal Absorption/drug effects*;Nutritional Status/drug effects;Organ Transplantation*;Pharmacokinetics;Postoperative Complications;Treatment Outcome
11361049;Adult;Area Under Curve;Biological Availability;Confidence Intervals;Cross-Over Studies;Dietary Fats;Food-Drug Interactions*;Gastrointestinal Diseases/chemically induced;Half-Life;Headache/chemically induced;Humans;Least-Squares Analysis;Male;Metabolic Clearance Rate;Middle Aged;Quinoxalines/adverse effects;Quinoxalines/blood;Quinoxalines/pharmacokinetics*;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*
11426073;Adult;Anti-HIV Agents/adverse effects*;Anti-HIV Agents/therapeutic use;Antidepressive Agents, Second-Generation/adverse effects*;Antidepressive Agents, Second-Generation/pharmacokinetics;Antidepressive Agents, Second-Generation/therapeutic use;Cytochrome P-450 Enzyme System/metabolism;Depression/complications;Depression/drug therapy*;Drug Interactions;Female;Fluoxetine/adverse effects;Fluoxetine/pharmacokinetics;Fluoxetine/therapeutic use;Food-Drug Interactions;HIV Infections/complications;HIV Infections/drug therapy*;Humans;Male;Middle Aged;Serotonin Syndrome/chemically induced*;Serotonin Uptake Inhibitors/adverse effects*;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/therapeutic use
11531805;Adolescent;Adult;Anaphylaxis/etiology*;Animals;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Brachyura;Decapoda (Crustacea);Exercise*;Food Hypersensitivity/etiology*;Food-Drug Interactions*;Humans;Male;Middle Aged;Shellfish/adverse effects;Triticum/adverse effects
11549099;3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors*;Adolescent;Adult;Aged;Aged, 80 and over;Aging/metabolism;Area Under Curve;Bronchodilator Agents/administration & dosage;Bronchodilator Agents/adverse effects;Bronchodilator Agents/pharmacokinetics*;Carboxylic Acids;Cyclic Nucleotide Phosphodiesterases, Type 4;Cyclohexanecarboxylic Acids;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Nitriles;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*
11552202;Adult;Aged;Anticoagulants/blood;Anticoagulants/pharmacology*;Biological Availability;Dietary Proteins/adverse effects;Drug Evaluation;Drug Monitoring;Drug Resistance;Enteral Nutrition/adverse effects*;Food, Formulated/adverse effects*;Food, Formulated/analysis;Food-Drug Interactions*;Humans;Male;Warfarin/blood;Warfarin/pharmacology*
11572503;Administration, Oral;Beverages/adverse effects*;Biological Availability;Child;Citrus/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Flavoring Agents/administration & dosage;Food-Drug Interactions*;Humans;Hypnotics and Sedatives/administration & dosage;Hypnotics and Sedatives/adverse effects*;Hypnotics and Sedatives/pharmacokinetics;Injections, Intravenous;Intestinal Absorption/drug effects;Intestines/enzymology;Liver/enzymology;Midazolam/administration & dosage;Midazolam/adverse effects*;Midazolam/pharmacokinetics;Mixed Function Oxygenases/antagonists & inhibitors;Taste/drug effects
11605310;Acetaminophen/administration & dosage;Acetaminophen/adverse effects*;Acetaminophen/blood;Adult;Aged;Alanine Transaminase/metabolism;Alcoholism/complications*;Alcoholism/metabolism;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/adverse effects*;Analgesics, Non-Narcotic/blood;Aspartate Aminotransferases/metabolism;Chemical and Drug Induced Liver Injury*;Cytochrome P-450 CYP2E1/metabolism;Diagnosis, Differential;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Liver/drug effects*;Liver/enzymology;Liver/metabolism*;Liver Diseases/blood;Liver Diseases/enzymology;Liver Function Tests;Treatment Outcome
11718495;Administration, Oral;Adult;Aminosalicylic Acid/pharmacology;Antacids/pharmacology*;Antibiotics, Antitubercular/administration & dosage;Antibiotics, Antitubercular/adverse effects;Antibiotics, Antitubercular/pharmacokinetics*;Area Under Curve;Beverages;Citrus;Clofazimine/pharmacology;Cross-Over Studies;Cycloserine/administration & dosage;Cycloserine/adverse effects;Cycloserine/pharmacokinetics*;Dietary Fats/pharmacology*;Drug Interactions;Electrophoresis, Capillary;Ethionamide/pharmacology;Fasting/physiology*;Female;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Male
11724078;Adult;Aminosalicylic Acid/administration & dosage*;Aminosalicylic Acid/adverse effects;Aminosalicylic Acid/pharmacokinetics*;Antacids/pharmacology;Antitubercular Agents/administration & dosage*;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus;Cross-Over Studies;Dietary Fats/pharmacology;Double-Blind Method;Drug Combinations;Drug Interactions;Female;Food-Drug Interactions;Half-Life;Humans;Male;Powders;Therapeutic Equivalency
11763808;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Anticoagulants/therapeutic use;Diet;Female;Food-Drug Interactions*;Hemostatics/administration & dosage;Hemostatics/adverse effects*;Hemostatics/therapeutic use;Humans;International Normalized Ratio;Seaweed/chemistry*;Vitamin K/administration & dosage;Vitamin K/adverse effects*;Vitamin K/therapeutic use;Warfarin/administration & dosage;Warfarin/adverse effects*;Warfarin/therapeutic use
11816871;Adult;Beverages/adverse effects*;Citrus*;Clozapine/adverse effects;Clozapine/analogs & derivatives*;Clozapine/pharmacokinetics*;Clozapine/therapeutic use;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Prospective Studies;Psychiatric Status Rating Scales;Schizophrenia/blood*;Schizophrenia/drug therapy
11823753;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Administration, Oral;Adult;Area Under Curve;Beverages/adverse effects*;Biological Availability;Carrier Proteins/metabolism;Citrus;Double-Blind Method;Female;Flavonoids/metabolism;Food-Drug Interactions/physiology*;Fruit*;HeLa Cells;Histamine H1 Antagonists/pharmacokinetics*;Humans;Intestinal Absorption;Male;Malus;Membrane Transport Proteins*;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism*;Organic Anion Transporters, Sodium-Dependent;Symporters;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics*
11823754;Adult;Area Under Curve;Beverages/adverse effects*;Biological Availability;Biotransformation;Blood Pressure/drug effects;Calibration;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions/physiology*;Heart Rate/drug effects;Humans;Male;Mixed Function Oxygenases/metabolism;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Purines;Quality Control;Sildenafil Citrate;Sulfones
11837383;Adult;Aged;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics*;Angiotensin-Converting Enzyme Inhibitors/pharmacology*;Area Under Curve;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Isoquinolines/administration & dosage;Isoquinolines/adverse effects;Isoquinolines/blood;Isoquinolines/pharmacokinetics*;Isoquinolines/pharmacology*;Kinetics;Male;Middle Aged;Peptidyl-Dipeptidase A/blood;Tetrahydroisoquinolines*
11865964;Adult;Analysis of Variance;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics;Area Under Curve;Chemistry, Pharmaceutical;Cross-Over Studies;Dietary Fats/pharmacokinetics;Eating/physiology*;Endothelin Receptor Antagonists*;Fasting/metabolism;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Receptors, Endothelin/physiology;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*
11936567;Administration, Oral;Adult;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/adverse effects;Anti-HIV Agents/blood;Area Under Curve;Biological Availability;Confidence Intervals;Cross-Over Studies;Didanosine/administration & dosage;Didanosine/adverse effects;Didanosine/blood*;Dietary Fats/blood;Fasting/blood;Female;Food-Drug Interactions/physiology*;Humans;Male;Microspheres;Tablets, Enteric-Coated
11936572;Adult;Analysis of Variance;Anti-Infective Agents/blood;Anti-Infective Agents/pharmacokinetics;Area Under Curve;Beverages*;Calcium/pharmacokinetics*;Ciprofloxacin/blood*;Ciprofloxacin/pharmacokinetics;Citrus/metabolism*;Cross-Over Studies;Female;Food, Fortified*/adverse effects;Food-Drug Interactions/physiology*;Humans;Male;Middle Aged;Statistics, Nonparametric;Therapeutic Equivalency
11953660;Biological Availability;Enteral Nutrition;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects;Pharmacokinetics;Treatment Outcome
11956673;Adult;Beverages*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/urine;Chromatography, High Pressure Liquid;Citrus*;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Flavanones*;Flavonoids/blood;Flavonoids/pharmacokinetics;Flavonoids/urine;Food-Drug Interactions;Humans;Hydrocortisone/analogs & derivatives*;Hydrocortisone/urine;Male;Mixed Function Oxygenases/metabolism;Smoking/blood*;Stereoisomerism;Verapamil/adverse effects;Verapamil/blood;Verapamil/pharmacokinetics*;Verapamil/urine
11957745;Animals;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Drug Interactions;Food-Drug Interactions;Humans;Hydroxymethylglutaryl CoA Reductases/adverse effects;Hydroxymethylglutaryl CoA Reductases/pharmacokinetics*
7836549;Aged;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Humans;Intestinal Absorption;Middle Aged;Tacrine/adverse effects;Tacrine/blood;Tacrine/pharmacokinetics*
11966676;Amlodipine/pharmacokinetics*;Beverages/adverse effects*;Biological Availability;Citrus*;Food-Drug Interactions*;Humans
11971236;Dietary Supplements/adverse effects*;Food-Drug Interactions;Germany;Humans;Kava/adverse effects*;Liver Diseases/etiology*;United States;United States Food and Drug Administration
12004838;Anticholesteremic Agents/pharmacology;Beverages/adverse effects*;Calcium Channel Blockers/pharmacology;Citrus/adverse effects*;Food-Drug Interactions*;Humans
12009003;Adolescent;Adult;Anticonvulsants/adverse effects*;Anticonvulsants/therapeutic use;Biotin/blood;Calcium/blood;Carnitine/blood;Carnitine/deficiency;Dietetics;Edema/chemically induced;Folic Acid/blood;Food-Drug Interactions*;Humans;Middle Aged;Seizures/drug therapy*;Serum Albumin/analysis;Serum Albumin/drug effects*;Valproic Acid/adverse effects*;Valproic Acid/therapeutic use;Weight Gain/drug effects
12014354;Aged;Aged, 80 and over;Anacardiaceae*/adverse effects;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Blood Coagulation/drug effects;Blood Coagulation Disorders/chemically induced;Food-Drug Interactions*;Fruit/adverse effects;Humans;International Normalized Ratio/adverse effects;Male;Middle Aged;Warfarin/adverse effects;Warfarin/therapeutic use*
12051573;Administration, Oral;Adult;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/adverse effects*;Antiparasitic Agents/pharmacokinetics*;Area Under Curve;Food-Drug Interactions;Humans;Male;Maximum Tolerated Dose;Thiazoles/administration & dosage;Thiazoles/adverse effects*;Thiazoles/blood;Thiazoles/pharmacokinetics*
7857345;Adult;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Food-Drug Interactions*;Humans;Immunologic Factors/adverse effects;Immunologic Factors/blood;Immunologic Factors/pharmacokinetics*;Male;Pyrrolidonecarboxylic Acid/adverse effects;Pyrrolidonecarboxylic Acid/analogs & derivatives*;Pyrrolidonecarboxylic Acid/blood;Pyrrolidonecarboxylic Acid/pharmacokinetics;Spectrophotometry, Ultraviolet;Therapeutic Equivalency;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*;Thiazolidines
12095536;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors*;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Adolescent;Adult;Antitussive Agents/pharmacokinetics*;Aryl Hydrocarbon Hydroxylases*;Beverages/adverse effects*;Biological Availability;Biotransformation;Citrus*;Cytochrome P-450 CYP2D6/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Dealkylation;Dextromethorphan/pharmacokinetics*;Digestive System/enzymology;Digestive System/metabolism*;Female;Food-Drug Interactions*;Humans;Male;Membrane Proteins/metabolism;Oxidoreductases, N-Demethylating/antagonists & inhibitors*;Oxidoreductases, N-Demethylating/metabolism;Phenotype;Reproducibility of Results
12125178;Alcoholic Beverages/adverse effects*;Biological Availability;Drug Interactions*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/pharmacokinetics;Risk Factors
12162471;Adolescent;Adult;Area Under Curve;Capsules/administration & dosage;Capsules/pharmacokinetics;Carbamates;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/physiology;Food-Drug Interactions;Health;Humans;Male;Middle Aged;Organophosphates/administration & dosage;Organophosphates/adverse effects;Organophosphates/blood;Organophosphates/pharmacokinetics*;Prodrugs/administration & dosage;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/blood;Sulfonamides/pharmacokinetics*;Suspensions/administration & dosage;Suspensions/pharmacokinetics;Tablets/administration & dosage;Tablets/pharmacokinetics
12165187;Adverse Drug Reaction Reporting Systems;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism*;Drug Interactions*;Food-Drug Interactions;Humans;Iatrogenic Disease*;Internet;Interprofessional Relations;Plant Preparations/adverse effects*
12171043;Anti-HIV Agents/adverse effects;Anti-HIV Agents/therapeutic use*;Food-Drug Interactions*;HIV Infections/drug therapy*;Humans
12362927;Administration, Oral;Adolescent;Adult;Antiparasitic Agents/administration & dosage;Antiparasitic Agents/adverse effects;Antiparasitic Agents/pharmacokinetics*;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Humans;Ivermectin/administration & dosage;Ivermectin/adverse effects;Ivermectin/pharmacokinetics*;Male;Middle Aged;Mydriasis/chemically induced;Pupil/drug effects
12371301;Anticholesteremic Agents/pharmacokinetics*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 Enzyme System/metabolism;Drug Synergism*;Food-Drug Interactions*;Humans;Simvastatin/pharmacokinetics*
12387000;Diabetes Mellitus, Type 2/diet therapy*;Dietary Fiber/analysis;Dietary Supplements*/adverse effects;Dietary Supplements*/analysis;Diglycerides/analysis;Food, Organic*/adverse effects;Food, Organic*/analysis;Food-Drug Interactions;Glycoside Hydrolase Inhibitors;Humans;Hypercholesterolemia/diet therapy;Hyperglycemia/diet therapy;Hypertension/drug therapy
12389073;Administration, Oral;Adult;Aged;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/blood;Antineoplastic Agents, Phytogenic/pharmacokinetics*;Area Under Curve;Beverages/adverse effects*;Biological Availability;Carcinoma, Small Cell/drug therapy;Chromatography, High Pressure Liquid;Citrus paradisi/adverse effects*;Cross-Over Studies;Etoposide/administration & dosage;Etoposide/adverse effects;Etoposide/blood;Etoposide/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Infusions, Intravenous;Lung Neoplasms/drug therapy;Male;Middle Aged;Pilot Projects
7859239;Adult;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Double-Blind Method;Fasting;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Theophylline/administration & dosage;Theophylline/adverse effects;Theophylline/pharmacokinetics*;Therapeutic Equivalency
12389876;Antineoplastic Agents/economics;Antineoplastic Agents/pharmacology;Antineoplastic Agents/therapeutic use*;Benzamides;Clinical Trials as Topic;Drug Interactions;Drug Resistance, Neoplasm;Food-Drug Interactions;Gastrointestinal Neoplasms/drug therapy;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy;Patient Education as Topic;Piperazines/economics;Piperazines/pharmacology;Piperazines/therapeutic use*;Pyrimidines/economics;Pyrimidines/pharmacology;Pyrimidines/therapeutic use*;Sarcoma/drug therapy;Stromal Cells
12426769;Animals;Anticoagulants/adverse effects*;Drug Interactions;Food-Drug Interactions;Herb-Drug Interactions;Humans;Phytotherapy;Plants, Medicinal;Warfarin/adverse effects*
12463728;Adult;Anti-Anxiety Agents/blood;Anti-Anxiety Agents/pharmacokinetics*;Area Under Curve;Benzodiazepines*;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/adverse effects*;Fasting;Food-Drug Interactions*;Half-Life;Humans;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/pharmacokinetics*;Male;Postprandial Period;Time Factors
12492049;Biological Availability;Carbamates;Dietary Fats/administration & dosage;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Infections/metabolism*;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/pharmacokinetics*;HIV Protease Inhibitors/therapeutic use;Humans;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*;Sulfonamides/therapeutic use;Vitamin E/administration & dosage
12520629;Administration, Oral;Adolescent;Adult;Biological Availability;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Sex Factors;Sodium Oxybate/administration & dosage;Sodium Oxybate/adverse effects;Sodium Oxybate/pharmacokinetics*;Solutions
12551706;Adult;Antiparkinson Agents/adverse effects;Antiparkinson Agents/blood;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Benserazide/adverse effects;Benserazide/blood;Benserazide/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Drug Administration Schedule;Drug Combinations;Fasting;Female;Food*;Food-Drug Interactions;Half-Life;Humans;Levodopa/adverse effects;Levodopa/blood;Levodopa/pharmacokinetics*;Male;Time Factors;Tyrosine/analogs & derivatives*;Tyrosine/blood
12578152;Adolescent;Adult;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/pharmacology*;Food-Drug Interactions*;Humans;Ketolides*;Macrolides*;Male;Middle Aged
12611197;Beverages/adverse effects*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans
7899788;Adolescent;Adult;Albendazole/adverse effects;Albendazole/pharmacokinetics*;Albendazole/therapeutic use*;Animals;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions;Humans;Ivermectin/adverse effects;Ivermectin/therapeutic use*;Male;Microfilariae/drug effects;Middle Aged;Onchocerca/drug effects;Onchocerca/embryology;Onchocerca/growth & development;Onchocerciasis/drug therapy*;Onchocerciasis/parasitology
12611563;Animals;Arthritis, Rheumatoid/therapy;Asthma/therapy;Cardiomyopathies/therapy;Disease Progression;Food-Drug Interactions;HIV Infections/prevention & control;Humans;Hypothyroidism/therapy;Infertility, Male/therapy;Liver Diseases/blood;Male;Neoplasms/prevention & control;Selenium/adverse effects;Selenium/deficiency;Selenium/therapeutic use*
12634980;Administration, Oral;Aged;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Aryl Hydrocarbon Hydroxylases/genetics;Case-Control Studies;Cytochrome P-450 CYP2C9;Dose-Response Relationship, Drug;Drug Interactions;Drug Overdose;Female;Food-Drug Interactions;Genotype;Hemorrhage/chemically induced;Humans;Inpatients;International Normalized Ratio;Male;Mutation;Polymorphism, Genetic;Prospective Studies;Risk Factors;Vitamin K/administration & dosage
12638394;3',5'-Cyclic-GMP Phosphodiesterases;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 5;Dietary Fats/administration & dosage*;Drug Administration Schedule;Erectile Dysfunction/drug therapy;Food-Drug Interactions;Half-Life;Humans;Imidazoles/administration & dosage;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Male;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Phosphoric Diester Hydrolases/metabolism*;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Postprandial Period;Sulfones;Time Factors;Triazines;Vardenafil Dihydrochloride
12638395;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Cyclooxygenase 2;Cyclooxygenase 2 Inhibitors;Cyclooxygenase Inhibitors/administration & dosage;Cyclooxygenase Inhibitors/adverse effects;Cyclooxygenase Inhibitors/pharmacokinetics*;Dietary Fats;Dose-Response Relationship, Drug;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions;Humans;Isoenzymes/antagonists & inhibitors*;Male;Membrane Proteins;Middle Aged;Prostaglandin-Endoperoxide Synthases;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/pharmacokinetics*;Tablets;Time Factors
12653694;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Asthma/complications;Drug Eruptions/drug therapy;Drug Eruptions/etiology*;Food-Drug Interactions/physiology;Humans;Urticaria/chemically induced*;Urticaria/complications;Urticaria/drug therapy
12723461;Administration, Oral;Adult;Area Under Curve;Biomarkers;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Food-Drug Interactions;Gas Chromatography-Mass Spectrometry;Half-Life;Humans;Hydrogen-Ion Concentration;Imidazoles/administration & dosage;Imidazoles/pharmacokinetics*;Imidazoles/pharmacology;Male;Mitogen-Activated Protein Kinases/antagonists & inhibitors*;Pyridines/administration & dosage;Pyridines/pharmacokinetics*;Pyridines/pharmacology;p38 Mitogen-Activated Protein Kinases
12743672;Administration, Oral;Adult;Analysis of Variance;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Anticoagulants/pharmacology*;Area Under Curve;Azetidines/adverse effects;Azetidines/pharmacokinetics*;Azetidines/pharmacology*;Benzylamines;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions;Glycine/analogs & derivatives*;Glycine/blood;Half-Life;Humans;Male;Metabolic Clearance Rate;Partial Thromboplastin Time;Prodrugs/adverse effects;Prodrugs/pharmacokinetics;Prodrugs/pharmacology;Prothrombin Time;Thrombin/antagonists & inhibitors*
12807517;11-beta-Hydroxysteroid Dehydrogenases;Adult;Aldosterone/blood;Beverages/adverse effects*;Citrus paradisi*;Depression, Chemical;Edema/etiology*;Edema/metabolism;Female;Food-Drug Interactions*;Humans;Hydroxysteroid Dehydrogenases/antagonists & inhibitors*;Hydroxysteroid Dehydrogenases/metabolism;Mineralocorticoids/metabolism*;Potassium/blood;Renin/blood
12811362;Adult;Area Under Curve;Beverages*;Biotransformation;Calcium Channel Blockers/pharmacokinetics;Citrus*;Citrus paradisi*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Drug Interactions;Enzyme Inhibitors/pharmacology*;Felodipine/pharmacokinetics;Female;Food-Drug Interactions*;Furocoumarins/pharmacology*;Half-Life;Humans;Male;Middle Aged;NADP/metabolism;Radiation-Sensitizing Agents/pharmacology*;Wine*
8321071;Biological Availability;Food/adverse effects*;Humans;Intestinal Absorption*;Pharmacokinetics*
12830268;Anticoagulants/administration & dosage;Anticoagulants/antagonists & inhibitors*;Drug Monitoring;Food-Drug Interactions*;Humans;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/antagonists & inhibitors*
12860494;Adult;Area Under Curve;Blood Glucose/analysis;Cross-Over Studies;Cyclohexanes/adverse effects;Cyclohexanes/pharmacokinetics*;Cyclohexanes/pharmacology;Double-Blind Method;Food-Drug Interactions*;Gastric Emptying/drug effects*;Half-Life;Humans;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology;Insulin/blood;Male;Middle Aged;Phenylalanine/adverse effects;Phenylalanine/analogs & derivatives;Phenylalanine/pharmacokinetics*;Phenylalanine/pharmacology;Time Factors
12920426;Adult;Antidepressive Agents, Second-Generation/pharmacokinetics*;Area Under Curve;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Fluvoxamine/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Humans;Male
12936879;Absorption;Beverages*/adverse effects*;Citrus paradisi*/adverse effects;Food-Drug Interactions/physiology*;Humans
14517193;Administration, Oral;Adolescent;Adult;Antiparasitic Agents/adverse effects;Antiparasitic Agents/pharmacokinetics*;Antiparasitic Agents/therapeutic use*;Cohort Studies;Dose-Response Relationship, Drug;Double-Blind Method;Eating;Fasting;Food-Drug Interactions;Humans;Macrolides/adverse effects;Macrolides/pharmacokinetics*;Macrolides/therapeutic use*;Male;Middle Aged;Nausea/chemically induced;Onchocerciasis/drug therapy*;Treatment Outcome;Vomiting/chemically induced
14518700;Adult;Cross-Over Studies;Drug Administration Schedule;Drug Therapy, Combination;Fasting;Food*;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/virology;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/adverse effects*;HIV Protease Inhibitors/pharmacokinetics;HIV Protease Inhibitors/therapeutic use;Humans;Indinavir/administration & dosage*;Indinavir/adverse effects;Indinavir/pharmacokinetics;Indinavir/therapeutic use;Kidney Diseases/chemically induced;Kidney Diseases/prevention & control*;Middle Aged;Ritonavir/administration & dosage*;Ritonavir/adverse effects;Ritonavir/pharmacokinetics;Ritonavir/therapeutic use
14531370;Adolescent;Adult;Aged;Anesthetics/administration & dosage;Anesthetics/adverse effects;Anesthetics/metabolism;Dietary Supplements*/adverse effects;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Plant Preparations/administration & dosage*;Plant Preparations/adverse effects;Plant Preparations/metabolism;Preanesthetic Medication/adverse effects;Surveys and Questionnaires
14533574;Drug Interactions*;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Nurse's Role;Patient Education as Topic;Phytotherapy/adverse effects*;Preoperative Care/methods*;Preoperative Care/nursing;Surgery, Plastic/nursing;Time Factors
14558393;Dietary Supplements*/adverse effects;Drug Interactions;Food-Drug Interactions;Humans;Physician-Patient Relations
14574774;Depressive Disorder/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use*;Netherlands;Phenelzine/adverse effects;Phenelzine/therapeutic use;Secondary Prevention;Time Factors;Tranylcypromine/adverse effects;Tranylcypromine/therapeutic use
692645;Biogenic Amines/adverse effects;Biogenic Amines/analysis;Cheese/analysis;Food Analysis*;Fruit/analysis;Histamine/analysis;Humans;Hungary;Hypertension/etiology;Meat/analysis;Monoamine Oxidase Inhibitors/therapeutic use;Tyramine/adverse effects;Tyramine/analysis*;Vegetables/analysis;Wine/analysis
8520091;Anticonvulsants/pharmacokinetics;Anticonvulsants/pharmacology*;Anticonvulsants/therapeutic use;Clinical Trials as Topic;Epilepsy/drug therapy;Folic Acid/pharmacology*;Folic Acid Deficiency/drug therapy;Food, Fortified;Food-Drug Interactions*;Humans;Phenytoin/pharmacokinetics;Phenytoin/pharmacology*;Phenytoin/therapeutic use
14576716;Adult;Adverse Drug Reaction Reporting Systems;Age Factors;Aged;California;Diet*;Dietary Supplements/adverse effects;Dietary Supplements/utilization*;Educational Status;Female;Food-Drug Interactions;Health Maintenance Organizations/statistics & numerical data*;Humans;Male;Middle Aged;Nutrition Surveys;Risk Factors;Sex Factors
14606933;Administration, Oral;Adolescent;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions/physiology;Half-Life;Humans;Male;Tacrolimus/administration & dosage;Tacrolimus/adverse effects;Tacrolimus/analogs & derivatives*;Tacrolimus/pharmacokinetics*
14616409;Administration, Oral;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Food*;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Time Factors;Triazoles/administration & dosage;Triazoles/adverse effects;Triazoles/pharmacokinetics*;Voriconazole
14672861;Dietary Fats/administration & dosage;Dietary Proteins/administration & dosage;Environmental Exposure/adverse effects*;Female;Food-Drug Interactions*;Humans;Lead Poisoning/etiology*;New South Wales;Nutritional Status*;Pregnancy;Pregnancy Complications/etiology;Public Health;Trace Elements/administration & dosage;Vitamins/administration & dosage
14675888;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects*;Diagnosis, Differential;Electrocardiography;Food-Drug Interactions;Heart Block/chemically induced*;Heart Block/diagnosis*;Heart Block/physiopathology;Honey/adverse effects*;Humans;Male;Middle Aged;Verapamil/administration & dosage;Verapamil/adverse effects*
14679681;Aged;Aged, 80 and over;Anticoagulants/adverse effects*;Food-Drug Interactions*;Garlic/adverse effects*;Humans;International Normalized Ratio;Male;Phenindione/adverse effects*;Phenindione/analogs & derivatives*
14684645;Aged;Anticoagulants/adverse effects*;Beverages/adverse effects*;Fatal Outcome;Food-Drug Interactions*;Gastrointestinal Hemorrhage/chemically induced;Heart Diseases/chemically induced;Hemorrhage/chemically induced*;Humans;International Normalized Ratio;Male;Pericardium;Vaccinium macrocarpon*;Warfarin/adverse effects*
14734983;Food-Drug Interactions*;Humans;Infusions, Intravenous/adverse effects*;Infusions, Intravenous/nursing;Injections, Intravenous/adverse effects*;Injections, Intravenous/nursing;Parenteral Nutrition, Total/adverse effects*;Parenteral Nutrition, Total/nursing
14749688;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Phytotherapy*;Plants, Medicinal/adverse effects*
14973309;Administration, Oral;Adult;Antiviral Agents/adverse effects;Antiviral Agents/blood;Antiviral Agents/pharmacokinetics;Antiviral Agents/urine;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Dietary Fats;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Half-Life;Humans;Male;Mass Spectrometry;Middle Aged;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Ribavirin/adverse effects;Ribavirin/analogs & derivatives*;Ribavirin/blood;Ribavirin/pharmacokinetics*;Ribavirin/urine;Time Factors
8592993;Adult;Anti-Infective Agents/administration & dosage;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Biotransformation;Blood Proteins/metabolism;Creatinine/blood;Creatinine/urine;Feces/chemistry;Fluoroquinolones*;Food-Drug Interactions;Half-Life;Humans;Male;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Probenecid/pharmacology;Quinolones/administration & dosage;Quinolones/adverse effects;Quinolones/pharmacokinetics*;Renal Agents/pharmacology;Saliva/metabolism
14980003;Animals;Antimalarials/adverse effects;Antimalarials/blood;Antimalarials/metabolism*;Blood Proteins/metabolism*;Electrocardiography/drug effects;Fasting;Food-Drug Interactions;Lipoproteins/metabolism*;Long QT Syndrome/chemically induced*;Long QT Syndrome/metabolism;Phenanthrenes/adverse effects;Phenanthrenes/blood;Phenanthrenes/metabolism*;Postprandial Period;Protein Binding;Rabbits
15011605;Acquired Immunodeficiency Syndrome/drug therapy*;Anti-HIV Agents/administration & dosage*;Anti-HIV Agents/adverse effects;Dose-Response Relationship, Drug;Drug Synergism;Drug Therapy, Combination;Food-Drug Interactions;Humans;Indinavir/administration & dosage*;Indinavir/adverse effects;Randomized Controlled Trials as Topic;Ritonavir/administration & dosage;Ritonavir/adverse effects
15017321;Anticoagulants*/administration & dosage;Anticoagulants*/adverse effects;Anticoagulants*/metabolism;Aryl Hydrocarbon Hydroxylases/genetics;Community Health Nursing/methods;Cytochrome P-450 CYP2C9;Drug Interactions;Drug Monitoring/methods;Drug Monitoring/nursing;Food-Drug Interactions;Home Care Services;Humans;International Normalized Ratio;Liver/metabolism;Metabolic Clearance Rate;Patient Education as Topic/methods;Prothrombin Time;Vitamin K*/administration & dosage;Vitamin K*/adverse effects;Warfarin*/administration & dosage;Warfarin*/adverse effects;Warfarin*/metabolism
15033405;Chemistry, Pharmaceutical;Contraceptives, Oral, Combined/administration & dosage*;Contraceptives, Oral, Combined/adverse effects;Contraceptives, Postcoital/administration & dosage*;Contraceptives, Postcoital/adverse effects;Female;Food-Drug Interactions;Humans;Nausea/chemically induced;Norethindrone/administration & dosage;Randomized Controlled Trials as Topic
15132100;Anticholesteremic Agents/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Rhabdomyolysis/chemically induced*;Simvastatin/adverse effects*
15145962;Beverages/adverse effects*;Citrus*;Dietary Supplements;Drug Interactions*;Drug Labeling/legislation & jurisprudence;Female;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Male;Pharmacogenetics;Sex Factors
15206993;Adult;Anticholesteremic Agents/pharmacokinetics*;Citrus*;Cross-Over Studies;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Simvastatin/analogs & derivatives*;Simvastatin/metabolism;Simvastatin/pharmacokinetics*
15211967;Acenocoumarol/pharmacokinetics;Acenocoumarol/therapeutic use*;Aged;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Enteral Nutrition/adverse effects*;Food, Formulated/adverse effects*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Monitoring, Physiologic;Protein Binding
8617704;Acute Disease;Animals;Beer;Cheese/adverse effects;Depressive Disorder/drug therapy;Diet/adverse effects*;Fishes;Food-Drug Interactions*;Fruit;Humans;Hypertension/chemically induced;Hypertension/prevention & control*;Meat;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Poultry;Tyramine/adverse effects;Vegetables
15311686;Adjuvants, Immunologic/administration & dosage;Adjuvants, Immunologic/therapeutic use*;Adolescent;Adult;Aged;B-Lymphocytes/drug effects;B-Lymphocytes/immunology;B-Lymphocytes/radiation effects;Benzimidazoles/administration & dosage;Benzimidazoles/therapeutic use*;Child;Combined Modality Therapy;Diet Therapy/methods;Food-Drug Interactions*;Humans;Middle Aged;Psoriasis*/diet therapy;Psoriasis*/drug therapy;Psoriasis*/immunology;Radioactive Pollutants/adverse effects*;Radioisotopes;T-Lymphocytes/drug effects;T-Lymphocytes/immunology;T-Lymphocytes/radiation effects;Treatment Outcome;Ukraine
15341178;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Nurse's Role;Patient Education as Topic;Phytotherapy*/adverse effects;Phytotherapy*/nursing
15346578;Anti-Allergic Agents/adverse effects;Dietary Supplements;Drug Interactions*;Food-Drug Interactions;Polypharmacy*;Terfenadine/adverse effects
15449971;Beverages*;Cardiovascular Agents/adverse effects;Cardiovascular Agents/pharmacokinetics*;Cardiovascular Agents/therapeutic use;Cardiovascular Diseases/drug therapy*;Citrus paradisi*;Food-Drug Interactions*;Humans
15456329;Adolescent;Adult;Aged;Animals;Anti-Inflammatory Agents, Non-Steroidal*/metabolism;Anti-Inflammatory Agents, Non-Steroidal*/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal*/therapeutic use;Arthritis, Rheumatoid/drug therapy*;Butanones*/metabolism;Butanones*/pharmacokinetics;Butanones*/therapeutic use;Child;Child, Preschool;Clinical Trials as Topic;Cyclooxygenase Inhibitors*/adverse effects;Cyclooxygenase Inhibitors*/therapeutic use;Drug Interactions;Food-Drug Interactions;Humans;Middle Aged;Osteoarthritis/drug therapy*;Stomach Diseases/chemically induced*
15477727;Dietary Supplements/adverse effects*;Food, Organic*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans
15488686;Absorption/drug effects;Administration, Oral;Animals;Antineoplastic Agents/adverse effects;Antineoplastic Agents/therapeutic use;Area Under Curve;Biological Availability*;Capsules/administration & dosage;Capsules/chemistry;Capsules/pharmacokinetics;Chemistry, Pharmaceutical/methods*;Clinical Trials, Phase I as Topic;Clinical Trials, Phase II as Topic;Dogs;Drug Administration Schedule;Drug Evaluation, Preclinical;Fasting/metabolism;Food-Drug Interactions;Humans;Male;Models, Animal;Morpholines/metabolism;Morpholines/pharmacology*;Morpholines/therapeutic use;Nanostructures/chemistry*;Nausea/chemically induced;Nausea/prevention & control;Substance P/antagonists & inhibitors;Substance P/metabolism;Substance P/pharmacology;Tablets/administration & dosage;Tablets/chemistry;Tablets/pharmacokinetics;Technology, Pharmaceutical/methods;Technology, Pharmaceutical/trends;Upper Gastrointestinal Tract/drug effects;Upper Gastrointestinal Tract/metabolism;Vomiting/chemically induced;Vomiting/prevention & control
15497788;Acenocoumarol/adverse effects;Acenocoumarol/pharmacokinetics*;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Dose-Response Relationship, Drug;Drug Administration Routes;Enteral Nutrition/adverse effects*;Food, Formulated;Food-Drug Interactions*;Humans
15561855;Adolescent;Adult;Aged;Aged, 80 and over;Anti-Bacterial Agents/pharmacokinetics*;Anti-Bacterial Agents/therapeutic use*;Area Under Curve;Bronchitis/drug therapy;Bronchitis/microbiology;Community-Acquired Infections/drug therapy*;Community-Acquired Infections/metabolism*;Drug Interactions;Female;Fluoroquinolones/pharmacokinetics*;Fluoroquinolones/therapeutic use*;Food-Drug Interactions;Humans;Male;Mass Spectrometry;Middle Aged;Models, Biological;Pneumonia/drug therapy;Pneumonia/microbiology;Population;Reproducibility of Results;Respiratory Tract Infections/drug therapy*;Respiratory Tract Infections/metabolism*;Sinusitis/drug therapy;Sinusitis/microbiology
8700059;Algorithms*;Decision Trees*;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Nursing Assessment;Phenytoin/adverse effects*
15570603;ATP Binding Cassette Transporter, Sub-Family B/metabolism;Administration, Oral;Animals;Area Under Curve;Beverages/adverse effects*;Biological Availability;Citrus;Food-Drug Interactions/physiology*;Fruit*;Histamine H1 Antagonists/pharmacokinetics*;Intestinal Absorption;Male;Malus;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/metabolism;Rats;Rats, Sprague-Dawley;Terfenadine/analogs & derivatives*;Terfenadine/pharmacokinetics*
15621963;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/blood*;Atorvastatin Calcium;Beverages;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Heptanoic Acids/adverse effects;Heptanoic Acids/blood*;Humans;Male;Middle Aged;Pyrroles/adverse effects;Pyrroles/blood*;Rhabdomyolysis/blood*;Rhabdomyolysis/etiology
15635342;Child;Child Health Services;Chronic Disease/therapy;Communication;Complementary Therapies/adverse effects*;Complementary Therapies/methods*;Complementary Therapies/standards;Complementary Therapies/utilization;Dietary Supplements/utilization*;Disabled Children/statistics & numerical data*;Drug Interactions;Female;Food-Drug Interactions;Humans;Male;Professional-Family Relations*;Treatment Outcome
15635366;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects*;Blood Pressure/drug effects*;Cheese;Depression/drug therapy;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Nutrition Policy*;Tyramine/administration & dosage*;United States
8707145;Caffeine/adverse effects*;Food-Drug Interactions*;Humans;Nicotine/adverse effects*;Nursing Assessment
15682573;Anticoagulants/agonists;Benzodiazepines/agonists;Beverages/adverse effects*;Calcium Channel Blockers/blood;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Food-Drug Interactions*;Humans;Warfarin/agonists
15823765;Administration, Oral;Adult;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Analgesics, Opioid/therapeutic use;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Area Under Curve;Cross-Over Studies;Drug Combinations;Food-Drug Interactions;Half-Life;Humans;Ibuprofen/pharmacokinetics*;Ibuprofen/therapeutic use;Intestinal Absorption;Male;Metabolic Clearance Rate;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*;Oxycodone/therapeutic use;Pain, Postoperative/drug therapy;Tablets;Therapeutic Equivalency
15831778;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Half-Life;Humans;Hydromorphone/administration & dosage;Hydromorphone/adverse effects;Hydromorphone/pharmacokinetics*;Male
15832116;Administration, Oral;Deglutition Disorders/drug therapy*;Deglutition Disorders/nursing;Delayed-Action Preparations;Drug Administration Schedule;Enteral Nutrition/adverse effects;Food-Drug Interactions;Humans;Intestinal Absorption
15889002;Absorption;Dietary Fiber/adverse effects*;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*;Pharmacokinetics
8713690;Animals;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase/metabolism;Monoamine Oxidase/physiology;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology*;Monoamine Oxidase Inhibitors/therapeutic use
15915310;Complementary Therapies/standards*;Dietary Supplements/adverse effects;Dietary Supplements/standards*;Evidence-Based Medicine*;Food-Drug Interactions;Herb-Drug Interactions;Herbal Medicine/standards*;Humans;Practice Guidelines as Topic;Self Medication
15951007;Clinical Trials as Topic;Dietary Supplements/adverse effects*;Evidence-Based Medicine;Fatty Acids, Omega-3/adverse effects*;Fatty Acids, Omega-3/therapeutic use*;Fibrinolytic Agents/adverse effects*;Fibrinolytic Agents/therapeutic use*;Food-Drug Interactions*;Hemorrhage/etiology*;Humans;Thrombosis/prevention & control*
15980352;Adolescent;Adult;Benzoates*/administration & dosage;Benzoates*/adverse effects;Benzoates*/metabolism;Benzoates*/pharmacokinetics;CCR5 Receptor Antagonists*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;HIV Fusion Inhibitors*/administration & dosage;HIV Fusion Inhibitors*/adverse effects;HIV Fusion Inhibitors*/metabolism;HIV Fusion Inhibitors*/pharmacokinetics;Humans;Male;Middle Aged;Piperazines;Spiro Compounds*/administration & dosage;Spiro Compounds*/adverse effects;Spiro Compounds*/metabolism;Spiro Compounds*/pharmacokinetics
15991880;Adult;Anticonvulsants/adverse effects;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dibenzazepines/adverse effects;Dibenzazepines/blood;Dibenzazepines/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged
15999499;Adult;Alcohol Drinking*;Erectile Dysfunction/drug therapy;Food-Drug Interactions*;Humans;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Male;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Sulfones/adverse effects;Sulfones/pharmacokinetics;Triazines/adverse effects;Triazines/pharmacokinetics;Vardenafil Dihydrochloride
16035690;Animals;Bleeding Time;Clinical Trials as Topic;Drug Evaluation, Preclinical;Evidence-Based Medicine;Food-Drug Interactions;Garlic*/adverse effects;Garlic*/chemistry;Garlic*/physiology;Humans;Hyperlipidemias/prevention & control;Hypertension/prevention & control;Infection Control;Neoplasms/prevention & control;Phytotherapy/adverse effects;Phytotherapy/methods*;Phytotherapy/standards;Research Design/standards
16043212;Coumarins/administration & dosage;Coumarins/adverse effects;Coumarins/pharmacokinetics;Dietary Supplements*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Pharmacogenetics/methods;Warfarin/administration & dosage*;Warfarin/adverse effects;Warfarin/pharmacokinetics*
16048029;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Benzodiazepines/metabolism;Beverages/adverse effects;Biological Availability;Calcium Channel Blockers/metabolism;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism*;Cyclosporine/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Intestinal Absorption/drug effects
8851570;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Atovaquone;Biological Availability;Food-Drug Interactions;HIV Seropositivity/metabolism*;Humans;Male;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects;Naphthoquinones/pharmacokinetics*;Suspensions
16076481;Animals;Blood Coagulation/drug effects*;Blood Coagulation/physiology*;Clinical Trials as Topic;Dietary Supplements/adverse effects*;Dietary Supplements/classification*;Evidence-Based Medicine;Fibrinolytic Agents/adverse effects*;Fibrinolytic Agents/classification;Fibrinolytic Agents/therapeutic use*;Food-Drug Interactions*;Hemorrhage/etiology*;Hemorrhage/prevention & control;Humans;Risk Assessment/methods;Risk Factors
16158798;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;Binding, Competitive;Biological Availability;Citrus paradisi/metabolism*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Flavonoids/pharmacokinetics;Food-Drug Interactions*;Furocoumarins/pharmacokinetics;Herb-Drug Interactions;Humans;Hypericum/adverse effects;Hypnotics and Sedatives/metabolism;Liver/metabolism;Oxidation-Reduction
16164493;Adult;Aged;Area Under Curve;Blood Specimen Collection;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Estradiol/adverse effects;Estradiol/analogs & derivatives*;Estradiol/pharmacokinetics;Female;Food-Drug Interactions;Hormones/blood;Humans;Mass Spectrometry;Middle Aged;Postmenopause/physiology*;Selective Estrogen Receptor Modulators/adverse effects*;Selective Estrogen Receptor Modulators/pharmacokinetics*
16181450;Antioxidants/therapeutic use;Cholecalciferol/therapeutic use;Diet/adverse effects*;Fatty Acids, Unsaturated/therapeutic use;Food-Drug Interactions;Glutens/adverse effects;Humans;Oxidative Stress;Psoriasis/diet therapy*;Psoriasis/drug therapy;Psoriasis/etiology*;Vitamin B 12/therapeutic use
16190498;Anticoagulants*;Food-Drug Interactions*;Humans;International Normalized Ratio;Phytotherapy/adverse effects*;Urinary Tract Infections/prevention & control*;Vaccinium macrocarpon*;Warfarin*
16192747;Anti-Bacterial Agents/pharmacokinetics;Anti-Bacterial Agents/therapeutic use;Anticonvulsants/pharmacokinetics;Anticonvulsants/therapeutic use;Antifungal Agents/adverse effects;Antifungal Agents/therapeutic use*;Clinical Trials as Topic;Cross Infection/prevention & control*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Drug Monitoring;Echinocandins;Food-Drug Interactions;Humans;Immunocompromised Host;Intensive Care Units;Lipopeptides;Liver/drug effects;Liver/enzymology;Mycoses/drug therapy*;Mycoses/prevention & control;Peptides, Cyclic/adverse effects;Peptides, Cyclic/therapeutic use*;Polypharmacy;Pyrimidines/adverse effects;Pyrimidines/therapeutic use*;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use;Triazoles/adverse effects;Triazoles/therapeutic use*;Voriconazole
16199918;Calcium Channel Blockers/adverse effects*;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions*;Humans
16239022;Clinical Trials as Topic*;Dietary Supplements/adverse effects*;Evidence-Based Medicine*;Fibrinolytic Agents/adverse effects*;Food, Organic/adverse effects*;Food-Drug Interactions*;Humans;Plants, Medicinal/adverse effects*;Risk Assessment/methods*;Risk Factors
16265911;Adult;Dietary Supplements*;Drug Interactions;Drug Labeling;Female;Food Additives*/adverse effects;Food-Drug Interactions;Humans;Legislation, Drug;Legislation, Food;Male;Plant Structures*/adverse effects;Plants, Medicinal*/adverse effects;Russia;Safety
16268317;Citrus paradisi/adverse effects;Drug Interactions*;Drug Therapy/nursing*;Food-Drug Interactions;Humans;Hypericum/adverse effects
8857072;Adrenergic Agents/pharmacology*;Adult;Analysis of Variance;Benzamides/adverse effects;Benzamides/therapeutic use*;Blood Pressure/drug effects;Double-Blind Method;Drug Interactions;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Hypertension/chemically induced;Injections, Intravenous;Male;Moclobemide;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Selegiline/adverse effects;Selegiline/therapeutic use*;Tyramine/pharmacology*
16288258;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Enzyme Inhibitors/adverse effects;Food-Drug Interactions*;Humans
16291710;Adenine/adverse effects;Adenine/analogs & derivatives*;Adenine/blood;Adenine/pharmacokinetics;Adult;Anti-HIV Agents/adverse effects;Anti-HIV Agents/blood;Anti-HIV Agents/pharmacokinetics*;Didanosine/adverse effects;Didanosine/blood;Didanosine/pharmacokinetics*;Drug Interactions;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Male;Organophosphonates/adverse effects;Organophosphonates/blood;Organophosphonates/pharmacokinetics*;Prodrugs/adverse effects;Prodrugs/pharmacokinetics*;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/blood;Reverse Transcriptase Inhibitors/pharmacokinetics*;Tenofovir
16291715;Administration, Oral;Adult;Antidepressive Agents, Second-Generation/administration & dosage;Antidepressive Agents, Second-Generation/adverse effects;Antidepressive Agents, Second-Generation/pharmacokinetics*;Biological Availability;Citalopram/administration & dosage;Citalopram/adverse effects;Citalopram/pharmacokinetics*;Double-Blind Method;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Infusions, Intravenous;Male;Serotonin Uptake Inhibitors/administration & dosage;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/pharmacokinetics*
16305298;Dietary Supplements/adverse effects;Drug Evaluation/methods*;Food-Drug Interactions*;Humans;Intestinal Absorption;Nutritional Status;Pharmaceutical Services;Pharmacokinetics
16306299;Biological Availability;Drug Administration Routes;Enteral Nutrition/adverse effects;Enteral Nutrition/methods*;Food-Drug Interactions/physiology*;Humans;Pharmaceutical Preparations/administration & dosage*
16326816;Animals;Area Under Curve;Beverages*/adverse effects;Biological Availability;Carbamazepine/pharmacokinetics;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors*/adverse effects;Food-Drug Interactions*;Fruit*;Male;Metabolic Clearance Rate;Rats;Rats, Wistar
16337049;Anticoagulants/pharmacology*;Aspirin/pharmacology;Azetidines/pharmacology;Benzylamines/pharmacology;Calcium Channel Blockers/pharmacology*;Food Additives/adverse effects*;Food-Drug Interactions*;Honey/adverse effects*;Humans;Soy Foods/adverse effects*
16357446;Antitubercular Agents/adverse effects*;Antitubercular Agents/therapeutic use;Cheese*;Fish Products*;Food-Drug Interactions*;Humans;Isoniazid/adverse effects*;Isoniazid/therapeutic use;Risk Factors;Tuberculosis/drug therapy;Wine*
8857073;Adult;Analysis of Variance;Anti-Allergic Agents/adverse effects;Anti-Allergic Agents/chemistry;Anti-Allergic Agents/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Double-Blind Method;Drug Design;Drug Hypersensitivity/drug therapy;Drug Packaging;Food-Drug Interactions;Histamine/pharmacology;Humans;Male;Middle Aged
16365957;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/chemistry;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Furocoumarins/metabolism;Humans;Male;Piperazines/blood;Purines;Sildenafil Citrate;Sulfones;Vasodilator Agents/blood
16425970;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics;Chromatography, High Pressure Liquid;Clinical Chemistry Tests;Cross-Over Studies;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/administration & dosage;Eating/drug effects;European Union;Fasting;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Humans;Hydrogen-Ion Concentration;Male;Mass Spectrometry;Nifedipine/adverse effects;Nifedipine/blood;Nifedipine/pharmacokinetics*;Solubility;Tablets;Technology, Pharmaceutical/methods;Time Factors
16428030;Antidepressive Agents/adverse effects;Antidepressive Agents/chemical synthesis;Antidepressive Agents/therapeutic use;Depression/drug therapy*;Dermatitis, Phototoxic/etiology;Food-Drug Interactions;Herb-Drug Interactions;Humans;Hypericum/adverse effects*;Phytotherapy/adverse effects*;Plant Extracts/adverse effects*;Plant Extracts/therapeutic use;Risk Assessment
16520665;Adolescent;Adult;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Male;Middle Aged;Protein-Tyrosine Kinases/antagonists & inhibitors*;Protein-Tyrosine Kinases/metabolism;Pyrroles/adverse effects;Pyrroles/blood;Pyrroles/pharmacokinetics*
16569183;Enteral Nutrition*/adverse effects;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Pharmacy Service, Hospital;Prospective Studies
16610971;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Blood Coagulation/drug effects;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/pharmacology*
8881693;Dermatitis, Phototoxic/pathology*;Female;Food-Drug Interactions;Humans;Middle Aged;PUVA Therapy/adverse effects*;Vegetables/adverse effects*
16613116;Beverages/adverse effects*;Food-Drug Interactions*;Humans;Vaccinium macrocarpon/adverse effects*;Warfarin/adverse effects*
16638738;Adult;Aluminum Hydroxide/pharmacology;Antacids/pharmacology*;Cross-Over Studies;Dietary Carbohydrates/pharmacology;Dietary Fats/pharmacology;Drug Combinations;Drug Interactions;Factor Xa Inhibitors;Fasting/metabolism;Food-Drug Interactions*;Histamine H2 Antagonists/pharmacology;Humans;Intestinal Absorption/drug effects;Magnesium Hydroxide/pharmacology;Male;Morpholines/adverse effects;Morpholines/blood;Morpholines/pharmacokinetics*;Morpholines/pharmacology;Prothrombin Time;Ranitidine/pharmacology*;Rivaroxaban;Thiophenes/adverse effects;Thiophenes/blood;Thiophenes/pharmacokinetics*;Thiophenes/pharmacology
16699355;Anticoagulants/therapeutic use*;Cross-Sectional Studies;Female;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Heart Valve Prosthesis Implantation*/adverse effects;Humans;International Normalized Ratio;Male;Middle Aged;Patient Education as Topic/methods;Population Surveillance;Thromboembolism/etiology;Thromboembolism/prevention & control;Vitamin K/metabolism;Warfarin/therapeutic use*
16772772;Aged;Anticoagulants/adverse effects*;Beverages/adverse effects*;Drug Synergism;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;Hypoprothrombinemias/chemically induced*;International Normalized Ratio*;Male;Vaccinium macrocarpon*;Warfarin/adverse effects*
16773618;Aged;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects*;Combined Modality Therapy;Cross-Over Studies;Diet, Protein-Restricted*/adverse effects;Drug Therapy, Combination;Female;Food-Drug Interactions*;Humans;Levodopa/administration & dosage;Levodopa/adverse effects*;Male;Middle Aged;Neurologic Examination*;Parkinson Disease/diet therapy*;Parkinson Disease/physiopathology;Patient Satisfaction;Pilot Projects;Postprandial Period*/physiology;Single-Blind Method
16814135;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/therapeutic use;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Hypertension/drug therapy*;Intestines/enzymology
16850557;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism
16855078;Administration, Cutaneous;Administration, Oral;Adolescent;Adult;Blood Pressure/drug effects*;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions;Heart Rate/drug effects;Humans;Hypertension/chemically induced*;Hypertension/physiopathology;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Reference Values;Selegiline/administration & dosage;Selegiline/adverse effects*;Time Factors;Tranylcypromine/administration & dosage;Tranylcypromine/adverse effects;Tyramine/administration & dosage;Tyramine/adverse effects*
2248078;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects*;Benzamides/administration & dosage;Benzamides/adverse effects*;Depressive Disorder/drug therapy*;Follow-Up Studies;Humans;Moclobemide;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*
8888098;Deamino Arginine Vasopressin/adverse effects*;Food-Drug Interactions;Humans;Renal Agents/adverse effects*;Water Intoxication/etiology*
16856145;Administration, Oral;Aged;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects*;Blood Pressure/drug effects*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Therapy, Combination;Female;Food-Drug Interactions*;Heart Rate/drug effects*;Humans;Indans/administration & dosage;Indans/adverse effects*;Levodopa/administration & dosage;Levodopa/adverse effects;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Parkinson Disease/drug therapy*;Risk Factors;Tyramine*/administration & dosage
16871472;Adult;Alprazolam/therapeutic use;Animals;Antidepressive Agents, Second-Generation/therapeutic use;Antidepressive Agents, Tricyclic/adverse effects*;Anxiety/complications;Anxiety/drug therapy;Clomipramine/adverse effects*;Drug Eruptions/pathology*;Female;Food-Drug Interactions*;Gadus morhua*;Humans;Hypnotics and Sedatives/therapeutic use;Meat/adverse effects*;Obsessive-Compulsive Disorder/complications;Obsessive-Compulsive Disorder/drug therapy;Paroxetine/therapeutic use;Urticaria/chemically induced*;Urticaria/pathology*
16905501;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
16905502;Dietary Supplements/adverse effects*;Food-Drug Interactions*;Hemorrhage/etiology;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects*
16945054;Anticoagulants/adverse effects*;Beverages*;Food-Drug Interactions;Humans;International Normalized Ratio;Vaccinium macrocarpon*;Warfarin/adverse effects*
16988203;3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors*;Administration, Oral;Adult;Aminopyridines/administration & dosage;Aminopyridines/blood;Aminopyridines/metabolism;Aminopyridines/pharmacokinetics*;Area Under Curve;Benzamides/administration & dosage;Benzamides/blood;Benzamides/metabolism;Benzamides/pharmacokinetics*;Cross-Over Studies;Cyclic Nucleotide Phosphodiesterases, Type 4;Cyclopropanes/administration & dosage;Cyclopropanes/blood;Cyclopropanes/metabolism;Cyclopropanes/pharmacokinetics;Dietary Fats/administration & dosage*;Dietary Fats/adverse effects;Dietary Fats/pharmacokinetics;Fasting;Female;Food-Drug Interactions*;Half-Life;Headache/diagnosis;Headache/epidemiology;Humans;Male;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics*
16988211;Adult;Amlodipine/adverse effects;Amlodipine/pharmacokinetics*;Anticholesteremic Agents/pharmacokinetics;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics;Area Under Curve;Atorvastatin Calcium;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/adverse effects;Dietary Fats/pharmacokinetics;Disorders of Excessive Somnolence/chemically induced;Dose-Response Relationship, Drug;Drug Combinations;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Heptanoic Acids/adverse effects;Heptanoic Acids/pharmacokinetics*;Humans;Male;Middle Aged;Pyrroles/adverse effects;Pyrroles/pharmacokinetics*;Tablets;Therapeutic Equivalency
8901078;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Biological Availability;Delayed-Action Preparations;Dietary Fats/pharmacology*;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Humans;Male;Middle Aged;Nausea/chemically induced;Oxycodone/administration & dosage;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*
16989032;Bacteriuria/prevention & control;Double-Blind Method;Female;Food-Drug Interactions;Fruit;Humans;Phytotherapy;Plant Preparations*/therapeutic use;Randomized Controlled Trials as Topic;Self Care/methods;Urinary Tract Infections*/prevention & control;Urinary Tract Infections*/therapy;Vaccinium macrocarpon*;Warfarin
17023070;Anticoagulants/adverse effects*;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Warfarin/adverse effects*
17101740;Citrus paradisi/adverse effects*;Citrus paradisi/chemistry;Clinical Trials as Topic;Drug-Related Side Effects and Adverse Reactions*;Food-Drug Interactions*;Humans;Molecular Structure;Pharmaceutical Preparations/administration & dosage;Pharmaceutical Preparations/chemistry
17112309;Aged;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug-Related Side Effects and Adverse Reactions/etiology;Food-Drug Interactions*;Humans
17146730;Acetamides/administration & dosage*;Acetamides/adverse effects;Acetamides/blood;Acetamides/pharmacokinetics*;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Fasting/blood;Female;Food-Drug Interactions;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Male;Maximum Tolerated Dose;Middle Aged;Neoplasms/drug therapy*;Neoplasms/metabolism;Neoplasms/pathology;Netherlands;Pilot Projects;Postprandial Period;Treatment Outcome;Tubulin Modulators/administration & dosage*;Tubulin Modulators/adverse effects;Tubulin Modulators/blood;Tubulin Modulators/pharmacokinetics*
17212251;Aged;Diuretics/adverse effects*;Food-Drug Interactions;Humans;Minerals/adverse effects*;Salts/adverse effects*;Sodium/deficiency*;Sodium Chloride, Dietary/administration & dosage
17215845;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;Adult;Aged;Aged, 80 and over;Beverages/adverse effects*;Biological Availability;Blotting, Western;Carrier Proteins/biosynthesis*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/biosynthesis;Cytochrome P-450 CYP3A/genetics;Cytochrome P-450 Enzyme System/biosynthesis;Cytochrome P-450 Enzyme System/genetics;Female;Fluorescent Antibody Technique;Food-Drug Interactions*;Histamine H1 Antagonists/blood;Humans;Immunohistochemistry;Intestines/metabolism*;Male;Middle Aged;Organic Anion Transporters/biosynthesis;Organic Anion Transporters/genetics;Pharmaceutical Preparations/metabolism*;RNA/biosynthesis;RNA/genetics;Reverse Transcriptase Polymerase Chain Reaction;Terfenadine/analogs & derivatives;Terfenadine/blood
17253883;Anti-Bacterial Agents/pharmacology*;Area Under Curve;Biological Availability;Biotransformation;Carbamates/administration & dosage;Carbamates/pharmacokinetics*;Carbamates/pharmacology;Cyclohexanes/administration & dosage;Cyclohexanes/pharmacokinetics*;Cyclohexanes/pharmacology;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Drug Administration Schedule;Drug Interactions;Enzyme Induction/drug effects;Enzyme Inhibitors/pharmacology*;Fasting;Food-Drug Interactions*;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/pharmacokinetics*;Hypoglycemic Agents/pharmacology;Intestinal Absorption;Phenylalanine/administration & dosage;Phenylalanine/analogs & derivatives*;Phenylalanine/pharmacokinetics;Phenylalanine/pharmacology;Piperidines/administration & dosage;Piperidines/pharmacokinetics*;Piperidines/pharmacology;Postprandial Period
8930779;Adult;Analysis of Variance;Biological Availability;Chromatography;Cross-Over Studies;Delayed-Action Preparations;Drug Combinations;Ephedrine/administration & dosage;Ephedrine/adverse effects;Ephedrine/blood;Ephedrine/pharmacokinetics*;Food-Drug Interactions*;Half-Life;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/adverse effects;Histamine H1 Antagonists/blood;Histamine H1 Antagonists/pharmacokinetics*;Humans;Loratadine/administration & dosage;Loratadine/adverse effects;Loratadine/blood;Loratadine/pharmacokinetics*;Male;Vasoconstrictor Agents/administration & dosage;Vasoconstrictor Agents/adverse effects;Vasoconstrictor Agents/blood;Vasoconstrictor Agents/pharmacokinetics*
17269895;Animals;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Food-Drug Interactions*;Humans;Intestine, Small/metabolism*;Models, Biological;Prognosis
17296276;Administration, Oral;Animals;Brain/metabolism;Chylomicrons/blood;Chylomicrons/metabolism*;DDT/administration & dosage;DDT/blood;DDT/pharmacokinetics*;DDT/toxicity;Dietary Fats/administration & dosage;Dietary Fats/adverse effects*;Facial Muscles/drug effects;Food-Drug Interactions*;Hyperlipidemias/blood;Hyperlipidemias/etiology;Hyperlipidemias/metabolism*;Infusions, Intravenous;Male;Peanut Oil;Plant Oils/administration & dosage;Plant Oils/adverse effects*;Postprandial Period;Protein Binding;Rats;Rats, Wistar;Tremor/chemically induced;Triglycerides/blood;Triglycerides/metabolism*
17322161;Anticoagulants/adverse effects*;Aryl Hydrocarbon Hydroxylases;Beverages;Clinical Trials as Topic;Cytochrome P-450 CYP2C9;Drug Monitoring;Female;Flavonoids;Food-Drug Interactions*;Hemorrhage/chemically induced;Humans;International Normalized Ratio;Male;Vaccinium macrocarpon*;Vitamin K Deficiency;Warfarin/adverse effects*;Warfarin/pharmacokinetics*
17328583;Adolescent;Adult;Aged;Antacids/pharmacology;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics*;Azithromycin/administration & dosage;Azithromycin/adverse effects;Azithromycin/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Dietary Fats/pharmacology;Drug Interactions;Female;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Humans;Male;Microspheres;Middle Aged;Sample Size
17346019;Alcohol Drinking/adverse effects*;Alcohol Drinking/epidemiology;Alcohol Drinking/metabolism;Alcohol Drinking/prevention & control*;Alcoholic Beverages/analysis;Attitude to Health;Ethanol/analysis;Food-Drug Interactions;Health Behavior;Health Knowledge, Attitudes, Practice;Health Promotion/organization & administration*;Helping Behavior;Humans;Life Style*;Nurse's Role/psychology*;Patient Education as Topic/organization & administration;Social Support;United Kingdom/epidemiology
17368832;Anticoagulants/antagonists & inhibitors*;Food-Drug Interactions*;Humans;International Normalized Ratio;Tea/adverse effects*;Vegetables*;Vitamin K/pharmacology;Warfarin/antagonists & inhibitors*
17389552;Adolescent;Adult;Area Under Curve;Circadian Rhythm;Codon, Nonsense/antagonists & inhibitors*;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Immunoblotting;Male;Oxadiazoles/administration & dosage;Oxadiazoles/adverse effects;Oxadiazoles/pharmacokinetics*
17389557;Adolescent;Adult;Area Under Curve;Cross-Over Studies;Darunavir;Drug Combinations;Fasting;Female;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage;HIV Protease Inhibitors/adverse effects;HIV Protease Inhibitors/pharmacokinetics*;HIV Seronegativity;Half-Life;Humans;Male;Middle Aged;Ritonavir/administration & dosage;Ritonavir/adverse effects;Ritonavir/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*
17463218;Adolescent;Adult;Anti-Bacterial Agents/administration & dosage;Anti-Bacterial Agents/adverse effects*;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dietary Fats;Fasting;Food;Food-Drug Interactions*;Gastric Emptying;Humans;Male;Mass Spectrometry;Middle Aged;Nucleic Acid Synthesis Inhibitors;Rifamycins/administration & dosage;Rifamycins/adverse effects*;Rifamycins/blood;Rifamycins/pharmacokinetics*;Therapeutic Equivalency
17468508;Animals;Attitude of Health Personnel;Catechin;Diet;Eating;Food-Drug Interactions;Humans;Hypertension/prevention & control;Milk/adverse effects*;Milk Proteins/adverse effects;Postprandial Period;Swine;Swine, Miniature;Tea*;Vasodilation
9022564;Acute Kidney Injury/chemically induced;Aminoglycosides;Amphotericin B/adverse effects;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Animals;Anti-Bacterial Agents/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Antihypertensive Agents/pharmacology;Antihypertensive Agents/therapeutic use;Cisplatin/adverse effects;Contrast Media/adverse effects;Diet, Sodium-Restricted/adverse effects*;Food-Drug Interactions*;Humans;Hypertension/therapy*;Immunosuppressive Agents/adverse effects;Renal Circulation/drug effects
17495279;Adolescent;Adult;Antipsychotic Agents/administration & dosage*;Antipsychotic Agents/adverse effects;Antipsychotic Agents/blood;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Fasting;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Piperidines/administration & dosage*;Piperidines/adverse effects;Piperidines/blood;Piperidines/pharmacokinetics*;Psychotic Disorders;Serotonin 5-HT2 Receptor Agonists*;Tablets;Therapeutic Equivalency;Urea/administration & dosage;Urea/adverse effects;Urea/analogs & derivatives*;Urea/blood;Urea/pharmacokinetics
17530235;Citrus paradisi*;Drug Overdose;Food-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage*;Immunosuppressive Agents/adverse effects*;Immunosuppressive Agents/pharmacokinetics;Liver Transplantation;Middle Aged;Tacrolimus/administration & dosage*;Tacrolimus/adverse effects*;Tacrolimus/pharmacokinetics
17542349;Administration, Oral;Adolescent;Adult;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Chromatography, High Pressure Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Male;Middle Aged;Organic Chemicals/administration & dosage;Organic Chemicals/adverse effects;Organic Chemicals/pharmacokinetics;Serotonin Receptor Agonists/administration & dosage;Serotonin Receptor Agonists/adverse effects;Serotonin Receptor Agonists/pharmacokinetics*
17545920;Animals;Antineoplastic Agents, Hormonal/pharmacology;Apoptosis/drug effects;Bone Density/drug effects*;Bone Density Conservation Agents/pharmacology*;Breast Neoplasms/drug therapy*;Breast Neoplasms/pathology;Cell Line, Tumor;Cell Proliferation/drug effects;Combined Modality Therapy;Food-Drug Interactions*;Lignans/pharmacology*;Mice;Mice, Nude;Ovariectomy;Premenopause;Seeds;Sesamum*;Tamoxifen/antagonists & inhibitors*;Tumor Burden/drug effects;Xenograft Model Antitumor Assays
17612708;Administration, Cutaneous;Antidepressive Agents*/adverse effects;Antidepressive Agents*/pharmacology;Antidepressive Agents*/therapeutic use;Depression/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors*/adverse effects;Monoamine Oxidase Inhibitors*/pharmacology;Monoamine Oxidase Inhibitors*/therapeutic use;Selegiline*/adverse effects;Selegiline*/pharmacology;Selegiline*/therapeutic use
17617289;Adult;Asthenia/chemically induced;Biological Availability;Capsules;Clonidine/administration & dosage;Clonidine/adverse effects;Clonidine/analogs & derivatives*;Clonidine/blood;Clonidine/pharmacokinetics;Cross-Over Studies;Dietary Fats*;Dosage Forms;Female;Food-Drug Interactions;Humans;Male;Muscle Relaxants, Central/administration & dosage*;Muscle Relaxants, Central/adverse effects;Muscle Relaxants, Central/blood;Muscle Relaxants, Central/pharmacokinetics*;Tablets
17640157;Depressive Disorder/drug therapy;Diet;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Tyramine/metabolism
17656620;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adult;Area Under Curve;Confidence Intervals;Cross-Over Studies;Dietary Fats*;Dipeptidyl-Peptidase IV Inhibitors*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Half-Life;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Male;Models, Statistical;Nitriles/administration & dosage;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*
17688173;Adult;Anti-Infective Agents/chemistry;Anti-Infective Agents/metabolism*;Anti-Infective Agents/pharmacokinetics*;Beverages/adverse effects*;Biological Availability;Calcium Carbonate/adverse effects;Chemistry, Pharmaceutical;Ciprofloxacin/chemistry;Ciprofloxacin/metabolism*;Ciprofloxacin/pharmacokinetics*;Citrus*;Cross-Over Studies;Drug Monitoring;Female;Food-Drug Interactions;Humans;Hydrogen-Ion Concentration;Intestinal Absorption;Linear Models;Male;Metabolic Clearance Rate;Nigeria;Solubility;Spectrophotometry, Ultraviolet;Tablets;Time Factors;Vitis*
9049582;Administration, Oral;Adult;Cholesterol/blood*;Cross-Over Studies;Female;Food-Drug Interactions;Humans;Male;Phenylurea Compounds/adverse effects;Phenylurea Compounds/pharmacokinetics*;Single-Blind Method;Sterol O-Acyltransferase/antagonists & inhibitors*;Sterol O-Acyltransferase/blood*
17691921;Adult;Beverages/analysis;Blood Pressure/drug effects;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Calcium Channel Blockers/pharmacology*;Citrus/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/genetics*;Cytochrome P-450 Enzyme System/metabolism*;DNA/genetics;DNA/isolation & purification;Felodipine/adverse effects;Felodipine/pharmacokinetics*;Felodipine/pharmacology*;Food-Drug Interactions*;Furocoumarins/chemistry;Furocoumarins/pharmacology*;Genotype;Heart Rate/drug effects;Humans;Hydroxylation;Male;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Molecular Sequence Data;Polymorphism, Genetic;Testosterone/metabolism
17875111;Aged;Aspirin/adverse effects*;Aspirin/pharmacokinetics;Beverages;Citrus*;Food-Drug Interactions*;Humans;Male;Platelet Aggregation Inhibitors/adverse effects*;Platelet Aggregation Inhibitors/blood;Platelet Aggregation Inhibitors/pharmacokinetics;Purpura/chemically induced;Tetrazoles/adverse effects*;Tetrazoles/blood;Tetrazoles/pharmacokinetics
17906915;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Dietary Supplements/adverse effects;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Plant Preparations/adverse effects;Registries
17916059;Antidepressive Agents, Second-Generation/therapeutic use*;Anxiety Disorders/drug therapy*;Biological Availability;Citalopram/adverse effects;Citalopram/pharmacokinetics;Citalopram/therapeutic use*;Depressive Disorder, Major/drug therapy*;Drug Interactions;Food-Drug Interactions;Humans
17919554;Aged;Anticoagulants/adverse effects*;Atrial Fibrillation/blood;Atrial Fibrillation/drug therapy*;Beverages*;Blood Coagulation Disorders/blood;Blood Coagulation Disorders/chemically induced*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Vaccinium macrocarpon*;Warfarin/adverse effects*
17955954;Animals;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use;Drug Interactions;Food-Drug Interactions*;Humans;Plant Preparations/adverse effects*
17958008;Beverages/adverse effects;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans
17966839;Adult;Aged;Analysis of Variance;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/pharmacokinetics*;Farnesyltranstransferase/antagonists & inhibitors;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/pharmacokinetics*
17967158;Aged;Animals;Drug Interactions/physiology*;Food-Drug Interactions/physiology;Humans;Medication Errors/adverse effects;Polypharmacy*
17971226;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacology;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans
18007569;Absorption;Administration, Oral;Adolescent;Adult;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*
18035186;Antiparkinson Agents/administration & dosage;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacology;Antiparkinson Agents/therapeutic use*;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;Humans;Indans/administration & dosage;Indans/adverse effects;Indans/pharmacology;Indans/therapeutic use*;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use*;Neuroprotective Agents/administration & dosage;Neuroprotective Agents/adverse effects;Neuroprotective Agents/pharmacology;Neuroprotective Agents/therapeutic use*;Parkinson Disease/drug therapy*;Selegiline/administration & dosage;Selegiline/adverse effects;Selegiline/pharmacology;Selegiline/therapeutic use
18042475;Administration, Oral;Adult;Area Under Curve;Asian Continental Ancestry Group;Biological Availability;China;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Fluorobenzenes/administration & dosage*;Fluorobenzenes/adverse effects;Fluorobenzenes/pharmacokinetics*;Food-Drug Interactions;Hospitals, University;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics*;Male;Mass Spectrometry;Pyrimidines/administration & dosage*;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Rosuvastatin Calcium;Sex Factors;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics*
18074531;Adrenergic beta-Antagonists/adverse effects*;Arrhythmias, Cardiac/chemically induced*;Calcium Channel Blockers/adverse effects*;Citrus paradisi;Coronary Vasospasm/chemically induced;Depression/chemically induced;Depression, Chemical;Drug Interactions;Food-Drug Interactions;Heart Rate/drug effects;Humans;Lipid Metabolism Disorders/chemically induced;Myocardial Contraction/drug effects;Sympathetic Nervous System/physiopathology
18074548;Anaphylaxis/chemically induced;Anti-Allergic Agents/adverse effects*;Anti-Allergic Agents/pharmacology;Arrhythmias, Cardiac/chemically induced;Citrus paradisi;Cystitis/chemically induced;Drug Interactions;Food-Drug Interactions;Histamine/physiology;Histamine H1 Antagonists/adverse effects*;Histamine H1 Antagonists/pharmacology;Humans;Seizures/chemically induced*;Sleep Wake Disorders/chemically induced*
18084364;Citrus/adverse effects;Citrus paradisi/adverse effects;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Pharmaceutical Preparations/metabolism*;Punicaceae/adverse effects;Vitis/adverse effects
18162024;Adolescent;Adult;Aged;Aged, 80 and over;Depressive Disorder, Major/drug therapy*;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Duloxetine Hydrochloride;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Outpatients;Serotonin Uptake Inhibitors/administration & dosage*;Serotonin Uptake Inhibitors/adverse effects;Thiophenes/administration & dosage*;Thiophenes/adverse effects;Treatment Outcome
18176118;Administration, Oral;Adult;Aged;Algorithms;Area Under Curve;Creatine Kinase/blood;Cross-Over Studies;Dose-Response Relationship, Drug;Erlotinib Hydrochloride;Exanthema/chemically induced;Fasting;Food-Drug Interactions*;Glossitis/chemically induced;Hematuria/chemically induced;Humans;Liver/drug effects;Liver/enzymology;Male;Middle Aged;Molecular Structure;Patient Dropouts/statistics & numerical data;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics;Quinazolines/chemistry;Quinazolines/metabolism;Quinazolines/pharmacokinetics*;Receptor, Epidermal Growth Factor/antagonists & inhibitors*;Time Factors;gamma-Glutamyltransferase/blood
18272698;Aged;Enteral Nutrition/adverse effects*;Food-Drug Interactions/physiology*;Humans;Levodopa/adverse effects*;Levodopa/pharmacokinetics;Male;Parkinson Disease/metabolism;Parkinson Disease/therapy
18285619;Administration, Oral;Adult;Area Under Curve;Biological Availability;Blood Pressure/drug effects;Capsules;Cross-Over Studies;Dextroamphetamine/administration & dosage;Dextroamphetamine/adverse effects;Dextroamphetamine/chemistry;Dextroamphetamine/metabolism;Dextroamphetamine/pharmacokinetics*;Eating/physiology*;Fasting/physiology*;Female;Flushing/chemically induced;Food-Drug Interactions;Half-Life;Headache/chemically induced;Humans;Hyperkinesis/chemically induced;Lisdexamfetamine Dimesylate;Lysine/chemistry;Lysine/metabolism;Male;Metabolic Clearance Rate;Molecular Structure;Tachycardia/chemically induced
18363537;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Dietary Carbohydrates/administration & dosage;Dietary Proteins/pharmacology*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/pharmacokinetics*
18363644;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Beverages/adverse effects;Citrus paradisi*;Cytochrome P-450 CYP3A/biosynthesis;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Induction;Evidence-Based Medicine;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Hypericum*;Immunosuppressive Agents/adverse effects*;Kidney Transplantation*;Liver/drug effects*;Liver/enzymology;Plant Preparations/adverse effects;Receptors, Steroid/drug effects;Receptors, Steroid/metabolism;Risk Assessment;Up-Regulation
18380391;Beverages/adverse effects*;Food-Drug Interactions;Glycyrrhiza/adverse effects*;Glycyrrhiza/chemistry;Humans;Hypertension/diagnosis;Hypertension/etiology*;Tea/adverse effects*
18382075;Aged;Aged, 80 and over;Biological Availability;Female;Food-Drug Interactions*;Health Status*;Humans;Intestinal Absorption;Male;Nutritional Status/drug effects*;Nutritional Status/physiology*;Pharmaceutical Preparations/administration & dosage*;Pharmacokinetics
9129556;Anti-Allergic Agents/adverse effects;Anti-Asthmatic Agents/adverse effects;Citrus*;Food-Drug Interactions*;Humans;Pharmacology;Societies;Terfenadine/adverse effects;Torsades de Pointes/chemically induced;United States;United States Food and Drug Administration
18438069;Beverages*;Dose-Response Relationship, Drug;Food-Drug Interactions;Glycyrrhiza/adverse effects*;Humans;Hypertension/chemically induced*;Hypertension/etiology;Rhabdomyolysis/chemically induced*;Rhabdomyolysis/etiology;Tea/adverse effects*
18484490;Administration, Oral;Administration, Rectal;Alendronate/administration & dosage;Alendronate/chemistry;Alendronate/pharmacokinetics*;Animals;Biological Availability;Bone Density Conservation Agents/administration & dosage;Bone Density Conservation Agents/chemistry;Bone Density Conservation Agents/pharmacokinetics*;Chemical Phenomena;Chemistry, Pharmaceutical;Chemistry, Physical;Diffusion;Food-Drug Interactions;Intestinal Absorption/physiology*;Isotope Labeling;Male;Rabbits;Solubility;Technetium/chemistry
18552451;Blood Pressure/drug effects;Carbolines/administration & dosage*;Carbolines/adverse effects;Carbolines/pharmacokinetics;Carbolines/pharmacology;Cyclic GMP/metabolism;Erectile Dysfunction/drug therapy*;Food-Drug Interactions;Humans;Male;Muscle Relaxation/drug effects;Muscle, Smooth/metabolism;Penis/blood supply;Penis/metabolism;Phosphodiesterase 5 Inhibitors*;Phosphodiesterase Inhibitors/administration & dosage*;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/pharmacokinetics;Phosphodiesterase Inhibitors/pharmacology;Randomized Controlled Trials as Topic;Tadalafil
18589558;Adolescent;Adult;Aged;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Fasting/physiology;Female;Food-Drug Interactions;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/adverse effects;Immunosuppressive Agents/pharmacokinetics*;Male;Middle Aged;Tacrolimus/administration & dosage;Tacrolimus/adverse effects;Tacrolimus/pharmacokinetics*;Tandem Mass Spectrometry;Therapeutic Equivalency
18663908;Beverages*;Biological Availability;Citrus paradisi/metabolism*;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Flavonoids/pharmacology*;Food-Drug Interactions*;Humans;Psychotropic Drugs/pharmacokinetics;Psychotropic Drugs/pharmacology*
18717508;Analgesics, Opioid/therapeutic use*;Chronic Disease;Clinical Trials as Topic;Delayed-Action Preparations;Drug Interactions;Follow-Up Studies;Food-Drug Interactions;Humans;Oxymorphone/adverse effects;Oxymorphone/pharmacokinetics;Oxymorphone/pharmacology;Oxymorphone/therapeutic use*;Pain/drug therapy*
18721117;Biological Availability;Clinical Trials as Topic;Delayed-Action Preparations;Diabetes Mellitus, Type 2/drug therapy*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Hypoglycemic Agents/administration & dosage*;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Metformin/administration & dosage*;Metformin/adverse effects;Metformin/pharmacokinetics;Renal Insufficiency/complications
18768996;Antineoplastic Agents*/adverse effects;Antineoplastic Agents*/pharmacokinetics;Antineoplastic Agents*/pharmacology;Antineoplastic Agents*/therapeutic use;Breast Neoplasms*/drug therapy;Breast Neoplasms*/pathology;Drug Resistance, Neoplasm;Female;Food-Drug Interactions;Humans;Neoplasm Metastasis;Protein Kinase Inhibitors*/adverse effects;Protein Kinase Inhibitors*/pharmacokinetics;Protein Kinase Inhibitors*/pharmacology;Protein Kinase Inhibitors*/therapeutic use;Quinazolines*/adverse effects;Quinazolines*/pharmacokinetics;Quinazolines*/pharmacology;Quinazolines*/therapeutic use;Receptor, ErbB-2/metabolism
18793575;Adult;Area Under Curve;Chromatography, Liquid;Cross-Over Studies;Dietary Fats/pharmacology;Endothelin A Receptor Antagonists;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Pyridines/adverse effects;Pyridines/pharmacokinetics*;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Tandem Mass Spectrometry
18793577;Administration, Oral;Adolescent;Adult;Area Under Curve;Biological Availability;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Half-Life;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/adverse effects;Methylphenidate/pharmacokinetics*;Therapeutic Equivalency
9129557;Adult;Anti-Allergic Agents/pharmacokinetics*;Anti-Asthmatic Agents/pharmacokinetics*;Area Under Curve;Beverages;Citrus/adverse effects*;Electrocardiography/drug effects;Food-Drug Interactions*;Humans;Male;Oxidation-Reduction;Reference Values;Terfenadine/pharmacokinetics*
18926963;Acenocoumarol/administration & dosage*;Administration, Oral;Adult;Age Factors;Aged;Aged, 80 and over;Anticoagulants/administration & dosage*;Drug Interactions;Educational Status;Family Practice;Female;Food-Drug Interactions;Health Knowledge, Attitudes, Practice*;Hemorrhage/chemically induced*;Hemorrhage/prevention & control;Humans;Male;Medicine;Middle Aged;Patient Care Team*;Residence Characteristics;Specialization;Surveys and Questionnaires;Young Adult
18927522;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages/adverse effects;Citrus paradisi;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug Interactions;Enzyme Inhibitors/adverse effects;Food-Drug Interactions;Herb-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism;Muscular Diseases/chemically induced*;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/metabolism;Simvastatin/adverse effects*;Simvastatin/metabolism;Solute Carrier Organic Anion Transporter Family Member 1b1;Tea
18955941;Antidepressive Agents/adverse effects;Antidepressive Agents/pharmacokinetics;Antidepressive Agents/therapeutic use*;Brain/drug effects;Cheese/adverse effects;Depressive Disorder/blood;Depressive Disorder/drug therapy*;Dose-Response Relationship, Drug;Drug Interactions;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacokinetics;Monoamine Oxidase Inhibitors/therapeutic use*;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/therapeutic use;Tyramine/adverse effects;Tyramine/metabolism
18998611;Acetaminophen/adverse effects*;Acetaminophen/pharmacokinetics;Acetaminophen/therapeutic use;Analgesics, Non-Narcotic/adverse effects*;Analgesics, Non-Narcotic/pharmacokinetics;Analgesics, Non-Narcotic/therapeutic use;Arthritis/drug therapy;Food-Drug Interactions;Humans;Wine/adverse effects*
19014837;Adolescent;Adult;Area Under Curve;Blood Glucose/analysis;Chromatography, High Pressure Liquid;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics;Dipeptidyl-Peptidase IV Inhibitors/pharmacology*;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions;Glucagon-Like Peptide 1/blood;Half-Life;Humans;Insulin/blood;Korea;Male;Metabolic Clearance Rate;Organic Chemicals/adverse effects;Organic Chemicals/pharmacokinetics;Organic Chemicals/pharmacology*;Piperidones;Pyrimidines;Young Adult
19014838;Adult;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Chemistry, Pharmaceutical;Clarithromycin/administration & dosage*;Clarithromycin/adverse effects;Clarithromycin/pharmacokinetics*;Cross-Over Studies;Delayed-Action Preparations;Fasting;Food-Drug Interactions;Half-Life;Humans;Jordan;Male;Metabolic Clearance Rate;Tablets;Therapeutic Equivalency
19026256;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/agonists;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy;Cross-Over Studies;Dietary Fats/metabolism*;Drug Administration Schedule;Energy Intake/physiology*;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Piperazines/administration & dosage;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Psychotic Disorders/blood*;Psychotic Disorders/drug therapy;Schizophrenia/blood*;Schizophrenia/drug therapy;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Young Adult
19048359;ATP Binding Cassette Transporter, Sub-Family B;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Administration, Oral;Animals;Beverages/adverse effects*;Caco-2 Cells;Cell Polarity;Citrus paradisi*/chemistry;Colchicine/administration & dosage;Colchicine/metabolism*;Dose-Response Relationship, Drug;Flavanones/isolation & purification;Flavanones/pharmacology;Food-Drug Interactions*;Fruit;Furocoumarins/isolation & purification;Furocoumarins/pharmacology;Humans;Ileum/drug effects;Ileum/metabolism*;Intestinal Absorption*/drug effects;Jejunum/drug effects;Jejunum/metabolism*;Male;Permeability;Quinidine/pharmacology;Rats;Rats, Wistar;Risk Assessment;Time Factors;Tubulin Modulators/administration & dosage;Tubulin Modulators/metabolism*;Verapamil/pharmacology
19052281;Dosage Forms;Drug Incompatibility;Enteral Nutrition/adverse effects;Enteral Nutrition/methods*;Food-Drug Interactions;Humans;Pharmaceutical Preparations/administration & dosage*;Practice Guidelines as Topic
9144013;Aged;Aged, 80 and over;Animals;Female;Food-Drug Interactions*;Histamine/poisoning*;Humans;Isoniazid/administration & dosage;Isoniazid/adverse effects*;Tuberculosis, Lymph Node/drug therapy*;Tuna*
19058474;Aged;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Beverages/adverse effects;Fatal Outcome;Flavonoids/adverse effects;Food-Drug Interactions*;Gastrointestinal Hemorrhage/chemically induced*;Humans;Male;Pericardial Effusion/chemically induced*;Phytotherapy/adverse effects;Vaccinium macrocarpon/adverse effects*;Vaccinium macrocarpon/metabolism;Warfarin/adverse effects*;Warfarin/metabolism
19075045;Administration, Oral;Adult;African Americans/genetics;African Americans/statistics & numerical data;Anti-Ulcer Agents/administration & dosage;Anti-Ulcer Agents/adverse effects;Anti-Ulcer Agents/blood;Anti-Ulcer Agents/pharmacokinetics;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Area Under Curve;Carbonated Beverages*;Cross-Over Studies;Dose-Response Relationship, Drug;Drug Administration Schedule;Eating;European Continental Ancestry Group/genetics;European Continental Ancestry Group/statistics & numerical data;Fasting;Female;Food-Drug Interactions*;Gastric Mucosa/drug effects*;Gastric Mucosa/metabolism;Humans;Hydrogen-Ion Concentration/drug effects;Intestinal Absorption/drug effects;Male;Middle Aged;Omeprazole/administration & dosage;Omeprazole/adverse effects;Omeprazole/blood;Omeprazole/pharmacokinetics;Suspensions;Triazoles/administration & dosage;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics*;Young Adult
19126824;Aged;Female;Food-Drug Interactions/physiology*;Humans;International Normalized Ratio/methods;Tea/adverse effects*;Tea/metabolism;Warfarin/adverse effects*;Warfarin/metabolism
19133704;Administration, Oral;Adult;Area Under Curve;Benzhydryl Compounds/administration & dosage;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/pharmacokinetics*;Biological Availability;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/pharmacokinetics*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Postprandial Period;Randomized Controlled Trials as Topic;Young Adult
19167586;Administration, Oral;Adolescent;Adrenergic alpha-2 Receptor Agonists;Adrenergic alpha-Agonists/administration & dosage;Adrenergic alpha-Agonists/adverse effects;Adrenergic alpha-Agonists/pharmacokinetics*;Adult;Area Under Curve;Asthenia/chemically induced;Biological Availability;Blood Pressure/drug effects;Capsules;Clonidine/adverse effects;Clonidine/analogs & derivatives*;Clonidine/blood;Clonidine/pharmacokinetics;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting;Female;Food;Food-Drug Interactions;Half-Life;Humans;Male;Malus*;Middle Aged;Young Adult
19188677;Adult;Aged;Antineoplastic Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Solubility
19206053;Adult;Aged;Arrhythmias, Cardiac/chemically induced;Biological Availability;Biotransformation;Citrus paradisi/metabolism;Drug Interactions;Female;Food-Drug Interactions;Humans;Hypericum/adverse effects;Hypericum/metabolism;Intestinal Absorption;Male;Membrane Transport Proteins/physiology*;Middle Aged;Muscular Diseases/chemically induced;Pharmacokinetics*;Xenobiotics/pharmacokinetics
19222985;Chronic Disease;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy*;Depressive Disorder, Major/psychology;Drug Interactions;Drug Resistance;Electroconvulsive Therapy;Food-Drug Interactions;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Risk Factors
19243207;Adult;Amitriptyline/administration & dosage;Amitriptyline/adverse effects;Amitriptyline/analogs & derivatives*;Amitriptyline/pharmacokinetics;Antidepressive Agents, Tricyclic/administration & dosage;Antidepressive Agents, Tricyclic/adverse effects;Antidepressive Agents, Tricyclic/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Sample Size;Young Adult
2489809;Animals;Aspirin;Drug Interactions;Duodenal Ulcer/chemically induced*;Rats;Stomach Ulcer/chemically induced*;Sucrose/adverse effects*
9155792;Adult;Cheese/adverse effects*;Emergencies;Female;Food-Drug Interactions*;Humans;Hypertension/drug therapy;Hypertension/etiology*;Hypertension/nursing;Monoamine Oxidase Inhibitors/adverse effects*
19253346;Administration, Oral;Animals;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Azetidines/administration & dosage;Azetidines/pharmacology;Benzylamines/administration & dosage;Benzylamines/pharmacology;Biological Availability;Blood Coagulation/drug effects;Drug Design;Factor Xa Inhibitors;Food-Drug Interactions*;Humans;Rats;Thrombin/antagonists & inhibitors;Vitamin K/antagonists & inhibitors;Vitamin K/pharmacokinetics*;Vitamin K Deficiency/blood
19255348;Drug Interactions/physiology;Food-Drug Interactions/physiology;Humans;Patient Education as Topic/methods*;Practice Guidelines as Topic*;Rheumatic Heart Disease/drug therapy;Therapeutic Equivalency;Warfarin/administration & dosage*;Warfarin/adverse effects;Warfarin/pharmacokinetics*
19281729;Administration, Oral;Adult;Aged;Aged, 80 and over;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/therapeutic use*;Area Under Curve;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Fasting;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Male;Middle Aged;Neoplasms/drug therapy*;Therapeutic Equivalency;Topotecan/adverse effects;Topotecan/pharmacokinetics*;Topotecan/therapeutic use*
19293342;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Ghrelin/agonists*;Human Growth Hormone/metabolism;Humans;Indoles;Insulin-Like Growth Factor I/metabolism;Male;Oligopeptides/adverse effects;Oligopeptides/pharmacokinetics*;Oligopeptides/pharmacology*;Tryptophan/analogs & derivatives
19328861;Aged;Antacids/pharmacokinetics*;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biotransformation;Double-Blind Method;Drug Interactions;Female;Food-Drug Interactions;Humans;Intestinal Absorption;Linear Models;Male;Middle Aged;Pyridones/adverse effects;Pyridones/pharmacokinetics*;Therapeutic Equivalency
19373300;Antidepressive Agents/adverse effects*;Beverages;Drug Interactions;Food-Drug Interactions;Humans;Isocarboxazid/adverse effects;Monoamine Oxidase Inhibitors/adverse effects*;Patient Education as Topic;Phenelzine/adverse effects;Risk Factors;Serotonin Syndrome/chemically induced;Tranylcypromine/adverse effects
19398716;Abdominal Pain/chemically induced;Aged;Aged, 80 and over;Biotransformation;Dose-Response Relationship, Drug;Female;Fever/chemically induced;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Glutathione/administration & dosage;Glutathione/adverse effects;Glutathione/analogs & derivatives*;Glutathione/pharmacokinetics;Glutathione/therapeutic use;Humans;Male;Maximum Tolerated Dose;Middle Aged;Myelodysplastic Syndromes/drug therapy*;Neutropenia/chemically induced;Prodrugs/administration & dosage;Prodrugs/adverse effects;Prodrugs/pharmacokinetics;Prodrugs/therapeutic use*;Tablets
19446149;Administration, Oral;Adult;Aluminum Hydroxide/pharmacology;Antacids/pharmacology*;Area Under Curve;Benzoates/administration & dosage;Benzoates/adverse effects;Benzoates/pharmacokinetics*;Biological Availability;Calcium, Dietary/pharmacology;Capsules;Cross-Over Studies;Dietary Fats/pharmacology;Drug Combinations;Drug Interactions;Female;Food-Drug Interactions*;Humans;Hydrazines/administration & dosage;Hydrazines/adverse effects;Hydrazines/pharmacokinetics*;Magnesium/pharmacology;Male;Middle Aged;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics*;Receptors, Thrombopoietin/agonists;Tablets;Young Adult
19458055;Abdominal Pain/chemically induced;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Biological Availability;Diarrhea/chemically induced;Drug Administration Schedule;Eating;Fasting;Female;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Neoplasms/drug therapy;Neoplasms/metabolism*;Neoplasms/pathology;Organoplatinum Compounds/administration & dosage;Organoplatinum Compounds/adverse effects;Organoplatinum Compounds/pharmacokinetics*;Vomiting/chemically induced
19473600;Adolescent;Adult;Benzhydryl Compounds/adverse effects;Benzhydryl Compounds/blood;Benzhydryl Compounds/pharmacokinetics*;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions*;Humans;Male;Middle Aged;Muscarinic Antagonists/adverse effects;Muscarinic Antagonists/blood;Muscarinic Antagonists/pharmacokinetics*
9160173;Anticholesteremic Agents/pharmacokinetics*;Anticholesteremic Agents/therapeutic use*;Arteriosclerosis/drug therapy;Arteriosclerosis/etiology;Brain/metabolism;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/therapeutic use*;Fatty Acids, Monounsaturated/pharmacokinetics;Fatty Acids, Monounsaturated/therapeutic use;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors*;Hypercholesterolemia/complications;Hypercholesterolemia/drug therapy;Indoles/pharmacokinetics;Indoles/therapeutic use;Liver/metabolism;Lovastatin/analogs & derivatives;Lovastatin/pharmacokinetics;Lovastatin/therapeutic use;Pravastatin/pharmacokinetics;Pravastatin/therapeutic use;Simvastatin
19476741;Adjuvants, Immunologic/pharmacology;Adjuvants, Immunologic/therapeutic use;Animals;Diabetes Mellitus/therapy;Food-Drug Interactions;Grifola*/chemistry;Humans;Neoplasms/therapy;beta-Glucans/analysis
19480806;Dietetics/education;Enteral Nutrition/adverse effects;Enteral Nutrition/methods;Enteral Nutrition/standards;Evidence-Based Medicine;Feeding Behavior;Food Preservation/standards;Food Service, Hospital/standards;Food, Formulated/adverse effects;Food, Formulated/standards;Food-Drug Interactions;Humans;Malnutrition/diagnosis;Malnutrition/prevention & control;Malnutrition/therapy;Mass Screening/methods;Mass Screening/standards;Medical Records/standards;Nutrition Assessment;Nutritional Support/standards*;Parenteral Nutrition/adverse effects;Parenteral Nutrition/methods;Parenteral Nutrition/standards;Parenteral Nutrition Solutions/administration & dosage;Parenteral Nutrition Solutions/chemistry;Parenteral Nutrition Solutions/standards;Patient Care Planning;Quality Assurance, Health Care;Risk Factors;Spain;Surveys and Questionnaires
19553405;Adult;Aged;Aged, 80 and over;Anticoagulants/pharmacokinetics*;Beverages/adverse effects*;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Vaccinium macrocarpon/adverse effects*;Warfarin/pharmacokinetics*
19572422;Adult;Aged;Anti-HIV Agents/administration & dosage;Anti-HIV Agents/pharmacology;Anti-HIV Agents/therapeutic use;Child;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Fasting;Female;Food-Drug Interactions;Glucuronosyltransferase/genetics;Glucuronosyltransferase/metabolism;HIV Infections/drug therapy*;HIV Integrase Inhibitors/administration & dosage;HIV Integrase Inhibitors/adverse effects;HIV Integrase Inhibitors/pharmacokinetics;HIV Integrase Inhibitors/pharmacology*;HIV Integrase Inhibitors/therapeutic use;Humans;Inactivation, Metabolic;Intestinal Absorption;Male;Microsomes, Liver/enzymology;Polypharmacy;Pregnancy;Pregnancy Complications, Infectious/drug therapy;Pyrrolidinones/administration & dosage;Pyrrolidinones/adverse effects;Pyrrolidinones/pharmacokinetics;Pyrrolidinones/pharmacology*;Pyrrolidinones/therapeutic use;Raltegravir Potassium
19585717;Arrhythmias, Cardiac/chemically induced*;Clinical Trials as Topic;Drug Approval;Drug Interactions;Exercise Tolerance/drug effects;Food-Drug Interactions;France;Humans;Intermittent Claudication/drug therapy*;Mortality;Pentoxifylline/administration & dosage;Pentoxifylline/adverse effects;Pentoxifylline/therapeutic use;Phosphodiesterase Inhibitors/administration & dosage;Phosphodiesterase Inhibitors/adverse effects;Phosphodiesterase Inhibitors/therapeutic use;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use;Randomized Controlled Trials as Topic;Risk;Tetrazoles/administration & dosage;Tetrazoles/adverse effects*;Tetrazoles/therapeutic use;Walking
19591515;Administration, Oral;Adolescent;Adult;Clozapine/administration & dosage;Clozapine/adverse effects;Clozapine/pharmacokinetics*;Cross-Over Studies;Fasting;Food-Drug Interactions*;Humans;Male;Middle Aged
19601724;Animals;Anti-Allergic Agents*/administration & dosage;Anti-Allergic Agents*/adverse effects;Anti-Allergic Agents*/pharmacokinetics;Anti-Allergic Agents*/therapeutic use;Carrier Proteins/metabolism;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/biosynthesis;Diet*;Dose-Response Relationship, Drug;Drug Interactions*;Drug Therapy, Combination;Food-Drug Interactions;Humans;Models, Biological
19617468;Administration, Oral;Antifungal Agents/administration & dosage*;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics;Area Under Curve;Drug Administration Schedule;Food-Drug Interactions;Gastric Mucosa/metabolism;Humans;Mycoses/drug therapy*;Triazoles/administration & dosage*;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics
19637955;Anticoagulants/pharmacokinetics*;Female;Food-Drug Interactions*;Fruit/adverse effects*;Humans;Middle Aged;Punicaceae/adverse effects*;Venous Thrombosis/drug therapy;Warfarin/pharmacokinetics*
19646718;Adult;Atrial Fibrillation/chemically induced;Autoimmune Diseases/epidemiology;Comorbidity;Contraindications;Dose-Response Relationship, Drug;Drug Interactions;Estrogens/pharmacokinetics;Estrogens/physiology;Female;Food-Drug Interactions;Gastritis/epidemiology;Heart Diseases/epidemiology;Hormone Replacement Therapy*;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Intestinal Absorption/drug effects;Male;Middle Aged;Osteoporosis/chemically induced;Pregnancy;Pregnancy Complications/epidemiology;Thyrotropin/blood;Thyroxine/administration & dosage;Thyroxine/adverse effects;Thyroxine/blood;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use*
19663519;Adolescent;Adult;Age Factors;Aged;Dosage Forms;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Evaluation;Electrocardiography/drug effects;Female;Food-Drug Interactions;Glycation End Products, Advanced/antagonists & inhibitors*;Humans;Male;Middle Aged;Pyridinium Compounds/administration & dosage*;Pyridinium Compounds/adverse effects;Pyridinium Compounds/pharmacokinetics;Sulfonamides/administration & dosage*;Sulfonamides/adverse effects;Sulfonamides/pharmacokinetics;Therapeutic Equivalency
19667002;Drug Incompatibility;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/administration & dosage*;Practice Guidelines as Topic
19728565;Adolescent;Adult;Amodiaquine/administration & dosage;Amodiaquine/adverse effects;Amodiaquine/pharmacokinetics*;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Artemisinins/adverse effects;Artemisinins/pharmacokinetics*;Biological Availability;Cross-Over Studies;Drug Combinations;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Spectrometry, Mass, Electrospray Ionization;Young Adult
19766437;Absorption;Anticoagulants/adverse effects*;Anticoagulants/metabolism*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism*;Drug Overdose;Female;Food-Drug Interactions;Humans;Middle Aged;Phenindione/adverse effects;Phenindione/analogs & derivatives*;Phenindione/metabolism;Severity of Illness Index;Vitamin K/antagonists & inhibitors*
19779132;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/biosynthesis;Adrenergic beta-1 Receptor Antagonists;Adrenergic beta-Antagonists/pharmacokinetics*;Animals;Beverages*/adverse effects;Biological Transport/drug effects;Cell Culture Techniques;Cell Membrane Permeability/drug effects;Citrus paradisi/chemistry*;Dose-Response Relationship, Drug;Flavanones/adverse effects;Flavanones/isolation & purification;Food-Drug Interactions*;Humans;Intestinal Absorption*;LLC-PK1 Cells;Oocytes/metabolism;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/biosynthesis;Propanolamines/pharmacokinetics*;Rats;Rats, Wistar;Species Specificity;Swine;Transfection;Xenopus laevis
19823793;Age Factors;Aged;Aged, 80 and over;Cytochrome P-450 Enzyme System/physiology;Diagnosis, Differential;Drug Interactions/physiology*;Drug Therapy, Combination/adverse effects*;Drug Tolerance/physiology;Drug-Related Side Effects and Adverse Reactions/diagnosis;Drug-Related Side Effects and Adverse Reactions/etiology*;Drug-Related Side Effects and Adverse Reactions/physiopathology;Food-Drug Interactions;Geriatrics*;Herb-Drug Interactions;Humans;Isoenzymes/physiology;Metabolic Clearance Rate/physiology;Pharmacokinetics*;Polypharmacy*
19881206;Administration, Oral;Angiotensin-Converting Enzyme Inhibitors/administration & dosage;Angiotensin-Converting Enzyme Inhibitors/metabolism;Antineoplastic Agents, Phytogenic/administration & dosage;Antineoplastic Agents, Phytogenic/adverse effects;Antineoplastic Agents, Phytogenic/metabolism;Benzimidazoles/administration & dosage;Benzimidazoles/metabolism;Benzoates/administration & dosage;Benzoates/metabolism;Camptothecin/administration & dosage;Camptothecin/adverse effects;Camptothecin/analogs & derivatives;Camptothecin/metabolism;Coumaric Acids;Cyclohexanes/administration & dosage;Cyclohexanes/metabolism*;Drug Interactions;Flavonoids;Food-Drug Interactions;Functional Food;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/metabolism*;Intestinal Absorption*;Monocarboxylic Acid Transporters/physiology;Phenols;Phenylalanine/administration & dosage;Phenylalanine/analogs & derivatives*;Phenylalanine/metabolism;Polyphenols
19922894;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Capsules;Chromatography, High Pressure Liquid;Cross-Over Studies;Diclofenac/administration & dosage;Diclofenac/adverse effects;Diclofenac/pharmacokinetics*;Female;Food-Drug Interactions;Gelatin;Humans;Intestinal Absorption;Male;Young Adult
9205821;Administration, Oral;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Blood Cell Count/drug effects;Blood Chemical Analysis;Blood Pressure/drug effects;Body Temperature/drug effects;Chromatography, Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Electrocardiography/drug effects;Endopeptidases/metabolism;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/urine;Food-Drug Interactions;Heart Rate/drug effects;Humans;Japan;Male;Mass Spectrometry;Pilot Projects;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/blood;Pyrrolidines/pharmacokinetics*;Pyrrolidines/urine
19925488;Adult;Anaphylaxis/etiology*;Anaphylaxis/immunology;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Aspirin/adverse effects*;Exercise*;Female;Food-Drug Interactions;Humans;Immunoglobulin E/analysis;Male;Skin Tests;Wheat Hypersensitivity/complications*;Wheat Hypersensitivity/immunology
19948946;Adolescent;Adult;Aged;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Beverages;Citrus paradisi*;Cross-Over Studies;Food-Drug Interactions*;Fusion Proteins, bcr-abl/metabolism;Headache/chemically induced;Humans;Male;Middle Aged;Protein-Tyrosine Kinases/metabolism;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Vomiting/chemically induced;Young Adult
20001610;Anti-HIV Agents/chemistry;Anti-HIV Agents/therapeutic use*;Benzoxazines/adverse effects;Benzoxazines/chemistry;Benzoxazines/metabolism;Benzoxazines/pharmacokinetics;Benzoxazines/therapeutic use*;Chemistry, Pharmaceutical;Food-Drug Interactions;HIV Infections/drug therapy*;HIV Infections/virology;HIV-1;Humans;Reverse Transcriptase Inhibitors/adverse effects;Reverse Transcriptase Inhibitors/chemistry;Reverse Transcriptase Inhibitors/metabolism;Reverse Transcriptase Inhibitors/pharmacokinetics;Reverse Transcriptase Inhibitors/therapeutic use*
20014671;Alcoholic Beverages/adverse effects;Calcium, Dietary/adverse effects;Citrus paradisi/adverse effects;Dietary Fiber/adverse effects;Dietary Proteins/adverse effects;Drug Prescriptions/nursing;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Hypericum/adverse effects;Nurse Practitioners/organization & administration*;Patient Education as Topic/organization & administration;Safety Management;Vitamin K/adverse effects
20028328;Animals;Cardiovascular Diseases/prevention & control*;Dietary Fiber;Dietary Supplements*;Fatty Acids/pharmacology;Food-Drug Interactions;Herb-Drug Interactions;Humans;Salvia*/chemistry;Seeds/chemistry;alpha-Linolenic Acid/pharmacology
20029019;Anticoagulants/therapeutic use*;Female;Food-Drug Interactions*;Fruit/adverse effects*;Hematoma/diagnosis;Hematoma/etiology*;Humans;International Normalized Ratio;Middle Aged;Punicaceae/adverse effects*;Warfarin/therapeutic use*
20040339;Administration, Oral;Adult;Area Under Curve;Cimetidine/pharmacokinetics;Cimetidine/pharmacology;Cross-Over Studies;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Interactions;Female;Food-Drug Interactions*;Histamine H2 Antagonists/pharmacokinetics;Histamine H2 Antagonists/pharmacology;Humans;Hypoglycemic Agents/pharmacology;Male;Metformin/pharmacokinetics;Metformin/pharmacology;Middle Aged;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Uracil/adverse effects;Uracil/analogs & derivatives*;Uracil/pharmacokinetics;Young Adult
20044363;Dosage Forms;Drug Incompatibility;Enteral Nutrition/adverse effects*;Enteral Nutrition/methods*;Food-Drug Interactions;Humans;Practice Guidelines as Topic*;Prescription Drugs*
20053516;Animals;Anti-Infective Agents/chemistry*;Anti-Infective Agents/metabolism;Biological Availability;Calcium/chemistry;Caseins/chemistry;Chromatography, High Pressure Liquid;Ciprofloxacin/chemistry*;Ciprofloxacin/metabolism;Food-Drug Interactions*;Hydrogen-Ion Concentration;Kinetics;Lipids/chemistry;Milk/adverse effects*;Reproducibility of Results;Solid Phase Extraction;Solubility;Spectrometry, Mass, Electrospray Ionization;Tablets
20065263;Antioxidants/administration & dosage;Antioxidants/adverse effects*;Arecaceae/chemistry*;Beverages/adverse effects*;Blood Coagulation/drug effects;Fatty Acids/adverse effects;Food-Drug Interactions*;Fruit/chemistry*;Humans;United States;Vitamin K/adverse effects;Warfarin/administration & dosage;Warfarin/adverse effects*
9211455;Biological Availability;Diet;Enteral Nutrition/adverse effects;Enteral Nutrition/nursing*;Food-Drug Interactions*;Gastric Emptying/physiology;Humans;Intubation, Gastrointestinal;Sorbitol/adverse effects
20081065;Administration, Oral;Adolescent;Adult;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics*;Area Under Curve;Bleeding Time;Dose-Response Relationship, Drug;Factor Xa/metabolism;Factor Xa Inhibitors*;Food-Drug Interactions;Half-Life;Humans;International Normalized Ratio;Male;Middle Aged;Partial Thromboplastin Time;Prothrombin Time;Pyridines/adverse effects*;Pyridines/pharmacokinetics*;Single-Blind Method;Tablets;Thiazoles/adverse effects*;Thiazoles/pharmacokinetics*;Young Adult
20110012;Adolescent;Adult;Antiparkinson Agents/administration & dosage*;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Area Under Curve;Benzothiazoles/administration & dosage*;Benzothiazoles/adverse effects;Benzothiazoles/pharmacokinetics*;Biological Availability;Body Mass Index;Chemistry, Pharmaceutical;Delayed-Action Preparations;Dietary Fats;Food-Drug Interactions;Humans;Male;Reproducibility of Results;Young Adult
20137764;Adult;Amines/pharmacokinetics;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics*;Area Under Curve;Biological Availability;Carbamates/adverse effects;Carbamates/pharmacokinetics*;Cross-Over Studies;Cyclohexanecarboxylic Acids/pharmacokinetics;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Prodrugs;Young Adult;gamma-Aminobutyric Acid/adverse effects;gamma-Aminobutyric Acid/analogs & derivatives*;gamma-Aminobutyric Acid/pharmacokinetics
20137768;Adolescent;Adult;Area Under Curve;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Chromatography, Liquid/methods;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;Humans;Male;Nifedipine/administration & dosage;Nifedipine/adverse effects;Nifedipine/pharmacokinetics*;Osmosis;Tablets;Tandem Mass Spectrometry/methods;Therapeutic Equivalency;Young Adult
20197487;Administration, Oral;Adult;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics*;Area Under Curve;Artemisinins/administration & dosage;Artemisinins/adverse effects;Artemisinins/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Dose-Response Relationship, Drug;Food-Drug Interactions*;Humans;Male;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects;Naphthoquinones/pharmacokinetics*;Tablets;Tandem Mass Spectrometry;Young Adult
20374180;Amlodipine/administration & dosage*;Amlodipine/blood*;Beverages/adverse effects;Blood Pressure/drug effects;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/blood*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Food-Drug Interactions*;Humans;Hypertension/blood;Hypertension/drug therapy*;Hypertension/physiopathology;Japan;Male;Middle Aged;Nifedipine/administration & dosage*;Nifedipine/blood*
20400647;Adult;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/chemistry;Antifungal Agents/pharmacokinetics*;Ascorbic Acid/administration & dosage*;Beverages/analysis*;Biological Availability;Biotransformation;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Itraconazole/adverse effects;Itraconazole/analogs & derivatives*;Itraconazole/blood;Itraconazole/chemistry;Itraconazole/pharmacokinetics*;Male;Miconazole/blood;Miconazole/chemistry;Spectrometry, Mass, Electrospray Ionization;Tandem Mass Spectrometry;Young Adult
20432867;Animals;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Bacteria/metabolism;Bifidobacterium;Drug Interactions;Food-Drug Interactions;Humans;Intestines/metabolism;Intestines/microbiology;Lactobacillus rhamnosus;Probiotics/administration & dosage*;Probiotics/adverse effects;Vitamin K/biosynthesis;Vitamin K/metabolism;Warfarin/administration & dosage*
20457501;Animals;Anti-Infective Agents/pharmacokinetics*;Biological Availability;Caseins/metabolism*;Cattle;Ciprofloxacin/chemistry;Ciprofloxacin/pharmacokinetics*;Food-Drug Interactions*;Milk/adverse effects*;Solubility;Tablets
20457591;Adolescent;Adult;Cross-Over Studies;Dietary Fats/administration & dosage*;Female;Food-Drug Interactions*;HIV Infections/drug therapy;HIV Integrase Inhibitors/adverse effects;HIV Integrase Inhibitors/blood;HIV Integrase Inhibitors/pharmacokinetics*;Humans;Male;Middle Aged;Pyrrolidinones/adverse effects;Pyrrolidinones/blood;Pyrrolidinones/pharmacokinetics*;Raltegravir Potassium;Young Adult
9220063;Anaphylaxis/diagnosis;Animals;Antitubercular Agents/adverse effects*;Diagnosis, Differential;Food-Drug Interactions*;Foodborne Diseases/diagnosis*;Foodborne Diseases/etiology;Humans;Isoniazid/adverse effects*;Tuna*
20481649;Animals;Antifungal Agents/adverse effects;Antifungal Agents/pharmacokinetics*;Antifungal Agents/pharmacology;Area Under Curve;Biological Availability;Drug Interactions;Drug Resistance, Fungal;Food-Drug Interactions;Fungi/drug effects;Humans;Mycoses/drug therapy*;Mycoses/microbiology;Triazoles/adverse effects;Triazoles/pharmacokinetics*;Triazoles/pharmacology
20484610;Adult;Amines/administration & dosage;Amines/adverse effects;Amines/blood;Amines/pharmacokinetics*;Analgesics, Non-Narcotic/administration & dosage;Analgesics, Non-Narcotic/adverse effects;Analgesics, Non-Narcotic/blood;Analgesics, Non-Narcotic/pharmacokinetics;Anticonvulsants/administration & dosage;Anticonvulsants/adverse effects;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics;Biological Availability;Calcium Channel Blockers/administration & dosage;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Cyclohexanecarboxylic Acids/administration & dosage;Cyclohexanecarboxylic Acids/adverse effects;Cyclohexanecarboxylic Acids/blood;Cyclohexanecarboxylic Acids/pharmacokinetics*;Delayed-Action Preparations/administration & dosage;Delayed-Action Preparations/adverse effects;Delayed-Action Preparations/pharmacokinetics;Dietary Fats/administration & dosage*;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Gastric Emptying/drug effects;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Stomach/metabolism*;Young Adult;gamma-Aminobutyric Acid/administration & dosage;gamma-Aminobutyric Acid/adverse effects;gamma-Aminobutyric Acid/blood;gamma-Aminobutyric Acid/pharmacokinetics*
20509982;Appetite/drug effects;Dietary Supplements;Drug Monitoring;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Nutritional Status
20512335;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/pharmacokinetics*;Area Under Curve;Beverages/adverse effects;Biological Availability;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors*;Drug Labeling;Female;Food-Drug Interactions*;Humans;Indoles/administration & dosage;Indoles/pharmacokinetics*;Male;Midazolam/metabolism;Middle Aged;Neoplasms/drug therapy;Neoplasms/pathology;Pyrroles/administration & dosage;Pyrroles/pharmacokinetics*
20520305;Fabaceae/adverse effects*;Fabaceae/metabolism;Food-Drug Interactions/physiology*;Humans;Hypertension/chemically induced;Hypertension/metabolism;Levodopa/adverse effects;Levodopa/metabolism;Tyramine/adverse effects;Tyramine/metabolism
20529767;Antineoplastic Agents/therapeutic use;Benzamides;Drug Eruptions/prevention & control;Drug Interactions;Drug Resistance, Neoplasm;Erythropoietin/therapeutic use;Fertility/drug effects;Food-Drug Interactions;France;Granulocyte Colony-Stimulating Factor/therapeutic use;Heart Diseases/chemically induced;Heart Diseases/prevention & control;Humans;Imatinib Mesylate;Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*;Metabolic Diseases/chemically induced;Metabolic Diseases/prevention & control;Neutropenia/chemically induced;Neutropenia/prevention & control;Piperazines/therapeutic use;Protein Kinase Inhibitors/adverse effects*;Protein-Tyrosine Kinases/antagonists & inhibitors;Pyrimidines/adverse effects*;Pyrimidines/therapeutic use;Recombinant Proteins
20534818;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/blood;Anticoagulants/pharmacokinetics*;Anticoagulants/urine;Area Under Curve;Asian Continental Ancestry Group;Blood Coagulation/drug effects*;Body Mass Index;Chromatography, Liquid;Cross-Over Studies;Dietary Fats*;European Continental Ancestry Group;Factor Xa Inhibitors*;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Models, Biological;Partial Thromboplastin Time;Prothrombin Time;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/blood;Pyridines/pharmacokinetics*;Pyridines/urine;Tandem Mass Spectrometry;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*;Thiazoles/urine;Young Adult
20584229;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Anticoagulants/metabolism;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects*;Benzimidazoles/metabolism;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Dabigatran;Drug Interactions;Food-Drug Interactions;Humans;Morpholines/administration & dosage;Morpholines/adverse effects*;Morpholines/metabolism;Pyrazoles/administration & dosage;Pyrazoles/adverse effects*;Pyrazoles/metabolism;Pyridones/administration & dosage;Pyridones/adverse effects*;Pyridones/metabolism;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects*;Thiophenes/metabolism;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*;beta-Alanine/metabolism
20628041;Antiparkinson Agents/adverse effects*;Carbidopa/administration & dosage;Drug Therapy, Combination;Enteral Nutrition/adverse effects*;Food-Drug Interactions*;Humans;Intensive Care Units;Length of Stay;Levodopa/adverse effects*;Male;Middle Aged;Neuroleptic Malignant Syndrome/etiology*;Parkinson Disease/drug therapy
20630973;Aged;Anticoagulants/adverse effects*;Brassica/adverse effects*;Diet/adverse effects;Dyspnea/chemically induced;Female;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;International Normalized Ratio;Pulmonary Embolism/drug therapy;Recurrence;Vitamin K Deficiency/etiology*;Warfarin/adverse effects*
9274239;Adolescent;Adult;Age Factors;Aged;Calcium Compounds/therapeutic use*;Calcium, Dietary/administration & dosage*;Calcium, Dietary/adverse effects;Child;Child, Preschool;Female;Food, Fortified*;Food-Drug Interactions;Humans;Infant;Infant, Newborn;Male;Middle Aged;Nutritional Requirements*;Pregnancy;Sex Factors
20642557;Aged;Aged, 80 and over;Anticoagulants/pharmacology*;Anticoagulants/therapeutic use;Cardiovascular Diseases/drug therapy*;Food-Drug Interactions*;Humans;Male;Middle Aged;Prospective Studies;Prothrombin Time*;Vaccinium macrocarpon/adverse effects*;Warfarin/pharmacology*;Warfarin/therapeutic use
20652662;Adult;Cheese/adverse effects*;Chest Pain/drug therapy;Chest Pain/etiology;Chest Pain/physiopathology;Electrocardiography;Female;Food-Drug Interactions*;Heart/drug effects;Heart/physiopathology;Humans;Injections, Intravenous;Monoamine Oxidase Inhibitors/adverse effects*;Morphine/therapeutic use;Myocardial Infarction/blood;Myocardial Infarction/chemically induced*;Myocardial Infarction/physiopathology;Nitroprusside/therapeutic use;Phenelzine/adverse effects*;Treatment Outcome;Troponin I/blood;Vasodilator Agents/therapeutic use
20653361;Animals;Antifungal Agents/therapeutic use*;Azoles/therapeutic use*;Disease Management;Drug Interactions*/physiology;Food-Drug Interactions*/physiology;Humans;Mycoses/drug therapy*;Mycoses/etiology;Transplantation*/adverse effects
20694287;Dietary Fiber*;Food-Drug Interactions*;Humans
20852003;Acetamides/adverse effects;Acetamides/blood;Acetamides/pharmacokinetics*;Acetamides/therapeutic use;Adult;Biological Availability;Capsules;Cross-Over Studies;Food-Drug Interactions;Half-Life;Humans;Hypnotics and Sedatives/adverse effects;Hypnotics and Sedatives/blood;Hypnotics and Sedatives/pharmacokinetics*;Hypnotics and Sedatives/therapeutic use;Isoquinolines/adverse effects;Isoquinolines/blood;Isoquinolines/pharmacokinetics*;Isoquinolines/therapeutic use;Male;Orexin Receptors;Reaction Time/drug effects;Receptors, G-Protein-Coupled/antagonists & inhibitors*;Receptors, Neuropeptide/antagonists & inhibitors*;Tablets;Task Performance and Analysis;Therapeutic Equivalency;Wakefulness/drug effects;Young Adult
20864621;Administration, Oral;Adolescent;Adult;Biotransformation;Cytochrome P-450 CYP2D6/metabolism;Dizziness/chemically induced;Double-Blind Method;Drug Administration Schedule;Electrocardiography;Enzyme Inhibitors/administration & dosage;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/pharmacokinetics*;Enzyme Inhibitors/urine;Female;Food-Drug Interactions*;Glucosyltransferases/antagonists & inhibitors*;Heart Rate/drug effects;Humans;Intestinal Absorption;Male;Models, Biological;Nausea/chemically induced;Pyrrolidines/administration & dosage;Pyrrolidines/adverse effects;Pyrrolidines/blood;Pyrrolidines/pharmacokinetics*;Pyrrolidines/urine;Vomiting/chemically induced;Young Adult
20869315;Antacids/adverse effects;Anti-Infective Agents/adverse effects;Anticonvulsants/adverse effects;Antiemetics/adverse effects;Antineoplastic Agents/adverse effects;Child;Complementary Therapies/adverse effects;Drug Interactions*;Food-Drug Interactions;Humans;Neoplasms/drug therapy*
20926751;Adenosine A1 Receptor Antagonists/administration & dosage;Adenosine A1 Receptor Antagonists/adverse effects;Adenosine A1 Receptor Antagonists/blood;Adenosine A1 Receptor Antagonists/pharmacokinetics*;Administration, Oral;Adolescent;Adult;Aged;Biological Availability;Cross-Over Studies;Diuretics/administration & dosage;Diuretics/adverse effects;Diuretics/blood;Diuretics/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Metabolic Clearance Rate;Middle Aged;Sex Characteristics;Xanthines/administration & dosage;Xanthines/adverse effects;Xanthines/blood;Xanthines/pharmacokinetics*;Young Adult
20928982;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/history*;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use;Drug Interactions;Drug Monitoring;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/drug therapy;History, 20th Century;History, 21st Century;Humans;International Normalized Ratio;Mixed Function Oxygenases/antagonists & inhibitors;Patient Education as Topic;Thrombophilia/drug therapy;Thrombosis/prevention & control;Vitamin K/metabolism;Vitamin K/therapeutic use;Vitamin K Epoxide Reductases;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/history*;Warfarin/pharmacokinetics;Warfarin/therapeutic use
20959524;Adult;Benzothiazoles/administration & dosage;Benzothiazoles/adverse effects*;Benzothiazoles/analysis;Benzothiazoles/pharmacokinetics*;Dopamine Agonists/administration & dosage;Dopamine Agonists/adverse effects*;Dopamine Agonists/analysis;Dopamine Agonists/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Drugs, Investigational/administration & dosage;Drugs, Investigational/adverse effects*;Drugs, Investigational/analysis;Drugs, Investigational/pharmacokinetics*;Female;Food-Drug Interactions;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Plasma/chemistry;Urine/chemistry
20970282;Aged, 80 and over;Amiodarone/adverse effects*;Arrhythmias, Cardiac/chemically induced;Arrhythmias, Cardiac/therapy;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Electric Countershock;Electrocardiography;Emergency Service, Hospital;Female;Food-Drug Interactions*;Humans;Torsades de Pointes/chemically induced;Torsades de Pointes/therapy
20980999;Administration, Oral;Adult;Aged;Cohort Studies;Cross-Over Studies;Dietary Fats/metabolism*;Fatigue/chemically induced;Female;Food-Drug Interactions/physiology*;Humans;Hypertension/chemically induced;Male;Middle Aged;Neoplasms/drug therapy;Neoplasms/metabolism*;Pyrimidines/administration & dosage;Pyrimidines/adverse effects*;Pyrimidines/pharmacokinetics*;Sulfonamides/administration & dosage;Sulfonamides/adverse effects*;Sulfonamides/pharmacokinetics*
21038340;Aryl Hydrocarbon Hydroxylases/chemistry*;Aryl Hydrocarbon Hydroxylases/metabolism;Binding Sites;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP2D6/chemistry*;Cytochrome P-450 CYP2D6/metabolism;Humans;Molecular Dynamics Simulation;Protein Binding;Protein Structure, Tertiary;Quantitative Structure-Activity Relationship;Small Molecule Libraries/chemical synthesis;Small Molecule Libraries/chemistry*;Small Molecule Libraries/toxicity
21085830;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics;Antitubercular Agents/therapeutic use*;Brazil;Chemical and Drug Induced Liver Injury;Drug Interactions;Female;Food-Drug Interactions;Humans;Pregnancy;Risk Factors;Tuberculosis/drug therapy*;Tuberculosis/metabolism
21085831;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics;Antitubercular Agents/therapeutic use*;Drug Interactions;Female;Food-Drug Interactions;Humans;Pregnancy;Pregnancy Complications/drug therapy;Tuberculosis/drug therapy*;Tuberculosis, Multidrug-Resistant/drug therapy
21098692;Adult;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical/methods;Confidence Intervals;Cross-Over Studies;Delayed-Action Preparations;Diet, High-Fat*;Fasting;Female;Food-Drug Interactions*;Humans;Hydromorphone/administration & dosage*;Hydromorphone/adverse effects;Hydromorphone/chemistry;Hydromorphone/pharmacokinetics*;Male;Naltrexone/administration & dosage;Therapeutic Equivalency
21120480;Adult;Aged;Area Under Curve;Cross-Over Studies;Dose-Response Relationship, Drug;Electrocardiography/drug effects;Fasting/metabolism;Female;Food-Drug Interactions;Humans;Magnetic Resonance Imaging;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/pathology;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Quinazolines/therapeutic use*;Tomography, X-Ray Computed;Treatment Outcome;Young Adult
21124269;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Antioxidants/administration & dosage*;Antioxidants/adverse effects;Beverages/adverse effects*;Food-Drug Interactions*;Gastrointestinal Hemorrhage/etiology;Gastrointestinal Hemorrhage/prevention & control;Health Knowledge, Attitudes, Practice;Humans;Vaccinium macrocarpon*;Warfarin/administration & dosage*;Warfarin/adverse effects
21125816;Administration, Oral;Adult;Antiviral Agents/administration & dosage;Antiviral Agents/adverse effects;Antiviral Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Calibration;Chromatography, High Pressure Liquid;Cross-Over Studies;Fasting/metabolism;Female;Food-Drug Interactions;Ganciclovir/pharmacokinetics;Guanine/administration & dosage;Guanine/adverse effects;Guanine/analogs & derivatives*;Guanine/pharmacokinetics;Humans;Male;Mass Spectrometry;Reproducibility of Results;Tablets;Young Adult
21142260;Animals;Beverages;Biological Availability;Citrus paradisi/chemistry*;Cytochrome P-450 Enzyme System/adverse effects;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*
9333047;Adolescent;Adult;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Anti-Ulcer Agents/pharmacology*;Area Under Curve;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Half-Life;Humans;Levofloxacin*;Male;Ofloxacin/adverse effects;Ofloxacin/pharmacokinetics*;Reference Values;Spectrophotometry, Ultraviolet;Sucralfate/pharmacology*
21147941;Administration, Cutaneous;Antidepressive Agents/adverse effects*;Antidepressive Agents/therapeutic use;Blood Pressure/drug effects*;Cheese;Depressive Disorder, Major/drug therapy;Feeding Behavior;Food-Drug Interactions;Humans;Hypertension/chemically induced*;Hypertension/prevention & control;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Myocardium;Risk Factors;Selegiline/adverse effects;Selegiline/pharmacokinetics;Selegiline/therapeutic use*;Tyramine
21162177;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/metabolism*;Beverages/adverse effects;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Food-Drug Interactions*;Fruit;Health Knowledge, Attitudes, Practice*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage;Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism*;Patient Education as Topic
21163558;Antioxidants/analysis;Combined Modality Therapy;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/diet therapy*;Diabetes Mellitus, Type 2/drug therapy*;Diabetes Mellitus, Type 2/enzymology;Dyslipidemias/prevention & control;Female;Food-Drug Interactions*;Glyburide/adverse effects;Glyburide/therapeutic use*;Glycated Hemoglobin A/analysis;Humans;Hyperglycemia/prevention & control;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/therapeutic use*;Male;Middle Aged;Oxidoreductases/blood;Sesame Oil/adverse effects;Sesame Oil/therapeutic use*;Severity of Illness Index
21185864;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy*;Clinical Trials as Topic;Food-Drug Interactions;Heparin, Low-Molecular-Weight/therapeutic use*;Humans;Thromboembolism/drug therapy*;Thromboembolism/etiology;Thromboembolism/prevention & control;Venous Thrombosis/complications;Venous Thrombosis/drug therapy*;Venous Thrombosis/prevention & control;Warfarin/therapeutic use
21194458;Anticonvulsants/blood;Anticonvulsants/pharmacokinetics*;Critical Care*;Drug Monitoring;Food-Drug Interactions;Humans;Hypoalbuminemia/drug therapy;Hypoalbuminemia/therapy;Parenteral Nutrition*/adverse effects
21235125;Anti-Allergic Agents/pharmacokinetics;Anti-Anxiety Agents/pharmacokinetics;Anti-Bacterial Agents/pharmacokinetics;Antimalarials/pharmacokinetics;Beverages/adverse effects*;Biological Availability;Calcium Channel Blockers/pharmacokinetics;Citrus paradisi/adverse effects*;Food-Drug Interactions*;HIV Protease Inhibitors/pharmacokinetics;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Risk Factors
21248612;Administration, Oral;Adolescent;Adult;Antifibrinolytic Agents/administration & dosage;Antifibrinolytic Agents/adverse effects;Antifibrinolytic Agents/therapeutic use*;Delayed-Action Preparations;Diet, High-Fat*;Fasting;Female;Food-Drug Interactions;Humans;Menorrhagia/drug therapy*;Middle Aged;Tablets;Time Factors;Tranexamic Acid/administration & dosage;Tranexamic Acid/adverse effects;Tranexamic Acid/therapeutic use;Treatment Outcome;Young Adult
21254874;Animals;Beverages*/adverse effects;Beverages*/analysis;Citrus paradisi*/adverse effects;Citrus paradisi*/chemistry;Food-Drug Interactions*;Humans;Pharmacokinetics*
21257798;Adolescent;Adult;Area Under Curve;Biological Availability;Double-Blind Method;Female;Food-Drug Interactions;Humans;Janus Kinases/antagonists & inhibitors;Male;Middle Aged;Neutropenia/chemically induced;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics*;Pyrazoles/pharmacology*;STAT3 Transcription Factor/blood;Young Adult
21268318;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Health Knowledge, Attitudes, Practice*;Humans;Patient Education as Topic;Rhabdomyolysis/chemically induced;Rhabdomyolysis/prevention & control*;Simvastatin/administration & dosage;Simvastatin/adverse effects*
21298205;Anti-Arrhythmia Agents/adverse effects;Anti-Arrhythmia Agents/pharmacokinetics;Anti-Arrhythmia Agents/therapeutic use*;Beverages*;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/metabolism;Citrus paradisi*;Food-Drug Interactions;Humans
21301274;Beverages/adverse effects*;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Middle Aged;Vaccinium macrocarpon*;Warfarin/adverse effects*
21359645;Administration, Oral;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Food/adverse effects*;Food-Drug Interactions*;Humans;Warfarin*/adverse effects;Warfarin*/pharmacokinetics;Warfarin*/therapeutic use
21422239;Administration, Oral;Adolescent;Adult;Biological Availability;Blood Cell Count;Butyrates/administration & dosage;Butyrates/adverse effects*;Butyrates/analysis;Butyrates/pharmacokinetics*;Dose-Response Relationship, Drug;Double-Blind Method;Drugs, Investigational/administration & dosage;Drugs, Investigational/adverse effects*;Drugs, Investigational/analysis;Drugs, Investigational/pharmacokinetics*;Female;Fetal Hemoglobin/analysis;Food-Drug Interactions;Half-Life;Hematinics/administration & dosage;Hematinics/adverse effects*;Hematinics/analysis;Hematinics/pharmacokinetics*;Humans;Male;Metabolic Clearance Rate;Plasma/chemistry;Reticulocytes/drug effects;Urine/chemistry;Young Adult
21432599;Attention Deficit Disorder with Hyperactivity/diagnosis;Attention Deficit Disorder with Hyperactivity/drug therapy*;Central Nervous System Stimulants/administration & dosage;Central Nervous System Stimulants/adverse effects;Central Nervous System Stimulants/therapeutic use*;Child;Cross-Over Studies;Delayed-Action Preparations/adverse effects;Delayed-Action Preparations/therapeutic use*;Female;Food Deprivation;Food-Drug Interactions*;Humans;Male;Methylphenidate/administration & dosage;Methylphenidate/adverse effects;Methylphenidate/therapeutic use*;Single-Blind Method
21443600;Administration, Oral;Adolescent;Adult;Biological Availability;Cross-Over Studies;Dermatologic Agents/administration & dosage;Dermatologic Agents/adverse effects;Dermatologic Agents/blood*;Fasting/blood;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Tretinoin/administration & dosage;Tretinoin/adverse effects;Tretinoin/blood*;Young Adult
21453201;Animals;Clinical Trials as Topic/methods;Drug Interactions/physiology;Drug-Related Side Effects and Adverse Reactions/chemically induced*;Drug-Related Side Effects and Adverse Reactions/metabolism;Drug-Related Side Effects and Adverse Reactions/prevention & control;Food-Drug Interactions/physiology;Humans;Indans/adverse effects;Indans/pharmacokinetics;Indans/therapeutic use*;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism;Serotonin Agents/adverse effects;Serotonin Agents/pharmacokinetics;Serotonin Agents/therapeutic use;Treatment Outcome
21474406;Administration, Oral;Aged;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Food-Drug Interactions;Hospital Units*;Humans;Inpatients/psychology*;International Normalized Ratio;Knowledge;Middle Aged;Patient Education as Topic*;Physical and Rehabilitation Medicine*;Prospective Studies;Rehabilitation*;Self Medication;Surveys and Questionnaires;Vitamin K/antagonists & inhibitors
2642594;Anti-Bacterial Agents/pharmacokinetics;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Antineoplastic Agents/pharmacokinetics;Cardiovascular Agents/pharmacokinetics;Food/adverse effects*;Humans;Intestinal Absorption;Pharmacokinetics*
21501216;Aged;Analysis of Variance;Anticholesteremic Agents/blood*;Anticholesteremic Agents/therapeutic use;Atorvastatin Calcium;Beverages*;Citrus paradisi/metabolism*;Cohort Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Heptanoic Acids/blood*;Heptanoic Acids/therapeutic use;Humans;Lipid Metabolism/drug effects;Lipid Metabolism Disorders/blood;Lipid Metabolism Disorders/drug therapy*;Male;Middle Aged;Pyrroles/blood*;Pyrroles/therapeutic use;Time Factors
21508758;Dietary Supplements*/adverse effects;Female;Food-Drug Interactions;Herb-Drug Interactions;Humans;Legislation, Food;Physician-Patient Relations;Plant Preparations/adverse effects;United States
21515596;Anticoagulants/administration & dosage;Anticoagulants/adverse effects*;Atrial Fibrillation/epidemiology*;Cardiology/standards*;Europe;Hemorrhage/chemically induced;Hemorrhage/epidemiology*;Humans;Risk Factors;Societies, Medical/standards;Stroke/epidemiology;Stroke/prevention & control;Thrombosis/epidemiology*;Thrombosis/prevention & control
21517925;Administration, Oral;Adult;Asian Continental Ancestry Group;China;Chromatography, Liquid/methods*;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Half-Life;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Isoindoles/administration & dosage;Isoindoles/adverse effects;Isoindoles/pharmacokinetics*;Male;Tablets;Tandem Mass Spectrometry/methods*;Young Adult
21532276;Administration, Oral;Alendronate/administration & dosage;Alendronate/pharmacokinetics*;Alendronate/urine;Animals;Bone Density Conservation Agents/administration & dosage;Bone Density Conservation Agents/pharmacokinetics*;Bone Density Conservation Agents/urine;Calcium/analysis;Food-Drug Interactions;Male;Mineral Waters/adverse effects*;Mineral Waters/analysis;Rats;Rats, Wistar;Time Factors
21535728;Allyl Compounds/administration & dosage;Allyl Compounds/adverse effects*;Animals;Biological Availability;Calcium Channel Blockers/blood;Calcium Channel Blockers/pharmacokinetics*;Dietary Supplements/adverse effects*;Food-Drug Interactions;Garlic/chemistry;Half-Life;Male;Metabolic Clearance Rate;Nifedipine/blood;Nifedipine/pharmacokinetics*;Plant Extracts/adverse effects;Plant Extracts/chemistry;Plant Roots/chemistry;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/adverse effects*;Random Allocation;Rats;Rats, Sprague-Dawley;Reproducibility of Results;Sulfides/administration & dosage;Sulfides/adverse effects*;Time Factors;Vasodilator Agents/blood;Vasodilator Agents/pharmacokinetics*
21544521;Animal Feed/adverse effects;Animals;Behavior, Animal/drug effects*;Body Temperature/drug effects;Body Weight/drug effects*;Dietary Fats*/administration & dosage;Dietary Fats*/adverse effects;Dopamine Agonists/pharmacology*;Dose-Response Relationship, Drug;Food-Drug Interactions*;Male;Quinpirole/pharmacology*;Rats;Rats, Sprague-Dawley;Receptors, Dopamine/metabolism*;Yawning/drug effects
21545633;Antimetabolites, Antineoplastic;Biological Transport/drug effects;Carbonated Beverages/adverse effects*;Cola/adverse effects*;Food-Drug Interactions*;Humans;Hydrogen-Ion Concentration;Kidney/metabolism;Liver/metabolism;Lymphoma/drug therapy;Lymphoma/urine;Male;Methotrexate/pharmacokinetics*;Methotrexate/therapeutic use;Middle Aged;Urine/chemistry
21548660;Adult;Area Under Curve;Benzopyrans/adverse effects;Benzopyrans/blood;Benzopyrans/metabolism;Benzopyrans/pharmacokinetics*;Biotransformation/physiology;Cross-Over Studies;Dopamine beta-Hydroxylase/antagonists & inhibitors;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/blood;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/pharmacokinetics;Food Deprivation/physiology;Food-Drug Interactions/physiology*;Humans;Imidazoles/adverse effects;Imidazoles/blood;Imidazoles/metabolism;Imidazoles/pharmacokinetics*;Male;Therapeutic Equivalency;Young Adult
21610201;Adolescent;Adult;Area Under Curve;Benzofurans/adverse effects*;Benzofurans/pharmacokinetics;Benzofurans/pharmacology;Blood Glucose/drug effects*;C-Peptide/secretion;Dietary Fats/administration & dosage;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Insulin/secretion;Male;Middle Aged;Receptors, G-Protein-Coupled/agonists*;Sulfones/adverse effects*;Sulfones/pharmacokinetics;Sulfones/pharmacology;Young Adult
9503566;Blood Pressure/drug effects*;Diet*;Food-Drug Interactions*;Humans;Monoamine Oxidase/metabolism;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology*;Substrate Specificity;Tyramine/administration & dosage*;Tyramine/metabolism
21628600;Antiparkinson Agents/adverse effects;Antiparkinson Agents/therapeutic use*;Brain/drug effects*;Brain/enzymology;Dietary Proteins/adverse effects;Dietary Proteins/metabolism*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Hypertension/etiology;Hypertension/prevention & control;Indans/adverse effects;Indans/therapeutic use*;Monoamine Oxidase/metabolism*;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Parkinson Disease/drug therapy*;Parkinson Disease/enzymology;Patient Safety;Risk Assessment;Risk Factors;Treatment Outcome;Tyramine/adverse effects;Tyramine/metabolism*
21682192;ATP Binding Cassette Transporter, Sub-Family B/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/drug effects;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Beverages*;Citrus paradisi*;Cytochrome P-450 CYP3A/drug effects;Cytochrome P-450 CYP3A/metabolism;Flavonoids/adverse effects;Food-Drug Interactions*;Furocoumarins/adverse effects;Humans;Intestinal Absorption/drug effects*;Intestines/metabolism*
21691746;Adolescent;Adult;Aniline Compounds/administration & dosage*;Aniline Compounds/adverse effects;Aniline Compounds/pharmacokinetics;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects;Antineoplastic Agents/pharmacokinetics;Area Under Curve;Chromatography, Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Female;Food-Drug Interactions;Half-Life;Humans;Male;Middle Aged;Nitriles/administration & dosage*;Nitriles/adverse effects;Nitriles/pharmacokinetics;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics;Proto-Oncogene Proteins c-abl/antagonists & inhibitors;Quinolines/administration & dosage*;Quinolines/adverse effects;Quinolines/pharmacokinetics;Tandem Mass Spectrometry;Tissue Distribution;Young Adult;src-Family Kinases/antagonists & inhibitors
21704240;Adult;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cholesterol Ester Transfer Proteins/antagonists & inhibitors;Cross-Over Studies;Dietary Fats/administration & dosage*;Drug Administration Schedule;Food-Drug Interactions*;Humans;Male;Sulfhydryl Compounds/administration & dosage;Sulfhydryl Compounds/adverse effects;Sulfhydryl Compounds/pharmacokinetics*;Time Factors;Young Adult
21704241;Administration, Oral;Adolescent;Adult;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects;Anticholesteremic Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Dietary Fats/administration & dosage;Fasting;Female;Fenofibrate/administration & dosage;Fenofibrate/adverse effects;Fenofibrate/analogs & derivatives*;Fenofibrate/pharmacokinetics;Food-Drug Interactions*;Humans;Male;Prodrugs;Tablets;Therapeutic Equivalency;Young Adult
21705359;Antihypertensive Agents/therapeutic use;Blood Pressure/physiology;Cost-Benefit Analysis;Diet/adverse effects;Diet, Sodium-Restricted/methods;Dose-Response Relationship, Drug;Food-Drug Interactions;Health Promotion/economics;Health Promotion/methods;Heart Failure/etiology*;Heart Failure/physiopathology;Heart Failure/prevention & control;Humans;Hypertension/etiology*;Hypertension/physiopathology;Hypertension/prevention & control;Hypertrophy, Left Ventricular/etiology;Hypertrophy, Left Ventricular/physiopathology;Life Style;Obesity/prevention & control;Risk Factors;Sodium Chloride, Dietary/adverse effects*;Ventricular Dysfunction, Left/etiology;Ventricular Dysfunction, Left/physiopathology;Weight Loss
21715058;Acenocoumarol/adverse effects*;Acenocoumarol/pharmacokinetics;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Anticoagulants/pharmacokinetics;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Ethanol/pharmacokinetics;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food Labeling;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans;Internet;Legislation, Drug;Patient Education as Topic;Spain;United States;United States Food and Drug Administration;Vitamin K/antagonists & inhibitors;Vomiting/etiology
21720234;Bipolar Disorder/blood*;Bipolar Disorder/drug therapy;Carbonated Beverages/adverse effects*;Cola*/adverse effects;Food-Drug Interactions/physiology*;Humans;Lithium/blood*;Lithium/therapeutic use;Male;Middle Aged
21721019;Animals;Arylsulfotransferase/biosynthesis*;Arylsulfotransferase/genetics;Caffeine/administration & dosage*;Caffeine/adverse effects;Central Nervous System Stimulants/administration & dosage;Enzyme Induction*;Female;Food-Drug Interactions;Intestinal Mucosa/enzymology*;Intestinal Mucosa/metabolism;Intestine, Small/enzymology*;Intestine, Small/metabolism;Liver/enzymology*;Liver/metabolism;Male;Organ Specificity;Phosphodiesterase Inhibitors/administration & dosage;Purinergic P1 Receptor Antagonists/administration & dosage;RNA, Messenger/metabolism;Random Allocation;Rats;Rats, Sprague-Dawley;Sex Characteristics;Sulfotransferases/biosynthesis*;Sulfotransferases/genetics
21733905;Adolescent;Antifungal Agents/pharmacokinetics*;Antifungal Agents/therapeutic use;Enteral Nutrition/adverse effects*;Food-Drug Interactions;Hematopoietic Stem Cell Transplantation/methods;Humans;Male;Mycoses/prevention & control;Pyrimidines/pharmacokinetics*;Pyrimidines/therapeutic use;Suspensions;Triazoles/pharmacokinetics*;Triazoles/therapeutic use;Voriconazole
9505992;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Area Under Curve;Bilirubin/metabolism*;Cross-Over Studies;Cyclosporins/administration & dosage;Cyclosporins/pharmacokinetics*;Dietary Fats/adverse effects*;Food-Drug Interactions*;Humans;Immunosuppressive Agents/administration & dosage;Immunosuppressive Agents/pharmacokinetics*
21803422;Adult;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Linagliptin;Male;Middle Aged;Purines/adverse effects;Purines/pharmacokinetics*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics*;Tandem Mass Spectrometry;Young Adult
21812328;Antioxidants/analysis;Beverages/adverse effects*;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A Inhibitors*;Enzyme Inhibitors/pharmacology*;Female;Flavanones/analysis;Food-Drug Interactions/physiology*;Forecasting;Furocoumarins/analysis;Humans;In Vitro Techniques;Linear Models;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Models, Statistical;Oxidation-Reduction;Testosterone/metabolism
21816140;Biomedical Technology;Dietary Supplements*/adverse effects;Drug-Related Side Effects and Adverse Reactions;Functional Food*/adverse effects;Humans;Medicine*;Nutritional Sciences*
21819160;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adult;Cross-Over Studies;Delayed-Action Preparations;Dipeptides/administration & dosage;Dipeptides/adverse effects;Dipeptides/pharmacokinetics*;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Combinations;Drug Therapy, Combination;Female;Food-Drug Interactions;Humans;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics*;Male;Metformin/administration & dosage;Metformin/adverse effects;Metformin/pharmacokinetics*;Tablets;Therapeutic Equivalency;Young Adult
21819239;Administration, Oral;Anticoagulants/pharmacology*;Antithrombins/adverse effects;Antithrombins/therapeutic use*;Factor Xa Inhibitors;Food-Drug Interactions;Hemostatics/metabolism;Heparin, Low-Molecular-Weight/adverse effects;Heparin, Low-Molecular-Weight/therapeutic use*;Humans;Pharmacogenetics;Prothrombin/antagonists & inhibitors;Thrombin/therapeutic use;Thrombosis/drug therapy;Vitamin K/antagonists & inhibitors;Warfarin/adverse effects;Warfarin/therapeutic use*
21831129;Acute Coronary Syndrome/drug therapy*;Acute Coronary Syndrome/physiopathology;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/pharmacology*;Dose-Response Relationship, Drug;Drug Interactions;Drug Monitoring/methods;Food-Drug Interactions;Hemorrhage/chemically induced;Humans;Thrombosis/prevention & control*;Vitamin K/antagonists & inhibitors
21852006;Adolescent;Adult;Beverages/adverse effects;Caffeine/adverse effects;Caffeine/blood*;Coffee*/adverse effects;Female;Food-Drug Interactions*;Humans;International Normalized Ratio;Male;Warfarin/blood*
21856591;Adult;Carica/adverse effects*;Food-Drug Interactions;Goiter, Nodular/surgery;Humans;Hypothyroidism/complications*;Hypothyroidism/drug therapy*;Intestinal Absorption;Male;Thyroidectomy;Thyrotropin/blood;Thyroxine/blood;Thyroxine/pharmacokinetics;Thyroxine/therapeutic use*;Triiodothyronine/blood
21909143;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Food-Drug Interactions;Hematopoietic Stem Cell Transplantation*;Humans;Myocardial Infarction/blood;Myocardial Infarction/drug therapy*;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use*;Platelet Count;Thrombocytopenia/blood;Thrombocytopenia/drug therapy*;Thrombosis/blood;Thrombosis/drug therapy*;Transplantation, Homologous
21910510;Administration, Oral;Adult;Angiotensin I/blood;Angiotensin II/blood;Angiotensin II Type 1 Receptor Blockers/adverse effects*;Angiotensin II Type 1 Receptor Blockers/blood;Angiotensin II Type 1 Receptor Blockers/pharmacokinetics*;Angiotensin II Type 1 Receptor Blockers/urine;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/pharmacokinetics;Antihypertensive Agents/pharmacology;Biphenyl Compounds/adverse effects*;Biphenyl Compounds/blood;Biphenyl Compounds/pharmacokinetics*;Biphenyl Compounds/urine;Blood Pressure/drug effects;Dizziness/chemically induced;Dose-Response Relationship, Drug;Double-Blind Method;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Metabolic Clearance Rate;Middle Aged;Pyrimidines/adverse effects*;Pyrimidines/blood;Pyrimidines/pharmacokinetics*;Pyrimidines/urine;Renin/blood;Tetrazoles/adverse effects*;Tetrazoles/blood;Tetrazoles/pharmacokinetics*;Tetrazoles/urine;Young Adult
9527781;Adult;Analysis of Variance;Dietary Fats/adverse effects*;Double-Blind Method;Food-Drug Interactions*;HIV Protease Inhibitors/administration & dosage*;HIV Protease Inhibitors/blood;HIV Protease Inhibitors/pharmacokinetics*;Humans;Indinavir/administration & dosage*;Indinavir/blood;Indinavir/pharmacokinetics*;Male;Metabolic Clearance Rate
21936891;Animals;Atherosclerosis/prevention & control;Cholesterol/blood;Cholesterol/metabolism;Cholesterol, Dietary/adverse effects;Cholesterol, HDL/blood*;Cholic Acid/adverse effects;Combined Modality Therapy;Dietary Supplements*;Fluorobenzenes/antagonists & inhibitors*;Fluorobenzenes/therapeutic use;Food-Drug Interactions*;Globulins/isolation & purification;Globulins/therapeutic use*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/chemistry*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Hypercholesterolemia/blood;Hypercholesterolemia/diet therapy*;Hypercholesterolemia/drug therapy;Hypercholesterolemia/metabolism;Lipoproteins/metabolism;Liver/metabolism;Male;Pyrimidines/antagonists & inhibitors*;Pyrimidines/therapeutic use;Rats;Rats, Wistar;Risk Factors;Rosuvastatin Calcium;Soybean Proteins/isolation & purification;Soybean Proteins/therapeutic use*;Sulfonamides/antagonists & inhibitors*;Sulfonamides/therapeutic use;Triglycerides/metabolism
22016977;Contraindications;Documentation*;Drug Administration Schedule;Drug Compounding/standards*;Drug Dosage Calculations;Drug Prescriptions/standards;Drugs, Chinese Herbal/adverse effects;Drugs, Chinese Herbal/pharmacology;Drugs, Chinese Herbal/standards*;Female;Food-Drug Interactions;Humans;Pregnancy;Terminology as Topic
22020317;Administration, Oral;Adult;Aged;Aged, 80 and over;Antimetabolites, Antineoplastic/administration & dosage;Antimetabolites, Antineoplastic/adverse effects;Antimetabolites, Antineoplastic/pharmacokinetics*;Antimetabolites, Antineoplastic/therapeutic use;Biological Availability;Cross-Over Studies;Drug Administration Schedule;Drug Combinations;Fasting;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Neoplasms/drug therapy*;Oxonic Acid/administration & dosage;Oxonic Acid/adverse effects;Oxonic Acid/pharmacokinetics*;Oxonic Acid/therapeutic use;Proton Pump Inhibitors/administration & dosage;Proton Pump Inhibitors/pharmacology*;Proton Pump Inhibitors/therapeutic use;Tegafur/administration & dosage;Tegafur/adverse effects;Tegafur/pharmacokinetics*;Tegafur/therapeutic use;Treatment Outcome
22031686;Adult;Aged;Calcium Channel Blockers/adverse effects;Citrus paradisi/adverse effects*;Cross-Sectional Studies;Drug-Related Side Effects and Adverse Reactions*;Emergency Medical Services;Female;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects;Male;Middle Aged;Pharmacovigilance;Risk
22057852;Administration, Oral;Adult;Aged;Aged, 80 and over;Area Under Curve;Biological Availability;Cross-Over Studies;Diet, High-Fat;Drug Administration Schedule;Eating;Fasting;Fatigue/chemically induced;Female;Food*;Food-Drug Interactions;Histone Deacetylase Inhibitors/administration & dosage;Histone Deacetylase Inhibitors/adverse effects;Histone Deacetylase Inhibitors/pharmacokinetics*;Humans;Hydroxamic Acids/administration & dosage;Hydroxamic Acids/adverse effects;Hydroxamic Acids/pharmacokinetics*;Indoles;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Neoplasms/drug therapy;Neoplasms/metabolism*;Neoplasms/pathology;Treatment Outcome;Vomiting/chemically induced
22058101;4-Aminopyridine/administration & dosage;4-Aminopyridine/adverse effects;4-Aminopyridine/pharmacokinetics*;Adolescent;Adult;Analysis of Variance;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Fasting/physiology;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Multiple Sclerosis/drug therapy*;Potassium Channel Blockers/administration & dosage;Potassium Channel Blockers/adverse effects;Potassium Channel Blockers/pharmacokinetics;Prospective Studies;Sex Factors;Walking/physiology;Young Adult
22122815;Adolescent;Adult;Antidepressive Agents, Second-Generation/administration & dosage*;Antidepressive Agents, Second-Generation/adverse effects;Antidepressive Agents, Second-Generation/pharmacokinetics;Area Under Curve;Biological Availability;Delayed-Action Preparations;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Piperazines/blood;Trazodone/administration & dosage*;Trazodone/adverse effects;Trazodone/pharmacokinetics
22124880;Adult;Amides/adverse effects;Amides/blood;Amides/metabolism;Amides/pharmacokinetics*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/blood;Antihypertensive Agents/metabolism;Antihypertensive Agents/pharmacokinetics*;Beverages/adverse effects*;Beverages/analysis;Biological Transport/drug effects;Citrus paradisi/chemistry*;Cross-Over Studies;Flavanones/analysis;Flavanones/pharmacology;Food-Drug Interactions*;Fruit/chemistry;Fumarates/adverse effects;Fumarates/blood;Fumarates/metabolism;Fumarates/pharmacokinetics*;HEK293 Cells;Half-Life;Humans;Intestinal Mucosa/enzymology*;Male;Organic Anion Transporters/antagonists & inhibitors*;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism;Recombinant Proteins/antagonists & inhibitors;Recombinant Proteins/metabolism;Renin/antagonists & inhibitors;Terfenadine/analogs & derivatives;Terfenadine/metabolism;Young Adult
22129380;Animals;Antioxidants/administration & dosage;Antioxidants/analysis;Beverages/adverse effects;Beverages/analysis;Dietary Supplements*/adverse effects;Dietary Supplements*/analysis;Flavonoids/administration & dosage;Flavonoids/analysis;Food-Drug Interactions;Fruit*/chemistry;Functional Food*/adverse effects;Functional Food*/analysis;Humans;Phenols/administration & dosage;Phenols/analysis;Punicaceae*/chemistry
22129569;Administration, Oral;Adult;Area Under Curve;Asian Continental Ancestry Group*;Cardiovascular Agents/administration & dosage*;Cardiovascular Agents/adverse effects;Cardiovascular Agents/blood;Cardiovascular Agents/pharmacokinetics*;Chemistry, Pharmaceutical;Cross-Over Studies;Delayed-Action Preparations;Female;Food-Drug Interactions;Humans;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Republic of Korea;Tetrazoles/administration & dosage*;Tetrazoles/adverse effects;Tetrazoles/blood;Tetrazoles/pharmacokinetics*;Therapeutic Equivalency;Young Adult
22133697;Antipsychotic Agents/administration & dosage*;Antipsychotic Agents/adverse effects;Antipsychotic Agents/pharmacokinetics*;Dopamine Antagonists/administration & dosage*;Dopamine Antagonists/adverse effects;Dopamine Antagonists/pharmacokinetics*;Dopamine D2 Receptor Antagonists;Dose-Response Relationship, Drug;Evidence-Based Medicine;Food-Drug Interactions;Humans;Patient Selection;Piperazines/administration & dosage*;Piperazines/adverse effects;Piperazines/pharmacokinetics*;Psychotic Disorders/diagnosis;Psychotic Disorders/drug therapy*;Psychotic Disorders/metabolism;Psychotic Disorders/psychology;Receptors, Dopamine D2/metabolism;Risk Assessment;Thiazoles/administration & dosage*;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Treatment Outcome
22137030;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/blood;Anti-Inflammatory Agents, Non-Steroidal/therapeutic use;Antioxidants/administration & dosage;Antioxidants/analysis;Antioxidants/therapeutic use*;Dietary Supplements*;Fatty Acids, Omega-3/therapeutic use;Fish Oils/therapeutic use*;Food-Drug Interactions*;Gene Expression Regulation/drug effects;Haptoglobins/genetics;Haptoglobins/metabolism;Hepatic Insufficiency/etiology;Hepatic Insufficiency/prevention & control;Injections, Intraperitoneal;Liver/drug effects*;Liver/metabolism;Liver/pathology;Liver/physiopathology;Male;NF-kappa B/genetics;NF-kappa B/metabolism;Oxidative Stress/drug effects;RNA, Messenger/metabolism;Rats;Rats, Sprague-Dawley;Reperfusion Injury/metabolism;Reperfusion Injury/pathology;Reperfusion Injury/physiopathology;Reperfusion Injury/prevention & control*;Triiodothyronine/administration & dosage;Triiodothyronine/blood;Triiodothyronine/therapeutic use*;Tumor Necrosis Factor-alpha/genetics;Tumor Necrosis Factor-alpha/metabolism
22139686;ATP-Binding Cassette, Sub-Family B, Member 1/antagonists & inhibitors;ATP-Binding Cassette, Sub-Family B, Member 1/genetics;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism*;Animals;Biological Transport/drug effects;Drug Interactions*;Food-Drug Interactions;Gene Expression Regulation/drug effects;Herb-Drug Interactions;Humans;Intestines/drug effects*;Intestines/metabolism;Kidney/drug effects*;Kidney/metabolism;Liver/drug effects*;Liver/metabolism;Organic Anion Transporters/antagonists & inhibitors;Organic Anion Transporters/genetics;Organic Anion Transporters/metabolism*;Pharmacokinetics*;Plant Preparations/adverse effects;Plant Preparations/pharmacology
22149151;Adult;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Cross-Over Studies;Delayed-Action Preparations;Diclofenac/administration & dosage;Diclofenac/adverse effects;Diclofenac/analogs & derivatives*;Diclofenac/pharmacokinetics;Dietary Fats;Drug Administration Schedule;Food-Drug Interactions*;Humans;Male;Republic of Korea;Therapeutic Equivalency;Young Adult
22206795;Administration, Oral;Adult;Aged;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects;Antineoplastic Agents/blood;Antineoplastic Agents/pharmacokinetics*;Antineoplastic Agents/urine;Area Under Curve;Biotransformation;Cross-Over Studies;Double-Blind Method;Feces/chemistry;Female;Food-Drug Interactions;Half-Life;Humans;Male;Metabolic Clearance Rate;Metabolomics;Middle Aged;Models, Biological;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/blood;Piperidines/pharmacokinetics*;Piperidines/urine;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics*;Protein Kinase Inhibitors/urine;Quinazolines/administration & dosage;Quinazolines/adverse effects;Quinazolines/blood;Quinazolines/pharmacokinetics*;Quinazolines/urine;United Kingdom;Young Adult
22216470;Anticholesteremic Agents/administration & dosage;Anticholesteremic Agents/adverse effects*;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Food-Drug Interactions;Humans;Patient Education as Topic;Rhabdomyolysis/chemically induced;Rhabdomyolysis/prevention & control*;Simvastatin/administration & dosage;Simvastatin/adverse effects*
22217686;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects*;Breast Neoplasms/drug therapy*;Drug Administration Schedule;Drug Interactions;Drug-Related Side Effects and Adverse Reactions/diagnosis*;Female;Food-Drug Interactions;Humans;Hungary;Medication Adherence*;Molecular Targeted Therapy*
22231999;Aged;Aged, 80 and over;Anticoagulants/therapeutic use*;Atrial Fibrillation/drug therapy;Female;Food-Drug Interactions*;Humans;International Normalized Ratio;Vaccinium macrocarpon/adverse effects*;Warfarin/metabolism;Warfarin/therapeutic use*
22265646;Acenocoumarol/adverse effects*;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans
9545149;2-Hydroxypropyl-beta-cyclodextrin;Administration, Oral;Adolescent;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/antagonists & inhibitors;Antifungal Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Cyclodextrins/blood;Cyclodextrins/urine;Dose-Response Relationship, Drug;Drug Evaluation;Eating;Fasting;Food/adverse effects*;Food-Drug Interactions/physiology*;Humans;Itraconazole/administration & dosage;Itraconazole/analogs & derivatives;Itraconazole/blood;Itraconazole/pharmacokinetics*;Male;Middle Aged;Pharmaceutical Solutions;beta-Cyclodextrins*
22294059;Area Under Curve;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/blood;Calcium Channel Blockers/chemistry;Calcium Channel Blockers/pharmacokinetics*;Chromatography, High Pressure Liquid;Cross-Over Studies;Data Interpretation, Statistical;Dietary Carbohydrates/administration & dosage;Dietary Carbohydrates/adverse effects;Dietary Fats/administration & dosage;Dietary Fats/adverse effects;Dihydropyridines/administration & dosage*;Dihydropyridines/blood;Dihydropyridines/chemistry;Dihydropyridines/pharmacokinetics*;Drug Administration Schedule;Drug Labeling*;Eating;Fasting;Female;Food-Drug Interactions*;Humans;Male;Pilot Projects;Stereoisomerism;Therapeutic Equivalency;Time Factors
22309265;Administration, Oral;Adult;Antihypertensive Agents/administration & dosage;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group;Blood Pressure/drug effects;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;KATP Channels/metabolism*;Male;Propylamines/administration & dosage;Propylamines/adverse effects;Propylamines/pharmacokinetics*;Sex Factors;Young Adult
22324070;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/therapeutic use;Cardiovascular Diseases/drug therapy*;Cardiovascular Diseases/prevention & control;Dabigatran;Drug Approval*;Drug Interactions;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/prevention & control;Humans;Morpholines/administration & dosage;Morpholines/adverse effects;Morpholines/therapeutic use;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/therapeutic use;Pyridines/administration & dosage;Pyridines/adverse effects;Pyridines/therapeutic use;Pyridones/administration & dosage;Pyridones/adverse effects;Pyridones/therapeutic use;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/therapeutic use;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/therapeutic use*
22349808;Administration, Oral;Adult;Area Under Curve;Capsules;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Fasting;Female;Food-Drug Interactions*;Headache/chemically induced;Humans;Male;Metabolic Clearance Rate;Pyrimidines/administration & dosage;Pyrimidines/adverse effects;Pyrimidines/pharmacokinetics*;Young Adult
22365344;Acenocoumarol/adverse effects*;Alcoholic Beverages/adverse effects*;Anticoagulants/adverse effects*;Conjunctival Diseases/etiology*;Cooking*;Dipteryx/adverse effects*;Eye Hemorrhage/etiology*;Flavoring Agents/adverse effects*;Food-Drug Interactions*;Hemorrhage/chemically induced*;Humans
22390368;Administration, Oral;Aged;Asian Continental Ancestry Group;Delayed-Action Preparations;Dopamine Agonists/administration & dosage;Dopamine Agonists/adverse effects;Dopamine Agonists/blood;Dopamine Agonists/pharmacokinetics;Female;Follow-Up Studies;Food-Drug Interactions*;Humans;Indoles/administration & dosage*;Indoles/adverse effects;Indoles/blood;Indoles/pharmacokinetics*;Levodopa/administration & dosage;Male;Parkinson Disease/blood;Parkinson Disease/drug therapy*;Parkinson Disease/metabolism*;Tablets/administration & dosage;Tablets/adverse effects;Tablets/pharmacokinetics
22420652;Acetaminophen/adverse effects;Animals;Anti-Inflammatory Agents, Non-Steroidal/administration & dosage*;Anti-Inflammatory Agents, Non-Steroidal/adverse effects;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics;Biological Availability;Fasting;Food-Drug Interactions*;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/prevention & control*;Humans;Nonprescription Drugs/administration & dosage;Nonprescription Drugs/adverse effects;Nonprescription Drugs/pharmacokinetics
22456294;Adamantane/administration & dosage;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Adult;Analysis of Variance;Area Under Curve;Asian Continental Ancestry Group*;Biomarkers/blood;Blood Glucose/drug effects*;Cross-Over Studies;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Diabetes Mellitus, Type 2/ethnology;Dipeptidyl-Peptidase IV Inhibitors/administration & dosage*;Dipeptidyl-Peptidase IV Inhibitors/adverse effects;Dipeptidyl-Peptidase IV Inhibitors/pharmacokinetics*;Drug Administration Schedule;Drug Monitoring;Eating*;Feeding Behavior*;Female;Food-Drug Interactions*;Glucagon-Like Peptide 1/blood;Humans;Intestinal Absorption;Japan/epidemiology;Male;Middle Aged;Nitriles/administration & dosage*;Nitriles/adverse effects;Nitriles/pharmacokinetics*;Postprandial Period;Pyrrolidines/administration & dosage*;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*;Treatment Outcome
22456303;Administration, Oral;Adolescent;Adult;Analysis of Variance;Area Under Curve;Biological Availability;Capsules;Cross-Over Studies;Delayed-Action Preparations;Food-Drug Interactions*;GABA Agonists/administration & dosage*;GABA Agonists/adverse effects;GABA Agonists/blood;GABA Agonists/pharmacokinetics*;Humans;Linear Models;Male;Middle Aged;Phosphinic Acids/administration & dosage*;Phosphinic Acids/adverse effects;Phosphinic Acids/blood;Phosphinic Acids/pharmacokinetics*;Propylamines/administration & dosage*;Propylamines/adverse effects;Propylamines/blood;Propylamines/pharmacokinetics*;Young Adult
22465646;Abdominal Pain/etiology;Citrus paradisi*;Colectomy;Electrocardiography;Female;Food-Drug Interactions*;Humans;Intestines/surgery;Ischemia/chemically induced*;Ischemia/surgery;Middle Aged;Multiple Organ Failure/complications;Piperidines/adverse effects*;Serotonin Agents/adverse effects*;Shock/drug therapy;Shock/etiology;Splanchnic Circulation/physiology*;Tryptamines/adverse effects*
9550749;Citrus/adverse effects*;Drug Synergism;Food-Drug Interactions*;Humans;Terfenadine/pharmacokinetics*;Terfenadine/therapeutic use
22473649;Administration, Oral;Antidotes/therapeutic use*;Blood Coagulation Factor Inhibitors/adverse effects*;Blood Coagulation Factor Inhibitors/therapeutic use;Blood Coagulation Factors/therapeutic use*;Charcoal/therapeutic use*;Drug Interactions;Drug Monitoring/methods;Factor Xa Inhibitors*;Hemorrhage/blood;Hemorrhage/chemically induced*;Hemorrhage/drug therapy*;Humans;Practice Guidelines as Topic;Thrombin/antagonists & inhibitors*
22480286;Anticoagulants*/administration & dosage;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Atrial Fibrillation/blood;Atrial Fibrillation/drug therapy*;Benzimidazoles*/administration & dosage;Benzimidazoles*/adverse effects;Benzimidazoles*/pharmacokinetics;Benzimidazoles*/therapeutic use;Clinical Trials as Topic;Dabigatran;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Molecular Structure;Stroke/blood;Stroke/prevention & control*;Thromboembolism/blood;Thromboembolism/prevention & control*;Treatment Outcome;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*;beta-Alanine/pharmacokinetics;beta-Alanine/therapeutic use
22495943;ATP-Binding Cassette, Sub-Family B, Member 1/metabolism;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics*;Anticoagulants/therapeutic use*;Arthroplasty, Replacement, Hip;Arthroplasty, Replacement, Knee;Atrial Fibrillation/blood;Atrial Fibrillation/complications;Atrial Fibrillation/drug therapy;Clinical Trials as Topic;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Factor Xa Inhibitors;Food-Drug Interactions;Formularies, Hospital*;Humans;Prothrombin/antagonists & inhibitors;Stroke/blood;Stroke/prevention & control;Thromboembolism/blood;Thromboembolism/etiology;Thromboembolism/prevention & control*
22499231;Animals;Beverages*/analysis;Cytochrome P-450 Enzyme Inhibitors*;Cytochrome P-450 Enzyme System/biosynthesis;Enzyme Induction;Enzyme Inhibitors/isolation & purification;Enzyme Inhibitors/pharmacology*;Flavonoids/isolation & purification;Flavonoids/pharmacology*;Food-Drug Interactions;Fruit*/chemistry;Fruit*/growth & development;Liver/drug effects*;Liver/enzymology;Male;Mice;Mice, Inbred ICR;Microsomes, Liver/drug effects;Microsomes, Liver/enzymology;Thailand;Up-Regulation
22514335;Animals;Benzo(a)pyrene/adverse effects;Charcoal/metabolism*;Clinical Trials as Topic;Coffee*;Food-Drug Interactions*;Humans;Inactivation, Metabolic;Male;Meat/adverse effects;Methylcholanthrene/adverse effects;Mice;Pharmaceutical Preparations/metabolism*;Pharmacokinetics;Polycyclic Aromatic Hydrocarbons/adverse effects;Rats;Smoking/adverse effects;Smoking/metabolism*
22528540;Antioxidants/administration & dosage;Antioxidants/adverse effects*;Ascorbic Acid/administration & dosage;Ascorbic Acid/adverse effects*;Dietary Supplements/adverse effects*;Dose-Response Relationship, Drug;Food-Drug Interactions;Humans;Hypervitaminosis A/chemically induced*;Vitamin A/administration & dosage;Vitamin A/adverse effects*;Vitamin E/administration & dosage;Vitamin E/adverse effects*;beta Carotene/administration & dosage;beta Carotene/adverse effects*
22530414;Anticoagulants/adverse effects*;Beverages/adverse effects*;Food-Drug Interactions*;Fruit/adverse effects*;Humans;International Normalized Ratio;Punicaceae/adverse effects*;Warfarin/adverse effects*
22615291;Adolescent;Adult;Antifungal Agents/administration & dosage*;Antifungal Agents/adverse effects;Antifungal Agents/blood;Antifungal Agents/pharmacokinetics*;Capsules;Chemistry, Pharmaceutical;Cross-Over Studies;Eating;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Suspensions;Tablets;Triazoles/administration & dosage*;Triazoles/adverse effects;Triazoles/blood;Triazoles/pharmacokinetics*;Young Adult
22644797;Adult;Aged;Cross-Over Studies;Diarrhea/chemically induced;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Energy Intake*;Fasting;Fatigue/chemically induced;Female;Food-Drug Interactions*;Humans;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Indazoles/adverse effects;Indazoles/pharmacokinetics*;Male;Middle Aged;Nausea/chemically induced;Tablets;Young Adult
22648492;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacology;Anticoagulants/therapeutic use*;Drug Administration Schedule;Drug Design*;Drug Interactions;Drug Monitoring/methods;Food-Drug Interactions;Heparin, Low-Molecular-Weight/adverse effects;Heparin, Low-Molecular-Weight/therapeutic use;Humans;Time Factors;Venous Thromboembolism/drug therapy*;Venous Thromboembolism/pathology;Vitamin K/antagonists & inhibitors
9555148;Anti-Allergic Agents/adverse effects*;Anti-Allergic Agents/pharmacology;Citrus/adverse effects*;Food-Drug Interactions*;Humans;Terfenadine/adverse effects*;Terfenadine/pharmacology
22650326;Administration, Oral;Adult;Analysis of Variance;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Area Under Curve;Asian Continental Ancestry Group*;China;Cross-Over Studies;Double-Blind Method;Drug Administration Schedule;Fasting/blood;Fasting/metabolism;Female;Food-Drug Interactions;Half-Life;Humans;Least-Squares Analysis;Linear Models;Male;Metabolic Clearance Rate;Models, Biological;Postprandial Period;Quinolones/administration & dosage*;Quinolones/adverse effects;Quinolones/blood;Quinolones/pharmacokinetics*;Young Adult
22669570;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Dietary Fats/pharmacology*;Fasting;Food-Drug Interactions*;Humans;Male;Metabolic Clearance Rate;Sirolimus/adverse effects;Sirolimus/analogs & derivatives*;Sirolimus/pharmacokinetics;Stomatitis/chemically induced;Time Factors;Tonsillitis/chemically induced;Young Adult
22697192;Administration, Cutaneous;Adult;Adverse Drug Reaction Reporting Systems/statistics & numerical data;Aged;Depressive Disorder/drug therapy*;Drug Eruptions/etiology;Drug Interactions;Drug-Related Side Effects and Adverse Reactions;Female;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Hypertension/prevention & control*;Male;Middle Aged;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Selegiline/administration & dosage*;Selegiline/adverse effects;Self-Injurious Behavior/chemically induced;Tyramine/adverse effects*;United States
22717215;Biological Availability;Dietary Supplements/adverse effects;Dietetics*;Energy Metabolism/drug effects;Food-Drug Interactions*;Humans;Intestinal Absorption/drug effects*;Nutritional Status;Pharmacokinetics;Risk Factors
22717418;Adolescent;Adult;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/adverse effects;Analgesics, Opioid/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Dose-Response Relationship, Drug;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Naltrexone/pharmacology;Narcotic Antagonists/pharmacology;Oxycodone/administration & dosage;Oxycodone/adverse effects;Oxycodone/pharmacokinetics*;Tablets;Therapeutic Equivalency;Young Adult
22735461;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Diet, High-Fat;Energy Intake;Factor Xa Inhibitors*;Fasting;Food-Drug Interactions*;Humans;Male;Partial Thromboplastin Time/statistics & numerical data;Prothrombin Time/statistics & numerical data;Pyridones/adverse effects;Pyridones/pharmacokinetics*;Pyridones/pharmacology*;Pyrrolidines/adverse effects;Pyrrolidines/pharmacokinetics*;Pyrrolidines/pharmacology*
22759078;Adamantane/adverse effects;Adamantane/analogs & derivatives*;Adamantane/pharmacokinetics;Administration, Oral;Adolescent;Adult;Antimalarials/adverse effects*;Antimalarials/pharmacokinetics*;Area Under Curve;Chromatography, Liquid;Dose-Response Relationship, Drug;Double-Blind Method;Fasting;Female;Food-Drug Interactions;Half-Life;Humans;Male;Mass Spectrometry;Middle Aged;Peroxides/adverse effects*;Peroxides/pharmacokinetics*;Young Adult
22769968;Adsorption;Cyclic GMP/physiology;Drug Interactions;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Gastrointestinal Diseases/physiopathology;Gastrointestinal Tract/drug effects;Gastrointestinal Tract/physiopathology;Hearing/drug effects;Heart/drug effects;Heart/physiopathology;Heart Diseases/chemically induced;Heart Diseases/physiopathology;Humans;Nervous System Diseases/chemically induced;Nervous System Diseases/physiopathology;Nitric Oxide/physiology;Phosphodiesterase 5 Inhibitors/adverse effects*;Phosphodiesterase 5 Inhibitors/pharmacokinetics*;Reproduction/drug effects;Tissue Distribution
22773284;Antibody Formation/drug effects;Antibody Formation/immunology;Breast Feeding*;Child Development/physiology*;Communicable Diseases/immunology*;Drug Contamination;Environmental Pollutants/adverse effects;Food-Drug Interactions/immunology;Health Promotion;Humans;Immunity, Cellular/drug effects;Immunity, Cellular/immunology;Infant, Newborn;Infection Control/methods*;Milk, Human/immunology*;Nervous System/growth & development;Vaccination/methods;Vaccines*/classification;Vaccines*/immunology;Vaccines*/pharmacology
9555149;Anti-Allergic Agents/adverse effects*;Citrus/adverse effects*;Food-Drug Interactions*;Terfenadine/adverse effects*
22788578;Animals;Anticarcinogenic Agents/adverse effects;Cardiotonic Agents/adverse effects*;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/metabolism;Dietary Supplements/adverse effects*;Enzyme Inhibitors/adverse effects;Food-Drug Interactions*;Humans;Immunologic Factors/adverse effects;Stilbenes/adverse effects*;Vasodilator Agents/adverse effects;Wine/adverse effects;Wine/analysis
22818558;Administration, Oral;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Benzimidazoles*/administration & dosage;Benzimidazoles*/adverse effects;Dabigatran;Drug Contamination;Drug Monitoring/methods*;Food-Drug Interactions;Hemorrhage/chemically induced;Hemorrhage/prevention & control;Heparin/administration & dosage;Heparin/adverse effects*;Humans;Hypersensitivity/etiology;Hypersensitivity/prevention & control;Injections, Subcutaneous/adverse effects;Necrosis/etiology;Necrosis/prevention & control;Osteoporosis/chemically induced;Osteoporosis/prevention & control;Skin Diseases/chemically induced;Skin Diseases/prevention & control;Subcutaneous Tissue/drug effects;Thrombocytopenia/chemically induced;Thrombocytopenia/prevention & control;Warfarin*/administration & dosage;Warfarin*/adverse effects;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives*
22834058;Anticoagulants/administration & dosage*;Anticoagulants/adverse effects;Atrial Fibrillation/drug therapy*;Diet;Dose-Response Relationship, Drug;Food-Drug Interactions*;Health Behavior;Health Education;Humans;Risk Factors;Vegetables*;Vitamin K/administration & dosage*;Vitamin K/adverse effects;Warfarin/administration & dosage*;Warfarin/adverse effects
22856466;Animals;Biomarkers/metabolism;Cell Proliferation/drug effects;Cell Shape/drug effects;Dietary Supplements/adverse effects;Epithelial Cells/drug effects;Epithelial Cells/metabolism;Epithelial Cells/pathology;Estrogen Replacement Therapy/methods*;Female;Flax/adverse effects;Flax/chemistry*;Food-Drug Interactions*;Hyperplasia;Menopause*/metabolism;Ovariectomy/adverse effects;Phytoestrogens/adverse effects;Phytoestrogens/therapeutic use*;Powders;Proliferating Cell Nuclear Antigen/metabolism;Random Allocation;Rats;Rats, Sprague-Dawley;Seeds/adverse effects;Seeds/chemistry*;Uterus/drug effects*;Uterus/metabolism;Uterus/pathology
22866966;Cardiovascular Diseases/etiology;Cardiovascular Diseases/prevention & control;Drug Interactions;Food-Drug Interactions*;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacokinetics;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Medication Adherence;Pharmacogenetics*
22875751;Consumer Product Safety;Dietary Supplements*/adverse effects;Food-Drug Interactions*;Health Promotion*;Herb-Drug Interactions*;Humans;Patient Education as Topic;Professional-Patient Relations;Quality of Health Care;United States
22931521;Anticoagulants*/adverse effects;Anticoagulants*/pharmacokinetics;Anticoagulants*/therapeutic use;Clinical Trials as Topic;Drug Discovery;Drug Interactions;Food-Drug Interactions;Glomerular Filtration Rate;Humans;Inactivation, Metabolic;Kidney Diseases/complications*;Kidney Diseases/metabolism;Thromboembolism/blood;Thromboembolism/complications;Thromboembolism/drug therapy*;Treatment Outcome
22932947;Adult;Antithyroid Agents/administration & dosage;Antithyroid Agents/blood;Antithyroid Agents/pharmacokinetics;Antithyroid Agents/therapeutic use;Capsules;Chemistry, Pharmaceutical;Coffee/adverse effects*;Cross-Over Studies;Drug Carriers/administration & dosage;Drug Carriers/pharmacokinetics*;Drug Carriers/therapeutic use;Female;Food-Drug Interactions*;Gels;Goiter, Nodular/drug therapy;Hormone Replacement Therapy;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy;Hypothyroidism/metabolism;Intestinal Absorption*;Male;Middle Aged;Neoplasm Recurrence, Local/drug therapy;Thyroid Gland/drug effects;Thyroid Gland/secretion;Thyroid Nodule/drug therapy;Thyrotropin/blood;Thyrotropin/secretion;Thyroxine/administration & dosage;Thyroxine/blood;Thyroxine/pharmacokinetics*;Thyroxine/therapeutic use
9578193;Aged;Antiparkinson Agents/adverse effects;Antiparkinson Agents/pharmacokinetics*;Antiparkinson Agents/therapeutic use;Area Under Curve;Female;Food-Drug Interactions*;Half-Life;Humans;Indoles/adverse effects;Indoles/pharmacokinetics*;Indoles/therapeutic use;Male;Middle Aged;Parkinson Disease/drug therapy;Parkinson Disease/metabolism*
22937625;Adult;Beverages/adverse effects*;Child;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans
22940371;Adolescent;Adult;Beverages;Citrus/chemistry*;Citrus paradisi/chemistry*;Colchicine/adverse effects;Colchicine/pharmacokinetics*;Drug Labeling;Female;Food-Drug Interactions*;Gout Suppressants/adverse effects;Gout Suppressants/pharmacokinetics;Humans;Male;Middle Aged;Time Factors;Young Adult
22943121;Animals;Depression/drug therapy*;Depression/physiopathology;Drug Design*;Drug Interactions;Food-Drug Interactions;Heart Failure/drug therapy;Heart Failure/physiopathology;Humans;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use*;Neurodegenerative Diseases/drug therapy;Neurodegenerative Diseases/physiopathology;Parkinson Disease/drug therapy;Parkinson Disease/physiopathology
22943633;Adult;Anthocyanins/analysis;Aryl Hydrocarbon Hydroxylases/antagonists & inhibitors;Beverages/adverse effects*;Beverages/analysis;Blueberry Plants/adverse effects*;Blueberry Plants/chemistry;Buspirone/pharmacokinetics*;Citrus paradisi/adverse effects;Citrus paradisi/chemistry;Cytochrome P-450 CYP2C9;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors;Drug Interactions;Female;Fluconazole/pharmacology;Flurbiprofen/pharmacokinetics*;Food-Drug Interactions*;Furocoumarins/analysis;Humans;Male;Microsomes, Liver/drug effects;Microsomes, Liver/metabolism;Middle Aged;Phenols/analysis
22950522;Administration, Oral;Adolescent;Adult;Cross-Over Studies;Dose-Response Relationship, Drug;Double-Blind Method;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;Humans;Intracellular Signaling Peptides and Proteins/antagonists & inhibitors*;Male;Methotrexate/administration & dosage;Middle Aged;Protein Kinase Inhibitors/administration & dosage*;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/pharmacokinetics*;Protein-Serine-Threonine Kinases/antagonists & inhibitors*;Young Adult
22951237;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects;Cross-Cultural Comparison;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Major/diagnosis;Depressive Disorder, Major/drug therapy;Depressive Disorder, Major/psychology;Dose-Response Relationship, Drug;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;General Practice;Humans;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Practice Guidelines as Topic;Referral and Consultation;Risk Factors;Secondary Prevention;Treatment Outcome
22951238;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage;Antidepressive Agents/adverse effects*;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Treatment-Resistant/diagnosis;Depressive Disorder, Treatment-Resistant/drug therapy;Depressive Disorder, Treatment-Resistant/psychology;Drug Interactions;Food-Drug Interactions*;Humans;Hypertension, Malignant/chemically induced;Monoamine Oxidase Inhibitors/administration & dosage;Monoamine Oxidase Inhibitors/adverse effects*;Serotonin Agents/administration & dosage;Serotonin Agents/adverse effects;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology;Sympathomimetics/administration & dosage;Sympathomimetics/adverse effects;Tyramine/administration & dosage;Tyramine/adverse effects
22951239;Administration, Cutaneous;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Drug Interactions;Food-Drug Interactions*;Humans;Hypertension, Malignant/chemically induced;Hypertension, Malignant/diagnosis;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects;Risk Factors;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology;Tyramine/administration & dosage;Tyramine/adverse effects
22951241;Administration, Cutaneous;Administration, Oral;Antidepressive Agents/administration & dosage*;Antidepressive Agents/adverse effects*;Anxiety Disorders/diagnosis;Anxiety Disorders/drug therapy;Anxiety Disorders/psychology;Bipolar Disorder/diagnosis;Bipolar Disorder/drug therapy;Bipolar Disorder/psychology;Comorbidity;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Depressive Disorder, Treatment-Resistant/diagnosis;Depressive Disorder, Treatment-Resistant/drug therapy;Depressive Disorder, Treatment-Resistant/psychology;Diagnosis, Differential;Drug Interactions;Food-Drug Interactions;Humans;Hypertension, Malignant/chemically induced;Hypertension, Malignant/diagnosis;Medication Adherence;Monoamine Oxidase Inhibitors/administration & dosage*;Monoamine Oxidase Inhibitors/adverse effects*;Patient Education as Topic;Primary Health Care*;Serotonin Syndrome/diagnosis;Serotonin Syndrome/etiology
22951980;Acetates/pharmacokinetics*;Adult;Anti-Asthmatic Agents/pharmacokinetics*;Beverages/adverse effects*;Biological Availability*;Citrus paradisi*;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Prospective Studies;Quinolines/pharmacokinetics*;Young Adult
3640717;Aged;Biological Availability/drug effects;Dietetics;Drug Interactions*;Female;Food/adverse effects*;Humans;Intestinal Absorption/drug effects;Male
9604126;Administration, Oral;Adult;Analysis of Variance;Anticonvulsants/adverse effects;Anticonvulsants/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Male;Middle Aged;Triazoles/adverse effects;Triazoles/pharmacokinetics*
22956350;Administration, Oral;Asian Continental Ancestry Group;Febuxostat;Female;Food-Drug Interactions;Gout Suppressants/administration & dosage;Gout Suppressants/adverse effects;Gout Suppressants/pharmacokinetics*;Humans;Indicators and Reagents;Male;Sex Characteristics;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/pharmacokinetics*;Xanthine Oxidase/antagonists & inhibitors;Young Adult
22998389;Animals;Antioxidants/adverse effects;Antioxidants/metabolism*;Antioxidants/therapeutic use;Biotransformation;Dietary Supplements*/adverse effects;Enzyme Induction;Enzyme Inhibitors/adverse effects;Enzyme Inhibitors/metabolism;Enzyme Inhibitors/therapeutic use;Flavonoids/adverse effects;Flavonoids/metabolism*;Flavonoids/therapeutic use;Food-Drug Interactions;Glutathione Transferase/antagonists & inhibitors;Glutathione Transferase/biosynthesis*;Glutathione Transferase/chemistry;Glutathione Transferase/metabolism;Humans;Liver/drug effects;Liver/enzymology;Liver/metabolism;Xenobiotics/pharmacokinetics
23010558;Adult;Aged;Benzamides/administration & dosage;Benzamides/adverse effects;Benzamides/pharmacokinetics;Benzamides/therapeutic use*;Blood Glucose/analysis;Cross-Over Studies;Diabetes Mellitus, Type 2/blood;Diabetes Mellitus, Type 2/drug therapy*;Dose-Response Relationship, Drug;Drug Administration Schedule;Enzyme Activators/administration & dosage;Enzyme Activators/adverse effects;Enzyme Activators/pharmacokinetics;Enzyme Activators/therapeutic use*;Fasting;Female;Food-Drug Interactions*;Glucokinase/metabolism;Half-Life;Humans;Hyperglycemia/prevention & control*;Hypoglycemic Agents/administration & dosage;Hypoglycemic Agents/adverse effects;Hypoglycemic Agents/pharmacokinetics;Hypoglycemic Agents/therapeutic use*;Male;Metabolic Clearance Rate;Middle Aged;Postprandial Period;Single-Blind Method;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/pharmacokinetics;Sulfones/therapeutic use*
23027198;Adolescent;Adult;Aged;Antifungal Agents/administration & dosage;Antifungal Agents/therapeutic use*;Biological Availability;Chromatography, High Pressure Liquid;Drug Monitoring;Female;Food-Drug Interactions;Gastrointestinal Diseases/metabolism;Hematopoietic Stem Cell Transplantation;Humans;Immunosuppressive Agents/adverse effects;Leukemia, Myeloid, Acute/metabolism*;Male;Middle Aged;Multivariate Analysis;Myelodysplastic Syndromes/metabolism*;Prospective Studies;Spectrophotometry, Ultraviolet;Tacrolimus/adverse effects;Triazoles/administration & dosage;Triazoles/therapeutic use*;Young Adult
23097095;Coffee/adverse effects*;Drug Carriers/pharmacokinetics*;Female;Food-Drug Interactions*;Humans;Intestinal Absorption*;Male;Thyroxine/pharmacokinetics*
23102570;Antineoplastic Agents/therapeutic use*;Energy Drinks/adverse effects*;Food-Drug Interactions*;Humans;Neoplasms/drug therapy*
23104241;Administration, Oral;Adult;Anticonvulsants/adverse effects;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/adverse effects;Antipsychotic Agents/blood*;Antipsychotic Agents/pharmacokinetics;Antipsychotic Agents/therapeutic use*;Caffeine/adverse effects;Case-Control Studies;Central Nervous System Stimulants/adverse effects;Chi-Square Distribution;Chromatography, High Pressure Liquid;Clozapine/administration & dosage;Clozapine/adverse effects;Clozapine/blood*;Clozapine/pharmacokinetics;Clozapine/therapeutic use*;Cross-Sectional Studies;Drug Interactions;Drug Monitoring/methods;Drug Resistance*;Female;Food-Drug Interactions;Humans;Least-Squares Analysis;Logistic Models;Male;Middle Aged;Multivariate Analysis;Odds Ratio;Psychiatric Status Rating Scales;Risk Factors;Schizophrenia/blood;Schizophrenia/diagnosis;Schizophrenia/drug therapy*;Schizophrenic Psychology;Spectrophotometry, Ultraviolet;Treatment Failure;Valproic Acid/adverse effects
23117668;Administration, Oral;Anticoagulants/adverse effects;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics;Benzimidazoles/therapeutic use;Blood Coagulation/drug effects*;Blood Coagulation Tests;Dabigatran;Dose-Response Relationship, Drug;Drug Interactions;Drug Monitoring*;Food-Drug Interactions;Hemostasis/drug effects;Humans;Morpholines/adverse effects;Morpholines/pharmacokinetics;Morpholines/therapeutic use;Pyrazoles/adverse effects;Pyrazoles/pharmacokinetics;Pyrazoles/therapeutic use;Pyridones/adverse effects;Pyridones/pharmacokinetics;Pyridones/therapeutic use;Rivaroxaban;Switzerland;Thiophenes/adverse effects;Thiophenes/pharmacokinetics;Thiophenes/therapeutic use;Thromboembolism/blood;Thromboembolism/drug therapy*;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives;beta-Alanine/pharmacokinetics;beta-Alanine/therapeutic use
23165864;Aryl Hydrocarbon Hydroxylases/genetics;Cytochrome P-450 CYP2C19;Female;Food-Drug Interactions;Humans;Kidney Diseases/metabolism;Liver Diseases/metabolism;Male;Sex Characteristics;Thalidomide/adverse effects;Thalidomide/pharmacokinetics*
23184666;Adolescent;Adult;Analysis of Variance;Area Under Curve;Arrhythmias, Cardiac/chemically induced*;Arrhythmias, Cardiac/diagnosis;Arrhythmias, Cardiac/physiopathology;Biotransformation;Caffeine/administration & dosage;Caffeine/adverse effects*;Chi-Square Distribution;Cross-Over Studies;Cytochrome P-450 CYP1A2/metabolism;Drug Interactions;Electrocardiography;Fasting/metabolism;Female;Food-Drug Interactions*;Half-Life;Headache/chemically induced;Heart Rate/drug effects*;Hematologic Agents/administration & dosage;Hematologic Agents/adverse effects*;Hematologic Agents/blood;Hematologic Agents/pharmacokinetics*;Humans;Hydroxylation;Intestinal Absorption;London;Male;Metabolic Clearance Rate;Postprandial Period;Quinazolines/administration & dosage;Quinazolines/adverse effects*;Quinazolines/blood;Quinazolines/pharmacokinetics*;Young Adult
9611659;Adult;Antitubercular Agents/adverse effects*;Biogenic Amines/adverse effects*;Cheese/adverse effects*;Female;Food Hypersensitivity/diagnosis;Food Hypersensitivity/etiology;Food-Drug Interactions*;Humans;Isoniazid/adverse effects*
23184849;Acute Kidney Injury/chemically induced;Beverages/adverse effects*;Biological Availability;Breast Neoplasms/chemically induced;Citrus paradisi/adverse effects*;Citrus paradisi/metabolism;Cytochrome P-450 CYP3A;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Fruit/metabolism;Furocoumarins/metabolism;Humans;Metabolic Detoxication, Phase I*;Pharmaceutical Preparations/metabolism;Rhabdomyolysis/chemically induced;Risk Factors;Torsades de Pointes/chemically induced
23188923;Animals;Antineoplastic Agents/administration & dosage;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/pharmacokinetics;Dietary Supplements/adverse effects;Food-Drug Interactions*;Herb-Drug Interactions*;Humans;Neoplasms/drug therapy;Plant Preparations/adverse effects;Plant Preparations/pharmacology
23230999;Administration, Oral;Adult;Area Under Curve;Biological Availability;Cross-Over Studies;Doxylamine/administration & dosage;Doxylamine/adverse effects;Doxylamine/analogs & derivatives*;Doxylamine/pharmacokinetics;Fasting/metabolism;Female;Food-Drug Interactions*;Half-Life;Humans;Male;Middle Aged;Tablets/administration & dosage;Tablets/adverse effects;Tablets/pharmacokinetics*;Tablets, Enteric-Coated;Young Adult
23256289;Alcohol Drinking/adverse effects;Antipsychotic Agents/adverse effects;Antipsychotic Agents/therapeutic use;Aripiprazole;Combined Modality Therapy;Depressive Disorder/drug therapy;Dietary Supplements/adverse effects*;Food*;Food-Drug Interactions*;Humans;Male;Malnutrition/chemically induced*;Malnutrition/diagnosis;Malnutrition/prevention & control;Middle Aged;Piperazines/adverse effects;Piperazines/therapeutic use;Prescription Drugs/adverse effects*;Quinolones/adverse effects;Quinolones/therapeutic use
23297175;Beverages*;Biological Availability;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Food-Drug Interactions*;Furocoumarins/adverse effects;Furocoumarins/analysis;Humans;Organic Anion Transporters/metabolism;Pharmacokinetics*
23331476;Beverages/adverse effects;Blood Glucose/analysis;Caffeine/adverse effects*;Diabetes Mellitus, Type 1/blood;Diabetes Mellitus, Type 1/drug therapy;Diabetes Mellitus, Type 1/metabolism;Diabetes Mellitus, Type 2/blood*;Diabetes Mellitus, Type 2/metabolism;Diabetes, Gestational/blood;Diabetes, Gestational/metabolism;Evidence-Based Medicine*;Female;Food-Drug Interactions;Humans;Hyperglycemia/chemically induced*;Hyperinsulinism/chemically induced;Hypoglycemia/chemically induced;Hypoglycemic Agents/therapeutic use;Insulin/therapeutic use;Insulin Resistance*;Male;Pregnancy;Randomized Controlled Trials as Topic
23362039;Aging*;Alcohol Drinking/adverse effects;Alcohol Drinking/epidemiology*;Alcoholism/epidemiology;Australia/epidemiology;Binge Drinking/epidemiology;Disease Susceptibility;Europe/epidemiology;Food-Drug Interactions;Humans;Hypnotics and Sedatives/adverse effects;Hypnotics and Sedatives/therapeutic use*;North America/epidemiology;Patient Compliance;Prevalence;Substance-Related Disorders/epidemiology
23373097;Beverages;Citrus paradisi/chemistry*;Cytochrome P-450 CYP3A/metabolism;Cytochrome P-450 CYP3A Inhibitors;Drug-Related Side Effects and Adverse Reactions;Food-Drug Interactions*;Humans;Pharmaceutical Preparations/metabolism*
23399607;Citrus paradisi;Diabetes Mellitus, Type 2/drug therapy*;Diagnosis, Differential;Drug Interactions;Food-Drug Interactions;Humans;Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects*;Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use;Male;Middle Aged;Musculoskeletal Pain/chemically induced*;Myositis/chemically induced*;Quality of Life;Simvastatin/adverse effects*;Simvastatin/therapeutic use
23419230;Administration, Cutaneous;Administration, Oral;Caregivers/education;Cognitive Therapy;Combined Modality Therapy;Depressive Disorder/diagnosis;Depressive Disorder/drug therapy*;Depressive Disorder/psychology;Food-Drug Interactions;Humans;Medication Adherence*;Monoamine Oxidase Inhibitors/adverse effects;Monoamine Oxidase Inhibitors/therapeutic use*;Motivational Interviewing;Patient Education as Topic;Treatment Failure
9620100;Acetaminophen/adverse effects;Acetaminophen/pharmacokinetics;Acetaminophen/pharmacology*;Acetaminophen/therapeutic use;Adolescent;Adult;Aged;Aged, 80 and over;Analgesics/adverse effects;Analgesics/pharmacokinetics;Analgesics/pharmacology*;Analgesics/therapeutic use;Benzophenones/administration & dosage;Benzophenones/pharmacokinetics;Benzophenones/pharmacology*;Benzophenones/therapeutic use;Biological Availability;Bromobenzenes/administration & dosage;Bromobenzenes/pharmacokinetics;Bromobenzenes/pharmacology*;Bromobenzenes/therapeutic use;Double-Blind Method;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Naproxen/adverse effects;Naproxen/pharmacokinetics;Naproxen/pharmacology*;Naproxen/therapeutic use;Orthopedic Procedures*;Pain Measurement;Pain, Postoperative/drug therapy*;Time Factors
23458226;Administration, Oral;Adult;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/blood;Anticoagulants/chemistry;Anticoagulants/pharmacokinetics*;Area Under Curve;Biological Availability;Chemistry, Pharmaceutical;Cross-Over Studies;Dose-Response Relationship, Drug;Fasting/blood;Food-Drug Interactions*;Half-Life;Humans;Infusions, Intravenous;Intestinal Absorption*;Male;Metabolic Clearance Rate;Middle Aged;Models, Biological;Models, Statistical;Morpholines/administration & dosage;Morpholines/adverse effects;Morpholines/blood;Morpholines/chemistry;Morpholines/pharmacokinetics*;Postprandial Period;Rivaroxaban;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/blood;Thiophenes/chemistry;Thiophenes/pharmacokinetics*;Young Adult
23466967;Anticoagulants/administration & dosage;Anticoagulants/adverse effects;Anticoagulants/therapeutic use*;Antithrombins/administration & dosage;Antithrombins/adverse effects;Antithrombins/therapeutic use*;Atrial Fibrillation/complications*;Atrial Fibrillation/drug therapy;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/therapeutic use;Clinical Trials as Topic;Comorbidity;Dabigatran;Hemorrhage/chemically induced;Humans;Morpholines/administration & dosage;Morpholines/adverse effects;Morpholines/therapeutic use;Platelet Aggregation Inhibitors/administration & dosage;Platelet Aggregation Inhibitors/adverse effects;Platelet Aggregation Inhibitors/therapeutic use*;Pyrazoles/administration & dosage;Pyrazoles/adverse effects;Pyrazoles/therapeutic use;Pyridones/administration & dosage;Pyridones/adverse effects;Pyridones/therapeutic use;Risk Assessment/methods;Rivaroxaban;Stroke/drug therapy;Stroke/prevention & control*;Thiophenes/administration & dosage;Thiophenes/adverse effects;Thiophenes/therapeutic use;Warfarin/administration & dosage;Warfarin/adverse effects;Warfarin/therapeutic use;beta-Alanine/administration & dosage;beta-Alanine/adverse effects;beta-Alanine/analogs & derivatives;beta-Alanine/therapeutic use
23478684;Anti-Arrhythmia Agents/adverse effects;Anti-Arrhythmia Agents/pharmacokinetics*;Anti-Arrhythmia Agents/therapeutic use;Beverages;Biological Availability;Citrus paradisi;Diet;Dietary Fiber;Feeding Behavior;Food-Drug Interactions/physiology*;Humans;Plants, Medicinal
23495418;Cardiovascular Agents/adverse effects*;Citrus paradisi*;Food-Drug Interactions*;Humans
23497763;Acetanilides/administration & dosage;Acetanilides/adverse effects;Acetanilides/blood;Acetanilides/pharmacokinetics*;Administration, Oral;Adrenergic beta-Agonists/administration & dosage;Adrenergic beta-Agonists/adverse effects;Adrenergic beta-Agonists/blood;Adrenergic beta-Agonists/pharmacokinetics*;Adult;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Reference Values;Thiazoles/administration & dosage;Thiazoles/adverse effects;Thiazoles/blood;Thiazoles/pharmacokinetics*
23529727;Administration, Oral;Adult;Amidohydrolases/antagonists & inhibitors*;Anti-Bacterial Agents/administration & dosage*;Anti-Bacterial Agents/adverse effects;Anti-Bacterial Agents/blood;Anti-Bacterial Agents/pharmacokinetics*;Ascorbic Acid/administration & dosage*;Biological Availability;Cross-Over Studies;Drug Interactions;Female;Food-Drug Interactions*;Histamine H2 Antagonists/administration & dosage*;Humans;Male;Tablets;Treatment Outcome;Young Adult
23550054;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
23550055;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
9650536;Angiotensin-Converting Enzyme Inhibitors/adverse effects;Angiotensin-Converting Enzyme Inhibitors/pharmacokinetics;Angiotensin-Converting Enzyme Inhibitors/therapeutic use*;Calcium Channel Blockers/therapeutic use*;Diabetic Nephropathies/drug therapy;Diabetic Nephropathies/metabolism;Diuretics/therapeutic use*;Drug Therapy, Combination;Food-Drug Interactions;Heart Diseases/drug therapy*;Heart Diseases/metabolism;Humans;Hypertension/drug therapy*;Hypertension/metabolism;Myocardial Infarction/drug therapy;Myocardial Infarction/metabolism
23588433;Adrenergic alpha-Antagonists;Adrenergic beta-Antagonists;Antihypertensive Agents*/pharmacokinetics;Antihypertensive Agents*/pharmacology;Calcium Channel Blockers;Citrus paradisi;Diet;Diuretics;Food-Drug Interactions*;Humans
23636154;Adult;Aged;Aged, 80 and over;Cross-Sectional Studies;Drug Interactions*;Drug Monitoring;Female;Food-Drug Interactions;Humans;Internet;Male;Middle Aged;Nonprescription Drugs/administration & dosage;Nonprescription Drugs/adverse effects*;Patient Education as Topic/methods*;Prescription Drugs/administration & dosage;Prescription Drugs/adverse effects*;Sex Factors;Surveys and Questionnaires;United States
23757819;Aged;Citrus paradisi/adverse effects*;Food-Drug Interactions*;Humans;Middle Aged
23789936;Administration, Oral;Aged;Aged, 80 and over;Biological Availability;Capsules;Disease Progression;Dose-Response Relationship, Drug;Dyspnea/chemically induced;Female;Food-Drug Interactions;Gastrointestinal Diseases/chemically induced;Glycine/administration & dosage;Glycine/adverse effects;Glycine/analogs & derivatives*;Glycine/blood;Glycine/pharmacokinetics;Glycine/therapeutic use;Humans;Male;Middle Aged;Myelodysplastic Syndromes/blood;Myelodysplastic Syndromes/drug therapy*;Myelodysplastic Syndromes/enzymology;Protein Kinase Inhibitors/administration & dosage;Protein Kinase Inhibitors/adverse effects;Protein Kinase Inhibitors/blood;Protein Kinase Inhibitors/pharmacokinetics;Protein Kinase Inhibitors/therapeutic use*;Remission Induction;Sulfones/administration & dosage;Sulfones/adverse effects;Sulfones/blood;Sulfones/pharmacokinetics;Sulfones/therapeutic use*;Treatment Outcome;Urologic Diseases/chemically induced
23849436;Adult;Area Under Curve;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Phenoxyacetates/adverse effects;Phenoxyacetates/pharmacokinetics*;Tablets
24003187;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
24003188;Beverages/adverse effects*;Citrus paradisi/adverse effects*;Cytochrome P-450 CYP3A Inhibitors*;Drug-Related Side Effects and Adverse Reactions*;Female;Food-Drug Interactions/physiology*;Fruit/adverse effects*;Humans;Metabolic Detoxication, Phase I*
24021514;Administration, Oral;Dose-Response Relationship, Drug;Drug Administration Schedule;Drug Interactions;Food-Drug Interactions;Humans;Hypothyroidism/blood;Hypothyroidism/drug therapy*;Intestinal Absorption/physiology;Mental Disorders/blood;Mental Disorders/drug therapy*;Randomized Controlled Trials as Topic;Thyrotropin/blood;Thyroxine/administration & dosage*;Thyroxine/adverse effects;Thyroxine/pharmacokinetics*
24048240;Administration, Oral;Antineoplastic Agents/administration & dosage*;Antineoplastic Agents/adverse effects*;Antineoplastic Agents/therapeutic use;Food-Drug Interactions*;Humans
9663198;Anticoagulants/pharmacokinetics;Anticoagulants/therapeutic use*;Clinical Trials as Topic;Diet;Female;Food-Drug Interactions;Heart Valve Prosthesis/adverse effects*;Humans;Practice Guidelines as Topic;Pregnancy;Pregnancy Complications, Cardiovascular/prevention & control;Thromboembolism/etiology;Thromboembolism/prevention & control*;Vitamin K/administration & dosage;Warfarin/pharmacokinetics;Warfarin/therapeutic use
9663817;Adolescent;Adult;Anthelmintics/administration & dosage;Anthelmintics/adverse effects;Anthelmintics/pharmacokinetics*;Anthelmintics/therapeutic use;Benzimidazoles/administration & dosage;Benzimidazoles/adverse effects;Benzimidazoles/pharmacokinetics*;Benzimidazoles/therapeutic use;Biological Availability;Child;Cross-Over Studies;Fascioliasis/drug therapy;Fascioliasis/metabolism*;Female;Food-Drug Interactions*;Humans;Male;Middle Aged
9725481;Adult;Antihypertensive Agents/metabolism;Antihypertensive Agents/pharmacokinetics;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/metabolism;Calcium Channel Blockers/pharmacokinetics;Dihydropyridines/adverse effects;Dihydropyridines/metabolism;Dihydropyridines/pharmacokinetics*;Double-Blind Method;Food-Drug Interactions*;Humans;Male
9784932;Administration, Oral;Administration, Rectal;Analgesics, Opioid/administration & dosage;Analgesics, Opioid/pharmacokinetics*;Analgesics, Opioid/therapeutic use;Chemistry, Pharmaceutical;Child;Delayed-Action Preparations;Food-Drug Interactions;Humans;Morphine/administration & dosage;Morphine/pharmacokinetics*;Morphine/therapeutic use;Pain/drug therapy*
9786475;Adult;Anti-Infective Agents/administration & dosage*;Anti-Infective Agents/adverse effects;Anti-Infective Agents/metabolism;Anti-Infective Agents/pharmacokinetics*;Delayed-Action Preparations;Double-Blind Method;Fluoroquinolones*;Food-Drug Interactions;Humans;Male;Piperazines/administration & dosage*;Piperazines/adverse effects;Piperazines/metabolism;Piperazines/pharmacokinetics*;Quinolones/administration & dosage*;Quinolones/adverse effects;Quinolones/metabolism;Quinolones/pharmacokinetics*;Saliva/chemistry
9793622;Adolescent;Adult;Anti-Inflammatory Agents, Non-Steroidal/adverse effects*;Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics*;Area Under Curve;Biological Availability;Chromatography, High Pressure Liquid;Dietary Fats;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Naproxen/adverse effects*;Naproxen/pharmacokinetics*;Reproducibility of Results;Spectrometry, Fluorescence
6282186;Animals;Bacteria/metabolism;Biological Availability;Biotransformation;Dietary Fiber/adverse effects;Drug-Related Side Effects and Adverse Reactions*;Enzyme Induction;Food*;Humans;Intestines/microbiology;Pharmaceutical Preparations/metabolism
9796864;Antidepressive Agents/adverse effects*;Antidepressive Agents/pharmacokinetics;Antidepressive Agents/pharmacology;Beverages/adverse effects*;Citrus/adverse effects*;Cytochrome P-450 CYP1A2/drug effects;Cytochrome P-450 CYP1A2/metabolism;Cytochrome P-450 CYP1A2 Inhibitors;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme Inhibitors;Cytochrome P-450 Enzyme System/drug effects;Cytochrome P-450 Enzyme System/metabolism;Drug Interactions;Enzyme Induction/drug effects;Food-Drug Interactions*;Humans;Infant;Mixed Function Oxygenases/antagonists & inhibitors;Mixed Function Oxygenases/drug effects;Mixed Function Oxygenases/metabolism;Polymorphism, Genetic;Serotonin Uptake Inhibitors/adverse effects;Serotonin Uptake Inhibitors/pharmacokinetics;Serotonin Uptake Inhibitors/pharmacology
9808916;Antipsychotic Agents/adverse effects*;Child;Feeding and Eating Disorders/chemically induced*;Feeding and Eating Disorders/diet therapy;Food-Drug Interactions;Humans;Male;Risperidone/adverse effects*;Weight Gain/drug effects
9829163;Aged;Alzheimer Disease/drug therapy;Depression/drug therapy;Food-Drug Interactions;Humans;Monoamine Oxidase/physiology;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/classification;Monoamine Oxidase Inhibitors/pharmacology;Monoamine Oxidase Inhibitors/therapeutic use;Parkinson Disease/drug therapy;Tyramine/adverse effects
9833595;Adolescent;Adult;Biological Availability;Cross-Over Studies;Female;Food-Drug Interactions*;Humans;Male;Middle Aged;Oxazoles/adverse effects;Oxazoles/metabolism;Oxazoles/pharmacokinetics*;Oxazolidinones*;Serotonin Receptor Agonists/adverse effects;Serotonin Receptor Agonists/metabolism;Serotonin Receptor Agonists/pharmacokinetics*;Tryptamines
9845494;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics;Anti-HIV Agents/therapeutic use*;Biological Availability;Dose-Response Relationship, Drug;Drug Interactions;Drug Therapy, Combination;Food-Drug Interactions;HIV Infections/blood;HIV Infections/etiology;HIV Infections/prevention & control*;Health Personnel*;Humans;Occupational Exposure/adverse effects*;Patient Compliance
9875172;Beverages/adverse effects*;Citrus/adverse effects*;Complementary Therapies;Female;Food-Drug Interactions*;Humans;Middle Aged;Nifedipine/adverse effects*;Phytotherapy;United States;Vasodilator Agents/adverse effects*
9882026;Animals;Avitaminosis/chemically induced;Biological Availability;Digestive System/drug effects*;Dose-Response Relationship, Drug;Fat Substitutes/adverse effects*;Fat Substitutes/pharmacokinetics;Fatty Acids/adverse effects*;Fatty Acids/pharmacokinetics;Food-Drug Interactions;Humans;Sucrose/adverse effects;Sucrose/analogs & derivatives*;Sucrose/pharmacokinetics
9884817;Antifungal Agents/pharmacokinetics;Antifungal Agents/pharmacology;Antifungal Agents/therapeutic use*;Drug Interactions;Drug Monitoring/methods*;Food-Drug Interactions;Humans;Itraconazole/pharmacokinetics;Itraconazole/pharmacology;Itraconazole/therapeutic use*;Organ Specificity
9918208;Administration, Oral;Adult;Aged;Antimetabolites, Antineoplastic/administration & dosage*;Antimetabolites, Antineoplastic/adverse effects;Antimetabolites, Antineoplastic/pharmacokinetics;Biological Availability;Dose-Response Relationship, Drug;Drug Administration Schedule;Female;Food-Drug Interactions;Humans;Infusions, Intravenous;Male;Middle Aged;Neoplasms/drug therapy*;Neoplasms/metabolism;Quinazolines/administration & dosage*;Quinazolines/adverse effects;Quinazolines/pharmacokinetics
10048159;Alcohol Drinking/adverse effects*;Animals;Cytochrome P-450 CYP2E1/metabolism;Dietary Carbohydrates/administration & dosage*;Dietary Carbohydrates/metabolism;Dietary Fats/administration & dosage*;Dietary Fats/metabolism;Food-Drug Interactions;Hepatitis, Alcoholic/etiology;Hepatitis, Alcoholic/metabolism*;Hepatitis, Alcoholic/pathology;Male;Necrosis;Rats;Rats, Sprague-Dawley
6752254;Aged;Anemia, Hypochromic/chemically induced;Anemia, Hypochromic/drug therapy;Avitaminosis/chemically induced;Diet/adverse effects*;Drug Interactions;Drug Therapy*;Drug-Related Side Effects and Adverse Reactions;Humans;Kinetics;Nutritional Requirements;Vitamins/therapeutic use
10192596;Acute Disease;Bread/analysis;Cheese/analysis;Chromatography, High Pressure Liquid;Diet/adverse effects*;Food Analysis/statistics & numerical data;Food-Drug Interactions*;Humans;Hypertension/chemically induced;Monoamine Oxidase Inhibitors/adverse effects*;Soybeans/chemistry*;Tyramine/adverse effects*;Tyramine/analysis
10206085;Adolescent;Adult;Cross-Over Studies;Dietary Fats/pharmacology*;Fasting;Food-Drug Interactions/physiology*;Humans;Hypoglycemic Agents/blood*;Male;Thiazoles/adverse effects;Thiazoles/blood*;Thiazolidinediones*
10354963;Absorption;Adolescent;Adult;Anti-HIV Agents/adverse effects;Anti-HIV Agents/pharmacokinetics*;Area Under Curve;Cross-Over Studies;Eating;Fasting;Female;Food-Drug Interactions;Headache/chemically induced;Humans;Lamivudine/adverse effects;Lamivudine/pharmacokinetics*;Male;Metabolic Clearance Rate;Middle Aged;Nausea/chemically induced;Tablets;Therapeutic Equivalency;Zidovudine/adverse effects;Zidovudine/pharmacokinetics*
10391425;Diet, Protein-Restricted/adverse effects;Dietary Carbohydrates/administration & dosage;Dietary Fats/administration & dosage;Epilepsy/diet therapy*;Food-Drug Interactions;Humans;Ketosis*/etiology;Pharmaceutical Services*/standards;Starvation/complications;Starvation/physiopathology*
10423213;Anticoagulants/adverse effects*;Beverages*;Citrus*;Food-Drug Interactions;Humans;Male;Middle Aged;Warfarin/adverse effects*
10423596;Adult;Area Under Curve;Biological Availability;Butyrophenones/administration & dosage;Butyrophenones/adverse effects;Butyrophenones/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacology;Food-Drug Interactions;Half-Life;Histamine H1 Antagonists/administration & dosage;Histamine H1 Antagonists/adverse effects;Histamine H1 Antagonists/pharmacokinetics*;Humans;Male;Middle Aged;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Tablets
10431417;Cheese*;Female;Food-Drug Interactions*;Headache/chemically induced*;Humans;Hypertension/chemically induced*;Middle Aged;Monoamine Oxidase Inhibitors/adverse effects*;Tranylcypromine/adverse effects
10440622;Adolescent;Adult;Animals;Anti-Infective Agents/adverse effects;Anti-Infective Agents/pharmacokinetics*;Antitubercular Agents/adverse effects;Antitubercular Agents/pharmacokinetics*;Biological Availability;Cross-Over Studies;Dietary Fats/administration & dosage;Fluoroquinolones*;Food-Drug Interactions*;Humans;Male;Milk
10471981;Adult;Biological Availability;Cross-Over Studies;Fasting;Female;Food-Drug Interactions/physiology*;Humans;Indoles/adverse effects;Indoles/blood*;Male;Models, Statistical;Time Factors
10496300;Animals;Antimalarials/administration & dosage;Antimalarials/adverse effects;Antimalarials/pharmacokinetics;Antimalarials/pharmacology*;Artemisinins*;Clinical Trials as Topic;Drug Combinations;Drug Resistance, Microbial;Drug Resistance, Multiple;Ethanolamines/administration & dosage;Ethanolamines/adverse effects;Ethanolamines/pharmacokinetics*;Ethanolamines/pharmacology*;Fluorenes/administration & dosage;Fluorenes/adverse effects;Fluorenes/pharmacokinetics*;Fluorenes/pharmacology*;Food-Drug Interactions;Humans;Malaria/metabolism*;Plasmodium falciparum/physiology*;Sesquiterpenes/pharmacokinetics*
7560252;Adolescent;Adult;Antipsychotic Agents/administration & dosage;Antipsychotic Agents/adverse effects;Antipsychotic Agents/pharmacokinetics*;Biological Availability;Drug Tolerance;Food-Drug Interactions*;Half-Life;Humans;Intestinal Absorption;Isoxazoles/administration & dosage;Isoxazoles/adverse effects;Isoxazoles/pharmacokinetics*;Male;Metabolic Clearance Rate;Piperidines/administration & dosage;Piperidines/adverse effects;Piperidines/pharmacokinetics*;Time Factors
10507245;Acetylcholinesterase/blood*;Butyrylcholinesterase/blood*;Cholinesterase Inhibitors/administration & dosage;Cholinesterase Inhibitors/pharmacokinetics;Cholinesterase Inhibitors/pharmacology*;Cross-Over Studies;Fasting;Food*;Food-Drug Interactions/physiology*;Humans;Time Factors;Trichlorfon/administration & dosage;Trichlorfon/adverse effects;Trichlorfon/pharmacokinetics;Trichlorfon/pharmacology*
10583024;Absorption;Adolescent;Adult;Age Factors;Calcium Channel Blockers/administration & dosage*;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Etidronic Acid/administration & dosage;Etidronic Acid/adverse effects;Etidronic Acid/analogs & derivatives*;Etidronic Acid/pharmacokinetics;Fasting;Female;Food-Drug Interactions*;Humans;Male;Risedronate Sodium;Sex Factors;Time Factors
10594469;Adult;Aging;Antihypertensive Agents/administration & dosage*;Antihypertensive Agents/adverse effects;Antihypertensive Agents/pharmacokinetics*;Area Under Curve;Biological Availability;Cross-Over Studies;Delayed-Action Preparations;Digestive System/metabolism;Doxazosin/administration & dosage*;Doxazosin/adverse effects;Doxazosin/pharmacokinetics*;Female;Food-Drug Interactions;Half-Life;Humans;Male;Sex Characteristics;Therapeutic Equivalency
10610011;AIDS-Related Opportunistic Infections/metabolism;AIDS-Related Opportunistic Infections/prevention & control;Adult;Antifungal Agents/administration & dosage;Antifungal Agents/adverse effects*;Antifungal Agents/pharmacokinetics*;Atovaquone;Fasting;Female;Food-Drug Interactions;Humans;Male;Middle Aged;Naphthoquinones/administration & dosage;Naphthoquinones/adverse effects*;Naphthoquinones/pharmacokinetics*;Pneumonia, Pneumocystis/prevention & control;Trimethoprim, Sulfamethoxazole Drug Combination/pharmacokinetics
10718785;Administration, Oral;Adult;Biological Availability;Calcium Channel Blockers/adverse effects;Calcium Channel Blockers/pharmacokinetics*;Cross-Over Studies;Dietary Fats/pharmacology;Eating;Fasting;Food-Drug Interactions;Humans;Hydantoins;Imidazoles/adverse effects;Imidazoles/pharmacokinetics*;Imidazolidines*;Male;Piperazines/adverse effects;Piperazines/pharmacokinetics*
10721388;Benzodiazepines/adverse effects;Beverages/adverse effects*;Calcium Channel Blockers/adverse effects;Cisapride/adverse effects;Citrus/adverse effects*;Cyclosporine/adverse effects;Cytochrome P-450 Enzyme Inhibitors;Drug Prescriptions*;Food-Drug Interactions*;Herb-Drug Interactions;Humans;Terfenadine/adverse effects
10732665;Cheese/adverse effects*;Cheese/analysis;Diet*;Food/adverse effects*;Food-Drug Interactions*;Humans;Monoamine Oxidase Inhibitors/adverse effects*;Monoamine Oxidase Inhibitors/therapeutic use;Tyramine/adverse effects
10740993;Aged;Antidepressive Agents, Second-Generation/adverse effects*;Antidepressive Agents, Second-Generation/pharmacokinetics;Antidepressive Agents, Second-Generation/therapeutic use;Beverages*;Citrus*;Female;Fluoxetine/adverse effects*;Fluoxetine/pharmacokinetics;Fluoxetine/therapeutic use;Food-Drug Interactions*;Humans
10741622;Adult;Antihypertensive Agents/pharmacology;Beverages*;Blood Pressure/drug effects;Calcium Channel Blockers/pharmacology;Citrus*;Cytochrome P-450 CYP3A;Cytochrome P-450 Enzyme System/metabolism;Female;Food-Drug Interactions;Heart Rate/drug effects;Humans;Male;Mixed Function Oxygenases/metabolism;Nisoldipine/adverse effects;Nisoldipine/blood;Nisoldipine/pharmacokinetics;Nisoldipine/pharmacology*;Reference Values;Time Factors;Vasodilator Agents/pharmacology
10809344;Adult;Aged;Data Collection;Depression/drug therapy*;Drug Interactions;Female;Humans;Hypericum/therapeutic use*;Male;Mental Disorders/drug therapy*;Middle Aged;Phytotherapy*;Plants, Medicinal*;Retrospective Studies;Self Medication/adverse effects*
